<SEC-DOCUMENT>0001193125-25-293675.txt : 20251124
<SEC-HEADER>0001193125-25-293675.hdr.sgml : 20251124
<ACCEPTANCE-DATETIME>20251124160551
ACCESSION NUMBER:		0001193125-25-293675
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20251218
FILED AS OF DATE:		20251124
DATE AS OF CHANGE:		20251124

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALLURION TECHNOLOGIES, INC.
		CENTRAL INDEX KEY:			0001964979
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41767
		FILM NUMBER:		251512949

	BUSINESS ADDRESS:	
		STREET 1:		11 HURON DR STE 200
		CITY:			NATICK
		STATE:			MA
		ZIP:			01760
		BUSINESS PHONE:		508-647-4000

	MAIL ADDRESS:	
		STREET 1:		11 HURON DR STE 200
		CITY:			NATICK
		STATE:			MA
		ZIP:			01760

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALLURION TECHNOLOGIES HOLDINGS, INC.
		DATE OF NAME CHANGE:	20230207
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d923025ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:alur="http://www.allurion.com/20241231" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>DEF 14A</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="line-height:normal;background-color:white;">
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>
<div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:DocumentType" id="hidden150173850" contextRef="P01_01_2024To12_31_2024">DEF 14A</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P01_01_2024To12_31_2024" id="ixv-7425">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P01_01_2024To12_31_2024" id="ixv-7426">0001964979</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="alur-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="P01_01_2024To12_31_2024"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001964979</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context></ix:resources></ix:header></div><div><div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549 </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center"><div style="-sec-ix-hidden:hidden150173850;display:inline;">SCHEDULE 14A</div> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Proxy Statement Pursuant to Section&#160;14(a) of </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">the Securities Exchange Act of 1934 </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Amendment No.&#8195;) </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the Registrant&#8194;&#9746; </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other than the Registrant&#8194;&#9744; </div><div style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><div style="display:inline;">&#9744;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><div style="display:inline;">Preliminary Proxy Statement </div></div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div>&#9744;<div style="letter-spacing: 0px; top: 0px;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;display:inline;"></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; font-weight: bold; text-align: left; line-height: normal;">Confidential, for Use of the Commission Only (as permitted by Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">14a-6(e)(2))</div> </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><div style="display:inline;">&#9746;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><div style="display:inline;">Definitive Proxy St<div style="display:inline;">ate</div>ment </div></div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Definitive Additional Materials </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Soliciting Material Pursuant to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">&#167;240.14a-12</div> </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P01_01_2024To12_31_2024" id="ixv-7436">Allurion Technologies, Inc.</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Name of Registrant as Specified In Its Charter) </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check all boxes that apply): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9746;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">No fee required </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Fee paid previously with preliminary materials </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">14a-6(i)(1)</div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">0-11</div> </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/></div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div> </div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ALLURION TECHNOLOGIES, INC. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">11 HURON DRIVE </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NATICK, MASSACHUSETTS 01760 </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November 24, 2025 </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Fellow Stockholders: </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of the Board of Directors and management of Allurion Technologies, Inc., I cordially invite you to attend our annual meeting of stockholders on December 18, 2025 at 12:00&#160;p.m. Eastern Time. The 2025 Annual Meeting will be a completely virtual meeting of stockholders conducted via live audio webcast. You will be able to attend the meeting, vote your shares electronically, and submit your questions during the meeting by visiting <span style="font-style:italic">www.virtualshareholdermeeting.com/ALUR2025</span>. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given the virtual format, there is no opportunity to attend the 2025 Annual Meeting in person. To participate, you must have the <span style="white-space:nowrap">16-digit</span> number that is shown on your proxy card or the instructions that accompanied your proxy materials. The notice of meeting and proxy statement that follow describe the business that stockholders will consider at the 2025 Annual Meeting. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hope that you will be able to attend the 2025 Annual Meeting via our live audio webcast. However, regardless of whether you attend, your vote is very important. We are pleased to offer multiple options for voting your shares. You may vote by telephone, via the Internet, by mail, or during our live audio webcast of the 2025 Annual Meeting, as described beginning on page&#160;6 of the Proxy Statement. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thank you for your continued support of Allurion Technologies, Inc. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </p> <div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Shantanu Gaur </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Shantanu Gaur </p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc">TABLE OF CONTENTS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:95%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Page</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_1">Proxy Statement</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_2">Questions and Answers About the 2025 Annual Meeting of Stockholders</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proposals To Be Voted On</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_4">Proposal 1: Director Election Proposal</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_5">Proposal 2: Auditor Ratification Proposal</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">16</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_6">Proposal 3: Plan Amendment Proposal</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">18</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_7">Proposal 4: Option Repricing Proposal</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">28</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_9">Proposal 5: Preferred Shares Issuance Proposal</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">33</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_10">Proposal 6: Private Placement Warrant Shares Issuance Proposal</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">41</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_11">Proposal 7: Reverse Stock Split Proposal</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">44</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_12">Proposal 8: Adjournment Proposal</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">54</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_13">Corporate Governance</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">55</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_14">Committees of the Board</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">61</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_15">Report of the Audit Committee of the Board</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">64</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_16">Executive and Director Compensation</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">65</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_17">Security Ownership of Certain Beneficial Owners and Management</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">72</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_18">Certain Relationships and Related Person Transactions</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">74</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc923025_19">Additional Information</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">82</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> </div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">i </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g923025g00n04.jpg" alt="LOGO" style="width:2.99917in;height:0.637756in"/>
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ALLURION TECHNOLOGIES, INC. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">11 Huron Drive </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Natick, Massachusetts 01760 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </p> <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">TO BE HELD DECEMBER&#160;18, 2025 </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Stockholders: </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) of Allurion Technologies, Inc., a Delaware corporation (the &#8220;Company&#8221;), will be held at 12:00 p.m. Eastern Time on December&#160;18, 2025. The Annual Meeting will be a completely virtual meeting conducted via live audio webcast. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You will be able to attend the Annual Meeting online and submit your questions during the meeting by visiting <span style="font-style:italic">www.virtualshareholdermeeting.com/ALUR2025</span> and entering your <span style="white-space:nowrap">16-digit</span> control number included on your proxy card or in the instructions that accompanied your proxy materials. You will not be able to attend the Annual Meeting in person. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Annual Meeting will be held for the following purposes: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Proposal 1: To elect three Class&#160;II Directors named in the Proxy Statement to serve until the Company&#8217;s 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified or until their earlier death, resignation or removal; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Proposal 2: To ratify the appointment of Deloitte&#160;&amp; Touche LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2025; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Proposal 3: To approve an amendment and restatement of the Allurion Technologies, Inc. 2023 Stock Option and Incentive Plan (the &#8220;2023 Plan&#8221; and as amended and restated, the &#8220;Amended and Restated Plan&#8221;) to (i)&#160;increase the number of shares of common stock, par value $0.0001 per share (the &#8220;common stock&#8221;), of the Company authorized for issuance thereunder (with a corresponding increase to the number of shares of common stock that may be issued in respect of incentive stock options), (ii)&#160;amend the definition of Fully-Diluted Shares Outstanding, (iii)&#160;lower the <span style="white-space:nowrap">non-employee</span> director compensation limit, and (iv)&#160;extend the term of the plan, in each case, as described in such Proposal 3; </p></td></tr></table> </div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Proposal 4: To approve the repricing of certain outstanding stock options that have been granted under the 2023 Plan; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Proposal 5: To approve the issuance of shares of common stock upon the conversion of the Company&#8217;s Series B convertible preferred stock, par value $0.0001 per share, in accordance with NYSE Listing Rule 312.03(b)(i), 312.03(c) and 312.03(d); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Proposal 6: To approve the issuance of shares of common stock upon the exercise of certain private placement warrants for purposes of complying with NYSE Listing Rule 312.03(c); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Proposal 7: To approve an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation, as amended, to combine the outstanding shares of common stock into a lesser number of outstanding shares, by a ratio of not less than <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-1.5</span></span> and not more than <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-20,</span></span> with the exact ratio to be set within this range by the Board of Directors of the Company (the &#8220;Board&#8221;) in its sole discretion; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Proposal 8: To approve an adjournment of the Annual Meeting, if necessary, to permit further solicitation and vote of proxies if there are insufficient votes in favor of Proposals 3, 4, 5, 6 and 7. </p></td></tr></table></div>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div> <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board knows of no other matters to be presented at the Annual Meeting. Only stockholders of record of our common stock as of the close of business on October 31, 2025, the record date, are entitled to notice of and to vote at the Annual Meeting, or any postponement or adjournment thereof. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Whether or not you plan to attend the Annual Meeting online, we urge you to vote your shares via the toll-free telephone number or over the Internet, as described in the enclosed materials. You may also complete the proxy card included in the proxy materials and return your signed and dated proxy card in the enclosed return envelope. Please note, however, that if your shares are held on your behalf by a brokerage firm, bank or other nominee, and you wish to vote at the Annual Meeting, you must obtain a proxy issued in your name from that nominee. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">It is important that your shares be represented at the Annual Meeting regardless of the number of shares you may hold. Please consider the issues presented in the proxy statement for the Annual Meeting and promptly vote your shares to ensure that your shares are represented at the Annual Meeting. Submitting your proxy now will not prevent you from voting your shares at the Annual Meeting if you desire to do so, as your proxy is revocable at your option. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> (as amended) for the fiscal year ended December&#160;31, 2024 accompanies this Notice of Annual Meeting and the attached Proxy Statement. These materials are available at <span style="font-style:italic">www.virtualshareholdermeeting.com/ALUR2025.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you have any questions about submitting your proxy or require assistance, please contact Innisfree M&amp;A Incorporated, our proxy solicitor, toll-free at (877) <span style="white-space:nowrap">800-5192</span> or collect at (212) <span style="white-space:nowrap">750-5833.</span> Innisfree&#8217;s address is 501 Madison Avenue, 20th Floor, New York, New York 10022. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">By Order of the Board of Directors, </span></p> <div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Brendan M. Gibbons </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brendan M. Gibbons </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Legal and People Officer and Secretary </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Natick, Massachusetts </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November&#160;24, 2025 </p></div>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g923025g00n04.jpg" alt="LOGO" style="width:2.99917in;height:0.637756in"/>
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ALLURION TECHNOLOGIES, INC. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">11 Huron Drive </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Natick, Massachusetts 01760 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_1">PROXY STATEMENT </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">FOR THE </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">2025 ANNUAL MEETING OF STOCKHOLDERS </p> <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">TO BE HELD ON DECEMBER&#160;18, 2025 </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This proxy statement (the &#8220;Proxy Statement&#8221;) is being furnished in connection with the solicitation by the Board of Directors (the &#8220;Board&#8221; or &#8220;Board of Directors&#8221;) of Allurion Technologies, Inc. (&#8220;Allurion&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;) of proxies to be voted at our Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) to be held on December 18, 2025, at 12:00 p.m. Eastern Time, and at any postponement or adjournment of the Annual Meeting. The Annual Meeting will be a completely virtual meeting conducted via live audio webcast. You will be able to attend the Annual Meeting online and submit your questions during the meeting by visiting <span style="font-style:italic">www.virtualshareholdermeeting.com/ALUR2025 </span>and entering your <span style="white-space:nowrap">16-digit</span> control number included on your proxy card or in the instructions that accompanied your proxy materials. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is expected that the Notice of Meeting, this Proxy Statement and the accompanying proxy card, and our Annual Report on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ended December&#160;31, 2024, as amended (the &#8220;2024 Annual Report&#8221;), will be mailed on or about November 24, 2025 to our stockholders as of the close of business on the Record Date (as defined below). </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Record Date and Outstanding Shares </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of record of shares of our common stock, $0.0001 par value per share (the &#8220;common stock&#8221;), as of the close of business on October 31, 2025 (the &#8220;Record Date&#8221;), will be entitled to notice of and to vote at the Annual Meeting and any postponement or adjournment thereof. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the Record Date, there were 7,770,047 shares of common stock outstanding and entitled to vote at the Annual Meeting. Each share of common stock is entitled to one vote on any matter presented to stockholders at the Annual Meeting. The shares of common stock are our only voting securities. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Proposals </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, our stockholders will be asked: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">1.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To elect Dr.&#160;Omar Ishrak, R. Jason Richey and Douglas Hudson as Class&#160;II Directors to serve until our 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified or until their earlier death, resignation or removal (the &#8220;Director Election Proposal&#8221; or &#8220;Proposal 1&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">2.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To ratify the appointment of Deloitte&#160;&amp; Touche LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2025 (the &#8220;Auditor Ratification Proposal&#8221; or &#8220;Proposal&#160;2&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">3.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve an amendment and restatement of the Allurion Technologies, Inc. 2023 Stock Option and Incentive Plan (the &#8220;2023 Plan&#8221;, and as amended and restated, the &#8220;Amended and Restated Plan&#8221;) to (i)&#160;increase the number of shares of common stock authorized for issuance thereunder (with a </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top;text-align:left">
corresponding increase to the number of shares of common stock that may be issued in respect of incentive stock options), (ii) amend the definition of Fully-Diluted Shares Outstanding, (iii)&#160;lower the <span style="white-space:nowrap">non-employee</span> director compensation limit, and (iv)&#160;extend the term of the plan, in each case, as described in such Proposal 3 (the &#8220;Plan Amendment Proposal&#8221; or &#8220;Proposal 3&#8221;); </td></tr></table> </div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">4.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve the repricing of certain outstanding stock options that have been granted under the 2023 Plan (the &#8220;Option Repricing Proposal&#8221; or &#8220;Proposal 4&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">5.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve the issuance of shares of common stock upon the conversion of our Series B convertible preferred stock, par value $0.0001 per share (&#8220;Series B Preferred Stock&#8221;), in accordance with NYSE Listing Rule 312.03(b)(i), 312.03(c) and 312.03(d) (the &#8220;Preferred Shares Issuance Proposal&#8221; or &#8220;Proposal 5&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">6.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve the issuance of shares of common stock upon the exercise of the Private Placement Warrants (as defined below) for purposes of complying with NYSE Listing Rule 312.03(c) (the &#8220;Private Placement Warrant Shares Issuance Proposal&#8221; or &#8220;Proposal 6&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">7.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended (the &#8220;Charter&#8221;), to combine the outstanding shares of common stock into a lesser number of outstanding shares, by a ratio of not less than <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-1.5</span></span> and not more than <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-20,</span></span> with the exact ratio to be set within this range by the Board in its sole discretion (the &#8220;Reverse Stock Split Proposal&#8221; or &#8220;Proposal&#160;7&#8221;); and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">8.</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To approve an adjournment of the Annual Meeting, if necessary, to permit further solicitation and vote of proxies if there are insufficient votes in favor of Proposals 3, 4, 5, 6 and 7 (the &#8220;Adjournment Proposal&#8221; or &#8220;Proposal 8&#8221;). </p></td></tr></table> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Recommendations of the Board and Proxies </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board recommends that you vote your shares as indicated below: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="text-decoration:underline">FOR</span></span> the election of Dr.&#160;Omar Ishrak, Jason Richey and Douglas Hudson as Class&#160;II Directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="text-decoration:underline">FOR</span></span> the Auditor Ratification Proposal; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="text-decoration:underline">FOR</span></span><span style="font-weight:bold"> </span>the Plan Amendment Proposal; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="text-decoration:underline">FOR</span></span><span style="font-weight:bold"> </span>the Option Repricing Proposal; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div> </div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="text-decoration:underline">FOR</span></span> the Preferred Shares Issuance Proposal; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="text-decoration:underline">FOR</span></span> the Private Placement Warrant Shares Issuance Proposal; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="text-decoration:underline">FOR</span></span> the Reverse Stock Split Proposal; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="text-decoration:underline">FOR</span></span> the Adjournment Proposal, if necessary. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you return a properly completed proxy card, or vote your shares by telephone or Internet, your shares of common stock will be voted on your behalf as you direct. If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted in accordance with the recommendations of the Board set forth above. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any stockholder may revoke a proxy at any time prior to the Annual Meeting by signing and submitting a later-dated proxy or a written notice of revocation to our Secretary, or by granting a subsequent proxy through the Internet or telephone. Stockholders attending the Annual Meeting may also revoke their proxies by voting online at the Annual Meeting. Attendance at the Annual Meeting will not itself be deemed to revoke a proxy unless a stockholder gives affirmative notice at the Annual Meeting that such stockholder intends to revoke the proxy and vote online. If a stockholder&#8217;s shares are held in street name, such holder may change or revoke voting </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
instructions by following the specific directions provided by the stockholder&#8217;s bank or broker. See &#8220;<span style="font-style:italic">Can I change my vote after I submit my proxy?</span>&#8221; below. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Quorum and Adjournment; Abstentions, Votes Withheld and Broker <span style="white-space:nowrap">Non-Votes</span> </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The presence by remote communication (i.e., online) or by proxy of the holders of a majority in voting power of the shares of common stock issued and outstanding on the Record Date and entitled to vote is required to constitute a quorum at the Annual Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The stockholders that are present online or represented by proxy at the Annual Meeting may adjourn the meeting from time to time for any reason, regardless of whether a quorum is present. If the Annual Meeting is adjourned to another time, date or place (including an adjournment taken to address a technical failure to convene or continue a meeting using remote communication), notice is not required to be given of the adjourned meeting if the time, place (if any), and the means of remote communication by which stockholders and proxy holders may attend and participate at such adjourned meeting are announced at the Annual Meeting, displayed on the same electronic network used to enable stockholders and proxy holders to participate in the meeting by means of remote communication during the time scheduled for the Annual Meeting, or as set forth in the Notice of Annual Meeting. However, if the adjournment is for more than 30 days from the original meeting date, or if after the adjournment a new record date is fixed for the adjourned meeting, notice of the adjourned meeting and the means of remote communication, if any, will be given to each stockholder of record entitled to vote and each stockholder who, by law or under our organizational documents, is entitled to such notice. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any adjourned Annual Meeting at which a quorum is present, any business may be transacted that might have been transacted at the Annual Meeting as originally scheduled. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abstentions, votes withheld and broker <span style="white-space:nowrap">non-votes</span> will count in determining whether a quorum is present at the Annual Meeting and any adjourned meeting. A broker <span style="white-space:nowrap">non-vote</span> occurs if the broker or other nominee who holds shares represented by a proxy has not received instructions with respect to a particular proposal and does not have discretionary authority with respect to such proposal. Under the rules that govern brokers who are voting shares held in street name, brokers have the discretion to vote those shares on routine matters but not on <span style="white-space:nowrap">non-routine</span> matters. Proposals 3, 4, 5, 6, 7 and 8 are considered to be <span style="white-space:nowrap">&#8220;non-routine&#8221;</span> under these rules, such that your broker may not vote your shares on those proposals in the absence of your voting instructions. Conversely, Proposals 1 and 2 are considered to be a &#8220;routine&#8221; matter under these rules and thus if you do not return voting instructions to your broker by its deadline, your shares may be voted by your broker in its discretion on Proposals&#160;1 and 2. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The votes required, and the treatment of abstentions, votes withheld and broker <span style="white-space:nowrap">non-votes,</span> for each matter to be voted on at the Annual Meeting are set forth in &#8220;<span style="font-style:italic">How many votes are required for the approval of the proposals to be voted upon and how will votes withheld, abstentions and broker <span style="white-space:nowrap">non-votes</span> be treated?</span>&#8221; below. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other Matters </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We know of no other business that will be presented at the Annual Meeting. If any other matter properly comes before the stockholders for a vote at the Annual Meeting, the proxy holders named on our proxy card will vote your shares in accordance with their best judgment and consistent with applicable law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of our directors or executive officers since the beginning of the last fiscal year, or nominees for director, nor any associate of any of the foregoing, has any substantial interest, direct or indirect, by security holdings or otherwise, in any matter to be acted upon at the Annual Meeting, except as described below. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our named executive officers hold Eligible Options (as defined below) that would potentially benefit from the Option Repricing (as defined below), in each case subject to the terms and conditions described </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
below under &#8220;<span style="font-style:italic">Specifics of the Option Repricing</span>&#8221; in Proposal 4. The following table sets forth, with respect to the named executive officers therein, the number of shares subject to Eligible Options held by such named executive officer and the weighted average exercise price of the Eligible Options, in each case, as of the Record Date. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:76%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name and Position</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Number<br/>of<br/>Shares<br/>Subject<br/>to<br/>Eligible<br/>Options</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Weighted<br/>Average<br/>Exercise<br/>Price of<br/>Eligible<br/>Options</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Named Executive Officers</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shantanu Gaur, M.D., <span style="font-style:italic">Chief Executive Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">57,144</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">57.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brendan Gibbons, <span style="font-style:italic">Chief Legal and People Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10,153</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">74.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ojas Buch, <span style="font-style:italic">Chief Operating Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,271</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">35.75</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> </div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_2">QUESTIONS AND ANSWERS ABOUT THE 2025 ANNUAL MEETING OF STOCKHOLDERS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Why am I receiving this Proxy Statement? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You have received these proxy materials because our Board is soliciting your proxy to vote your shares at the Annual Meeting. This Proxy Statement includes information that we are required to provide to you under the rules of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and is designed to assist you in voting your shares. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Who is entitled to vote at the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Record Date for the Annual Meeting is October 31, 2025. You are only entitled to vote at the Annual Meeting if you were a stockholder of record at the close of business on the Record Date, or if you hold a valid proxy for the Annual Meeting. Each outstanding share of common stock is entitled to one vote for all matters before the Annual Meeting. At the close of business on the Record Date, there were 7,770,047 shares of common stock outstanding and entitled to vote at the Annual Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A list of our stockholders of record will be open for examination by any stockholder beginning ten days prior to the Annual Meeting at our headquarters located at 11 Huron Drive, Natick, MA 01760. If you would like to view the list, please contact our Corporate Secretary to schedule an appointment by&#160;emailing&#160;secretary@allurion.com or writing to such officer at the address above. In addition, the list will be available for inspection by stockholders on the virtual meeting website during the Annual Meeting. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What is the difference between being a &#8220;record holder&#8221; and holding shares in &#8220;street name&#8221;? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A record holder holds shares in such holder&#8217;s name. Shares held in &#8220;street name&#8221; are held in the name of a bank or brokerage firm on a person&#8217;s behalf. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Am I entitled to vote if my shares are held in &#8220;street name&#8221;? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Yes. If your shares are held by a bank or a brokerage firm, you are considered the &#8220;beneficial owner&#8221; of those shares held in &#8220;street name.&#8221; If your shares are held in street name, these proxy materials are being provided to you by your bank or brokerage firm, along with a voting instruction card included with the printed copies of our proxy materials. As the beneficial owner, you have the right to direct your bank or brokerage firm on how to vote your shares, and the bank or brokerage firm is required to vote your shares in accordance with your instructions. You are also invited to attend the Annual Meeting via the internet at&#160;<span style="font-style:italic">www.virtualshareholdermeeting.com/ALUR2025</span>. However, because you are not the stockholder of record, you may not vote your shares live online at the Annual Meeting unless you request and obtain a valid proxy from your broker or other agent. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How many shares must be present to hold the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A quorum must be present at the Annual Meeting for any business to be conducted. The presence at the Annual Meeting online or by proxy of the holders of a majority in voting power of the issued and outstanding shares of our common stock entitled to vote on the Record Date will constitute a quorum for the Annual Meeting. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Who can attend the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a stockholder of record or a beneficial owner as of the Record Date, you may attend and participate in the Annual Meeting by visiting the following website:&#160;<span style="font-style:italic">www.virtualshareholdermeeting.com/ALUR2025</span>. To attend and participate in the Annual Meeting, you will need the <span style="white-space:nowrap">16-digit</span> control number included on your proxy card or on the instructions that accompanied your proxy materials. If your shares are held in &#8220;street name,&#8221; you should contact your bank or broker to obtain your <span style="white-space:nowrap">16-digit</span> control number or otherwise vote through the bank or </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
broker. If you lose your <span style="white-space:nowrap">16-digit</span> control number, you may join the Annual Meeting as a &#8220;Guest&#8221; but you will not be able to vote, ask questions or access the list of stockholders as of the Record Date. The meeting webcast will begin promptly at 12:00 p.m. Eastern Time. We encourage you to access the meeting prior to the start time. Online <span style="white-space:nowrap">check-in</span> will begin at 11:45 a.m. Eastern Time, and you should allow ample time for the <span style="white-space:nowrap">check-in</span> procedures. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What if a quorum is not present at the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a quorum is not present at the scheduled time of the Annual Meeting, the Chairperson of the Annual Meeting is authorized by our Amended and Restated Bylaws (our &#8220;Bylaws&#8221;) to adjourn the meeting, without the vote of stockholders. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What does it mean if I receive more than one set of proxy materials? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It means that your shares are held in more than one account at the transfer agent and/or with banks or brokers. Please vote all of your shares. To ensure that all of your shares are voted, for each set of proxy materials, please submit your proxy by phone, via the Internet, or by signing, dating and returning the proxy card provided in the enclosed envelope. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How do I vote? </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stockholders of Record. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a stockholder of record, you may vote: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">By Internet before the Annual Meeting - You can vote over the Internet at <span style="font-style:italic">www.proxyvote.com</span> by following the instructions on the proxy card. You will need the 16-digit control number included on your proxy card. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">By Telephone - You can vote by telephone by calling <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">1-800-690-6903</span></span></span> and following the instructions on the proxy card. You will need the 16-digit control number included on your proxy card. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">By Mail - You can vote by mail by signing, dating and mailing your proxy card, which you received by mail. Proxy cards submitted by mail must be received no later than December&#160;17, 2025 to be voted at the Annual Meeting. </p></td></tr></table> </div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">During the Annual Meeting - If you attend the Annual Meeting online and wish to vote electronically during the meeting at<span style="font-style:italic"> www.virtualshareholdermeeting.com/ALUR2025</span>, you will need the <span style="white-space:nowrap">16-digit</span> control number included on your proxy card or on the instructions that accompanied your proxy materials. </p></td></tr></table> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Internet and telephone voting facilities for stockholders of record will be made available 24 hours a day and will close at 11:59 p.m., Eastern Time, on December&#160;17, 2025. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whether or not you expect to attend the Annual Meeting online, we urge you to vote your shares as promptly as possible to ensure your representation. If you submit your proxy, you may still decide to attend the Annual Meeting and vote your shares electronically. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Beneficial Owners of Shares Held in &#8220;Street Name.&#8221; </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are held in &#8220;street name&#8221; through a bank or brokerage firm, you will receive instructions on how to vote from the bank or broker. You must follow the bank&#8217;s or broker&#8217;s instructions in order for your shares to be voted. Internet and telephone voting also may be offered to stockholders owning shares through certain banks and brokers. If your shares are not registered in your own name and you would like to vote your shares online at the Annual Meeting, you should contact your bank or broker to obtain your <span style="white-space:nowrap">16-digit</span> control number or </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
otherwise vote through the bank or broker. If you lose your <span style="white-space:nowrap">16-digit</span> control number, you may join the Annual Meeting as a &#8220;Guest,&#8221; but you will not be able to vote, ask questions or access the list of stockholders as of the Record Date. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Can I change my vote after I submit my proxy? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Yes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a registered stockholder, you may revoke your proxy and change your vote: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">by submitting a duly executed proxy bearing a later date; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">by granting a subsequent proxy through the Internet or telephone; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">by giving written notice of revocation to our Secretary prior to or at the Annual Meeting; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">by voting online at the Annual Meeting. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your most recent proxy card or Internet or telephone proxy is the vote that is counted. Your attendance at the Annual Meeting by itself will not revoke your proxy unless you give written notice of revocation to the Secretary before your proxy is voted or you vote online at the Annual Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are held in street name, you may change or revoke your voting instructions by following the specific directions provided to you by your bank or broker, or you may vote online at the Annual Meeting using your <span style="white-space:nowrap">16-digit</span> control number or otherwise voting through your bank or broker. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Who will count the votes? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A representative of Broadridge Financial Solutions, Inc., our inspector of election, will tabulate and certify the votes. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What if I do not specify how my shares are to be voted? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you submit a proxy but do not indicate any voting instructions, the persons named as proxies will vote in accordance with the recommendations of the Board. The Board&#8217;s recommendations are indicated on page 2 of this Proxy Statement, as well as with the description of each proposal in this Proxy Statement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Will any other business be conducted at the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We know of no other business that will be presented at the Annual Meeting. If any other matter properly comes before the stockholders for a vote at the Annual Meeting, the proxy holders named on our proxy card will vote your shares in accordance with their best judgment and consistent with applicable law. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What if I have technical difficulties or trouble accessing the virtual meeting website? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will have technicians ready to assist you with any technical difficulties you may have accessing the virtual meeting website, and the information for assistance will be located on&#160;<span style="font-style:italic">www.virtualshareholdermeeting.com/ALUR2025</span>. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How many votes are required for the approval of the proposals to be voted upon and how will votes withheld, abstentions and broker <span style="white-space:nowrap">non-votes</span> be treated? </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:35%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:32%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:31%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Proposal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Votes Required</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Effect of Votes Withheld, Abstentions</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">and Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Proposal&#160;1</span>:</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Director Election Proposal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The plurality of the votes properly cast. The three nominees receiving the highest number of affirmative &#8220;FOR&#8221; votes will be elected as Class&#160;II Directors.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Votes withheld and broker <span style="white-space:nowrap">non-votes</span> will have no effect.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Proposal&#160;2</span>:</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Auditor Ratification Proposal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The affirmative vote of the holders of a majority of the votes properly cast.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Abstentions and broker <span style="white-space:nowrap">non-votes</span> will have no effect.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Proposal 3</span>:</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Plan Amendment Proposal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The affirmative vote of the holders of a majority of the votes properly cast.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Abstentions and broker <span style="white-space:nowrap">non-votes</span> will have no effect.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Proposal 4</span>:</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Option Repricing Proposal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The affirmative vote of the holders of a majority of the votes properly cast.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Abstentions and broker <span style="white-space:nowrap">non-votes</span> will have no effect.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Proposal 5</span>:</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Preferred Shares Issuance Proposal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The affirmative vote of the holders of a majority of the votes properly cast.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Abstentions and broker <span style="white-space:nowrap">non-votes</span> will have no effect.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Proposal 6</span>:</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Private Placement Warrant Shares Issuance Proposal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The affirmative vote of the holders of a majority of the votes properly cast.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Abstentions and broker <span style="white-space:nowrap">non-votes</span> will have no effect.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Proposal 7</span>:</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Reverse Stock Split</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The affirmative vote of the holders of a majority of the votes properly cast.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Abstentions and broker <span style="white-space:nowrap">non-votes</span> will have no effect.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Proposal 8</span>:</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Adjournment Proposal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The affirmative vote of the holders of a majority of the votes properly cast.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Abstentions and broker <span style="white-space:nowrap">non-votes</span> will have no effect.</td></tr>
</table> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What is a &#8220;vote withheld&#8221; and an &#8220;abstention&#8221; and how will votes withheld and abstentions be treated? </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A &#8220;vote withheld,&#8221; in the case of Proposal 1, or an &#8220;abstention,&#8221; in the case of Proposals 2, 3, 4, 5, 6, 7 or 8, represents a stockholder&#8217;s affirmative choice to decline to vote on a proposal. Votes withheld and abstentions are counted as present and entitled to vote for purposes of determining a quorum. Votes withheld have no effect on Proposal 1. Abstentions have no effect on Proposals 2, 3, 4, 5, 6, 7 and 8. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What are broker <span style="white-space:nowrap">non-votes</span> and do they count for determining a quorum? </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, broker <span style="white-space:nowrap">non-votes</span> occur when shares held by a broker in &#8220;street name&#8221; for a beneficial owner are not voted with respect to a particular proposal because the broker (i)&#160;has not received voting instructions from the beneficial owner and (ii)&#160;lacks discretionary voting power to vote those shares. Proposals 3, 4, 5, 6, 7 and 8 are considered to be <span style="white-space:nowrap">&#8220;non-routine&#8221;</span> under these rules, such that your broker may not vote your shares on those proposals in the absence of your voting instructions. Conversely, Proposals 1 and 2 are considered to be &#8220;routine&#8221; matters under these rules and thus if you do not return voting instructions to your broker by its deadline, your shares may be voted by your broker in its discretion on Proposals 1 and 2. Broker <span style="white-space:nowrap">non-votes</span> count for purposes of determining whether a quorum is present. </p> </div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Where can I find the voting results of the Annual Meeting? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We plan to announce preliminary voting results at the Annual Meeting and we will report the final results in a Current Report on Form <span style="white-space:nowrap">8-K,</span> which we intend to file with the SEC after the Annual Meeting. After the Form <span style="white-space:nowrap">8-K</span> is filed, you may obtain a copy by visiting the investor relations section of our website at <span style="font-style:italic">investors.allurion.com</span> or by writing to Allurion Technologies, Inc., 11 Huron Drive, Natick, MA 01760, Attention: Corporate Secretary. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">How and when did Allurion Technologies, Inc. become a public company? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&#160;9, 2023, Legacy Allurion (as defined below) and Allurion entered into the Business Combination Agreement (as subsequently amended on May&#160;2, 2023, the &#8220;Business Combination Agreement&#8221;) with Compute Health Acquisition Corp. (&#8220;CPUH&#8221; or &#8220;Compute Health&#8221;), Compute Health Corp. (&#8220;Merger Sub I&#8221;) and Compute Health LLC (&#8220;Merger Sub II&#8221; and, together with Merger Sub I, the &#8220;Merger Subs&#8221;). Pursuant to the Business Combination Agreement, on August&#160;1, 2023, the Mergers (as defined below) were consummated in three steps: (a)&#160;Compute Health merged with and into Allurion (the &#8220;CPUH Merger&#8221;), with Allurion surviving the CPUH Merger as a publicly listed entity and becoming the sole owner of the Merger Subs; (b)&#160;three hours following the consummation of the CPUH Merger, Merger Sub I merged with and into Legacy Allurion (the &#8220;Intermediate Merger&#8221;), with Legacy Allurion surviving the Intermediate Merger and becoming a direct, wholly-owned subsidiary of Allurion; and (c)&#160;thereafter, Legacy Allurion merged with and into Merger Sub II (the &#8220;Final Merger&#8221; and, collectively with the CPUH Merger and the Intermediate Merger, the &#8220;Mergers&#8221;, and together with all other transactions contemplated by the Business Combination Agreement, the &#8220;Business Combination&#8221;), with Merger Sub II surviving the Final Merger and remaining a direct, wholly-owned subsidiary of Allurion. Allurion&#8217;s common stock began trading on the NYSE under the ticker symbol &#8220;ALUR&#8221; on August&#160;2, 2023. Upon completion of the Business Combination, Legacy Allurion&#8217;s business operations continued as our business operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">What is &#8220;Legacy Allurion&#8221;? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">References in the Proxy Statement to Legacy Allurion refer to Allurion Technologies, LLC (f/k/a Allurion Technologies Opco, Inc., f/k/a Allurion Technologies, Inc.) prior to the closing of the Business Combination. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Who can provide me with additional information and help answer my questions? </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you would like additional copies, without charge, of this Proxy Statement or if you have questions about the proposals being considered at the Annual Meeting, including the procedures for voting your shares, you should contact Innisfree toll-free at (877) <span style="white-space:nowrap">800-5192</span> or collect at (212) <span style="white-space:nowrap">750-5833.</span> Innisfree&#8217;s address is 501&#160;Madison Avenue, 20th Floor, New York, New York 10022. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_4">PROPOSAL 1: CLASS&#160;II DIRECTOR ELECTION PROPOSAL </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, three Class&#160;II Directors are to be elected to hold office until our annual meeting of stockholders to be held in 2028 and until each such director&#8217;s respective successor is elected and qualified or until each such director&#8217;s earlier death, resignation or removal. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently have eight directors on our Board of Directors. As set forth in our Charter, the Board of Directors is divided into three classes with staggered, three-year terms. At each annual meeting of stockholders, directors who are elected to succeed those directors whose terms then expire will be elected to serve from the time of election and qualification until the third annual meeting following election. The current class structure is as follows: Class&#160;I, whose current term expires at the 2027 Annual Meeting; Class&#160;II, whose current term expires at the Annual Meeting and, if elected at the Annual Meeting, whose subsequent term will expire at the 2028 annual meeting of stockholders; and Class&#160;III, whose current term will expire at the 2026 annual meeting of stockholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our current Class&#160;I Directors are Dr.&#160;Shantanu Gaur, Krishna Gupta and Nicholas Lewin. Our current Class&#160;II Directors are Dr.&#160;Omar Ishrak, R. Jason Richey and Douglas Hudson, each of whom has been nominated by the Board of Directors for election as Class&#160;II Directors at the Annual Meeting. Our current Class&#160;III Directors are Michael Davin and Keith B. Johns II. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to that certain Investor Rights and <span style="white-space:nowrap">Lock-Up</span> Agreement, dated August&#160;1, 2023 (the &#8220;Investor Rights Agreement&#8221;), by and among us and certain of our stockholders (the &#8220;Investors&#8221;), the following persons have the following nomination rights with respect to our Board of Directors, subject to the limitations set forth in the Investor Rights Agreement: </p> </div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(i)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">one director and one independent director nominated by Dr.&#160;Shantanu Gaur, which are currently Dr.&#160;Gaur and Michael Davin; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(ii)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">one director and one independent director nominated by Remus Group Management, LLC, which are currently Krishna Gupta and Douglas Hudson; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(iii)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">one director nominated by Compute Health Sponsor LLC (the &#8220;Sponsor&#8221;), which is currently Dr.&#160;Omar Ishrak; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(iv)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">one independent director nominated by us and designated by RTW Investments, LP (&#8220;RTW&#8221;), which is currently Nicholas Lewin; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(v)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">one independent director nominated by us, which seat is currently vacant. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, each of the First RIFA and the Second RIFA (each as defined below) contain substantially similar rights which entitle RTW to designate one director to our Board, which is currently Mr.&#160;Lewin. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Amended Note Purchase Agreement (as defined below), RTW is entitled to designate two directors to our Board, which are currently Mr.&#160;Lewin and R. Jason Richey. In addition, we agreed to include an additional director nominee in our proxy statement for the 2024 annual meeting of stockholders, which additional nominee would go through our director nomination process, as described below, and RTW was granted the right to approve such nominee. In September 2024, we appointed Keith B. Johns II to our Board of Directors as a Class&#160;III director and RTW approved his appointment in satisfaction of such obligations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Charter and our Bylaws provide that, subject to the rights of any outstanding series of preferred stock to elect directors, the authorized number of directors is fixed, and may be changed from time to time, solely by the Board of Directors. Subject to the rights, if any, of the holders of any outstanding series of preferred stock to elect directors, when the number of directors is increased or decreased, the Board shall determine the class or classes to which the increased or decreased number of directors shall be apportioned, although no decrease in the number of directors may shorten the term of any incumbent director. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The division of our Board of Directors into three classes with staggered three-year terms may delay or prevent a change in control of our company. Subject to the rights of any outstanding series of preferred stock to elect and remove directors, our directors may be removed only for cause by the affirmative vote of the holders of not less than <span style="white-space:nowrap">two-thirds</span> of our outstanding voting stock entitled to vote in the election of directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the nominees has agreed to be named in this Proxy Statement and to serve if elected. We believe that all of the nominees will be able and willing to serve if elected. However, if any nominee should become unable or unwilling to serve for any reason, proxies may be voted for another person nominated as a substitute by our Board of Directors or our Board of Directors may reduce the number of directors. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The proposal regarding the election of directors requires the approval of a plurality of the votes cast. The three nominees receiving the highest number of affirmative &#8220;FOR&#8221; votes will be elected as Class&#160;II Directors. Votes withheld and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">THE BOARD UNANIMOUSLY RECOMMENDS A VOTE </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">FOR</span> THE ELECTION OF EACH OF THE CLASS II DIRECTOR NOMINEES. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Members of the Board of Directors and Nominees </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Nominees for Class&#160;II Director (terms to expire at the 2028 Annual Meeting of Stockholders) </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The current members of the Board who are also nominees for election to the Board at the Annual Meeting as Class&#160;II Directors are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:26%"/>

<td style="vertical-align:bottom;width:10%"/>
<td/>

<td style="vertical-align:bottom;width:10%"/>
<td/>

<td style="vertical-align:bottom;width:10%"/>
<td style="width:36%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Age</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Served&#160;as&#160;a&#160;Director<br/>Since</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Position with Allurion</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Dr.&#160;Omar&#160;Ishrak</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">70</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">2023</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">Co-Chairman&#160;and&#160;Director</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Douglas&#160;Hudson</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">56</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">2023</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">R. Jason Richey</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">52</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">2024</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The principal occupations and business experience, for at least the past five years, of each Class&#160;II Director are as follows: </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Dr.&#160;Omar Ishrak </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&#160;Omar Ishrak has served as a member of our Board of Directors since August 2023, and previously served as chairman of the board of directors of Compute Health Acquisition Corp. (formerly NYSE: CPUH) (&#8220;Compute Health&#8221;) from October 2020 to August 2023. Dr.&#160;Ishrak also serves on the board of directors at Intel Corporation (Nasdaq: INTC), where he served as independent chairman of the board from January 2020 to January 2023. Dr.&#160;Ishrak has also served on the board of directors of Amgen, Inc. (Nasdaq: AMGN) since July 2021, of Cargill, Inc., a private company, where he has served since January 2021, and of Insightec, Ltd., a private company, where he has served since May 2022. Dr.&#160;Ishrak was the chief executive officer of Medtronic plc (Nasdaq: MDT) from June 2011 to April 2020 and served as executive chairman and chairman of the board of directors until he stepped down in December 2020. Prior to joining Medtronic, Dr.&#160;Ishrak was the president and chief executive officer of GE Healthcare Systems. Earlier in his career, Dr.&#160;Ishrak amassed 13 years of technology development and business management experience, holding leadership positions at Diasonics Vingmed Ultrasound Ltd., and various product development and engineering positions at Philips Ultrasound Inc. He was inducted into the American Institute for Medical and Biological Engineering College of Fellows in 2016 and was elected to the National Academy of Engineering in 2020. Dr.&#160;Ishrak serves on the board of directors of the Cleveland Clinic, a nonprofit academic medical center. He is also a member of the Board of Trustees of the Asia Society, a leading educational organization dedicated to promoting mutual understanding and strengthening partnerships among peoples, leaders, and institutions of Asia and the United States in a global context. He earned a B.S. degree and Ph.D. in electrical engineering from the University of London, King&#8217;s College. He is also a fellow of King&#8217;s College. Dr.&#160;Ishrak is qualified to serve on our Board of Directors based on his extensive experience on boards of various healthcare and technology companies. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Douglas Hudson </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Douglas Hudson has served as a member of our Board of Directors since August 2023. Mr.&#160;Hudson has also served as the founder, chief executive officer and a director of Noho Dental, Inc. since July 2018, and as a director of Modern Age since October 2020. Previously, Mr.&#160;Hudson served on the board of directors of Relode.com, LLC from 2017 until August 2022. Mr.&#160;Hudson also served as the founder and chief executive officer of SmileDirectClub Inc. (formerly Nasdaq: SDC) from 2013 to 2017, and as chairman and chief executive officer of Simplex Healthcare from 2007 until 2013, when it was acquired by Arriva Medical LLC. Earlier in his career, Mr.&#160;Hudson served as founder, chief executive officer and director of HearingPlanet, Inc. from 1999 until 2007. Mr.&#160;Hudson received his B.S. in organizational behavior from Eckerd College and his M.B.A. from Vanderbilt University, and he completed the executive education programs at Harvard Business School. Mr.&#160;Hudson is qualified to serve on our Board of Directors due to his experience as an entrepreneur and an executive of health care companies. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">R. Jason Richey </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">R. Jason Richey has served on our Board of Directors since December 2024. Currently Mr.&#160;Richey is President and CEO of Magnolia Medical Technologies, a privately held medical device company based in Seattle, WA (&#8220;Magnolia&#8221;) since July 2025. Prior to Magnolia, Mr.&#160;Richey served as president and chief executive officer of Cytrellis Biosystems, Inc. (&#8220;Cytrellis&#8221;) from June 2022 to October 2024. Prior to his time at Cytrellis, he served as president of Cutera, Inc. (Nasdaq: CUTR) (&#8220;Cutera&#8221;) from July 2018 to June 2021. Prior to serving as Cutera&#8217;s president, Mr.&#160;Richey served as Cutera&#8217;s chief operating officer since July&#160;9, 2018. Mr.&#160;Richey also served as Cutera&#8217;s interim president and chief executive officer from January&#160;4, 2019 until July&#160;8, 2019. Immediately prior to joining Cutera, Mr.&#160;Richey served as the President of North America, for LivaNova, PLC, a $5&#160;billion global medical device manufacturer headquartered in London, England with presence in more than 110 countries worldwide. Mr.&#160;Richey joined LivaNova via the merger of Cyberonics Inc. and Sorin SpA. During his 17 year tenure with LivaNova/Cyberonics, he served the company in multiple positions of increasing responsibility, including: Vice President of Global Sales, Marketing, Market Access, and Government Affairs, President&#160;&amp; General Manager of the Neuromodulation Franchise, and Regional President, North America. At Cyberonics, among other roles, Mr.&#160;Richey served as the Vice President and General Manager of the company&#8217;s international business. Mr.&#160;Richey began his medical device career at B Braun Medical in sales and sales management. Mr.&#160;Richey holds a B.A. in Biology from Indiana University. Mr.&#160;Richey is qualified to serve on our Board of Directors due to his experience as an executive in innovative healthcare companies. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Class&#160;I Directors (terms to expire at the 2027 Annual Meeting of Stockholders) </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The current members of the Board who are Class&#160;I Directors are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:25%"/>

<td style="vertical-align:bottom;width:8%"/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td style="width:43%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Age</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Served&#160;as&#160;a&#160;Director<br/>Since</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Position with Allurion</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Dr.&#160;Shantanu&#160;Gaur</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">39</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">2009</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Chief&#160;Executive&#160;Officer&#160;and&#160;Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Krishna Gupta</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">38</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">2017</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Nicholas Lewin</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">48</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">2023</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The principal occupations and business experience, for at least the past five years, of each Class&#160;I Director nominee are as follows: </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Dr.&#160;Shantanu Gaur </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&#160;Shantanu Gaur<span style="font-weight:bold"><span style="font-style:italic"> </span></span>has served as our Chief Executive Officer and as a member of our Board of Directors since September 2009. Dr.&#160;Gaur founded Allurion in 2009 while at Harvard Medical School. Dr.&#160;Gaur graduated summa cum laude with a B.S. in Biology from Harvard College and with an M.D. from Harvard Medical School, where he was a Paul Revere Frothingham Scholar and Paul&#160;&amp; Daisy Soros Fellow. Dr.&#160;Gaur is qualified to serve on our Board of Directors because of his experience founding Allurion and serving as our Chief Executive Officer. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Krishna Gupta </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Krishna Gupta<span style="font-weight:bold"><span style="font-style:italic"> </span></span>has served as a member of our Board of Directors since January 2017. He is the founder of REMUS Capital and Romulus Capital (collectively referred to herein as &#8220;REMUS Capital&#8221;), technology-focused venture capital firms he initially founded in 2008. Mr.&#160;Gupta serves as a director on the boards of several privately held companies, including: Ceres Imaging, Inc., which provides computer vision-analytics in agriculture; Cogito Corporation, which provides voice artificial intelligence (&#8220;AI&#8221;) for large enterprises; Cohealo, Inc., which provides equipment sharing services for health systems; Spotta Ltd., which develops smart insect and pest monitoring solutions; and ZeroCater, Inc., which provides catering technology for enterprises. He was the first investor in Ginger, which was a leader in mental health software and merged with Headspace, Inc. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Mr.&#160;Gupta has also served as a member of the board of directors of Presto Automation, Inc. (Nasdaq: PRST) since 2017, where he served as chairman of the board from September 2022 to March 2024. Prior to REMUS Capital, Mr.&#160;Gupta held roles at McKinsey&#160;&amp; Company, a management consulting firm, and JPMorgan Chase&#160;&amp; Co., an investment banking firm, where he advised several Fortune 100 clients on technology M&amp;A deals. Mr.&#160;Gupta holds B.S. degrees in materials science and engineering, as well as in management sciences, both from the Massachusetts Institute of Technology. Mr.&#160;Gupta is qualified to serve on our Board of Directors due to his experience investing in technology and healthcare businesses. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Nicholas Lewin </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nicholas Lewin has served as a member of our Board of Directors since August 2023. Mr.&#160;Lewin has also served as a director of Establishment Labs Holding, Inc. (Nasdaq: ESTA) since September 2015, and as its chairman since December 2017. He has been a managing member and head of investments at Crown Predator Holdings LLC since 2008 and has been a private investor since 2000. Mr.&#160;Lewin has also served as a director of Game Square (Nasdaq: GAME) since October 2023. Mr.&#160;Lewin served as a director of Cutera Inc. (Nasdaq: CUTR) from May 2023 until April 2025. Mr.&#160;Lewin holds a bachelor&#8217;s degree in political science from Johns Hopkins University. Mr.&#160;Lewin is qualified to serve on our Board of Directors due to his experience as an investor in, and director of, innovative companies, including health care and medical device companies. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Class&#160;III Directors (terms to expire at the 2026 Annual Meeting of Stockholders) </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The current members of the Board who are Class&#160;III Directors are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:32%"/>

<td style="vertical-align:bottom;width:13%"/>
<td/>

<td style="vertical-align:bottom;width:13%"/>
<td/>

<td style="vertical-align:bottom;width:13%"/>
<td style="width:21%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Age</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Served&#160;as&#160;a&#160;Director<br/>Since</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Position<br/>with<br/>Allurion</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Michael&#160;Davin</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">67</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">2017</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Keith&#160;B.&#160;Johns&#160;II</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">61</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">2024</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The principal occupations and business experience, for at least the past five years, of each Class&#160;III Director are as follows: </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Michael Davin </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Michael Davin has served as a member of our Board of Directors since October 2017. Mr.&#160;Davin has also served as a director of several privately-held companies, including: Follica, Inc. since December 2020, Amsel Medical Corporation since August 2020, Cynosure, LLC since January 2020, and Inkbit Corporation since June 2018. Previously, Mr.&#160;Davin served as chairman, president, and chief executive officer of Cynosure Inc. (formerly Nasdaq: CYNO), from 2003 until March 2017, when it was acquired by Hologic Inc. Mr.&#160;Davin received his B.S. and B.A. from Southern New Hampshire University. Mr.&#160;Davin is qualified to serve on our Board of Directors due to his experience as a director of health care and technology companies, as well as his familiarity with Allurion as a director. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Keith B. Johns II </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Keith B. Johns II has served as a member of our Board since September 2024. Mr.&#160;Johns has also served as Chief Operating Officer of Adipo Therapeutics, LLC since September 2023, and as President of KJ Consulting LLC since March 2023. Previously, Mr.&#160;Johns served in various roles of increasing responsibility at Eli Lilly&#160;&amp; Company (NYSE: LLY) (&#8220;Eli Lilly&#8221;) during his over twenty-year tenure at Eli Lily. His last two roles were as Vice President and then Senior Vice President of Global Marketing and Alliance Management for the Diabetes and Obesity Business Unit from November 2017 to December 2022. Mr.&#160;Johns holds a bachelor&#8217;s degree from Allegheny College, a master&#8217;s degree from the University of South Carolina, and a M.B.A. from the University </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">14 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of North Carolina&#8217;s Kenan-Flagler Business School. Mr.&#160;Johns is qualified to serve on our Board due to his experience as an executive of a large healthcare company and his expertise in the obesity management space. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Board Diversity </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Corporate Governance Guidelines provide that diversity of background and experience should be considered in determining director candidates as well as other factors such as a candidate&#8217;s character, judgment, skills, education, expertise, and absence of conflicts of interest. Based on our commitment to diversity, our Corporate Governance Guidelines require that the Nominating and Corporate Governance Committee include in its initial list of director candidates for consideration in filling any vacancy on our Board of Directors at least one or more qualified candidates who reflect diverse backgrounds, including diversity of gender and race or ethnicity. However, we do not have a formal policy concerning the diversity of the Board of Directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our priority in the selection of directors is identification of members who will further the interests of our stockholders through their established records of professional accomplishment, their ability to contribute positively to the collaborative culture among board members, their knowledge of our business and understanding of the competitive landscape in which we operate, and their adherence to high ethical standards. Although we do not have a formal diversity policy and do not follow any ratio or formula with respect to diversity in order to determine the appropriate composition of the Board of Directors, the Nominating and Corporate Governance Committee and the Board of Directors are committed to creating a board of directors that promotes our strategic objectives and fulfills its responsibilities to our stockholders, and they consider diversity of gender, race, national origin, education, professional experience, and differences in viewpoints and skills when evaluating proposed director candidates. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Family Relationships; Arrangements; Legal Proceedings </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no family relationships among our directors and executive officers. There is no arrangement or understanding between any of our directors or executive officers and any other person or persons pursuant to which he or she was or is to be selected as a director or an executive officer except as described herein. There are no material legal proceedings to which any of our directors or executive officers is a party adverse to us or any of our subsidiaries or in which any such person has a material interest adverse to us or any of our subsidiaries. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">15 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_5">PROPOSAL 2: AUDITOR RATIFICATION PROPOSAL </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee of the Board (&#8220;Audit Committee&#8221;) has appointed Deloitte&#160;&amp; Touche LLP (&#8220;Deloitte&#8221;) as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2025. Deloitte also served as our independent registered public accounting firm for the fiscal years ended December&#160;31, 2024 and December&#160;31, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither Deloitte nor any of its members has any direct or indirect financial interest in or any connection with us in any capacity other than as our auditors, providing audit and <span style="white-space:nowrap">non-audit</span> related services. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A representative of Deloitte is expected to attend the Annual Meeting and to have an opportunity to make a statement and be available to respond to appropriate questions from stockholders. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Independent Registered Public Accounting Firm Fees </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fees billed by Deloitte (Boston, Massachusetts, PCAOB Auditor ID 34), our independent public accounting firm, for the fiscal years ended December&#160;31, 2024 and 2023 for audit services, audit-related services, tax services, and other services were approved by our Audit Committee. The following table summarizes the aggregate fees billed to us by Deloitte: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:56%"/>

<td style="vertical-align:bottom;width:11%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:11%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Type of Service</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Fiscal&#160;Year&#160;Ended<br/>December&#160;31,&#160;2024</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Fiscal&#160;Year&#160;Ended<br/>December&#160;31,&#160;2023</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,483,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,617,825</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-Related Fees<sup style="font-size:75%; vertical-align:top">(2)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees<sup style="font-size:75%; vertical-align:top">(3)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees<sup style="font-size:75%; vertical-align:top">(4)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,483,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,617,825</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Audit fees consist of fees billed for professional services rendered for the audit of our annual financial statements, the review of our interim financial statements included in our quarterly reports on Form <span style="white-space:nowrap">10-Q,</span> and in connection with our securities offerings, including registration statements, responding to SEC comment letters, comfort letters, and consents. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Audit-related fees consist of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Tax fees consist of fees billed for professional services rendered for tax compliance, tax advice and tax planning, and includes fees for tax return preparation. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">All other fees include any fees billed for products and services provided that are not audit, audit related or tax fees. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Audit Committee <span style="white-space:nowrap">Pre-Approval</span> Policy and Procedures </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Audit Committee has adopted procedures requiring the <span style="white-space:nowrap">pre-approval</span> of all audit and permissible <span style="white-space:nowrap">non-audit</span> services that are to be performed by our independent registered public accounting firm in order to assure that these services do not impair the auditor&#8217;s independence. In accordance with the <span style="white-space:nowrap">pre-approval</span> procedures, the Audit Committee generally approves the performance of specific services subject to a cost limit for all such services. This general approval is reviewed, and if necessary, modified, at least annually. Management must obtain the specific prior approval of the Audit Committee for each engagement of our independent registered public accounting firm to perform any other audit or permissible <span style="white-space:nowrap">non-audit</span> services. The Audit Committee may delegate <span style="white-space:nowrap">pre-approval</span> authority to one or more of its independent members, but does not delegate its responsibility to approve services performed by our independent registered public accounting firm to any member of management. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">16 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of the services rendered by Deloitte with respect to the 2024 and 2023 fiscal years were <span style="white-space:nowrap">pre-approved</span> by the Audit Committee in accordance with this policy. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Ratification </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although ratification of our appointment of Deloitte is not required, we value the opinions of our stockholders and believe that stockholder ratification of our appointment of Deloitte is a good corporate governance practice. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the appointment of Deloitte is not ratified by the stockholders, the Audit Committee will consider this fact when it appoints the independent registered public accounting firm for the fiscal year ending December&#160;31, 2025. Even if the appointment of Deloitte is ratified, the Audit Committee retains the discretion to appoint a different independent auditor at any time if it determines that such a change is in the interest of the Company. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Proposal 2 requires the affirmative vote of the holders of a majority of the votes properly cast. Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this Proposal 2. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">FOR</span> THE AUDITOR RATIFICATION PROPOSAL. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">17 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_6">PROPOSAL 3: PLAN AMENDMENT PROPOSAL </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors is asking stockholders to consider and vote upon a proposal to approve an amendment and restatement of the 2023 Plan. Our Board of Directors approved the Amended and Restated Plan on October&#160;15, 2025, subject to the approval by our stockholders at the Annual Meeting. The Amended and Restated Plan will updated the name of the 2023 Plan to the &#8220;Amended and Restated 2023 Equity Incentive Plan&#8221; and provides for the following material amendments to the 2023 Plan: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(i)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">increases the aggregate number of shares of common stock that may be issued under the 2023 Plan and the limit on the number of shares that may be issued pursuant to incentive stock options (&#8220;ISOs&#8221; and such limit, the &#8220;ISO Limit&#8221;) by, in each case, a number of shares of common stock resulting in the total number of shares of common stock available for issuance thereunder (the &#8220;Authorized Share Pool&#8221;) equal to 4,161,302 shares; provided, that upon consummation of the Exchange contemplated by Proposal 6, the Authorized Share Pool shall be further increased to 20% (the &#8220;Pool Percentage Amount&#8221;) of our Fully-Diluted Shares Outstanding (as defined below, giving effect to the proposed amendment) as of the date of consummation of such Exchange, and the ISO Limit shall be further increased to the lesser of such Authorized Share Pool or 9,000,000 shares. The Authorized Share Pool and ISO Limit will each continue to automatically increase each January&#160;1 through the term of the plan by the Annual Increase provisions described below; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(ii)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">amends the definition of Fully-Diluted Shares Outstanding as described herein; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(iii)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">lowers the <span style="white-space:nowrap">non-employee</span> director compensation limit, from $750,000 to $350,000 per year (or from $1,000,000 to $500,000 for the year that a director is first appointed or elected to our Board of Directors); and </p></td></tr></table> </div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(iv)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">extends the term of the 2023 Plan to the tenth anniversary of the date that stockholders approve the Amended and Restated Plan (with corresponding extension of the term of the Annual Increase). </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of the Proxy Statement, the anticipated number of Fully-Diluted Shares Outstanding (giving effect to the proposed amendment to the definition thereof) upon consummation of the Exchange will be approximately 49,937,374 and the Authorized Share Pool and ISO Limit, applying the Pool Percentage Amount thereto, would be increased to approximately 9,987,474 upon consummation of the Exchange, which would be a cumulative increase of 9,737,475 shares of common stock from the current Authorized Share Pool and ISO Limit under the 2023 Plan as of the date of this Proxy Statement. We expect to announce the number of Fully-Diluted Shares Outstanding (giving effect to the proposed amendment to the definition thereof) and the resulting proposed Authorized Share Pool and ISO Limit resulting from the application of the Pool Percentage Amount, as of the date of consummation of the Exchange, in a Current Report on Form <span style="white-space:nowrap">8-K</span> as promptly as possible after the consummation of the Exchange. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors believes that the proposed share pool increase and related changes to the 2023 Plan are reasonable, appropriate, and in the best interests of our stockholders. As of the Record Date, there are only 249,999&#160;shares of common stock remaining available for issuance under the 2023 Plan, and our Board of Directors believes this amount is insufficient to meet our future needs for attracting, motivating and retaining employees in a competitive market for talent, particularly in light of the lack of any retentive &#8220;holding power&#8221; in the Company&#8217;s outstanding equity awards to its named executive officers and other key employees. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the Record Date, there were stock options to acquire 216,507 shares of common stock outstanding under our equity compensation plans, with a weighted average exercise price of $61.68 and a weighted average remaining term of 6.9&#160;years. In addition, as of the Record Date, there were 361,420 shares outstanding under unvested restricted stock unit awards (&#8220;RSUs&#8221;) under our equity compensation plans, which unvested RSUs have a market value of $1.85 as of the Record Date. Other than the foregoing, no awards under our equity </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">18 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compensation plans were outstanding as of the Record Date. As of the Record Date and based solely on the closing market price of our common stock as reported on the New York Stock Exchange (&#8220;NYSE&#8221;) on such date, the market value of our common stock was equal to $1.85 per share. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this proposal is approved by our stockholders at the Annual Meeting, the Amended and Restated Plan will become effective on the date of the Annual Meeting (the &#8220;Restatement Effective Date&#8221;). If stockholders do not approve this proposal, the 2023 Plan will remain in effect in accordance with its terms. In such event, our Board of Directors will consider whether to adopt alternative arrangements based on its assessment of our needs. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Amended and Restated Plan Highlights </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amended and Restated Plan has a number of features intended to address stockholder concerns related to equity plans, including: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Awards subject to forfeiture/clawback</span>. Awards granted under the Amended and Restated Plan are subject to recoupment in accordance with any clawback policy that we adopt, including our Compensation Recovery Policy adopted effective as of October&#160;2, 2023. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Administered by independent directors</span>. The Amended and Restated Plan is administered by the Compensation Committee of the Board of Directors (the &#8220;Compensation Committee&#8221;), although it may delegate certain responsibilities to others as described below under &#8220;<span style="font-style:italic">Plan Administration</span>.&#8221; All members of the Compensation Committee are <span style="white-space:nowrap">&#8220;non-employee</span> directors&#8221; within the meaning of Rule <span style="white-space:nowrap">16b-3</span> under the Exchange Act and &#8220;independent&#8221; within the meaning of the NYSE Listing Rules. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">No discounted stock options</span>. Apart from limited exceptions, all stock options granted under the Amended and Restated Plan must have an exercise price equal to or greater than the fair market value of a share of common stock on the date the stock option is granted. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">No repricing without stockholder approval</span>. Stock options and stock appreciation rights will not be repriced in any manner without stockholder approval. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic"><span style="white-space:nowrap">Non-employee</span> director compensation</span>. The value of all awards awarded under the Amended and Restated Plan and all other cash compensation paid by us to any <span style="white-space:nowrap">non-employee</span> director in any calendar year for service as a director may not exceed $350,000 (or $500,000 for the year that a director is first appointed or elected to our Board of Directors). </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Rationale for Share Increase </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amended and Restated Plan is critical to our ongoing effort to increase stockholder value. Equity incentive awards are a critical component of our executive and key, <span style="white-space:nowrap">non-executive</span> employees&#8217; overall compensation, particularly given our focus on managing our cash burn, the general freeze on base salaries, and <span style="white-space:nowrap">non-payment</span> of cash bonuses since 2022. Our Compensation Committee and the Board of Directors believe that we must continue to offer a competitive equity compensation program to attract, retain and motivate the talented and qualified employees to execute our strategic business objectives. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2024, January 2025, February 2025, and November 2025, we successfully raised $17.3&#160;million, $9.9&#160;million, $6.1&#160;million, and $5.0 million, respectively, through equity issuances, and in each of April 2025 and November 2025, RTW converted $5.0&#160;million of principal amount of the Notes into 1,492,539 shares of common stock. These transactions, while providing critical funding for our operational initiatives and support for compliance with exchange listing requirements, had a significant dilutive impact on our trading price. As a result, our currently outstanding stock options and restricted stock awards have very little, if any, retentive value for our current employees. Currently, all of our outstanding stock options are very far &#8220;out of the money.&#8221; As of the Record Date, our outstanding stock options have a weighted average exercise price of $61.68, and the total value of unvested restricted stock awards for Mr.&#160;Gaur, Mr. Buch and Mr.&#160;Gibbons is $0, $22,700 and $22,700, respectively. </p> </div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">19 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we are unable to make equity grants with sufficient grant values, we anticipate having difficulty retaining and motivating our executive and key, <span style="white-space:nowrap">non-executive</span> employees. The Compensation Committee and Board of Directors view this as a significant risk to our ability to execute our strategic business objectives. However, we anticipate that if our request to increase the size of the reserved pool under the 2023 Plan is approved by our stockholders, it will be sufficient to provide equity incentives to attract, retain, and motivate employees for the near future with the automatic increase allowed under the 2023 Plan and Amended and Restated Plan. Our Compensation Committee determined the size of the increase in the number of shares of common stock that may be issued under the 2023 Plan based on projected future equity awards to executive and key, <span style="white-space:nowrap">non-executive</span> employees and annual director grants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee will carefully monitor our annual net burn rate, total dilution and equity expense in order to maximize stockholder value by granting equity incentive awards it believes are necessary and appropriate to attract, reward and retain our employees and independent directors. In an effort to limit our cash burn, our compensation philosophy prioritizes and reflects broad-based eligibility for equity incentive awards for high-performing employees. By doing so, we link the interests of those employees with those of our stockholders and motivate our employees to act as owners of the business. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Summary of the Amended and Restated Plan </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following description of the Amended and Restated Plan is a summary only and is qualified in its entirety by reference to the complete text of the Amended and Restated Plan. Stockholders are urged to read the actual text of the Amended and Restated Plan in its entirety, which is attached hereto as <span style="text-decoration:underline">Appendix A</span> to this Proxy Statement and is incorporated herein by reference. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Eligibility</span>. Any individual who is an employee of us or any of our affiliates, or any person who provides services to us or any of our affiliates, including members of the Board, is eligible to receive awards under the Amended and Restated Plan at the discretion of the plan administrator. As of the Record Date, approximately 61 individuals were eligible to participate in the Amended and Restated Plan, which includes three executive officers, 41 <span style="white-space:nowrap">non-executive</span> employees, 10 consultants, and seven <span style="white-space:nowrap">non-employee</span> directors. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Awards</span>. The Amended and Restated Plan provides for the grant of ISOs to employees, including employees of any parent or subsidiary, and for the grant of nonstatutory stock options (&#8220;NSOs&#8221;), stock appreciation rights, restricted stock awards, restricted stock unit awards, unrestricted stock awards, cash-based awards and dividend equivalent rights to employees, <span style="white-space:nowrap">non-employee</span> directors and consultants of Allurion or any of its affiliates. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Authorized Shares</span>. The shares of common stock that we may issue under the Amended and Restated Plan are authorized but unissued shares or shares that we reacquire. Subject to adjustment as set forth in the Amended and Restated Plan, the maximum number of shares of common stock reserved and available for issuance under the Amended and Restated Plan equals 4,161,302 shares; provided, that upon consummation of the Exchange, the Authorized Share Pool shall be further increased to 20% of our Fully-Diluted Shares Outstanding as of the date of consummation of the Exchange. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the number of shares of common stock reserved for issuance under the Amended and Restated Plan automatically increases on January&#160;1, 2026 and each January&#160;1 thereafter through January&#160;1, 2035, in an amount equal to (1) 5% of the number of Fully-Diluted Shares Outstanding as of the immediately preceding December&#160;31, or (2)&#160;a lesser number of shares of common stock determined by the Board or the Compensation Committee (the &#8220;Annual Increase&#8221;). Subject to such overall share limits, the maximum number of shares of common stock that may be issued on the exercise of ISOs under the Amended and Restated Plan shall not exceed 4,161,302&#160;shares; provided, that upon consummation of the Exchange, the ISO Limit shall be further increased to the lesser of (x) 20% of our Fully-Diluted Shares Outstanding as of the date of consummation of the Exchange and (y)&#160;9,000,000&#160;shares. The ISO Limit will be further cumulatively increased on January&#160;1, 2026 and each January&#160;1 thereafter by the lesser of the Annual Increase or 3,000,000 shares of common stock. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">20 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currently, under the 2023 Plan, the Fully-Diluted Shares Outstanding consists of the number of shares of common stock outstanding, plus the number of shares of common stock underlying outstanding awards granted under the 2023 Plan. If this Proposal 3 is adopted, the amendment to the 2023 Plan would expand the definition of Fully-Diluted Shares Outstanding to include (i)&#160;the number of shares of common stock outstanding, (ii)&#160;the number of shares of common stock underlying outstanding awards granted under the 2023 Plan, (iii)&#160;the number of shares of common stock available under the 2023 Plan for the issuance of additional awards and (iv)&#160;the number of shares of common stock issuable upon conversion or exercise of outstanding derivative securities, including any convertible debt securities, the Series B Preferred Stock upon the consummation of the Exchange and any other convertible preferred stock and warrants we issue. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares subject to stock awards granted under the Amended and Restated Plan that expire or terminate without being exercised or otherwise issued in full or that are paid out in cash rather than in shares do not reduce the number of shares available for issuance under the Amended and Restated Plan. Shares withheld under a stock award to satisfy the exercise, strike or purchase price of a stock award or to satisfy a tax withholding obligation also do not reduce the number of shares available for issuance under the Amended and Restated Plan. If any shares of common stock issued pursuant to a stock award under the Amended and Restated Plan, 2023 Plan, our Amended and Restated 2020 Stock Option and Grant Plan (the &#8220;2020 Plan&#8221;) or our 2010 Stock Incentive Plan (the &#8220;2010 Plan&#8221;) are forfeited back to or repurchased or reacquired by us (1)&#160;because of the failure to vest, (2)&#160;to satisfy the exercise, strike or purchase price, or (3)&#160;to satisfy a tax withholding obligation in connection with an award, the shares that are forfeited or repurchased or reacquired will revert to and again become available for issuance under the Amended and Restated Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="white-space:nowrap">Non-Employee</span> Director Compensation Limit</span>. The value of all awards awarded under the Amended and Restated Plan and all other cash compensation paid by us to any <span style="white-space:nowrap">non-employee</span> director in any calendar year may not exceed $350,000 (or $500,000 for the year in which a <span style="white-space:nowrap">non-employee</span> director is first appointed or elected to the Board). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Plan Administration</span>. The Board, or a duly authorized committee thereof, will administer the Amended and Restated Plan and is referred to as the &#8220;plan administrator&#8221; herein. The Board (or committee thereof) may also delegate to one or more of our officers the authority to (1)&#160;designate employees (other than officers) to receive specified stock awards and (2)&#160;determine the number of shares subject to such stock awards. Under the Amended and Restated Plan, the Board (or an authorized delegate) has the authority to determine award recipients, grant dates, the numbers and types of awards to be granted, the applicable fair market value in a manner consistent with the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), and the provisions of each award, including the period of exercisability, the vesting schedule applicable to a stock award and the number of shares of stock to be covered by any award. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Amended and Restated Plan, stock options and stock appreciation rights will not be repriced in any manner without stockholder approval. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stock Options</span>. ISOs and NSOs are granted under stock option agreements adopted by the plan administrator. The plan administrator determines the exercise price for stock options, within the terms and conditions of the Amended and Restated Plan, provided that the exercise price of a stock option generally shall not be less than 100% of the fair market value of a share of common stock on the date of grant, unless granted (i)&#160;pursuant to a transaction described in, and a manner consistent with, Section&#160;424(a) of the Code, (ii)&#160;to individuals who are not subject to U.S. income tax on the date of grant, or (iii)&#160;if the stock appreciation right is otherwise compliant with Section&#160;409A of the Code. Options granted under the Amended and Restated Plan vest at the rate and under the terms specified in the stock option agreement as determined by the plan administrator. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The plan administrator determines the term of stock options granted under the Amended and Restated Plan, up to a maximum of ten years. Unless the terms of an option holder&#8217;s stock option agreement provide otherwise or as otherwise provided by the plan administrator, if an option holder&#8217;s service relationship with us or any of our affiliates ceases for any reason other than disability, death, or cause, the option holder may generally exercise any </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">21 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
vested options for a period of three months following the cessation of service. This period may be extended in the event that exercise of the option is prohibited by applicable securities laws. Unless the terms of an option holder&#8217;s stock option agreement provide otherwise or as otherwise provided by the plan administrator, if an option holder&#8217;s service relationship with us or any of our affiliates ceases due to death, or an option holder dies within a certain period following cessation of service, the option holder or a beneficiary may generally exercise any vested options for a period of 12 months following the date of death. Unless the terms of an option holder&#8217;s stock option agreement provide otherwise or as otherwise provided by the plan administrator, if an option holder&#8217;s service relationship with us or any of our affiliates ceases due to disability, the option holder may generally exercise any vested options for a period of 12 months following the cessation of service. In the event of a termination for cause, options generally terminate upon the termination date. In no event may an option be exercised beyond the expiration of its term. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Acceptable consideration for the purchase of common stock issued upon the exercise of a stock option will be determined by the plan administrator and may include (1)&#160;cash, certified or bank check or other instrument acceptable to the plan administrator, (2)&#160;the tender of shares of common stock previously owned by the option holder that are not then subject to any restrictions under any equity incentive plan, (3)&#160;pursuant to a broker-assisted exercise arrangement, or (4)&#160;a net exercise of the option if it is an NSO. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the plan administrator provides otherwise, awards are generally are not transferable except by will or the laws of descent and distribution. Subject to approval of the plan administrator or a duly authorized officer, an option may be transferred pursuant to a domestic relations order. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Tax Limitations on ISOs</span>. The aggregate fair market value, determined at the time of grant, of common stock with respect to ISOs that are exercisable for the first time by an award holder during any calendar year under all of our stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our parent or subsidiary corporations unless (1)&#160;the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant and (2)&#160;the term of the ISO does not exceed five years from the date of grant. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Restricted Stock Unit Awards</span>. Restricted stock unit awards are granted under restricted stock unit award agreements adopted by the plan administrator. Restricted stock unit awards may be granted in consideration for any form of legal consideration (including services) that may be acceptable to the plan administrator and permissible under applicable law. A restricted stock unit award may be settled by delivery of shares of common stock (or cash to the extent explicitly provided in the award agreement) as determined by the plan administrator. Additionally, dividend equivalents may be credited in respect of shares covered by a restricted stock unit award. Except as otherwise provided in the applicable award agreement or by the plan administrator, restricted stock unit awards that have not vested will be automatically forfeited once the participant&#8217;s continuous service with us or our affiliates ends for any reason. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Restricted Stock Awards</span>. Restricted stock awards are granted under restricted stock award agreements adopted by the plan administrator. A restricted stock award may be awarded in consideration for cash, check, bank draft or money order, services to us or our affiliates, or any other form of legal consideration that may be acceptable to the plan administrator and permissible under applicable law. The plan administrator determines the terms and conditions of restricted stock awards, including vesting and forfeiture terms. If a participant&#8217;s service relationship with us ends for any reason, any or all of the shares of common stock held by the participant that have not vested as of the date the participant terminates service with us or any of our affiliates will automatically and without any requirement of notice to the participant be deemed to have been reacquired by us through a forfeiture condition or a repurchase right. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stock Appreciation Rights</span>. Stock appreciation rights are granted under stock appreciation right agreements adopted by the plan administrator. The plan administrator determines the strike price for a stock appreciation </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">22 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
right, which generally shall not be less than 100% of the fair market value of common stock on the date of grant, unless granted (i)&#160;pursuant to a transaction described in, and a manner consistent with, Section&#160;424(a) of the Code, (ii)&#160;to individuals who are not subject to U.S. income tax on the date of grant, or (iii)&#160;if the stock appreciation right is otherwise compliant with Section&#160;409A of the Code. A stock appreciation right granted under the Amended and Restated Plan vests at the rate specified in the stock appreciation right agreement as determined by the plan administrator. Stock appreciation rights may be settled in cash or shares of common stock or in any other form of payment, as determined by the plan administrator and specified in the stock appreciation right agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The plan administrator determines the term of stock appreciation rights granted under the Amended and Restated Plan, up to a maximum of ten years. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Other Stock Awards</span>. The plan administrator may grant other awards based in whole or in part by reference to common stock. The plan administrator will set the number of shares under the stock award (or cash equivalent) and all other terms and conditions of such awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Changes to Capital Structure</span>. In the event there is a specified type of change in our capital structure, such as a stock split, reverse stock split, recapitalization, or other similar change, appropriate adjustments will be made to (1)&#160;the class and maximum number of shares reserved for issuance under the Amended and Restated Plan, (2)&#160;the class of shares by which the share reserve may increase automatically each year, (3)&#160;the class and maximum number of shares that may be issued on the exercise of ISOs and (4)&#160;the class and number of shares and exercise price, strike price, or purchase price, if applicable, of all outstanding stock awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Sale Event</span>. The Amended and Restated Plan provides that upon the effectiveness of a &#8220;sale event,&#8221; as defined in the Amended and Restated Plan, an acquirer or successor entity may assume, continue or substitute outstanding awards under the Amended and Restated Plan. To the extent that awards granted under the Amended and Restated Plan are not assumed or continued or substituted by the successor entity, the Amended and Restated Plan and all awards granted under the Amended and Restated Plan shall terminate. In such case, except as may be otherwise provided in the relevant award agreement, all awards with time-based vesting, conditions or restrictions will become fully vested and nonforfeitable as of the sale event, and all awards with conditions and restrictions relating to the attainment of performance goals may become vested and nonforfeitable in connection with the sale event in the plan administrator&#8217;s discretion or to the extent specified in the relevant award agreement. In the event of such termination, individuals holding options and stock appreciation rights will be permitted to exercise any options and stock appreciation rights (to the extent exercisable) they then hold within a specified time period, as determined by the plan administrator, prior to the sale event. In addition, in connection with the termination of the Amended and Restated Plan upon a sale event, we may make or provide for a payment, in cash or in kind, to participants holding vested and exercisable options and stock appreciation rights equal to the difference between the per share consideration payable to stockholders in the sale event and the exercise price of the options or stock appreciation rights; provided, that any options or stock appreciation rights with exercise prices equal to or greater than such per share consideration will be cancelled for no consideration. We may also make or provide for a payment, in cash or in kind, to the participants holding other awards in an amount equal to the per share consideration payable to stockholders in the sale event multiplied by the number of vested shares of common stock under such awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Plan Amendment or Termination</span>. The Board has the authority to amend, suspend, or terminate the Amended and Restated Plan at any time, provided that such action does not materially impair the existing rights of any participant without such participant&#8217;s written consent. Certain material amendments also require approval of our stockholders. No ISOs may be granted after the tenth anniversary of the date the Board adopts the Amended and Restated Plan. No stock awards may be granted under the Amended and Restated Plan while it is suspended or after it is terminated. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">23 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Awards Granted under the 2023 Plan </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth, for each of the individuals and various groups indicated, the total number of shares subject to awards that have been granted under the 2023 Plan as of the Record Date, even if not currently outstanding. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:68%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center" colspan="6"><span style="font-weight:bold">Options</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center" colspan="2" rowspan="2"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Stock<br/>Awards</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number<br/>of&#160;Shares<br/>(#)</p></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Name and Position</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center" colspan="2"><span style="font-weight:bold">Average<br/>Exercise<br/>Price&#160;($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center" colspan="2"><span style="font-weight:bold">Number<br/>of&#160;Shares<br/>(#)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shantanu Gaur, M.D., <span style="font-style:italic">Chief Executive Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">57.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">57,144</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brendan Gibbons, <span style="font-style:italic">Chief Legal and People Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">74.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10,153</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,270</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ojas Buch, <span style="font-style:italic">Chief Operating Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">35.75</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,271</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,270</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current executive officers, as a group</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">56.25</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(1)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">79,568</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">24,540</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current directors who are not executive officers, as a group</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(1)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">22,094</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Each nominee for election as a director</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,620</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Each associate of any executive officers, current directors or director nominees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Each other person who received or is to receive 5&#160;percent of awards</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">48.71</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">14,656<br/></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;<br/></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">140,974</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current employees who are not executive officers, as a group</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">50.50</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(1)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">31,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">324,198</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> </div> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Represents the weighted-average exercise price for the group, prior to giving effect to the Option Repricing which stockholders are being asked to approve under Proposal 4. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">U.S. Federal Income Tax Consequences </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the principal U.S. federal income tax consequences to participants and us with respect to participation in the Amended and Restated Plan. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state or foreign jurisdiction in which a participant may reside. The information is based upon current U.S. federal income tax rules and therefore is subject to change when those rules change. Because the tax consequences to any participant may depend on his or her particular situation, each participant should consult the participant&#8217;s tax advisor regarding the federal, state, local and other tax consequences of the grant or exercise of an award or the disposition of stock acquired under the Amended and Restated Plan. The Amended and Restated Plan is not qualified under the provisions of Section&#160;401(a) of the Code and is not subject to any of the provisions of the Employee Retirement Income Security Act of 1974, as amended. Our ability to realize the benefit of any tax deductions described below depends on our generation of taxable income as well as the requirement of reasonableness and the satisfaction of our tax reporting obligations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Nonstatutory Stock Options</span>. Generally, there is no taxation upon the grant of a NSO. Upon exercise, a participant will recognize ordinary income equal to the excess, if any, of the fair market value of the underlying stock on the date of exercise of the stock option over the exercise price. If the participant is employed by us or one of our affiliates, that income will be subject to withholding taxes. The participant&#8217;s tax basis in those shares will be equal to their fair market value on the date of exercise of the stock option, and the participant&#8217;s capital gain holding period for those shares will begin on the day after they are transferred to the participant. Subject to the requirement of reasonableness, the deduction limits under Section&#160;162(m) of the Code and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income recognized by the participant. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Incentive Stock Option</span>s. The Amended and Restated Plan provides for the grant of stock options that are intended to qualify as &#8220;incentive stock options,&#8221; as defined in Section&#160;422 of the Code. Under the Code, a participant generally is not subject to ordinary income tax upon the grant or exercise of an ISO. If the participant </p> </div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">24 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
holds a share received upon exercise of an ISO for more than two years from the date the stock option was granted and more than one year from the date the stock option was exercised, which is referred to as the required holding period, the difference, if any, between the amount realized on a sale or other taxable disposition of that share and the participant&#8217;s tax basis in that share will be long-term capital gain or loss. If, however, a participant disposes of a share acquired upon exercise of an ISO before the end of the required holding period, which is referred to as a &#8220;disqualifying disposition,&#8221; the participant generally will recognize ordinary income in the year of the disqualifying disposition equal to the excess, if any, of the fair market value of the share on the date of exercise of the stock option over the exercise price (or, if less, the amount realized on a sale of such shares). However, if the sales proceeds are less than the fair market value of the share on the date of exercise of the stock option, the amount of ordinary income recognized by the participant will not exceed the gain, if any, realized on the sale. If the amount realized on a disqualifying disposition exceeds the fair market value of the share on the date of exercise of the stock option, that excess will be short-term or long-term capital gain, depending on whether the holding period for the share exceeds one year. For purposes of the alternative minimum tax, the amount by which the fair market value of a share of stock acquired upon exercise of an ISO exceeds the exercise price of the stock option generally will be an adjustment included in the participant&#8217;s alternative minimum taxable income for the year in which the stock option is exercised. If, however, there is a disqualifying disposition of the share in the year in which the stock option is exercised, there will be no adjustment for alternative minimum tax purposes with respect to that share. In computing alternative minimum taxable income, the tax basis of a share acquired upon exercise of an ISO is increased by the amount of the adjustment taken into account with respect to that share for alternative minimum tax purposes in the year the stock option is exercised. We are not allowed a tax deduction with respect to the grant or exercise of an ISO or the disposition of a share acquired upon exercise of an ISO after the required holding period. If there is a disqualifying disposition of a share, however, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant, subject to the requirement of reasonableness, the deduction limits under Section&#160;162(m) of the Code and provided that either the employee includes that amount in income or we timely satisfy our reporting requirements with respect to that amount. Generally, an ISO will not be eligible for the tax treatment described above if it is exercised more than three months following termination of employment (or one year in the case of termination of employment by reason of disability). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Restricted Stock Awards</span>. Generally, the recipient of a restricted stock award will recognize ordinary income at the time the stock is received equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. If, however, the stock is subject to restrictions constituting a substantial risk of forfeiture when it is received (for example, if the employee is required to work for a period of time in order to have the right to transfer or sell the stock), the recipient generally will not recognize income until the restrictions constituting a substantial risk of forfeiture lapse, at which time the recipient will recognize ordinary income equal to the excess, if any, of the fair market value of the stock on the date it becomes vested over any amount paid by the recipient in exchange for the stock. A recipient may, however, file an election with the IRS, within 30 days following the date of grant, to recognize ordinary income, as of the date of grant, equal to the excess, if any, of the fair market value of the stock on the date the award is granted over any amount paid by the recipient for the stock. The recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock award will be the amount paid for such shares <span style="font-style:italic">plus</span> any ordinary income recognized either when the stock is received or when the restrictions constituting a substantial risk of forfeiture lapse. Subject to the requirement of reasonableness, the deduction limits under Section&#160;162(m) of the Code and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock award. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Restricted Stock Unit Awards</span>. Generally, the recipient of a restricted stock unit award will generally recognize ordinary income at the time the restricted stock unit is settled in cash, stock or other property equal to the amount of cash or fair market value of the stock received (reduced by the amount, if any, paid by the recipient in exchange for the stock). The recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock unit award will be the amount paid for such </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">25 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shares <span style="font-style:italic">plus</span> any ordinary income recognized when the stock is delivered, and the participant&#8217;s capital gain holding period for those shares will begin on the day after they are transferred to the participant. Subject to the requirement of reasonableness, the deduction limits under Section&#160;162(m) of the Code and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock unit award. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stock Appreciation Rights</span>. Generally, the recipient of a stock appreciation right will recognize ordinary income equal to the fair market value of the stock or cash received upon exercise. Subject to the requirement of reasonableness, the deduction limits under Section&#160;162(m) of the Code and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock appreciation right. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Tax Consequences to the Company </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Compensation of Covered Employees</span>. Our ability to obtain a deduction for amounts paid under the Amended and Restated Plan could be limited by Section&#160;162(m) of the Code. Section&#160;162(m) of the Code limits our ability to deduct compensation, for U.S. federal income tax purposes, paid during any year to a &#8220;covered employee&#8221; (within the meaning of Section&#160;162(m) of the Code) in excess of $1.0&#160;million. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Golden Parachute Payments</span>. Our ability (or the ability of one of our subsidiaries) to obtain a deduction for future payments under the Amended and Restated Plan could also be limited by the golden parachute rules of Section&#160;280G of the Code, which prevent the deductibility of certain &#8220;excess parachute payments&#8221; made in connection with a change in control of an employer-corporation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Equity Compensation Plan Information </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes, as of December&#160;31, 2024, certain information concerning our equity compensation plans under which our equity securities are currently authorized for issuance. Share amounts presented in the table and footnotes below have been retroactively converted to reflect the reverse stock split we effected on January&#160;3, 2025, by application of the reverse stock split ratio of <span style="white-space:nowrap"><span style="white-space:nowrap">1-to-25.</span></span> Additionally, share amounts presented in the table and footnotes below do not reflect the issuance of 414,830 shares after December&#160;31, 2024 as of the Record Date, and only 249,999 shares of common stock remained available for issuance under the 2023 Plan as of the Record Date. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:30%"/>

<td style="vertical-align:bottom;width:17%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:16%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:17%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">(a)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">(b)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">(c)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Plan Category</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Number&#160;of&#160;Shares&#160;to&#160;be<br/>Issued&#160;Upon&#160;Exercise<br/>of Outstanding Options<br/>and RSUs</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap">Weighted-Average</span><br/>Exercise Price of<br/>Outstanding&#160;Options<sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Number&#160;of&#160;Shares<br/>Remaining&#160;Available<br/>for Future Issuance<br/>Under Equity<br/>Compensation Plans<br/>(Excluding Shares<br/>Reflected in Column<br/>(a))</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans approved by stockholders<sup style="font-size:75%; vertical-align:top">(2)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">370,272</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(3)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">58.19</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">328,198</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(4)(5)</sup>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans not approved by stockholders</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">370,272</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">58.19</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">328,198</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Represents the weighted average exercise price of outstanding stock options and warrants. Outstanding restricted stock units are not included in such weighted average exercise price calculations because restricted stock units do not have an exercise price. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">26 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Includes our 2010 Plan, our 2020 Plan, our 2023 Plan, and our 2023 Employee Stock Purchase Plan (our &#8220;ESPP&#8221;). </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (i) 265,772 shares of common stock issuable upon the exercise of outstanding stock options and (ii) 104,500 shares of common stock issuable upon vesting of restricted stock units. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">As of December&#160;31, 2024, there were 242,752 shares of common stock available for grant under our 2023 Plan, no shares available for grant under our 2010 Plan or 2020 Plan, and 85,446 shares of common stock available for grant under our ESPP. Amounts do not include the 229,948 shares of common stock which were added to the number of shares reserved and available for issuance under the 2023 Plan on January&#160;1, 2025 or the 45,990 shares of common stock which were added to the number of shares reserved and available for issuance under the ESPP on January&#160;1, 2025, in each case in accordance with the automatic annual increases described in footnote 5 below. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(5)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Our 2023 Plan provides that the number of shares reserved for issuance under the plan will automatically increase on January&#160;1, 2024 and each January&#160;1 thereafter through January&#160;1, 2033 by 5% of the number of Fully-Diluted Shares Outstanding as of the immediately preceding December&#160;31 or such lesser amount as determined by our Board of Directors or Compensation Committee. Our ESPP provides that the number of shares reserved for issuance under the plan will automatically increase on January&#160;1, 2024 and each January&#160;1 thereafter by the least of (i) 1% of the Fully-Diluted Shares Outstanding as of the immediately preceding December&#160;31, (ii) 64,000 shares of our common stock, or (iii)&#160;such lesser number of shares as determined by our Compensation Committee. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">New Plan Benefits Table </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No awards have been granted, and no shares of any class of our common stock have been issued, on the basis of the proposed share increase under the Amended and Restated Plan. It is not possible to determine the specific amounts and types of awards that may be awarded in the future under the proposed Amended and Restated Plan because the grant and actual <span style="white-space:nowrap">pay-out</span> of awards under the Amended and Restated Plan are subject to the discretion of the Compensation Committee. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Proposal 3 requires the affirmative vote of the holders of a majority of the votes properly cast. Abstentions and broker non-votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this Proposal 3. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">FOR</span> THE PLAN AMENDMENT PROPOSAL. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">27 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_7">PROPOSAL 4: OPTION REPRICING PROPOSAL </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are seeking stockholder approval of a proposed <span style="white-space:nowrap">one-time</span> repricing (the &#8220;Option Repricing&#8221;) of certain outstanding stock options granted to, and held by, certain of our employees, including our executive officers, and consultants through the Repricing Date (as defined below) (collectively, the &#8220;Eligible Optionholders&#8221;), under our 2023 Plan, that have exercise prices in excess of the Repriced Exercise Price (as defined below) and have been granted on or after August&#160;1, 2023 (such options, the &#8220;Eligible Options&#8221;), covering up to an aggregate of 110,990&#160;shares of our common stock. The Eligible Options were granted from September 20, 2023 through June&#160;14, 2024, and currently have per share exercise prices between $30.75 and $132.25. To participate in the Option Repricing, each holder of an Eligible Option must continue to be an employee or other service provider of the Company through the Repricing Date, unless otherwise provided by the Board or Compensation Committee. For the avoidance of doubt, options held by Eligible Optionholders that have a per share exercise price that is below the Repriced Exercise Price will not be considered Eligible Options and will not be impacted by the Option Repricing in any manner. Except as modified by the Option Repricing, all other terms and conditions of the Eligible Options, including, without limitation, any provisions with respect to vesting and term of the options, will remain in full force and effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&#160;15, 2025, the Board approved, following a review by the Compensation Committee, subject to the approval of the stockholders at the Annual Meeting, the Option Repricing. If approved by the stockholders at the Annual Meeting, effective as of the Repricing Date, the per share exercise price of each Eligible Option held by an Eligible Optionholder who is an employee or other service provider of our company on the Repricing Date (or for which participation in the Option Repricing has been specifically provided by the Board or Compensation Committee) will automatically be reduced to the greater of (i)&#160;the price per share of our common stock in any equity raise consummated prior to the Annual Meeting and (ii)&#160;the closing trading price per share of our common stock on the NYSE on the effective date of approval by our stockholders at the Annual Meeting (such date, the &#8220;Repricing Date,&#8221; and such exercise price per share of our common stock, the &#8220;Repriced Exercise Price&#8221;) without any action on the part of the Eligible Optionholders; provided, however, that, unless otherwise provided by the Board or Compensation Committee, an Eligible Option will revert to its original exercise price per share (the &#8220;Original Price&#8221;) if (i)&#160;such Eligible Option is exercised prior to the <span style="white-space:nowrap">one-year</span> anniversary of the Repricing Date (the &#8220;Retention Date&#8221;), (ii) an Eligible Optionholder&#8217;s Service Relationship (as defined in the 2023 Plan) is terminated by us for Cause (as defined in the applicable award agreement for Eligible Options granted under the 2023 Plan) prior to the Retention Date, or (iii)&#160;an Eligible Optionholder resigns from their employment or other service relationship with us for any reason prior to the Retention Date (provided that, for any Eligible Optionholder party to an employment agreement or offer letter pursuant to which such Eligible Optionholder is entitled to &#8220;good reason&#8221; protection, such Eligible Optionholder shall retain the Repriced Exercise Price if such Eligible Optionholder resigns for &#8220;good reason&#8221;). Notwithstanding the foregoing, in the event of (A)&#160;a Sale Event (as defined in the 2023 Plan) prior to the applicable Retention Date or (B)&#160;the termination of the Eligible Optionholder&#8217;s Service Relationship by us without &#8220;cause&#8221; (as determined in accordance with the applicable award agreement for such Eligible Option) or for &#8220;good reason&#8221; (as applicable for any Eligible Optionholder party to an employment agreement or offer letter pursuant to which such Eligible Optionholder is entitled to &#8220;good reason&#8221; protection) or (C)&#160;the Eligible Optionholder&#8217;s death or disability (as determined in accordance with the applicable award agreement for such Eligible Option), each Eligible Option shall retain the Repriced Exercise Price to the extent it has not otherwise reverted to the Original Price in accordance with the foregoing and the ability to exercise such Eligible Option may be accelerated to earlier than the Retention Date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board believes that the Option Repricing is in the best interests of the Company and our stockholders, as it provides incentives to retain and motivate the Eligible Optionholders without incurring (i)&#160;the stock dilution that would result from significant additional equity grants or (ii)&#160;additional cash expenditures that would result from additional cash compensation. Additionally, the Board continues to believe in value creation rather than value transfer and views the Option Repricing as consistent with its approach of orienting long-term incentives </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">28 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
toward stock options as a tool to minimize incremental dilution for stockholders, facilitate employee retention as we pursue our business strategy, restore the retention value of the Eligible Options, and provide Eligible Optionholders with actual retentive holding power and a more realistic incentive to drive stockholder value creation, thereby supporting our continued focus on stock price recovery and growth. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Rationale for Repricing </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As highlighted previously in connection with Proposal 3, equity incentive awards are a critical component of our executive and key, <span style="white-space:nowrap">non-executive</span> employees&#8217; overall compensation, particularly given our focus on managing our cash burn, the general freeze on base salaries, and <span style="white-space:nowrap">non-payment</span> of cash bonuses since 2022. A commitment to long-term equity incentive compensation also provides our employees, executive officers, and certain consultants with a strong link to our long-term performance and helps create an ownership culture by encouraging them to work toward our success, aligning their interests with those of our stockholders, and rewarding efforts that drive sustained increases in stockholder value. Given the intense competition for experienced and talented individuals with critical and high demand skills in our industry, long-term equity compensation, including stock options, also plays a significant role in our ability to attract, motivate, and retain qualified individuals who we believe can make the most meaningful contributions towards achieving our strategic business objectives. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currently, however, none of our outstanding stock options has any retentive value. In considering whether to implement the Option Repricing, the Board determined that adverse changes in the market price of our common stock since the Eligible Options were granted could materially interfere with our efforts to retain the services of the Eligible Optionholders. Our stock price has experienced a significant decline during the past few years. As a result, our Eligible Optionholders now hold options with exercise prices meaningfully above the recent trading range of our common stock (often referred to as &#8220;underwater&#8221; or <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">&#8220;out-of-the-money&#8221;).</span></span></span> As a result, our outstanding options provide no means of incentivizing or retaining such holders, as shown in the table below. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:29%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Range&#160;of&#160;Exercise<br/>Prices of Eligible<br/>Options</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Number&#160;of&#160;Shares<br/>Underlying<br/>Eligible Options</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Fair&#160;Market&#160;Value<br/>of Common Stock<br/>Per Share<sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">%&#160;Over&#160;Fair<br/>Market&#160;Value&#160;of<br/>Common Stock Per<br/>Share<sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">Non-executive</span> officer employees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><span style="white-space:nowrap">30.75&#160;-&#160;$135.25</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">29,002</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1.85</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><span style="white-space:nowrap">1,662%&#160;-&#160;7,311%</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive officers</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><span style="white-space:nowrap">35.75&#160;-&#160;$74.00&#8199;</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">79,568</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1.85</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><span style="white-space:nowrap">1,932%&#160;-&#160;4,000%</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consultants</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><span style="white-space:nowrap">30.75&#160;-&#160;$42.50&#8199;</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,420</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1.85</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><span style="white-space:nowrap">1,662%&#160;-&#160;2,297%</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> </div> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Fair market value is based on the closing price per share of our common stock on the NYSE on the Record Date. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwater options may be perceived by their holders as having little or no incentive or retention value due to the disparity between the exercise prices and the current stock price. The Board believes that the Option Repricing is in the best interests of our company and our stockholders, not only to restore the incentive and retentive value of the Eligible Options, but also to improve morale among our employees and certain consultants to ensure alignment and motivation to execute on our reprioritized strategy, drive value for our stockholders, and share in that value going forward. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to approving the Option Repricing, the Compensation Committee and/or Board reviewed and considered several alternatives to the Option Repricing. These alternatives included: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Extending an offer to exchange underwater options for another form of equity compensation</span>. However, any exchange proposal would have required compliance with the SEC&#8217;s tender offer rules and result in additional cash costs, complexities, and burdens on our resources. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Granting additional options or other types of equity awards</span>. However, this would result in increasing our overhang of outstanding equity awards, and we believe that adjusting already outstanding options </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">29 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
can realign the interests of the Eligible Optionholders with those of our stockholders in a less dilutive manner that would better serve the interests of our stockholders. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Waiting out the volatility in anticipation of future results and stock price appreciation</span>. However, given the significant depression on our stock price since our initial public offering, we are concerned that the time it may take for the Eligible Optionholders to receive long-term value from their options will jeopardize our ability to retain the Eligible Optionholders whose knowledge, skills, and performance are critical to our success. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Increase cash compensation</span>. However, significant increases in cash compensation would substantially increase our compensation expenses and reduce our cash on hand, which could adversely affect our business and operating results. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board ultimately determined that the Option Repricing would be the most effective tool in obtaining our objective of realigning interests of the Eligible Optionholders with those of our stockholders because it provides a direct and straightforward means of resetting the incentive value of the Eligible Options. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Specifics of the Option Repricing </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If approved by the stockholders at the Annual Meeting, effective as of the Repricing Date, the per share exercise price of each Eligible Option held by an Eligible Optionholder who is an employee or other service provider of our company through the Repricing Date (or for which participation in the Option Repricing has been specifically provided by the Board or Compensation Committee) will automatically be reduced to the Repriced Exercise Price; provided, however, that, unless otherwise provided by the Board or Compensation Committee, an Eligible Option will revert to the Original Price) if (i)&#160;such Eligible Option is exercised prior to the Retention Date, (ii) an Eligible Optionholder&#8217;s Service Relationship (as defined in the 2023 Plan) is terminated by us for Cause (as defined in the applicable award agreement for Eligible Options granted under the 2023 Plan) prior to the applicable Retention Date, or (iii)&#160;an Eligible Optionholder resigns from their employment or other service relationship with our company for any reason prior to the applicable Retention Date (provided that, for any Eligible Optionholder party to an employment agreement or offer letter pursuant to which such Eligible Optionholder is entitled to &#8220;good reason&#8221; protection, such Eligible Optionholder shall retain the Repriced Exercise Price if such Eligible Optionholder resigns for &#8220;good reason&#8221;). Notwithstanding the foregoing, in the event of (A)&#160;for Eligible Options granted under the 2023 Plan or 2020 Plan, a Sale Event (as defined in the applicable plan document) prior to the applicable Retention Date or (B)&#160;the termination of the Eligible Optionholder&#8217;s Service Relationship by our company without &#8220;cause&#8221; (as determined in accordance with the applicable plan document or award agreement for such Eligible Option) or for &#8220;good reason&#8221; (as applicable for any Eligible Optionholder party to an employment agreement or offer letter pursuant to which such Eligible Optionholder is entitled to &#8220;good reason&#8221; protection) or (iii)&#160;the Eligible Optionholder&#8217;s death or disability (as determined in accordance with the applicable plan document or award agreement for such Eligible Option), each Eligible Option shall retain the Repriced Exercise Price to the extent it has not otherwise reverted to the Original Price in accordance with the foregoing and the ability to exercise such Eligible Option may be accelerated to earlier than the applicable Retention Date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except for the reduction in the exercise price of the Eligible Options, the Option Repricing will have no other impact on the Eligible Options and all outstanding stock options under the 2023 Plan will continue to remain outstanding in accordance with the current terms and conditions set forth in the 2023 Plan and the applicable award agreements, including without limitation, any provisions with respect to vesting and term of the options. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">30 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides information as of the Record Date regarding the Eligible Options. The closing price of our common stock on the NYSE on such date was $1.85 per share. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:30%"/>

<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Range&#160;of&#160;Exercise<br/>Prices of Eligible<br/>Options</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Number&#160;of&#160;Shares<br/>Underlying<br/>Eligible Options</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Weighted&#160;Average<br/>Exercise Prices of<br/>Eligible Options</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Weighted&#160;Average<br/>Remaining Term<br/>of&#160;Eligible&#160;Options<br/>(Years)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">Non-executive</span> officer employees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><span style="white-space:nowrap">30.75&#160;-&#160;$135.25</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">29,002</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">51.34</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">8.5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive officers</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><span style="white-space:nowrap">35.75&#160;-&#160;$74.00&#8199;</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">79,568</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">56.25</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">8.5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consultants</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><span style="white-space:nowrap">30.75&#160;-&#160;$42.50&#8199;</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,420</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">40.46</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">8.5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Eligible Options </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our employees (including our named executive officers) hold Eligible Options that would potentially benefit from the Option Repricing, in each case subject to the terms and conditions described above under &#8220;<span style="font-style:italic">Specifics of the Option Repricing</span>.&#8221; The following table sets forth, with respect to the individuals and groups identified therein, the number of shares subject to Eligible Options held by such persons or groups and the weighted average exercise price of the Eligible Options, in each case, as of the Record Date. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:70%"/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:9pt; font-family:Times New Roman;font-weight:bold">Name and Position</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Number&#160;of<br/>Shares<br/>Subject to<br/>Eligible<br/>Options</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Weighted<br/>Average<br/>Exercise<br/>Price of<br/>Eligible<br/>Options</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Named Executive Officers</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shantanu Gaur, M.D., <span style="font-style:italic">Chief Executive Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">57,144</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">57.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brendan Gibbons, <span style="font-style:italic">Chief Legal and People Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10,153</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">74.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ojas Buch, <span style="font-style:italic">Chief Operating Officer</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,271</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">35.75</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current executive officers, as a group (3 persons)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">79,568</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">56.25</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current <span style="white-space:nowrap">non-employee</span> directors, as a group (7&#160;persons)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current <span style="white-space:nowrap">non-executive</span> officer employees, as a group (35 persons)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">31,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">50.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Interests of Certain Persons in the Option Repricing </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In considering the Board&#8217;s recommendation with respect to the approval of the Option Repricing, stockholders should be aware that, as discussed above, certain of our current employees, including our executive officers, hold Eligible Options that will be repriced if the proposal is approved at the Annual Meeting. The Board acknowledges that approval of this proposal may benefit our employees, executive officers, and their respective successors. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Accounting Treatment of the Option Repricing </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted the provisions of Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 718 (&#8220;Topic 718&#8221;) regarding accounting for share-based payments. Under FASB ASC Topic 718, we will recognize the original grant date fair value plus the incremental fair value resulting from the modification as compensation. The incremental compensation cost will be measured as the excess, if any, of the fair value of the repriced Eligible Options immediately following the Option Repricing over the fair value of the Eligible Options immediately prior to the Option Repricing. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">31 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Certain U.S. Federal Income Tax Consequences </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a general summary as of this date of the federal income tax consequences to us and to U.S. participants for options granted under the 2023 Plan. The federal tax laws may change and the tax consequences for any participant will depend upon his or her individual circumstances. Tax consequences for any particular individual may be different. This summary does not purport to be complete, and does not discuss state, local or <span style="white-space:nowrap">non-U.S.</span> tax consequences. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Incentive Stock Options </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For income tax purposes, the repricing of an Eligible Option that is an ISO is treated as a new option granted as of the Repricing Date and certain options previously denominated as ISOs may be converted to <span style="white-space:nowrap">non-qualified</span> stock options as a result of the Option Repricing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The grant (including the deemed grant as a result of the repricing) or exercise of an ISO under the 2023 Plan is not expected to result in any federal income tax consequences to the participant or to the Company. However, the amount by which the fair market value of the shares at the time of exercise exceeds the exercise price will be an &#8220;item of adjustment&#8221; for participants for purposes of the alternative minimum tax, unless the shares are sold or otherwise disposed of in the same year the ISO is exercised. Gain realized by participants on the sale of shares underlying an ISO is taxable at capital gains rates, and no tax deduction is available to us, unless the participant disposes of the shares within (i)&#160;two years after the date of grant of the option or (ii)&#160;within one year of the date the shares were transferred to the participant. If the shares are sold or otherwise disposed of before the end of the <span style="white-space:nowrap">one-year</span> and <span style="white-space:nowrap">two-year</span> periods specified above, the difference between the option exercise price and the fair market value of the shares on the date of the option&#8217;s exercise (or the date of sale, if less) will be taxed at ordinary income rates, and we will be entitled to a deduction to the extent that the participant recognizes ordinary income. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="white-space:nowrap">Non-Qualified</span> Stock Options </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The grant or repricing of a <span style="white-space:nowrap">non-qualified</span> stock option under the 2023 Plan is not expected to result in any federal income tax consequences to the participant or to the Company. Generally, upon exercise of a <span style="white-space:nowrap">non-qualified</span> stock option, the participant will realize ordinary income, and we will be entitled to a tax deduction, in an amount equal to the difference between the option exercise price and the fair market value of the shares at the time of exercise. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Tax Effect for the Company </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We generally will be entitled to a tax deduction in connection with the Option Repricing in an amount equal to the ordinary income realized by the holder at the time the holder recognizes such income (for example, the exercise of a <span style="white-space:nowrap">non-qualified</span> stock option). We will generally not be entitled to a tax deduction in the case of an ISO for which there is a qualifying disposition following exercise. Special rules limit the deductibility of compensation paid to our Chief Executive Officer and other &#8220;covered employees&#8221; within the meaning of Section&#160;162(m) of the Code. Under Code Section&#160;162(m), the annual compensation paid to any of these specified service providers will be deductible only to the extent that it does not exceed $1,000,000. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Required Vote and Recommendation of the Board for Proposal 4 </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The affirmative vote of the holders of a majority of the votes properly cast will be required to approve this Proposal 4. Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this Proposal 4. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">FOR</span> THE OPTION REPRICING PROPOSAL. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">32 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_9">PROPOSAL 5: PREFERRED SHARES ISSUANCE PROPOSAL </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board is asking stockholders to consider and vote upon a proposal to approve the issuance of shares of common stock upon the conversion of the Series B Preferred Stock, pursuant to a Securities Purchase and Exchange Agreement, dated as of November 11, 2025 (the &#8220;Exchange Agreement&#8221;), by and among us and RTW, in accordance with NYSE Listing Rule 312.03(b)(i), 312.03(c) and 312.03(d). </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As we evaluate our ability to regain compliance with the continued listing requirements of the NYSE and/or to gain compliance with the initial listing requirements of an alternative national securities exchange, achievement of stockholders&#8217; equity equal to or exceeding certain thresholds is a significant pathway to such potential compliance. As detailed below, pursuant to the Exchange Agreement, RTW has agreed to exchange all of the (i) principal amount of Notes (as defined below), including interest accrued on the Notes up to but excluding the closing date of the Exchange (as defined below); (ii) Company obligations under the First RIFA; and (c) Company obligations under the Second RIFA (clauses (i)-(iii), collectively, the &#8220;Exchange&#8221;). We entered into the Exchange Agreement with RTW and, subject to (among other things) the approval of this Proposal 5, the consummation of the Exchange, in order to effectuate the exchange of our outstanding indebtedness for shares of Series B Preferred Stock that would be reflected on our balance sheet as equity interests, resulting in a substantial increase in stockholders&#8217; equity set forth thereon. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Background </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Amended Note Purchase Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&#160;14, 2024, we entered into the Note Purchase Agreement with RTW Investments, LP, as agent for the purchasers (the &#8220;Note Purchasers&#8221;) party thereto from time to time (RTW in such capacity, the &#8220;Principal Purchaser&#8221;), and Acquiom Agency Services LLC as collateral agent for the Note Purchasers and Principal Purchaser, as amended on April&#160;16, 2024 by the First Amendment to the Note Purchase Agreement, on January&#160;7, 2025 by the Omnibus Amendment (the &#8220;Omnibus Amendment&#8221;) and on April&#160;15, 2025 by the Second Amendment to the Note Purchase Agreement (as amended, the &#8220;Amended Note Purchase Agreement&#8221;), pursuant to which the Company issued and sold $48&#160;million aggregate principal amount of convertible senior secured notes (the &#8220;Notes&#8221;) to the Note Purchasers in a private placement transaction. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Amended Note Purchase Agreement, $5.0&#160;million of principal amount of the Notes were mandatorily converted into 1,492,539 shares of common stock as a result of our market capitalization, as determined in accordance with the rules of the NYSE, falling below $15.0&#160;million (the &#8220;Market Capitalization Condition&#8221;). The Note Purchasers also had the right to provide us notice to convert up to an additional $5.0&#160;million of aggregate principal amount of the Notes into shares of our common stock at an agreed conversion rate, which we could accept or reject in our sole discretion. The Note Purchasers delivered such notice on November 4, 2025, which we accepted on November 5, 2025. On November 6, 2025, $5.0 million of principal amount of the Notes were converted at the floor conversion price of $3.35 per share of common stock (the &#8220;Floor Conversion Rate&#8221;) into 1,492,539 shares of common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, without regard to the Market Capitalization Condition, the Note Purchasers may provide us notice to convert up to an additional $5.0&#160;million aggregate principal amount of the Notes into shares of common stock at the <span style="white-space:nowrap">5-Day</span> VWAP Conversion Rate, which we may accept or reject in our sole discretion. The &#8220;5 Day VWAP Conversion Rate&#8221; is the lesser of (i)&#160;the quotient of $1,000 divided by the daily volume weighted average price (&#8220;VWAP&#8221;) of our common stock for the five consecutive trading day period ending on the trading day immediately preceding the date of the delivery of the Purchaser&#8217;s notice discounted by 5% and (ii)&#160;the Floor Conversion Rate. Finally, during the one year period ending on April&#160;15, 2026, the Note Purchasers in their sole discretion may provide us notice to convert up to an additional $1.0&#160;million aggregate principal amount of the Notes in any <span style="white-space:nowrap">30-day</span> period into shares of common stock at the <span style="white-space:nowrap">5-Day</span> VWAP Conversion Rate. If the Note </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">33 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Purchasers do not exercise their right to provide a notice to convert all or a portion of $1.0&#160;million aggregate principal amount of the Notes per month, any shortfall may be included in the amount to be converted in a subsequent <span style="white-space:nowrap">30-day</span> period. The maximum principal amount of the Notes that may be converted under such monthly conversion provision is $12.0&#160;million. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Revenue Interest Financing Agreements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&#160;9, 2023, we entered into a revenue interest financing agreement with certain entities that have engaged RTW as investment manager (collectively, the &#8220;RIFA Investors&#8221;), as amended by the Omnibus Amendment (the &#8220;RIFA Amendment&#8221;), dated as of April 14, 2024 and as amended by the Omnibus Amendment (as amended, the &#8220;First RIFA&#8221;), pursuant to which we received $40.0&#160;million upfront. In exchange, we are obligated to remit to the RIFA Investors certain revenue interest payments on all current and future products, digital solutions and services developed, imported, manufactured, marketed, offered for sale, promoted, sold, tested or otherwise distributed by us and our subsidiaries at a rate up to 6.0% of annual net sales prior to December&#160;31, 2026. On or after January&#160;1, 2027, we will remit revenue interest payments at a rate up to 10.0% of annual net sales, and we will continue to make revenue interest payments to RIFA Investors until December&#160;31, 2030. The RIFA Amendment, among other things, increased the rate of interest payments for net sales less than or equal to $100&#160;million prior to December&#160;31, 2026 from 6% to 12% and increased the rate on net sales of less than or equal to $100&#160;million on or after January&#160;1, 2027 from 10% to 12%. Additionally, the prepayment amount was modified such that, prior to March&#160;31, 2026, we are entitled to settle the revenue interest financing for a prepayment amount that would allow the RIFA Investors to yield a 20% internal rate of return. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, on October&#160;22, 2024, the RIFA Investors exercised their option pursuant to an amended and restated side letter, dated May&#160;2, 2023, by and among us and the RIFA Investors, to surrender 30,000 shares of our common stock representing $7.5&#160;million in consideration for an additional revenue interest financing agreement (the &#8220;Investment Conversion&#8221;). Accordingly, on October&#160;30, 2024, we and the RIFA Investors entered into an additional Revenue Interest Financing Agreement (as amended by the Omnibus Amendment, the &#8220;Second RIFA&#8221;). The Second RIFA has substantially identical terms and conditions as the First RIFA, except that the amount of financing provided under the Second RIFA is equal to the conversion amount of $7.5&#160;million. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Exchange Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November 11, 2025, we entered into the Exchange Agreement, pursuant to which RTW has agreed to exchange all of the (i) principal amount of Notes, including interest accrued on the Notes up to but excluding the closing date of the Exchange; (ii) Company&#8217;s obligations under the First RIFA; and (c) Company&#8217;s obligations under the Second RIFA. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consummation of the Exchange is subject to, among other things, stockholder approval of the issuance of the shares of common stock upon conversion of the Series B Preferred Stock (the &#8220;Preferred Shares&#8221; and such issuance, the &#8220;Preferred Shares Issuance&#8221;) in accordance with NYSE Listing Rules, compliance with the listing requirements of the national securities exchange on which the common stock is then listed and the approval for listing of such shares of common stock upon conversion of the Series B Preferred Stock by such national exchange. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We entered into the Exchange Agreement with RTW and, subject to (among other things) the approval of this Proposal 5, the consummation of the Exchange, in order to effectuate the exchange of our outstanding indebtedness for shares of Series B Preferred Stock that would be reflected on the Company&#8217;s balance sheet as equity interests, resulting in a substantial increase in stockholders&#8217; equity set forth thereon. As we evaluates our ability to regain compliance with the continued listing requirements of the NYSE and/or to gain compliance with the initial listing requirements of an alternative national securities exchange, achievement of stockholders&#8217; equity equal to or exceeding certain thresholds is a significant pathway to such potential compliance. </p> </div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">34 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This description of the Exchange Agreement and the transactions related thereto does not purport to be complete and is qualified in its entirety by reference to the full text of the Exchange Agreement, which was filed with the SEC as Exhibit 10.3 to our Form <span style="white-space:nowrap">8-K</span> on November 12, 2025. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NYSE Requirements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Listing Rules 312.03(b)(i), 312.03(c) and 312.03(d) </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NYSE Listing Rule 312.03(b)(i) provides that stockholder approval is required prior to the issuance of common stock, or of securities convertible into or exercisable for common stock, in any transaction or series of related transactions to a director, officer, controlling shareholder or member of a control group, or any other substantial security holder of the issuer that has an affiliated person who is an officer or director of the company (each, an &#8220;Active Related Party&#8221;), if the number of shares of common stock to be issued, or the number of shares of common stock into which the securities may be convertible or exercisable, exceeds either 1.0% of the number of shares of common stock or 1.0% of the voting power outstanding before the issuance. In addition, NYSE Listing Rule 312.03(c) provides that stockholder approval is required prior to the issuance of common stock, or of securities convertible into or exercisable for common stock, in any transaction or series of related transactions if: (i)&#160;the common stock has, or will have upon issuance, voting power equal to or in excess of 20% of the voting power outstanding before the issuance of such stock; or (ii)&#160;the number of shares of common stock to be issued is, or will be upon issuance, equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance of the common stock. However, stockholder approval under NYSE Listing Rules 312.03(b)(i) and 312.03(c) is not required if such transaction is a cash sale for a price that is at least the &#8220;Minimum Price.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#8220;Minimum Price&#8221; is defined as a price that is the lower of (i)&#160;the Official Closing Price immediately preceding the signing of the binding agreement, or (ii)&#160;the average Official Closing Price for the five trading days immediately preceding the signing of the binding agreement. &#8220;Official Closing Price&#8221; means the closing price on the NYSE as reported to the Consolidated Tape immediately preceding the signing of a binding agreement to issue the securities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, NYSE Listing Rule 312.03(d) provides that stockholder approval is required for any issuance that will result in a change of control of the issuer. Under applicable NYSE guidance, a change of control may be deemed to occur if a substantial stockholder acquires shares of common stock resulting in the ownership of additional shares, even though such stockholder owns less than a majority of the total voting power of all of the listed company&#8217;s outstanding shares of common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Continued Listing Standards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&#160;29, 2024, we received written notice (the &#8220;Market Cap Notice&#8221;) from the NYSE that we are not in compliance with the continued listing standard set forth in Section&#160;802.01B of the NYSE&#8217;s Listed Company Manual (the &#8220;Minimum Market Capitalization Standard&#8221;) because our average market capitalization was less than $50.0&#160;million over the consecutive 30 <span style="white-space:nowrap">trading-day</span> period ended August&#160;29, 2024, and our last reported stockholders&#8217; equity as of August&#160;29, 2024 was less than $50.0&#160;million. The Market Cap Notice did not result in the immediate delisting of our common stock from the NYSE. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with applicable NYSE procedures, we submitted a plan to the NYSE advising it of the definitive action(s) we have taken, are taking, and/or plan to take that would bring us into conformity with the Minimum Market Capitalization Standard within 18 months of receipt of the Market Cap Notice (the &#8220;Market Cap Cure Period&#8221;). The NYSE accepted our plan and currently reviews us on a quarterly basis to confirm our compliance with the plan. If we fail to comply with the plan, or we do not meet the Minimum Market Capitalization Standard at the end of the Market Cap Cure Period, we will be subject to NYSE&#8217;s prompt initiation of suspension and delisting procedures. Although the issuance of shares of common stock upon conversion of the Series B Preferred Stock may result in an increase in our market capitalization, we cannot assure you that it will </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">35 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
result in satisfaction of the Minimum Market Capitalization Standard. In addition, we may seek to list our common stock on an alternative national securities exchange. In order to do so, we will be required to comply with the initial listing requirements of such alternative national securities exchange, which may include an alternative market capitalization requirements. As we evaluate our ability to regain compliance with the continued listing requirements of the NYSE and/or to gain compliance with the initial listing requirements of an alternative national securities exchange, achievement of a market capitalization equal to or exceeding certain thresholds is a significant pathway to such potential compliance. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Series B Preferred Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rights and limitations of the Series B Preferred Stock will be set forth in a certificate of designations of rights and preferences of Series B Preferred Stock (the &#8220;Certificate of Designations&#8221;) to be filed with the Secretary of State of the State of Delaware prior to the Closing and, with respect to the registration rights described below, as set forth in the Exchange Agreement. This description of the Preferred Stock does not purport to be complete and is qualified in its entirety by reference to the complete text of the Certificate of Designations, attached as <span style="text-decoration:underline">Appendix B</span> of this Proxy Statement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">General </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each share of Series B Preferred Stock has an initial stated value of $1,000.00 per share and, when issued, each share of Series B Preferred Stock will be fully paid and <span style="white-space:nowrap">non-assessable.</span> With respect to the payment of dividends, distributions and payments upon the liquidation, dissolution and winding up of the company, the Series B Preferred Stock will rank senior to all other capital stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Conversion </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series B Preferred Stock is convertible into shares of common stock at the holder&#8217;s election at any time subject to the terms and conditions of the Exchange Agreement. Each share of Series B Preferred Stock converts into a number of shares of common stock equal to the amount determined by dividing (x)&#160;the stated value of $1,000, together with any accrued dividends, by (y)&#160;the conversion price of $3.37, subject to adjustment, and provided, that in no event shall a holder of Series B Preferred Stock have the right to convert such holders&#8217; Series&#160;B Preferred&#160;Stock if, following such conversion, such holder and its affiliates would own shares of common stock exceeding 9.9% of the total number of shares of common stock outstanding. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If certain corporate events occur and a holder of our Series B Preferred Stock elects to convert its shares of Series B Preferred Stock after a Make-Whole Fundamental Change (as defined in the Certificate of Designations), then the conversion rate shall be increased for such holder as set forth in the Certificate of Designations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Voting Rights </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of Series B Preferred Stock will be entitled to vote on all matters on which the holders of shares of common stock are entitled to vote, together as a single class; provided that holders of our Series B Preferred Stock shall not be entitled to vote to the extent the Series B Preferred Stock is not convertible as a result of the beneficial ownership limitation (as described below) or is otherwise not eligible to vote under the applicable rules of the NYSE or other applicable national securities exchange on which the common stock is then listed. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Dividend Rights </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series B Preferred Stock accrues dividends at a rate of 8.25% per annum. The dividends are payable to each record holder of the Series B Preferred Stock in cash; provided that (i) until the second-year anniversary of the Issuance of the Series B Preferred Stock and (ii) following the second-year anniversary of the issuance of the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">36 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Series B Preferred Stock, if we are unable to pay cash dividends in compliance with Delaware law, the Company will, in each case, pay the dividend by increasing the accrued value of the Series B Preferred Stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Liquidation Rights </span></p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of any liquidation, dissolution or winding up of the company, the holders of Series B Preferred Stock will be entitled to be paid out of the assets we have legally available for distribution to stockholders a liquidation preference per share equal to the greater of (i)&#160;the then accrued value plus any dividends, and (ii)&#160;the amount the holders of Series B Preferred Stock would have received upon such liquidation, dissolution or <span style="white-space:nowrap">winding-up</span> of the Company had all such holders converted such Series B Preferred Stock into common stock, in each case, before any distribution of assets is made to holders of all other capital stock. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Registration Rights </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of Series B Preferred Stock are entitled to certain rights with respect to registration of such shares under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Such shares are referred to as &#8220;registrable securities.&#8221; We will pay all registration expenses, other than underwriting discounts, selling commissions and stock transfer taxes, of the shares registered pursuant to the registrations described below. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time after the Closing, any holder of registrable securities may request that we register their shares for resale on a registration statement on Form <span style="white-space:nowrap">S-3,</span> subject to specified conditions and limitations. We must cause such registration statement to become effective as soon as reasonably practicable thereafter, but in any event within 90 days of the filing date. If the registration statement has not become effective by such date, or becomes suspended or subject to an effective stop order (subject to applicable grace periods), we will be required to pay liquidated damages of 0.25% of the deemed purchase price to the holders of Series B Preferred Stock every thirty days until such default is cured; provided that such damages shall not exceed 5% of the aggregate purchase consideration paid by the Series B Preferred Stock holders in the aggregate. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, if requested by the holders of Series B Preferred Stock, a sale of registrable securities may be conducted in an underwritten offering; provided, however, that such holders may not, without our prior written consent, launch more than two underwritten offerings within any <span style="white-space:nowrap">365-day</span> period. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Governance Rights </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Investor Rights Agreement, the First RIFA and the Second RIFA, RTW is entitled to designate one director to our Board, initially Nicholas Lewin, who was appointed to the Board effective as of August 2023. Pursuant to the terms of the Amended Note Purchase Agreement, RTW is entitled to designate two directors to our Board, initially Mr.&#160;Lewin and R. Jason Richey, the latter of whom was appointed to the Board effective as of December&#160;30, 2024. Additionally, in August 2024, we expanded our Board from seven to eight members and in September 2024, we appointed Keith B. Johns II to our Board, which appointment was approved by RTW in satisfaction of certain obligations to RTW set forth in the Amended Note Purchase Agreement. If the Exchange is consummated, RTW&#8217;s rights under each of the First RIFA, the Second RIFA and the Amended Note Purchase Agreement shall terminate and be replaced by the rights set forth in the Certificate of Designations, as described below. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Certificate of Designations, for so long as RTW or its affiliates beneficially own at least: (i) 10% of our securities, RTW will have the right to nominate an individual for election to the Board and (ii) 30% of our securities, RTW will have the right to nominate a second individual for election to the Board, in each case subject to the recommendation of the Nominating and Corporate Governance Committee of the Board (the &#8220;Nominating Committee&#8221;) and the approval of the Board. Such individuals shall initially be Nicholas Lewin and R. Jason Richey, respectively, who currently serve on our Board and whose terms expire at our 2026 annual meeting of stockholders and this Annual Meeting, respectively. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">37 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, for so long as (x)&#160;a Specified Breach Event (as defined below) has occurred and is continuing and (y)&#160;RTW or its affiliates beneficially own at least 10% of the Company&#8217;s securities, RTW will have the right to nominate two additional individuals for election to the Board, in each case subject to the recommendation of the Nominating Committee and the approval of the Board. Notwithstanding the foregoing, if the appointment of such individuals would result in a majority of the Board being comprised of individuals nominated by RTW, then (i)&#160;such nomination right shall be reduced so that all individuals nominated by RTW will represent less than a majority of the Board, (ii)&#160;we will use our best efforts to increase the size of the Board as necessary to permit the nomination of both individuals while all individuals nominated by RTW represent less than a majority of the Board, and (iii)&#160;the dividend rate of the Series B Preferred Stock will be increased by 2% during such period that at least one such individual cannot be appointed. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;Specified Breach Event&#8221; means a failure to satisfy our obligations under the Exchange Agreement to: (i)&#160;maintain at all times a minimum aggregate balance of $3.0&#160;million in unrestricted cash and (ii)&#160;obtain a marketing authorization from the Food and Drug Administration for one of our products no later than December&#160;31, 2026, which, in each case, has not been cured. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Beneficial Ownership Limitations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the Series B Preferred Stock provide that in no event shall the Series B Preferred Stock be converted into a number of shares of common stock exceeding 9.9% of the total number of shares of common stock outstanding. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Reason for Seeking Stockholder Approval </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As discussed above, Listing Rule 312.03(b)(i) requires us to obtain stockholder approval prior to the issuance of common stock, or of securities convertible into or exercisable for common stock, to an Active Related Party of the Company if the number of shares of common stock to be issued, or the number of shares of common stock into which the securities may be convertible or exercisable, exceeds 1% of the number of shares of common stock outstanding before the issuance and the transaction is not a cash sale for a price that is at least the Minimum Price. The NYSE determined that RTW is an Active Related Party under Listing Rule 312.03(b)(i). The Series B Preferred Stock currently has a Conversion Price greater than or equal to the Minimum Price as of the date of the Exchange Agreement. However, because the Conversion Price of the Series B Preferred Stock is subject to a reset provision in connection with a Make-Whole Fundamental Change (as defined in the Exchange Agreement) that may result in the Conversion Price falling to a price below the NYSE Minimum Price, pursuant to the terms of the Exchange Agreement, we may not deliver Preferred Shares in excess of 1% of the number of shares of our common stock outstanding unless we obtain stockholder approval of such issuance. We are also seeking stockholder approval under NYSE Listing Rule 312.03(c) because the number of Preferred Shares issuable pursuant to the Exchange Agreement exceeds 20% of the number of shares of common stock outstanding. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, if the Exchange Agreement is approved by our stockholders, the issuance of shares of our common stock to RTW upon such conversion may result in a &#8220;change of control&#8221; for the purposes of Listing Rule 312.03(d). Therefore, we are soliciting stockholder approval for the Preferred Shares Issuance as set forth in the Exchange Agreement, to satisfy such requirement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&#160;15, 2025, the disinterested members of the Board (the &#8220;Disinterested Directors&#8221;), after due consideration of all the factors the Disinterested Directors deemed to be relevant, (i)&#160;determined that the Exchange Agreement, including the form, terms and provisions therein, and the transactions contemplated thereby, including the Exchange (as defined below), were advisable, fair to and in the best interests of us and our disinterested stockholders; (ii)&#160;approved and authorized the Exchange Agreement, including the form, terms and provisions therein, and the transactions contemplated thereby, including the Exchange; and (iii)&#160;approved the execution and delivery of the Exchange Agreement, our performance by of our covenants and other obligations </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">38 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
contained thereunder and the consummation of the transactions or other actions contemplated by the Exchange Agreement. The Disinterested Directors also recommended that our stockholders approve and adopt resolutions approving the Preferred Shares Issuance to RTW pursuant to, and in accordance with, the terms and conditions set forth in the Exchange Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board and the Disinterested Directors additionally determined that the Exchange Agreement, the issuance of the Series B Preferred Stock, and the common stock that may be issued thereby, are in the best interests of the Company and our stockholders because (i)&#160;the corresponding increase in our stockholders equity that will result from the exchange of the Notes for the Series B Preferred Stock, and the contribution of that additional stockholders equity toward gaining compliance with the minimum stockholders&#8217; equity requirement of the NYSE and/or the minimum stockholders&#8217; equity requirement for initial listing of our common stock on an alternative national securities exchange; and (ii)&#160;the extinguishment of the Notes and revenue interest payments will allow us to utilize the cash otherwise needed to repay the Notes and revenue interest payments for working capital. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Exchange Agreement, we are required to use our best efforts to obtain stockholder approval of the issuance of the Preferred Shares. RTW&#8217;s obligation to consummate the closing of the Exchange (the &#8220;Closing&#8221;) is conditioned upon, among other things, the receipt of stockholder approval of the issuance of the Preferred Shares under NYSE Listing Rules no later than January&#160;31, 2026. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholder approval of this Proposal 5 will constitute stockholder approval for purposes of Listing Rule&#160;312.03(b)(i), Listing Rule 312.03(c) and Listing Rule 312.03(d) and will also satisfy our requirements to obtain stockholder approval under the Exchange Agreement. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Consequences for Failing to Obtain Stockholder Approval </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of this Proposal 5 is a closing condition for the Exchange Agreement. If we do not receive the approval contemplated in this Proposal 5, we will not be able to satisfy all conditions of RTW to close the transactions contemplated by the Exchange Agreement, and the Exchange will not be consummated. The Amended Note Purchase Agreement, First RIFA and Second RIFA will remain binding upon us. In addition, if the Exchange is not completed, we will be less likely to gain compliance with the minimum stockholders&#8217; equity requirement of the NYSE or an alternative national securities exchange to maintain our listing on the NYSE, and your securities may be delisted. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that this Proposal 5 is not approved by our stockholders, we will include a proposal in our definitive proxy statement on Schedule 14A seeking stockholder approval of the Preferred Shares Issuance in connection with our 2026 annual meeting of stockholders. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Interests of Certain Persons </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When you consider the Board&#8217;s recommendation to vote in favor of this Proposal 5, you should be aware that our directors and executive officers and existing stockholders may have interests that may be different from, or in addition to, the interests of other of our stockholders. In particular, RTW is a party to the transactions and has the nomination rights described above and, as a result, has an interest in the approval of this Proposal 5. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described elsewhere in this Proxy Statement, RTW has the power to vote 2,542,603 shares of common stock, or approximately 33% of our shares of common stock outstanding as of the Record Date. However, the Amended Note Purchase Agreement provides that, with respect to the shares of common stock issued upon conversion of the Notes, RTW shall either (i)&#160;refrain from voting such shares or (ii)&#160;vote such shares in the same proportion as the shares of common stock voted by holders of our common stock who are not affiliated with RTW. As of the date of this Proxy Statement, $10.0&#160;million of principal amount of the Notes have been converted into 2,985,078 shares of common stock. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">39 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Potential Adverse Effects </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Dilution </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our stockholders vote to approve the Preferred Shares Issuance, the issuance of shares of our common stock upon conversion of the Series B Preferred Stock will not require any additional approval by our common stockholders. The issuance of such common stock will have a dilutive effect on current stockholders other than the purchasers, in that the percentage ownership of the company held by such other current stockholders will decline as a result of the issuance of such common stock. The issuance of such common stock will also have a dilutive effect on book value per share and any future earnings per share. Dilution of equity interests could also cause prevailing market prices for our common stock to decline. Assuming that all of the shares of Series B Preferred Stock are converted into common stock at the current conversion price of $3.37, approximately 29.6&#160;million shares of common stock could be issued. Because the conversion price of the Series B Preferred Stock may be adjusted from time to time, the number of shares that will actually be issued is unknown. The ownership interest of the existing stockholders would be correspondingly reduced depending on the number of shares of common stock issued upon conversion of the Series B Preferred Stock. The sale into the public market of these shares also could materially and adversely affect the market price of the common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Potential Anti-Takeover Effect </span></p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Proposal 5 is approved, the issuance of the common stock could have an anti-takeover effect because such issuance would make it more difficult for, or discourage an attempt by, a party to obtain control of our company by tender offer or other means. The issuance of the common stock will increase the number of shares entitled to vote, increase the number of votes required to approve a change of control of our company, and dilute the interest of a party attempting to obtain control of our company. However, the existing indebtedness, which may have a similar anti-takeover effect, will be eliminated. The Board does not have any current knowledge of any effort by any third party to accumulate our securities or obtain control of our company by any means. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Potential Negative Effect on Market Price </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of our common stock issued upon conversion of the Series B Preferred Stock registered on the resale registration statement (as the same may be amended in the future) will be freely tradable without restriction or further registration. As a result, a substantial number of shares of our common stock may be sold by RTW in the public market. If there are significantly more shares of our common stock offered for sale than buyers are willing to purchase, then the market price of our common stock will decline to a market price at which buyers are willing to purchase the offered common stock and sellers remain willing to sell our common stock. The sale of the shares by RTW, or the perception that such sales may occur, could increase the volatility of the market price of our common stock or result in a significant decline in the public trading price of our common stock. We cannot predict the effect, if any, that market sales of those shares of common stock or the availability of those shares for sale will have on the market price of our common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required; Board Recommendation </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The affirmative vote of the holders of a majority of the votes cast at the Annual Meeting will be required to approve this proposal. Abstentions and broker <span style="white-space:nowrap">non-votes</span> will have no effect on the outcome of this proposal. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">THE BOARD UNANIMOUSLY RECOMMENDS A VOTE </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">FOR </span>THE PREFERRED SHARES ISSUANCE PROPOSAL. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">40 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_10">PROPOSAL 6: PRIVATE PLACEMENT WARRANT SHARES ISSUANCE PROPOSAL </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board is asking stockholders to consider and vote upon a proposal to approve the issuance of shares of our common stock (such shares, the &#8220;Private Placement Warrant Shares&#8221; and such issuance, the &#8220;Private Placement Warrant Shares Issuance&#8221;) upon the exercise of the Private Placement Warrants (as defined below), in accordance with NYSE Listing Rule 312.03(c). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">The Private Placement Warrants </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the securities purchase agreement, dated November 11, 2025, by and between us and each purchaser thereto (the &#8220;Securities Purchase Agreement&#8221;), we issued an aggregate of 2,994,012 shares of common stock (the &#8220;Private Placement Shares&#8221;) and 2,994,012 warrants (the &#8220;Private Placement Warrants&#8221;) in a private placement (the &#8220;Private Placement&#8221;), at an offering price of $1.67 per share and accompanying warrant. The Private Placement closed on November 14, 2025, and resulted in gross proceeds of approximately $5.0 million. The Company intends to use the net proceeds for working capital and general corporate purposes. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NYSE Listing Rule 312.03(c) </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NYSE Listing Rule 312.03(c) provides that stockholder approval is required prior to the issuance of common stock, or of securities convertible into or exercisable for common stock, in any transaction or series of related transactions if: (i)&#160;the common stock has, or will have upon issuance, voting power equal to or in excess of 20% of the voting power outstanding before the issuance of such stock; or (ii)&#160;the number of shares of common stock to be issued is, or will be upon issuance, equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance of the common stock. However, stockholder approval is not required if such transaction is a cash sale for a price that is at least the &#8220;Minimum Price,&#8221; defined in Listing Rule 312 as a price that is the lower of (i)&#160;the Official Closing Price immediately preceding the signing of the binding agreement, or (ii)&#160;the average Official Closing Price for the five trading days immediately preceding the signing of the binding agreement. &#8220;Official Closing Price&#8221; means the closing price on the NYSE as reported to the Consolidated Tape immediately preceding the signing of a binding agreement to issue the securities. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although the offering price per Private Placement Share was greater than the Minimum Price per share of Common Stock, no additional consideration was received for the Private Placement Warrants. Because the Minimum Price of a Private Placement Share of $1.625, together with the Black-Scholes value of the Private Placement Warrant, may collectively be greater than the offering price of $1.67 per Private Placement Share and accompanying Private Placement Warrant, the Private Placement Warrants may be deemed to have been issued at an offering price below the Minimum Price. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Private Placement Warrant Exercise </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Placement Warrants will not be exercisable until we obtain stockholder approval for the Private Placement Warrant Shares Issuance as required by the applicable rules and regulations of the NYSE. The Private Placement Warrants will then be immediately exercisable and will expire on the fifth anniversary of the date such stockholder approval is obtained. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stockholder Approval Requirement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed above, we may be required to obtain stockholder approval to approve the Private Placement Warrant Shares Issuance, in accordance with Listing Rule 312.03(c), because the Private Placement Warrants may be deemed to have been sold at an offering price below the Minimum Price. Pursuant to the Private Placement Purchase Agreement, we have agreed to use reasonable best efforts to hold a special meeting of </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">41 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stockholders seeking stockholder approval of the issuance of the Private Placement Warrant Shares by January&#160;31, 2026. If we do not obtain such stockholder approval at the Annual Meeting, we are obligated to call a meeting every 60 days thereafter to seek such stockholder approval until the earlier of the date on which such stockholder approval is obtained or the Private Placement Warrants are no longer outstanding. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Rights and Limitations </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Registration Rights </span></p> <div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have agreed to file a resale registration statement with the SEC within 60 days of the date of the Securities Purchase Agreement to register the resale of the Private Placement Warrant Shares. We must use commercially reasonable efforts to have such registration statement declared effective by the SEC as promptly as possible, but in no event later than the date which shall be either (a) in the event that the SEC does not review such registration statement, 90 days after the closing date of the Private Placement, or (b) in the event that the SEC does review such registration statement, 120 days after the closing date of the Private Placement (but in any event, no later than five trading days following the SEC&#8217;s notification that it has no further comments to the registration statement). </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Beneficial Ownership Limitations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A holder (together with its affiliates) may not exercise any portion of the Private Placement Warrants to the extent that the holder would own more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding Common Stock immediately after exercise, except that upon at least 61 days&#8217; prior notice from the holder to us, the holder may increase the amount of ownership of outstanding stock after exercising the holder&#8217;s Private Placement Warrants. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Reason for Seeking Stockholder Approval </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed above, we are required to obtain stockholder approval to approve the Private Placement Warrant Shares Issuance, in accordance with Listing Rule 312.03(c), because the Private Placement Warrants may be deemed to have been sold at an offering price below the Minimum Price. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholder approval of this Proposal 6 will constitute stockholder approval for purposes of Listing Rule&#160;312.03(c) and will satisfy our obligation to obtain stockholder approval under the Securities Purchase Agreement. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Consequences for Failing to Obtain Stockholder Approval </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that this Proposal 6 is not approved by our stockholders, we are obligated to call a meeting every 60 days thereafter to seek such stockholder approval until the earlier of the date on which such stockholder approval is obtained or the Private Placement Warrants are no longer outstanding. Such requirement to include such proposal potentially multiple times after this Annual Meeting imposes significant costs on us, including legal and accounting costs, and diversion of management attention. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Placement Warrants are not exercisable until we obtain stockholder approval of the Private Placement Warrant Shares Issuance. Thus, failure to obtain such approval will prevent holders of the Private Placement Warrants from exercising, and we will not be able to receive the exercise price for such Private Placement Warrants until we have obtained stockholder approval. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Potential Adverse Effects </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Dilution </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If our stockholders vote to approve the Private Placement Warrant Shares Issuance, the issuance of Private Placement Warrant Shares will not require any additional approval by our stockholders. The issuance of such </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">42 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Common Stock will have a dilutive effect on current stockholders other than the holders that exercise such warrants, in that the percentage ownership of the Company held by such other current stockholders will decline as a result of the issuance of such Common Stock. The issuance of such Common Stock will also have a dilutive effect on book value per share and any future earnings per share. Dilution of equity interests could also cause prevailing market prices for our Common Stock to decline. The dilutive impact of the Private Placement Warrant Shares Issuance cannot be fully determined as of the date hereof as such Private Placement Warrants are only expected to be exercised if the market price of the Common Stock is above the $1.67 exercise price thereof, and the timing and market price at the time of exercise will not be known until the applicable date of exercise of the Private Placement Warrants. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Potential Negative Effect on Market Price </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Placement Warrant Shares registered on the resale registration statement (as the same may be amended in the future) will be freely tradable without restriction or further registration. As a result, a substantial number of shares of our Common Stock may be sold by the holders of the Private Placement Warrants in the public market. If there are significantly more shares of our Common Stock offered for sale than buyers are willing to purchase, then the market price of our Common Stock will decline to a market price at which buyers are willing to purchase the offered Common Stock and sellers remain willing to sell our Common Stock. The sale of the shares by holders of the Private Placement Warrants, or the perception that such sales may occur, could increase the volatility of the market price of our Common Stock or result in a significant decline in the public trading price of our Common Stock. We cannot predict the effect, if any, that market sales of those shares of Common Stock or the availability of those shares for sale will have on the market price of our Common Stock. </p> <div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Required Vote and Recommendation of the Board for Proposal 6 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of the holders of a majority of the votes properly cast will be required to approve this Proposal 6. Abstentions are not considered to be votes cast and, accordingly, will have no effect on the outcome of this Proposal 6. </p> </div> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">THE BOARD OF DIRECTORS RECOMMENDS A VOTE <span style="text-decoration:underline">FOR</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">THE PRIVATE PLACEMENT WARRANT SHARES ISSUANCE PROPOSAL. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">43 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_11">PROPOSAL 7: REVERSE STOCK SPLIT PROPOSAL </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board has approved and declared advisable, and is asking stockholders to consider and vote upon, an amendment to our Charter to combine the outstanding shares of our common stock into a lesser number of outstanding shares, otherwise known as a &#8220;reverse stock split,&#8221; with the exact ratio and effective time of such Reverse Stock Split to be determined by our Board, subject to the limitations described below. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If approved by our stockholders at the Annual Meeting, the Board would have the sole discretion to effect the Reverse Stock Split at any time within one year of such approval, and to fix the specific ratio for the Reverse Stock Split within the range of not less than <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-1.5</span></span> and not more than <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-20.</span></span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Reverse Stock Split, if approved by our stockholders, would become effective upon the filing with the Secretary of State of the State of Delaware of a Certificate of Amendment to our Charter setting forth the Reverse Stock Split (the &#8220;Certificate of Amendment&#8221;), or at a later time if and as set forth in the Certificate of Amendment. The exact timing will be determined by the Board based on its evaluation as to when such action will be the most advantageous to us and our stockholders. In addition, the Board reserves the right, notwithstanding stockholder approval, to abandon the Reverse Stock Split if, at any time prior to the effectiveness of the Reverse Stock Split, the Board, in its sole discretion, determines that it is no longer in the best interests of our company and our stockholders to proceed. No further action on the part of stockholders will be required to either implement or abandon the Reverse Stock Split. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The proposed form Certificate of Amendment to our Charter to effect the Reverse Stock Split is attached as <span style="text-decoration:underline">Appendix C</span> to this Proxy Statement. Any amendment to our Charter to effect the Reverse Stock Split will include the ratio fixed by the Board within the range approved by our stockholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the Record Date, a total of 7,770,047 shares of our common stock were issued and outstanding and no shares were held in treasury. Based on such number of shares of our common stock issued and outstanding, immediately following the effectiveness of the Reverse Stock Split (and without giving any effect to the treatment of fractional shares), we will have, depending on the reverse stock split ratio selected by our Board, issued and outstanding shares of common stock as illustrated in the table under the heading &#8220;<span style="font-style:italic">Impact on Common Stock</span>&#8221; below. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Reverse Stock Split will not result in a reduction of the total number of shares of our common stock that we are authorized to issue by a corresponding ratio, and, as a result, the number of authorized shares of common stock available for issuance will increase. See &#8220;<span style="font-style:italic">Risk Factors&#8212;Risks Associated with the Reverse Stock</span> <span style="font-style:italic">Split</span>&#8221; below. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All holders of our common stock will be affected proportionately by the Reverse Stock Split. Each stockholder will hold the same percentage of the outstanding common stock immediately following the Reverse Stock Split as that stockholder did immediately prior to the Reverse Stock Split, except to the extent that the Reverse Stock Split results in stockholders receiving additional shares as a result of rounding up fractional shares. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Reasons for Reverse Stock Split </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appeal to a Broader Range of Investors to Generate Greater Investor Interest </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our primary objective in effectuating the Reverse Stock Split is to raise the per share trading price of our common stock in order to appeal to a broader range of investors. We believe that the low market price of our common stock impairs its acceptability to important segments of the institutional investor community and the investing public. An increase in our stock price may make our common stock more attractive to investors. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">44 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Brokerage firms may be reluctant to recommend lower-priced securities to their clients. Many institutional investors have policies prohibiting or discouraging them from holding lower-priced stocks in their portfolios, which reduces the number of potential purchasers of our common stock. Investment funds also may be reluctant to invest in lower-priced stocks. Investors may also be dissuaded from purchasing lower-priced stocks because the brokerage commissions, as a percentage of the total transaction, tend to be higher for such stocks. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, the analysts at many brokerage firms do not monitor the trading activity or otherwise provide coverage of lower-priced stocks. The trading market for our common stock depends, in part, on the research and reports that securities and industry analysts publish about us and our business. If few or no securities or industry analysts cover us, or current analysts cease coverage due to our share price, demand and the trading price for our common stock would likely be negatively impacted. Giving the Board the ability to effect the Reverse Stock Split, and thereby increase the price of our common stock, would give the Board the ability to address these issues if it is deemed necessary. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other Potential Benefits of the Reverse Stock Split </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Improved Perception of Our Common Stock as an Investment Security </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board believes that effecting the Reverse Stock Split is one potential means of increasing the share price of our common stock to improve the perception of our common stock as a viable investment security. Lower-priced stocks have a perception in the investment community as being risky and speculative, which may negatively impact not only the price of our common stock, but also our market liquidity. In the event the Reverse Stock Split increases the trading price of our common stock, it may have the effect of improving this negative perception and market liquidity. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Provide Flexibility to Respond to Future Business Needs&#160;&amp; Opportunities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The availability of additional authorized but unissued shares of our common stock would provide us with increased flexibility to consider and respond to future business needs and opportunities as they arise. While we are currently unaware of any such needs or opportunities, these could include future equity offerings, asset acquisitions, business combinations, and other strategic transactions. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Support the Continued Listing of Our Common Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on NYSE under the symbol &#8220;ALUR.&#8221; To maintain such listing, we must continue to comply with applicable NYSE listing rules, which, among other things, require a minimum bid price of $1.00 per share. While our common stock currently complies with this rule, we believe the Reverse Stock Split will reduce the risk that it becomes subject to delisting for this reason in the future. In addition, we may seek to list our common stock on an alternative national securities exchange. In order to do so, we will be required to comply with the initial listing requirements of such alternative national securities exchange, which may include a higher minimum bid price requirement. As we evaluate our ability to regain compliance with the continued listing requirements of the NYSE and/or to gain compliance with the initial listing requirements of an alternative national securities exchange, achievement of a minimum bid price equal to or exceeding certain thresholds is a significant pathway to such potential compliance. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Associated with the Reverse Stock Split </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are risks associated with the Reverse Stock Split, including that the Reverse Stock Split may not result in an increase in the trading price of our common stock. Reducing the number of outstanding shares of our common stock through a Reverse Stock Split is intended, absent other factors, to increase the per share market price of our common stock. However, other factors, such as our financial results, market conditions and the market perception of our business, may adversely affect the market price of our common stock. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">45 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The effect of the Reverse Stock Split on the trading price cannot be predicted with any certainty. The history of similar combinations for companies in similar circumstances is varied, particularly because some investors may view such action by us negatively. There is no assurance that: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Reverse Stock Split will result in a per share price that will attract brokers and investors who do not trade in lower-priced stocks; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Reverse Stock Split will enhance the marketability of our common stock to potential investors generally; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Reverse Stock Split would promote greater liquidity for our stockholders with respect to their shares. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Reverse Stock Split would have no effect on the number of shares of our authorized capital stock&#8212;the total number of authorized shares would remain the same as before the Reverse Stock Split, and only the number of outstanding shares of common stock would decrease. This would have the effect of increasing the number of shares of common stock available for issuance. As of the Record Date, the number of authorized shares of our common stock was 1,000,000,000 shares, which will not be affected by the Reverse Stock Split. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Risk of Dilution </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may authorize the issuance of the remaining authorized and unissued shares at the discretion of the Board when opportunities arise, without further stockholder action, except as may be required for a particular transaction by law, the rules of any exchange on which our securities may then be listed, or other agreements or restrictions. There are no preemptive rights relating to the common stock. As such, any issuance of additional shares of common stock would increase the number of outstanding shares of common stock and, unless such issuance was pro rata among existing stockholders, the percentage ownership of existing stockholders would be diluted accordingly. The issuance of additional shares also may cause a decline in the trading price of our common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">No Positive Effect on Market Capitalization </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market price of our common stock will also be based on the performance of our company and other factors, some of which are unrelated to the number of shares outstanding. If the Reverse Stock Split is implemented and the market price of our common stock declines, the percentage decline as an absolute number and as a percentage of our overall market capitalization may be greater than would occur in the absence of the Reverse Stock Split. If the market price of our common stock increases by an amount equal or lesser to the proportion of the Reverse Stock Split, then our market value of listed securities and market value of publicly-held shares will not increase. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Other Considerations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In evaluating the Reverse Stock Split, in addition to the considerations described above, the Board also took into account various other factors associated with reverse stock splits generally. These factors include: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the negative perception of reverse stock splits held by some investors, analysts, and other stock market participants; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the potential anti-takeover effect of the increased proportion of unissued shares to issued shares; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the adverse effect on liquidity that might be caused by a reduced number of shares outstanding. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While the interest of some investors in our common stock may increase if the Reverse Stock Split results in an increased trading price, certain investors, analysts and other stock market participants view reverse stock splits in a negative light, and our implementation of the Reverse Stock Split may have the effect of limiting interest and investment in our company by such individuals and entities, and may negatively impact the trading price of our common stock as a result. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">46 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As noted above, the Reverse Stock Split also would result in an increased proportion of unissued authorized shares to issued shares, which could have possible anti-takeover effects and could be used by us to oppose a hostile takeover attempt, or to delay or prevent changes in our control or management (for example, by permitting issuances that would dilute the stock ownership of a person seeking to effect a change in the composition of the Board or contemplating a tender offer or other transaction for the combination of us with another company). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These authorized but unissued shares could, within the limits imposed by applicable law, be issued in one or more transactions that could make a change of control of our company more difficult, and therefore more unlikely, or used to resist or frustrate a third-party transaction that is favored by a majority of the independent stockholders. For example, without further stockholder approval, the Board could (within the limits imposed by applicable law) strategically sell shares of common stock in a private transaction to purchasers who would oppose a takeover or favor our then-current Board, or the shares could be available for potential issuance pursuant to a shareholder rights plan. The additional authorized shares could be used to discourage persons from attempting to gain control of us by diluting the voting power of shares then outstanding, or increasing the voting power of persons that would support the Board in a potential takeover situation, including by preventing or delaying a proposed business combination that is opposed by our Board although perceived as desirable by some stockholders. The issuance of additional shares to certain persons allied with our management could have the effect of making it more difficult to remove our current management by diluting the stock ownership or voting rights of persons seeking to cause such removal. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Despite these possible anti-takeover effects, the Reverse Stock Split has been prompted by business and financial considerations and not by the threat of any hostile takeover attempt or any effort of which we are aware to accumulate our stock or to obtain control of us by means of a merger, tender offer, solicitation in opposition to management or otherwise (nor is our Board currently aware of any such attempts directed at us). Nevertheless, stockholders should be aware that approval of this Proposal 7 could facilitate future efforts by us to deter or prevent changes in our control, including transactions in which the stockholders might otherwise receive a premium for their shares over then-current market prices. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Finally, the Board considered that the liquidity of our common stock may be negatively impacted by the Reverse Stock Split, given the reduced number of shares that would be outstanding after the Reverse Stock Split, particularly if the per share trading price does not increase as a result of the Reverse Stock Split. In addition, if the Reverse Stock Split is implemented, it will increase the number of our stockholders who own &#8220;odd lots&#8221; of fewer than 100 shares of common stock, discussed below. Brokerage commission and other costs of transactions in odd lots are generally higher than the costs of transactions of more than 100 shares of common stock. Accordingly, the Reverse Stock Split may not achieve the desired results of increasing marketability of our common stock as described above. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Timing and Selection of Ratio </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to provide flexibility, the Board is seeking stockholder approval for a range of reverse split ratios of not less than <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-1.5</span></span> and not more than <span style="white-space:nowrap"><span style="white-space:nowrap">1-for-20.</span></span> The need for the range is due to the volatility of our stock price, which ranged from a high of $7.25 per share to a low of $0.5690 per share between August&#160;2, 2023 (the first day of trading of ALUR on the NYSE) and the date of this Proxy Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board believes that enabling the Board to set the exact reverse split ratio within the stated range will provide it with the flexibility to implement the Reverse Stock Split in a manner designed to maximize the anticipated benefits for stockholders. In determining whether to implement the Reverse Stock Split and selecting the exchange ratio, the Board will consider factors such as: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the historical trading price and trading volume of our common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the then-prevailing trading price and trading volume for our common stock; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">47 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the anticipated impact of the Reverse Stock Split on the trading price of and market for our common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the total number of shares of common stock outstanding; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">potential financing opportunities; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">prevailing general market and economic conditions. </p></td></tr></table> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board will have sole discretion as to any implementation of, and the exact timing and actual ratio of, the Reverse Stock Split within the range of ratios specified in this Proposal 7 and within one year after the date of the Annual Meeting. The Board may also determine that the Reverse Stock Split is no longer in the best interests of our Company and our stockholders and decide to abandon the Reverse Stock Split at any time before, during or after the Annual Meeting and prior to its effectiveness, without further action by the stockholders. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Impact on Stock Generally </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After the effective date of the Reverse Stock Split, if implemented by the Board, the number of shares of common stock issued and outstanding will be reduced due to the Reverse Stock Split, depending upon the ratio determined by the Board, and each stockholder will own a reduced number of shares of common stock. The principal effect of the Reverse Stock Split will be to proportionately decrease the number of outstanding shares of our common stock based on the reverse stock split ratio selected by our Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Reverse Stock Split will affect all holders of our common stock uniformly and will not affect any stockholder&#8217;s percentage ownership interest in us, except as described in &#8220;<span style="font-style:italic">Fractional Shares.</span>&#8221; In addition, the Reverse Stock Split will not affect any stockholder&#8217;s proportionate voting power (subject to the treatment of fractional shares). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of stockholders of record also will not be affected by the Reverse Stock Split; however, if approved and implemented, the Reverse Stock Split may result in some stockholders owning &#8220;odd lots&#8221; of less than 100 shares of our common stock. Odd lot shares may be more difficult to sell, and brokerage commissions and other costs of transactions in odd lots are generally somewhat higher than the costs of transactions in &#8220;round lots&#8221; of even multiples of 100 shares. Our Board believes, however, that these potential effects are outweighed by the benefits of the Reverse Stock Split. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Impact on Common Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Reverse Stock Split will not change the terms of the common stock. After the Reverse Stock Split, the shares of common stock will have the same voting rights and rights to dividends and distributions as, and will be identical in all other respects to, the common stock now authorized. The common stock will remain fully paid and <span style="white-space:nowrap">non-assessable.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below illustrates certain, but not all, possible Reverse Stock Split ratios within the proposed range, together with the implied number of issued and outstanding shares of the common stock resulting from implementation of the Reverse Stock Split based on 7,770,047 shares of common stock issued and outstanding as of the Record Date. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:23%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:75%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Example&#160;Ratios&#160;with&#160;Delegated<br/>Range of Ratios</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Implied Approximate Number of Issued and Outstanding Shares of Common<br/>Stock Following the Reverse Stock Split (1)</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap"><span style="white-space:nowrap">1-for-1.5</span></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">5,180,032</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1-for-5</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">1,554,010</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">1-for-10</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">777,005</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">1-for-15</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">518,004</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap"><span style="white-space:nowrap">1-for-20</span></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">388,503</td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><span style="font-style:italic"><sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-style:italic">Excludes the effect of fractional share treatment. </span></p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">48 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Impact on Options, Option Plans and Warrants </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Generally </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the Reverse Stock Split ratio, proportionate adjustments are generally required to be made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding options and warrants entitling the holders to purchase shares of common stock, and upon the conversion of convertible notes and convertible preferred stock. This would result in approximately the same aggregate price being required to be paid under such options or warrants upon exercise, and approximately the same value of shares of common stock being delivered upon such exercise immediately following the Reverse Stock Split as was the case immediately preceding the Reverse Stock Split. The number of shares reserved for issuance pursuant to these securities will be reduced proportionately based upon the reverse stock split ratio. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the Record Date, we had:&#8195; </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">7,770,047 shares of common stock issued and outstanding; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">216,507 shares of common stock reserved for issuance upon the exercise of outstanding options; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">361,420 shares of common stock reserved for issuance upon the vesting of restricted stock unit awards; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">20,543,592 shares of common stock reserved for issuance upon the exercise of outstanding warrants; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">7,807,300 shares of common stock reserved for issuance upon conversion of the Notes (as defined below); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">249,999 shares of common stock reserved for future issuances under the 2023 Plan; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">131,435 shares of common stock reserved for future issuances under the 2023 Employee Stock Purchase Plan (the &#8220;2023 ESPP&#8221;). </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Options and Option Plans </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our 2010 Stock Incentive Plan, Amended and Restated 2020 Stock Option and Grant Plan, 2023 Plan and 2023 ESPP (collectively, our &#8220;Stock Plans&#8221;), the Compensation Committee of the Board has the power to determine the appropriate adjustment to the awards granted and shares reserved for issuance under our Stock Plans in the event of a reverse stock split. Accordingly, if the Reverse Stock Split is approved and effected, we expect that the Compensation Committee will proportionately adjust the number of shares available for issuance under the Stock Plans, as well as the number of shares subject to any outstanding award under the Stock Plans, and the exercise, grant price or purchase price relating to any such award or right under the Stock Plans to reflect the Reverse Stock Split. The Compensation Committee will also determine the treatment of fractional shares subject to stock options and other outstanding awards under the Stock Plans. In addition, pursuant to the authority provided under the Stock Plans, the Compensation Committee is expected to authorize us to effect any other changes necessary, desirable or appropriate to give effect to the Reverse Stock Split, including any applicable technical, conforming changes to our Stock Plans. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Specifically, it is expected that the number of shares subject to awards under the Stock Plans will be adjusted in each case to equal the product of the number of shares subject to the applicable award immediately prior to the Reverse Stock Split multiplied by the reverse stock split ratio (rounded down to the nearest whole share), that the exercise price of any stock option will be adjusted to equal the quotient of the number of shares subject to the applicable stock option immediately prior to the Reverse Stock Split divided by the reverse stock split ratio (rounded up to the nearest whole cent), and that the stock price goal of any performance-based restricted stock units will be adjusted in each case to equal the product of the applicable price goal in effect immediately prior to the Reverse Stock Split multiplied by the reverse stock split ratio (rounded up to the nearest whole cent). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Warrants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Reverse Stock Split is approved and effected, our outstanding warrants to purchase shares of our common stock will be proportionately adjusted to reflect the Reverse Stock Split, including the number of shares </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">49 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchasable upon exercise of such warrants and their exercise prices. Any warrants, including warrants issued or assumed in the Business Combination, warrants issued in the public offering of our common stock and warrants in July 2025 and private warrants issued in multiple transactions in July 2024, January 2025 and February 2025, including the number of shares purchasable upon exercise of such warrants and their exercise prices, will likewise be proportionately adjusted to reflect the Reverse Stock Split. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">No Impact on Rights of Preferred Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Charter currently authorizes the issuance of 100,000,000 shares of preferred stock, $0.0001 par value per share, of which no shares of preferred stock are currently issued and outstanding. The Reverse Stock Split would not increase the authorized number of shares of our preferred stock, and the number of issued and outstanding shares of preferred stock will not change. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">No Effect on Par Value </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The proposed Reverse Stock Split will not affect the par value of our common stock, which will remain at $0.0001. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Procedures for Implementing the Reverse Stock Split </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The effective time of the Reverse Stock Split, if the Reverse Stock Split is approved by stockholders and implemented by us, will be the date and time set forth in the Certificate of Amendment that is filed with the Secretary of State of the State of Delaware (such time, the &#8220;Effective Time&#8221;). If the Reverse Stock Split is approved and the Board determines to proceed with the Reverse Stock Split, the exact timing of the filing of the Certificate of Amendment will be determined by our Board. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, at any time prior to the filing of the Certificate of Amendment with the Secretary of State of the State of Delaware, notwithstanding stockholder approval, and without further action by the stockholders, the Board, in its sole discretion, determines that it is in the best interests of us and our stockholders to delay the filing of the Certificate of Amendment or abandon the Reverse Stock Split, the Reverse Stock Split may be delayed or abandoned. The Board reserves the right to abandon the Reverse Stock Split without further action by our stockholders at any time before the effectiveness of the filing of the Certificate of Amendment with the Secretary of the State of Delaware, even if the authority to effect the Reverse Stock Split has been approved by our stockholders. By voting in favor of this Proposal 7, you are expressly also authorizing the Board to delay, not to proceed with, and abandon, the Reverse Stock Split if the Board should so decide, in its sole discretion, that such action is in the best interests of us and our stockholders. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Beneficial Holders of Common Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the implementation of the Reverse Stock Split, we intend to treat shares held by stockholders through a bank, broker or other nominee in the same manner as registered stockholders whose shares are registered in their names. Banks, brokers or other nominees will be instructed to effect the Reverse Stock Split for their beneficial holders holding our common stock in street name. However, these banks, brokers or other nominees may have different procedures than registered stockholders for processing the Reverse Stock Split. Stockholders who hold shares of our common stock with a bank, broker or other nominee and who have any questions in this regard are encouraged to contact their banks, brokers or other nominees. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Registered &#8220;Book-Entry&#8221; Holders of Common Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of our registered holders of common stock hold their shares electronically in book-entry form with our transfer agent, Continental Stock Transfer&#160;&amp; Trust Company (&#8220;CST&#8221;). These stockholders do not have stock certificates evidencing their ownership of the common stock. They are, however, provided with statements from CST reflecting the number of shares registered in their accounts. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">50 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholders who hold shares electronically in book-entry form with CST will not need to take action to receive evidence of their shares of post-Reverse Stock Split common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Fractional Shares </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not issue fractional shares in connection with the Reverse Stock Split. Instead, stockholders who otherwise would be entitled to receive fractional shares because they hold a number of shares not evenly divisible by the reverse stock split ratio will automatically be entitled to receive an additional fraction of a share of common stock to round up to the next whole share. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other Effects of the Reverse Stock Split </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After the Effective Time, we will continue to be subject to the periodic reporting and other requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Subject to our compliance with applicable continued listing requirements, our common stock will continue to be listed on the NYSE and traded under the symbol &#8220;ALUR,&#8221; although the exchange will add the letter &#8220;D&#8221; to the end of the trading symbol for a period of 20 trading days after the Effective Time to indicate that a Reverse Stock Split has occurred. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Reverse Stock Split is effected, then after the Effective Time, our common stock will have a new Committee on Uniform Securities Identification Procedures (&#8220;CUSIP&#8221;) number, which is a number used to identify our equity securities, and stock certificates for our common stock with the older CUSIP number will need to be exchanged for stock certificates with the new CUSIP number by following the procedures described above under &#8220;&#8212;<span style="font-style:italic">Procedure for Implementing the Reverse Stock Split</span>.&#8221; The Reverse Stock Split is not intended as, and will not have the effect of, a &#8220;going private transaction&#8221; as described by Rule <span style="white-space:nowrap">13e-3</span> under the Exchange Act. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Accounting Matters </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The proposed amendment to our Charter will not affect the par value of our common stock as noted above. As a result, at the Effective Time, the stated capital on our balance sheet attributable to the common stock will be reduced in the same proportion as the reverse stock split ratio, and the additional <span style="white-space:nowrap">paid-in</span> capital account will be credited with the amount by which the stated capital is reduced. The per share net income or loss and net book value of the common stock will be reclassified for prior periods to conform to the post-Reverse Stock Split presentation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Certain U.S. Federal Income Tax Consequences of the Reverse Stock Split </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following discussion summarizes certain U.S. federal income tax consequences of the Reverse Stock Split to holders of our common stock. This summary addresses the tax consequences only to U.S. Holders. For purposes of this discussion, a &#8220;U.S. Holder&#8221; is a beneficial owner of our common stock that, for U.S. federal income tax purposes, is or is treated as: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">an individual who is a citizen or resident of the United States; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a corporation (or other entity taxable as a corporation for U.S. Federal income tax purposes) created or organized under the laws of the United States, any state thereof, or the District of Columbia; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a trust if either a court within the United States is able to exercise primary supervision over the administration of such trust and one or more United States persons (within the meaning of Section&#160;7701(a)(30) of the Internal Code of 1986, as amended (the &#8220;Code&#8221;)) have the authority to control all substantial decisions of such trust, or the trust has a valid election in effect under applicable Treasury Regulations to be treated as a United States person for U.S. federal income tax purposes. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">51 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This summary is based upon current provisions of the Code, existing Treasury Regulations and current administrative rulings and court decisions, all of which are subject to change or different interpretation. Any change, which may or may not be retroactive, could alter the tax consequences to us or our stockholders as described in this summary. No ruling from the Internal Revenue Service (&#8220;IRS&#8221;) has been or will be requested in connection with the Reverse Stock Split and there can be no assurance that the IRS will not challenge the statements and conclusions set forth below or a court would not sustain any such challenge. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No attempt has been made to comment on all U.S. federal income tax consequences of the Reverse Stock Split that may be relevant to particular U.S. Holders, including holders that: (i)&#160;are subject to special tax rules such as dealers, brokers and traders in securities, mutual funds, regulated investment companies, real estate investment trusts, insurance companies, banks or other financial institutions or <span style="white-space:nowrap">tax-exempt</span> entities; (ii)&#160;acquired their shares in connection with stock options, stock purchase plans or other compensatory transactions; (iii)&#160;hold their shares as a hedge or as part of a hedging, straddle, &#8220;conversion transaction&#8221;, &#8220;synthetic security&#8221;, integrated investment or any risk reduction strategy; (iv)&#160;are partnerships, limited liability companies that are not treated as corporations for U.S. federal income tax purposes, S corporations, or other pass-through entities or investors in such pass-through entities; (v)&#160;do not hold their shares as capital assets for U.S. federal income tax purposes (generally, property held for investment within the meaning of Section&#160;1221 of the Code); (vi) hold their shares through individual retirement or other <span style="white-space:nowrap">tax-deferred</span> accounts; or (vii)&#160;who have a functional currency for U.S. federal income tax purposes other than the U.S. dollar. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">In addition, the following discussion does not address state, local or foreign tax consequences of the Reverse Stock Split, the Medicare tax on net investment income, U.S. federal estate and gift tax, the alternative minimum tax, the rules regarding qualified small business stock within the meaning of Section&#160;1202 of the Code, or any other aspect of any U.S. federal tax other than the income tax. The discussion generally assumes that for U.S. federal income tax purposes, the Reverse Stock Split will not be integrated or otherwise treated as part of a unified transaction with any other transaction. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">General Tax Treatment of the Reverse Stock Split </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Reverse Stock Split is intended to qualify as a &#8220;reorganization&#8221; under Section&#160;368(a) of the Code that should constitute a &#8220;recapitalization&#8221; for U.S. federal income tax purposes. Assuming the Reverse Stock Split qualifies as a reorganization, a U.S. Holder generally will not recognize gain or loss upon the exchange of our common stock for a lesser number of shares of common stock, based upon the reverse stock split ratio. A U.S. Holder&#8217;s aggregate tax basis in the lesser number of shares of common stock received in the Reverse Stock Split will be the same such U.S. Holder&#8217;s aggregate tax basis in the shares of our common stock that such U.S. Holder owned prior to the Reverse Stock Split. The holding period for the common stock received in the Reverse Stock Split will include the period during which a U.S. Holder held the shares of our common stock that were surrendered in the Reverse Stock Split. Treasury Regulations provide detailed rules for allocating the tax basis and holding period of the shares of our common stock surrendered to the shares of our common stock received pursuant to the Reverse Stock Split. U.S. Holders of shares of our common stock acquired on different dates and at different prices should consult their tax advisors regarding the allocation of the tax basis and holding period of such shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="font-weight:bold">THE FOREGOING IS A SUMMARY OF CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT, AND DOES NOT CONSTITUTE A TAX OPINION. EACH HOLDER OF OUR COMMON STOCK SHOULD CONSULT SUCH HOLDER&#8217;S TAX ADVISOR REGARDING THE TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Amendment Effective Date </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the proposed amendment to the Charter as described in this Proposal 7 is approved by the stockholders, upon the Board&#8217;s determination, if any, to effectuate the Reverse Stock Split and of the ratio (within the range </p> </div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">52 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
approved pursuant to this Proposal 7) of such Reverse Stock Split, we will file the Certificate of Amendment reflecting the adopted amendment to our Charter with the Secretary of State of the State of Delaware. The Certificate of Amendment will be effective upon its filing or at such later time as specified in the Certificate of Amendment. If the stockholders do not approve this Proposal 7, the Certificate of Amendment will not be filed with the Secretary of State of the State of Delaware. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Dissenters&#8217; Rights </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No dissenters&#8217; rights are available under the Delaware General Corporation Law or under our Charter or Bylaws to any stockholder who dissents from this Proposal 7. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Interests of Directors and Executive Officers </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our directors and executive officers do not have any substantial interest, directly or indirectly, in the matters set forth in this Proposal 7 except to the extent of their ownership of shares of common stock or any other of our securities. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The majority of the votes properly cast will be required to approve this Proposal 7. Abstentions and broker <span style="white-space:nowrap">non-votes</span> will have no effect on the outcome of this Proposal 7. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE </p> <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">FOR</span> THE REVERSE STOCK SPLIT PROPOSAL. </p> </div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">53 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_12">PROPOSAL 8: ADJOURNMENT PROPOSAL </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we fail to receive a sufficient number of votes to approve Proposals 3, 4, 5, 6 and 7, we may propose to adjourn or postpone the Annual Meeting. We currently do not intend to propose an adjournment or postponement at the Annual Meeting if there are sufficient votes to approve Proposals 3, 4, 5, 6 and 7. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Vote Required </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Proposal 8 requires the affirmative vote of the holders of a majority of the votes properly cast. Abstentions and broker <span style="white-space:nowrap">non-votes</span> are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this Proposal 8. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">FOR</span> THE ADJOURNMENT PROPOSAL. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">54 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_13">CORPORATE GOVERNANCE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">General </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that good corporate governance is important to ensure that our Company is managed for the long-term benefit of our stockholders. We periodically review our corporate governance policies and practices and compare them to those suggested by various authorities in corporate governance and the practices of other public companies. As a result, we have adopted policies and procedures that we believe are in the best interests of our Company and our stockholders. Key information regarding our corporate governance initiatives can be found on our corporate website at <span style="font-style:italic">investors.allurion.com </span>under &#8220;Governance Documents,&#8221; including our Corporate Governance Guidelines, our Code of Business Conduct and Ethics (our &#8220;Code of Conduct&#8221;), and the charters for the committees of our Board, described below. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Corporate Governance Guidelines </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Corporate Governance Guidelines assist our Board in the exercise of its duties and responsibilities and to serve the best interests of our Company and our stockholders. These guidelines, which provide a framework for the conduct of Board business, provide that: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">at least a majority of the members of the Board shall be independent directors as defined by NYSE rules; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the independent directors shall meet at least quarterly, and at other times at the request of any independent director, in executive session; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">directors shall have full and free access to management and, as necessary and appropriate, independent advisors; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">at least annually, the Nominating and Corporate Governance Committee of the Board (the &#8220;Nominating and Corporate Governance Committee&#8221;) shall oversee a self-evaluation by the Board to assess the effectiveness of the Board and its committees. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board is responsible for managing or supervising the management of our business and affairs. This includes appointing our Chief Executive Officer, advising management on strategic issues, approving our business and other plans, and monitoring our performance against those plans and against our operating and capital budgets. In addition, our Board also receives and considers recommendations from its various committees with respect to matters such as: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the compensation of our executive officers and directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">criteria for Board and committee membership; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">persons to be nominated for election as members of the Board and to each of the committees of the Board; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">matters relating to our corporate governance, including to our Code of Conduct and Corporate Governance Guidelines. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Independence </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board has determined that each member of the Board, other than Dr.&#160;Gaur, qualifies as independent, as defined under the listing standards of the NYSE. In addition, our Board has determined that each of the members of the Audit Committee, Nominating and Corporate Governance Committee, and Compensation Committee is independent in accordance with the rules of the NYSE and, in, the case of the members of the Audit Committee, the rules of the SEC as noted below under &#8220;<span style="font-style:italic">Committees of the Board.</span>&#8221; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">55 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In determining the independence of its members, the Board considered all the facts and circumstances it deemed relevant in determining their independence, including, but not limited to, the director&#8217;s commercial, industrial, banking, consulting, legal, accounting, charitable, and familial relationships. We are subject to the rules of the SEC and NYSE relating to the memberships, qualifications, and operations of the Audit Committee. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Director Qualifications </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Nominating and Corporate Governance Committee is responsible for identifying individuals qualified to serve as directors, consistent with criteria approved by our Board, and recommending to the Board qualified individuals to be nominated for election as directors at each annual meeting of stockholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In identifying prospective director candidates, the Nominating and Corporate Governance Committee may consider all facts and circumstances that it deems appropriate or advisable, including, among other things, the skills of the prospective candidate, such candidate&#8217;s depth and breadth of business experience or other background characteristics, such candidate&#8217;s independence, and the needs of the Board. At a minimum, the Nominating and Corporate Governance Committee must be satisfied that each recommended nominee meets the following minimum qualifications: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(i)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">relevant experience and expertise to enable the candidate to be able to offer germane advice and guidance to management; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(ii)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">proven achievement and competence in the candidate&#8217;s field; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(iii)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">the ability to exercise sound business judgment; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(iv)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">an understanding of the fiduciary responsibilities required of a director; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(v)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">commitment to devoting time and energy to our affairs; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(vi)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">a diverse personal background, perspective, and experience; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(vii)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">commitment to vigorously represent the long-term interests of our stockholders. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to any other standards the Nominating and Corporate Governance Committee deems appropriate from time to time for the overall structure and composition of the Board, the Nominating and Corporate Governance Committee may consider whether the candidate, if elected, assists in achieving a mix of Board members that represents a diversity of background and experience. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Nomination Policies and Procedures </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee will consider for recommendation any candidate properly recommended by a stockholder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholders who wish to nominate qualified candidates to serve as directors must notify us in writing, by notice delivered to the attention of our Secretary at the address of our executive offices as set forth in our periodic reports as filed with the SEC, of a proposed nominee. In order to ensure meaningful consideration of such candidates, notice must be timely received as set forth under &#8220;<span style="font-style:italic">Stockholder Proposals for 2026</span> <span style="font-style:italic">Annual Meeting of Stockholders</span>&#8221; below. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notice must set forth: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the nominee&#8217;s name, age, business address and residence address; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the nominee&#8217;s principal occupation or employment, and a description of the nominee&#8217;s background and qualifications as provided by the nominee; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the class and number of shares of our capital stock that are held of record or are beneficially owned by the nominee or their affiliates or associates; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">56 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any other information relating to such proposed nominee that is required to be disclosed in solicitations of proxies for election of directors in an election contest, or is otherwise required, in each case pursuant to Regulation 14A under the Exchange Act (including without limitation such person&#8217;s written consent to being named in the proxy statement as a nominee and to serving as a director if elected); and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">such other information as required by Section&#160;2 of Article I of our Bylaws. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notice also must include a description of all arrangements or understandings between or among the nominating stockholder and each nominee and any other person or persons (naming such person or persons) pursuant to which the nominations are to be made by the stockholder or concerning the nominee&#8217;s potential service on the Board, as well as certain representations by the nominee with respect to matters such as compliance with law and our corporate policies and procedures. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The nominating stockholder must provide such stockholder&#8217;s name and address, as they appear on our books, the class or series and number of all shares of our capital stock that are, directly or indirectly, owned beneficially or of record by such stockholder or any of their affiliates or associates (as such terms are defined in Rule <span style="white-space:nowrap">12b-2</span> promulgated under the Exchange Act), a description of all agreements, arrangements or understandings to which the stockholder or any of their affiliates or associates is a party pertaining to the nomination, and identification of the names and addresses of other stockholders (including beneficial owners) known by the nominating stockholder to support such nomination together, to the extent known, with the class and number of all shares of our capital stock owned beneficially or of record by such other stockholders or beneficial owners. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the stockholder director nomination process does not purport to be complete and is qualified in its entirety by reference to our Bylaws. Submissions received through our stockholder nomination process will be forwarded to the Nominating and Corporate Governance Committee for review. Only those submissions that comply with the procedures summarized herein and more fully set forth in our Bylaws, and those nominees who satisfy the qualifications determined by the Nominating and Corporate Governance Committee for our directors will be considered and eligible for election. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee may also engage third parties, including executive search firms, to assist it with identifying and evaluating potential director nominees. The Nominating and Corporate Governance Committee engaged True Capital Partners, LLC (&#8220;True&#8221;) to assist it in identifying candidates that satisfied the director qualifications that the Nominating and Corporate Governance Committee had established, and assist the committee in screening such candidates. Each of Mr.&#160;Hudson and Mr.&#160;Johns were identified and screened by True. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Investor Rights Agreement, the following persons have the following nomination rights with respect to our Board of Directors, subject to the limitations set forth in the Investor Rights Agreement: </p> </div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(i)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">one director and one independent director nominated by Dr.&#160;Shantanu Gaur, which are currently Dr.&#160;Gaur and Michael Davin; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(ii)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">one director and one independent director nominated by Remus Group Management, LLC, which are currently Krishna Gupta and Douglas Hudson; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(iii)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">one director nominated by the Sponsor, which is currently Dr.&#160;Omar Ishrak; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(iv)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">one independent director nominated by us and designated by RTW, which is currently Nicholas Lewin; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left">(v)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">one independent director nominated by us, which seat is currently vacant. </p></td></tr></table> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, each of the First RIFA and the Second RIFA contain substantially similar rights which entitle RTW to designate one director to our Board, which is currently Mr.&#160;Lewin. </p> </div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">57 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div> <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Amended Note Purchase Agreement, RTW is entitled to designate two directors to our Board, which are currently Mr.&#160;Lewin and R. Jason Richey. In addition, we agreed to include an additional director nominee in our proxy statement for the 2024 annual meeting of stockholders, which additional nominee would go through our director nomination process, as described below, and RTW was granted the right to approve such nominee. In September 2024, we appointed Keith B. Johns II to our Board of Directors as a Class&#160;III director and RTW approved his appointment in satisfaction of such obligations. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Board and Committee Meetings Attendance </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During 2024, the Board met 15 times and acted by written consent four times, the Audit Committee met seven times and acted by written consent one time, the Compensation Committee met three times and acted by written consent two times, and the Nominating and Corporate Governance Committee met four times and acted by written consent two times. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During 2024, each member of the Board attended in person or participated in 75% or more of the aggregate of (i)&#160;the total number of meetings of the Board (held during the period for which such person has been a director) and (ii)&#160;the total number of meetings held by all committees of the Board on which such person served (during the periods that such person served) except for Nicholas Lewin, who attended thirteen out of eighteen (72%) Board and Compensation Committee meetings due to unavoidable scheduling conflicts and travel. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Director Attendance at Annual Meeting of Stockholders </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Directors are encouraged to attend the annual meeting of stockholders to the extent practicable. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Communication with our Directors </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board provides to every interested party the ability to communicate with the Board, as a whole, and with individual directors on the Board through an established process for interested party communication (an &#8220;Interested Party Communication&#8221;) as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">For an Interested Party Communication directed to the Board as a whole, interested parties may send such communication to the attention of the Chair of the Board via U.S. Mail or Expedited Delivery Service to our principal office address. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">For an Interested Party Communication directed to an individual director in such director&#8217;s capacity as a member of the Board, interested parties may send such communication to the attention of the individual director via U.S. Mail or Expedited Delivery Service to our principal office address. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will forward any such Interested Party Communication to each director by U.S. mail, and the chairman of the Board in such person&#8217;s capacity as a representative of the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Communications from our officers or directors, and proposals submitted by securityholders to be included in our annual proxy statement pursuant to Rule <span style="white-space:nowrap">14a-8</span> of the Exchange Act (and related communications), will not be viewed as Interested Party Communications. Communications from our employees or agents will be viewed as Interested Party Communications only if such communications are made solely in such employee&#8217;s or agent&#8217;s capacity as an interested party. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Communications that are clearly of a marketing nature, or unduly hostile, threatening, illegal or similarly inappropriate, will not be forwarded, and we have the authority to discard such communications or take appropriate legal action. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">58 </p>

</div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>
<div style="display: none"><ix:header><ix:references><link:schemaRef xlink:type="simple" xlink:href="alur-20241231.xsd"/></ix:references></ix:header></div><div><div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Compensation Recovery Policy </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In light of the SEC&#8217;s adoption of final clawback rules in October 2022 and the NYSE&#8217;s adoption of final listing standards consistent with the SEC rules in June 2023, we adopted a Compensation Recovery Policy effective as of October&#160;2, 2023. If we are required to prepare an accounting restatement due to material <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-compliance</div> with any financial reporting requirements under applicable securities laws, the Compensation Recovery Policy requires (subject to certain limited exceptions described in the policy and permitted by the final clawback rules) that we recover erroneously awarded compensation received by any current or former executive officer in the three fiscal years prior to the date we were required to restate our financial statements that is in excess of the amount that would have been received based on the restated financial statements. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Compensation Committee Interlocks and Insider Participation </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During 2024, the members of our Compensation Committee included Michael Davin, Nicholas Lewin, and Douglas Hudson. None of the members of our Compensation Committee has ever been an officer or employee of our Company, or had any other relationship requiring disclosure herein. None of our executive officers serve, or have served during the last fiscal year, as a member of the board of directors or compensation committee of any other entity that has or has had one or more executive officers serving as a member of our Board or Compensation Committee. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Policy on Insider Trading, Pledging, and Hedging </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our <ix:nonNumeric name="ecd:InsiderTrdPoliciesProcAdoptedFlag" contextRef="P01_01_2024To12_31_2024" format="ixt:fixed-true" id="ixv-7440">Insider Trading Policy</ix:nonNumeric> prohibits our directors (including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-employee</div> directors), officers, employees, consultants, and their &#8220;affiliated persons&#8221; (as defined in our Insider Trading Policy) from engaging in the following transactions: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">trading in our securities, whether for their own account or for the account of another, while in the possession of material, nonpublic information about us; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">disclosing material, nonpublic information about us to others who may trade on the basis of that information (&#8220;tipping&#8221;); </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">selling any of our securities that they do not own at the time of the sale (referred to as a &#8220;short sale&#8221;); </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">buying or selling puts, calls, other derivative securities of our securities, or any derivative securities that provide the economic equivalent of ownership of any of our securities or an opportunity, direct or indirect, to profit from any change in the value of our securities or engaging in any other hedging transaction with respect to our securities; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">using our securities as collateral in a margin account; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">pledging our securities as collateral for a loan (or modifying an existing pledge). </div></td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Board Leadership Structure and Board&#8217;s Role in Risk Oversight </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Omar Ishrak is the chairman of the Board and our lead independent director. Dr.&#160;Ishrak presides at all meetings of our Board. Currently, the role of chairman of the Board is separated from the role of Chief Executive Officer. Separating these positions allows our Chief Executive Officer to focus on our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"><div style="white-space:nowrap;display:inline;">day-to-day</div></div> business, while allowing the chairman to lead the Board in its fundamental role of providing advice to and independent oversight of management. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board has not adopted a position description for the chairman. However, there is a shared understanding on the Board of the chairman&#8217;s responsibilities. The chairman&#8217;s primary role is to provide leadership to the Board and its committees, including chairing meetings in a manner that facilitates open discussions and expressions of competing views. The chairman is also responsible for, among other things, </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">59 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">assisting the Board in obtaining information required for the performance of its duties, retaining appropriately qualified and independent advisors as needed, working with the Board to support Board development and to ensure a proper committee structure is in place, providing a link between the Board and management, and acting in an advisory capacity to the Chief Executive Officer in all matters concerning the interests and management of Allurion. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board recognizes the time, effort, and energy that the Chief Executive Officer must devote to this position and the commitment required to serve as a chairman of the Board. Our Board also believes that our leadership structure ensures a greater role for the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-management</div> directors in the oversight of our Company and active participation of the independent directors in setting agendas and establishing priorities and procedures for the work of our Board. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Risk is inherent with every business, and how well a business manages risk can ultimately determine the business&#8217; success. As a medical device manufacturer, we face a number of risks, including risks related to patient safety, our financial condition, development and commercialization activities, operations, strategic direction, and intellectual property. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management is responsible for the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"><div style="white-space:nowrap;display:inline;">day-to-day</div></div> management of risks we face, while our Board, as a whole and through its committees, has responsibility for the oversight of risk management, including overseeing our Enterprise Risk Management Policy. In the Board&#8217;s risk oversight role, our Board has the responsibility to oversee that the risk management processes designed and implemented by management are adequate and functioning as designed. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The role of the Board in overseeing the management of our risks is conducted primarily through committees of the Board, as disclosed in the descriptions of each of the committees above and in the charters of each of the committees. The full Board (or the appropriate committee in the case of risks that are under the purview of a particular committee) discusses with management our major risk exposures, their potential impact on us, and the steps we take to manage them. When a committee is responsible for evaluating and overseeing the management of a particular risk or risks, the chairperson of the relevant committee reports on the discussion to the full Board during the committee reports portion of the next Board meeting. This process enables the Board and its committees to coordinate the risk oversight role, particularly with respect to risk interrelationships. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">60 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="toc923025_14" style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">COMMITTEES OF THE BOARD </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board has established three standing committees &#8211; Audit, Compensation, and Nominating and Corporate Governance &#8211; each of which operates under a written charter that has been approved by our Board as described below. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The members of each of the Board committees and committee Chairpersons are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellspacing="0" cellpadding="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:3%"/>
<td style="width:13%"/>
<td style="vertical-align:bottom;width:3%"/>
<td style="width:13%"/>
<td style="vertical-align:bottom;width:3%"/>
<td style="width:15%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8195;Audit&#8195;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Compensation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Nominating&#160;and<br/>Corporate<br/>Governance</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Omar Ishrak</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">X</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">X</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Davin</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">X</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">Chairperson</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas Hudson</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">X</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">Chairperson</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Krishna Gupta</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">X</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Keith B. Johns II</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nicholas Lewin</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">X</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Jason Richey</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center">Chairperson</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr></table><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Audit Committee </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The members of our Audit Committee include R. Jason Richey (Chair), Dr.&#160;Omar Ishrak, and Michael Davin, each of whom can read and understand fundamental financial statements. The Board has concluded that each member of the Audit Committee is independent under the rules and regulations of the SEC and the listing standards of the NYSE applicable to Audit Committee members. Michael Davin qualifies as an audit <div style="display:inline;">committee </div>financial expert within the meaning of SEC regulations and meets the financial literacy requirements of the NYSE. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Audit Committee assists the Board with its oversight of the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the integrity of our financial statements; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">our compliance with legal and regulatory requirements; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the qualifications, independence, and performance of our independent registered public accounting firm; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the design and implementation of our internal audit function, and our risk assessment and risk management activities. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee also is responsible for reviewing and discussing with management the adequacy and effectiveness of our disclosure controls and procedures, and it discusses with management and our independent registered public accounting firm the annual audit plan, the scope and timing of audit activities and the results of the audit. The Audit Committee also reviews our financial statements quarterly. As appropriate, the Audit Committee may initiate inquiries into certain aspects of our financial affairs. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, the Audit Committee is responsible for establishing and overseeing procedures for the receipt, retention, and treatment of any complaints regarding accounting, internal accounting controls, or auditing matters, as well as for the confidential and anonymous submissions by our employees of concerns regarding questionable accounting or auditing matters. In addition, the Audit Committee has direct responsibility for the appointment, compensation, retention, and oversight of the work of our independent registered public accounting firm. This includes sole authority to approve the hiring and discharging of our independent registered public accounting firm, all audit engagement terms and fees, and all permissible <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-audit</div> engagements with the independent auditor. Finally, the Audit Committee reviews and oversees all related-person transactions in accordance <div style="display:inline;">with</div> our policies and procedures. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">61 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Audit Committee operates under a written charter that satisfies the applicable rules and regulations of the SEC and the listing standards of the NYSE. A copy of the charter of our Audit Committee is available on our website at <div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">investors.allurion.com</div></div>. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Compensation Committee </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The members of our Compensation Committee include Michael Davin (Chair), Nicholas Lewin, and Douglas Hudson. The Board has concluded that each member of the Compensation Committee is independent under the rules and regulations of the SEC and the listing standards of the NYSE applicable to Compensation Committee members. The primary objective of the Compensation Committee is to develop and implement compensation policies and plans that ensure the attraction and retention of key management personnel, the motivation of management to achieve our goals and strategies, and the alignment of management&#8217;s interests with the long-term interests of our stockholders. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation Committee&#8217;s responsibilities include, among other things: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">reviewing and evaluating our Chief Executive Officer&#8217;s performance against established goals and objectives, and determining and approving the Chief Executive Officer&#8217;s compensation (including long-term incentives) based on such evaluation; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">reviewing, approving, and determining the compensation of our executive officers other than the Chief Executive Officer and, at the discretion of the Compensation Committee, other members of senior management; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">reviewing and recommending to the Board the compensation of our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-employee</div> directors; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">reviewing and making recommendations to the Board with regard to incentive-based compensation plans and the policies and procedures for awards thereunder, including making grants pursuant to such plans; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">overseeing the administration of all incentive compensation and equity-based plans for employees; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">administering our Compensation Recovery Policy, discussed in the section titled &#8220;Compensation Recovery Policy&#8221; above. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation Committee operates under a written charter that satisfies the applicable rules and regulations of the SEC and the listing standards of the NYSE. A copy of the charter of our Compensation Committee is available at <div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">investors.allurion.com</div></div>. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Nominating and Corporate Governance Committee </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The members of our Nominating and Corporate Governance Committee include Douglas Hudson (Chair), Dr.&#160;Omar Ishrak, and Krishna Gupta. The Board has concluded each member of the Nominating and Corporate Governance Committee is independent under the rules and regulations of the SEC and the listing standards of the NYSE. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee assists the Board with its identification and evaluation of individuals qualified to become members of the Board (including those recommended by stockholders), consistent with criteria approved by the Board, and recommends that the Board select certain director nominees for election at annual stockholder meetings. The Nominating and Corporate Governance Committee also develops and recommends to the Board a set of Corporate Governance Guidelines, monitors compliance with our Code of Conduct, and oversees the <div style="display:inline;">evaluation </div>of the Board, its committees and management. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">62 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Nominating and Corporate Governance Committee&#8217;s responsibilities include, among other things: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">establishing and recommending to the Board criteria for Board and committee membership, and establishing policies and processes to evaluate nominees&#8212;including those of stockholders&#8212;against such criteria; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">identifying, evaluating, and making recommendations to our Board regarding nominees for election to the Board and its committees, including to fill vacancies; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">evaluating the performance of our Board, our committees, and of individual directors; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">considering and making recommendations to our Board regarding the composition of our Board and its committees; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">overseeing an annual evaluation of our Board, its committees, and management; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">developing and recommending to the Board Corporate Governance Guidelines and periodically reviewing those guidelines and recommending any changes; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">monitoring compliance with our Code of Conduct; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">reviewing and assessing the adequacy of the Corporate Governance Guidelines and the Code of Conduct and recommending any changes to the Board for approval. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Nominating and Corporate Governance Committee operates under a written charter that satisfies the applicable listing standards of the NYSE. A copy of the charter of our Nominating and Corporate Governance Committee is available at <div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">investors.allurion.com</div></div>. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">63 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="toc923025_15" style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee has reviewed the audited consolidated financial statements of Allurion Technologies, Inc., a Delaware <div style="display:inline;">corporation </div>(the &#8220;Company&#8221;), for the fiscal year ended December&#160;31, 2024 and has discussed these financial statements with management and the Company&#8217;s independent registered public accounting firm. The Audit Committee has also received from, and discussed with, the Company&#8217;s independent registered public accounting firm the matters that they are required to provide to the Audit Committee, including the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;) and the Securities and Exchange Commission (&#8220;SEC&#8221;). </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s independent registered public accounting firm also provided the Audit Committee with a formal written statement required by the applicable requirements of the PCAOB describing all relationships between the independent registered public accounting firm and the Company, including the disclosures required by the applicable requirements of the PCAOB regarding the independent registered public accounting firm&#8217;s communications with the Audit Committee concerning independence. In addition, the Audit Committee discussed with the independent registered public accounting firm its independence from the Company. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on its discussions with management and the independent registered public accounting firm, and its review of the representations and information provided by management and the independent registered public accounting firm, the Audit Committee recommended to the Board that the audited consolidated financial statements be included in the Company&#8217;s Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">10-K</div> for the fiscal year ended December&#160;31, 2024 and be filed with the SEC. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael Davin </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Omar Ishrak </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">The Audit Committee Report does not constitute soliciting material and shall not be deemed to be filed or incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates the Audit Committee Report by reference therein. </div></div></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">64 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="toc923025_16" style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EXECUTIVE AND DIRECTOR COMPENSATION </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">We have opted to comply with the executive compensation disclosure rules applicable to &#8220;smaller reporting companies&#8221; and &#8220;emerging growth companies&#8221; as such terms are defined in the rules promulgated under the Securities Act. Share amounts presented for periods prior to the reverse stock split we effected on January&#160;3, 2025 have been retroactively converted by application of the reverse stock split ratio of <div style="white-space:nowrap;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">1-to-25.</div></div> </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section discusses the compensation awarded to, earned by, or paid to our chief executive officer and two other most highly compensated executive officers who were serving as executive officers as of December&#160;31, 2024 (our &#8220;Named Executive Officers&#8221; or &#8220;NEOs&#8221;). Our Named Executive Officers for the fiscal year ended December&#160;31, 2024 were: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Shantanu Gaur, M.D., our Chief Executive Officer; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Brendan Gibbons, our Chief Legal and People Officer; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Ojas Buch, our Chief Operating Officer. </div></td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">2024 Summary Compensation Table </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents information regarding the compensation awarded to, earned by or paid to our NEOs for services rendered in all capacities to us and our subsidiaries during the fiscal years ended December&#160;31, 2024 and December&#160;31, 2023. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:38%"/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; font-weight: bold; line-height: normal;">Name and Principal Position</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;">Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;">Salary&#160;($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;">Bonus&#160;($)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(1)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;">Stock<br/>Awards<br/>($)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(2)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;">Option<br/>Awards&#160;($)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(3)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="white-space:nowrap;display:inline;">Non-equity</div><br/>Incentive Plan<br/>Compensation<br/>($)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(4)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;">All Other<br/>Compensation<br/>($)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(5)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;">Total ($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dr.&#160;Shantanu Gaur</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">620,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,200,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">9,734</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,829,734</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Chief Executive Officer</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2023</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">354,875</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.5px">(6)</div>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">296,751</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">9,600</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">661,226</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Brendan Gibbons</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">371,282</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.5px">(7)</div>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">226,381</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,097,663</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Chief Legal and People Officer</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ojas Buch</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">233,333</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.5px">(8)</div>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">226,381</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">30,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">989,714</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Chief Operating Officer</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Amount reported in this column for Dr.&#160;Gaur consists of a $200,000 bonus in connection with our Business Combination and a $96,751 retention bonus. Retention bonus represents incentive award made to the executive for his continued employment through a target date. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Amounts shown reflect the grant date fair value of restricted stock units (&#8220;RSUs&#8221;) granted during such fiscal year, calculated in accordance with FASB ASC Topic 718, excluding any estimates of forfeitures related to service-based vesting conditions. For information regarding assumptions underlying the valuation of equity awards, see Note 14 to our consolidated financial statements included in our 2024 Annual Report. The amounts reported in this column reflect the accounting cost for the RSU awards, and do not correspond to the actual economic value that may be recognized by holders upon the vesting or settlement of the applicable awards. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Amounts shown reflect the grant date fair value of stock options granted during such fiscal year, calculated in accordance with FASB ASC Topic 718, excluding any estimates of forfeitures related to service-based vesting conditions. For information regarding assumptions underlying the valuation of equity awards, see Note 14 to our consolidated financial statements included in our 2024 Annual Report. The amounts reported in this column reflect the accounting cost for the option awards, and do not correspond to the actual economic value that may be recognized by holders upon the vesting or exercise of the applicable awards. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Each of Dr.&#160;Gaur, Mr.&#160;Gibbons, and Mr.&#160;Buch are eligible to receive performance-based cash bonuses, as described below under the heading &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Narrative to the Summary Compensation <div style="white-space:nowrap;display:inline;">Table&#8212;Non-equity</div> Incentive Plan </div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Compensation</div></div>.&#8221; However, no performance-based cash bonuses were earned or paid to the Named Executives Officers for the 2024 and 2023 fiscal years. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">65 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(5)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">For the 2024 fiscal year, amounts reported in this column include the following amounts: (i)&#160;for Dr.&#160;Gaur, $3,000 in payments in lieu of medical coverage, and $6,734 of 401(k) plan employer contributions and (ii)&#160;for Mr.&#160;Buch, $30,000 in reimbursement of relocation expenses. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(6)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">To preserve our cash prior to the Business Combination, Dr.&#160;Gaur&#8217;s annual base salary was reduced to $36,000 from April&#160;15, 2023 to July&#160;31, 2023. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(7)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Mr.&#160;Gibbons joined us as our Chief Legal Officer on January&#160;29, 2024, and the amounts reported in the &#8220;Salary&#8221; column represent salary payments earned following his commencement of employment. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(8)</td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Mr.&#160;Buch joined us as our Chief Operating Officer on June&#160;3, 2024, and the amounts reported in the &#8220;Salary&#8221; column represent salary payments earned following his commencement of employment. </div></td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Narrative to Summary Compensation Table </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Base Salaries </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We use base salaries to recognize the experience, skills, knowledge, and responsibilities required of all our employees, including our Named Executive Officers. Base salaries are reviewed annually and adjusted from time to time to align salaries with market levels after taking into account individual responsibilities, performance, and experience, as well as our financial condition. For the 2024 fiscal year, the annual base salaries for Dr.&#160;Gaur and Mr.&#160;Buch were $620,000 and $400,000, respectively. For the 2024 fiscal year, the annual base salary for Mr.&#160;Gibbons was initially $375,000, which was increased to $400,000 on May&#160;2, 2024 and was made retroactive to the commencement of his employment. Effective January&#160;1, 2025, Dr.&#160;Gaur voluntarily reduced his annual base salary by 50% for fiscal year 2025. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space:nowrap;display:inline;">Non-equity</div> Incentive Plan Compensation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of our Named Executive Officers is eligible to earn a performance-based annual cash bonus based on achievement of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">pre-established</div> company and individual performance criteria established by our Board of Directors or Compensation Committee in their discretion. For the 2024 fiscal year, the target annual bonus for each of Dr.&#160;Gaur and Mr.&#160;Buch was equal to 80%, and 50%, respectively, of their annual base salary, and the target annual bonus for Mr.&#160;Gibbons was initially equal to 40% of his annual base salary and was increased to 50% of his annual base salary on May&#160;2, 2024. However, no annual performance bonuses were earned or paid to our Named Executive Officers for the 2023 and 2024 fiscal years. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Equity Compensation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that equity grants provide our executives with a strong link to our long-term performance, create an ownership culture and help to align the interests of our executives with our stockholders. In addition, we believe that equity grants with a time-based vesting feature promote executive retention because this feature incentivizes our executive officers to remain in our employment during the vesting period. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Independent Compensation Consultant </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In assessing and setting the compensation of our Named Executive Officers, the Compensation Committee has engaged Pearl Meyer&#160;&amp; Partner LLC (&#8220;Pearl Meyer&#8221;) as its independent compensation consultant. Pearl Meyer advises the Compensation Committee on best practices in executive compensation and provides the Compensation Committee with market data in an effort to ensure our compensation program is competitive and designed to attract, retain, and incentivize our Named Executive Officers. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Employment Arrangements with our Named Executive Officers </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Employment Agreement with Dr.&#160;Shantanu Gaur </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into an employment agreement with Dr.&#160;Gaur, effective August&#160;1, 2023, pursuant to which we employ Dr.&#160;Gaur as our Chief Executive Officer on an &#8220;at will&#8221; basis. Dr.&#160;Gaur&#8217;s employment agreement </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">66 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provides that his initial annual base salary is $620,000, and is subject to periodic review by our Board of Directors or Compensation Committee. In addition, the employment agreement provides that Dr.&#160;Gaur is eligible to receive annual cash bonuses, which the target annual amount shall be 80% of his annual base salary. Dr.&#160;Gaur is also eligible to participate in the employee benefit plans generally available to our employees, subject to the terms of such plans. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a termination of Dr.&#160;Gaur&#8217;s employment by Allurion without &#8220;cause&#8221; (as defined in his employment agreement) or by his resignation for &#8220;good reason&#8221; (as defined in his employment agreement), subject to Dr.&#160;Gaur&#8217;s execution and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-revocation</div> of a separation agreement containing, among other things, a release of claims in favor of Allurion and its affiliates, Dr.&#160;Gaur will be entitled to receive (i)&#160;base salary continuation for 12 months following his termination date, and (ii)&#160;subject to Dr.&#160;Gaur&#8217;s election to receive continued health benefits under COBRA, payment of the full cost of such continuation coverage plus any administration fee until the earliest of (A) 12 months following termination; (B)&#160;the date he becomes eligible for group medical plan benefits under any other employer&#8217;s group medical plan; or (C)&#160;the expiration of Dr.&#160;Gaur&#8217;s COBRA health continuation period. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in lieu of the payments and benefits described above, in the event that Dr.&#160;Gaur&#8217;s employment is terminated by us without &#8220;cause&#8221; or by him for &#8220;good reason,&#8221; in each case, within three months prior to or 12 months following a &#8220;sale event&#8221; (as defined in our 2023 Plan), and subject to Dr.&#160;Gaur&#8217;s execution and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-revocation</div> of a separation agreement containing, among other things, a release of claims in favor of Allurion and its affiliates, Dr.&#160;Gaur will be entitled to receive (i)&#160;an amount in cash equal to 1.5 times the sum of (x)&#160;Dr.&#160;Gaur&#8217;s then-current base salary (or, his base salary in effect immediately prior to the sale event, if higher) and (y)&#160;Dr.&#160;Gaur&#8217;s target annual bonus for the then-current year (or, his target annual bonus in effect immediately prior to the sale event, if higher); (ii) full acceleration of vesting of all outstanding time-based equity awards held by Dr.&#160;Gaur; and (iii)&#160;subject to Dr.&#160;Gaur&#8217;s election to receive continued health benefits under COBRA, payment of the full cost of such continuation coverage plus any administration fee until the earliest of (A) 18 months following termination; (B)&#160;the date he becomes eligible for group medical plan benefits under any other employer&#8217;s group medical plan; or (C)&#160;the expiration of Dr.&#160;Gaur&#8217;s COBRA health continuation period. The cash severance payable to Dr.&#160;Gaur upon a termination of employment is generally payable in lump sum within 60 days following the date of termination, subject to limited exceptions. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Employment Agreement with Mr.&#160;Brendan Gibbons </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We entered into an employment agreement with Mr.&#160;Gibbons, effective on January&#160;29, 2024, pursuant to which we employ Mr.&#160;Gibbons as our Chief Legal Officer on an &#8220;at will&#8221; basis. Mr.&#160;Gibbons&#8217; employment agreement provides that Mr.&#160;Gibbons is eligible to receive annual cash bonuses, and to participate in the employee benefit plans generally available to our employees, subject to the terms of such plans. Mr.&#160;Gibbons&#8217; annual base salary is currently $400,000 and his target annual cash bonus amount is 50% of his annual base salary. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a termination of Mr.&#160;Gibbons&#8217; employment by Allurion without &#8220;cause&#8221; (as defined in his employment agreement) or by his resignation for &#8220;good reason&#8221; (as defined in his employment agreement), subject to Mr.&#160;Gibbons&#8217; execution and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-revocation</div> of a separation agreement containing, among other things, a release of claims in favor of Allurion and its affiliates, Mr.&#160;Gibbons will be entitled to receive (i)&#160;base salary continuation for 9 months following his termination date, and (ii)&#160;subject to Mr.&#160;Gibbons&#8217; election to receive continued health benefits under COBRA, payment of the full cost of such continuation coverage plus any administration fee until the earliest of (A) 12 months following termination; (B)&#160;the date he becomes eligible for group medical plan benefits under any other employer&#8217;s group medical plan; or (C)&#160;the expiration of Mr.&#160;Gibbons&#8217; COBRA health continuation period. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in lieu of the payments and benefits described above, in the event that Mr.&#160;Gibbons&#8217; employment is terminated by us without &#8220;cause&#8221; or by him for &#8220;good reason,&#8221; in each case, within 12 months </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">67 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">following a &#8220;sale event&#8221; (as defined in our 2023 Plan), and subject to Mr.&#160;Gibbons&#8217; execution and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-revocation</div> of a separation agreement containing, among other things, a release of claims in favor of Allurion and its affiliates, Mr.&#160;Gibbons will be entitled to receive (i)&#160;an amount in cash equal to 1 times the sum of (x)&#160;Mr.&#160;Gibbons then-current base salary (or, his base salary in effect immediately prior to the sale event, if higher) and (y)&#160;Mr.&#160;Gibbons target annual bonus for the then-current year (or, his target annual bonus in effect immediately prior to the sale event, if higher); (ii) full acceleration of vesting of all outstanding time-based equity awards held by Mr.&#160;Gibbons; and (iii)&#160;subject to Mr.&#160;Gibbons&#8217; election to receive continued health benefits under COBRA, payment of the full cost of such continuation coverage plus any administration fee until the earliest of (A) 12 months following termination; (B)&#160;the date he becomes eligible for group medical plan benefits under any other employer&#8217;s group medical plan; or (C)&#160;the expiration of Mr.&#160;Gibbons&#8217; COBRA health continuation period. The cash severance payable to Mr.&#160;Gibbons upon a termination of employment is generally payable in lump sum within 60 days following the date of termination, subject to limited exceptions. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a termination of Mr.&#160;Gibbons&#8217; employment due to his death or disability, and subject to Mr.&#160;Gibbons&#8217; execution and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-revocation</div> of a separation agreement containing, among other things, a release of claims in favor of Allurion and its affiliates, Mr.&#160;Gibbons (or his legal representatives or estate) will be entitled to receive a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">pro-rated</div> annual bonus for the year in which the date of termination occurs, as determined by the Board or Compensation Committee in its discretion. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Offer Letter with Mr.&#160;Ojas Buch </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We entered into an employment offer letter with Mr.&#160;Buch, dated May&#160;17, 2024, pursuant to which we employ Mr.&#160;Buch as our Chief Operating Officer on an &#8220;at will&#8221; basis. Mr.&#160;Buch&#8217;s offer letter provides that his initial annual base salary is $400,000, and is subject to periodic review and adjustments. In addition, the offer letter provides that Mr.&#160;Buch is eligible to receive incentive bonuses, which target amount shall be 50% of his base salary. Mr.&#160;Buch is also eligible to receive reimbursement of up to $30,000 in relocation expenses and participate in the employee benefit plans generally available to our employees, subject to the terms of such plans. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Buch will also be eligible to receive severance benefits consistent with those provided to our other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">C-suite</div> executives, excluding our CEO. Such severance benefits will include (i) 9 months of salary continuation if Mr.&#160;Buch&#8217;s employment is terminated without cause or for good reason, or (ii) 12 months of salary continuation and equity acceleration if Mr.&#160;Buch&#8217;s employment in the event of a change of control. </div><ix:nonNumeric name="ecd:AwardTmgMnpiDiscTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-4465"><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Equity Grant Timing </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="ecd:AwardTmgMethodTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-7441">Our Compensation Committee makes equity award grants periodically, including stock option grants to our Named Executive Officers. In addition, new hires may receive stock option grants at the time of their hiring.</ix:nonNumeric> <ix:nonNumeric name="ecd:AwardTmgMnpiCnsdrdFlag" contextRef="P01_01_2024To12_31_2024" format="ixt:fixed-false" id="ixv-4468"><ix:nonNumeric name="ecd:AwardTmgHowMnpiCnsdrdTextBlock" contextRef="P01_01_2024To12_31_2024" escape="true" id="ixv-4469">During 2024, our Compensation Committee did not take into account any material nonpublic information when <div style="display:inline;"><div style="display:inline;"><div style="display:inline;"><ix:nonNumeric name="ecd:AwardTmgPredtrmndFlag" contextRef="P01_01_2024To12_31_2024" format="ixt:fixed-true" id="ixv-7442">determining</ix:nonNumeric></div></div></div> the timing and terms of equity incentive awards in order to take advantage of a depressed stock price or an anticipated increase in stock price, and we did <div style="display:inline;"><div style="display:inline;"><div style="display:inline;"><ix:nonNumeric name="ecd:MnpiDiscTimedForCompValFlag" contextRef="P01_01_2024To12_31_2024" format="ixt:fixed-false" id="ixv-7443">not time</ix:nonNumeric></div></div></div> the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</ix:nonNumeric></ix:nonNumeric> During 2024, we did not grant stock options to our Named Executive Officers during any period beginning four business days before and ending one business day after the filing or furnishing of a Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">10-Q,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">10-K</div> or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">8-K</div> that discloses material nonpublic <div style="display:inline;">information</div>. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="display:inline;">68</div> </div></div></div></div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Outstanding Equity Awards at 2024 Fiscal Year End </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information concerning outstanding equity awards held by each of our NEOs as of December&#160;31, 2024: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:26%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Option Awards</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Stock Awards</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:7pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Grant Date</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Vesting<br/>Commencement<br/>Date</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options (#)<br/>(Exercisable)<sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options (#)<br/>(Unexercisable)<sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Option<br/>Exercise&#160;Price<br/>($)<sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Option<br/>Expiration<br/>Date</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Number&#160;of<br/>Shares&#160;or&#160;Units<br/>of Stock That<br/>Have Not<br/>Vested (#)<sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Market&#160;Value<br/>of Shares or<br/>Units&#160;of&#160;Stock<br/>That&#160;Have&#160;Not<br/>Vested ($)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Dr.&#160;Shantanu Gaur</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">08/03/2017</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,846</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">28.25</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">8/2/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">03/05/2020</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(2)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">01/01/2020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,956</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">29.25</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3/4/2030</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/20/2022</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(3)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/08/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">30,052</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">8,563</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">112.75</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12/19/2032</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">05/03/2024</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(4)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">05/03/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">57,144</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">57.50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5/2/2034</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Brendan Gibbons</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">02/08/2024</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(4)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">01/29/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10,153</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">74.00</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2/7/2034</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/08/2024</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(5)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/08/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,270</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">131,903</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Ojas Buch</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">06/03/2024</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(4)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">06/03/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,271</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">35.75</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6/2/2034</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/08/2024</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(5)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11/08/2024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">12,270</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">131,903</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Amounts reported have been adjusted to reflect the Reverse Stock Split. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This option vests in 48 equal monthly installments following the vesting commencement date, subject to the executive&#8217;s continuing service relationship on each vesting date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This option vests in 36 equal monthly installments beginning on the last date of each <span style="white-space:nowrap">one-month</span> period following the vesting commencement date, subject to the executive&#8217;s continuing service relationship on each vesting date. Upon the consummation of the Business Combination, <span style="white-space:nowrap">one-third</span> of the then unvested shares subject to the option accelerated and vested. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This option vests with respect to 25% of the shares on the first anniversary of the vesting commencement date, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the executive&#8217;s continuing service relationship on each vesting date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(5)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Represents RSUs which vest in two equal installments, with 50% vesting on the first anniversary of the vesting commencement date and the remaining 50% vesting on the second anniversary of the vesting commencement date, subject to the executive&#8217;s continuing service relationship on each vesting date. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Additional Narrative Disclosure </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Employee Benefits </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Named Executive Officers are eligible to participate in our welfare benefit plans, including medical, dental, vision, basic life and accidental death&#160;&amp; dismemberment, and short-term and long- term disability insurance benefits, in each case on the same basis as all of our other employees. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">401(k) Plan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Allurion participates in the ADP TotalSource Retirement Savings Plan (the &#8220;401(k) Plan&#8221;), which provides eligible U.S. employees (including our Named Executive Officers) with an opportunity to save for retirement on a tax advantaged basis. Under the 401(k) Plan, eligible employees may defer eligible compensation subject to applicable annual contribution limits imposed by the Code. Allurion&#8217;s employees&#8217; contributions are allocated to each participant&#8217;s individual account and employees may begin participating after an initial 90 day waiting period. Under the provisions of the 401(k) Plan, Allurion makes 2% matching contributions and may make discretionary <span style="white-space:nowrap">non-matching</span> contributions, as determined by our Board of Directors. The 401(k) Plan is intended to be qualified under Section&#160;401(a) of the Code with the 401(k) Plan&#8217;s related trust intended to be tax exempt under Section&#160;501(a) of the Code. As a <span style="white-space:nowrap">tax-qualified</span> retirement plan, contributions to the 401(k) Plan and earnings on those contributions are not taxable to the employees until distributed from the 401(k) Plan. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">69 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Director Compensation Table </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding the compensation awarded to, earned by, or paid to Allurion&#8217;s <span style="white-space:nowrap">non-employee</span> directors for service on our Board of Directors during the year ended December&#160;31, 2024. Dr.&#160;Gaur, who is our Chief Executive Officer, also served on our Board of Directors, but did not receive any additional compensation for his service as a director and therefore is not included in the table below. Dr.&#160;Gaur&#8217;s compensation for his service, as our Chief Executive Officer, is set forth above under &#8220;<span style="font-style:italic">&#8212;Summary Compensation Table.</span>&#8221; </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:52%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Fees&#160;Earned&#160;or<br/>Paid in Cash<br/>($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Stock&#160;Awards<br/>($)<sup style="font-size:75%; vertical-align:top">(1)(5)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Total<br/>Compensation<br/>($)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Omar Ishrak</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">105,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">105,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Krishna Gupta</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">95,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">95,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Davin</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">72,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">72,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas Hudson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">62,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">62,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nicholas Lewin</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">52,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">52,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Milena Alberti-Perez<sup style="font-size:75%; vertical-align:top">(2)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">52,480</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">195,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">248,230</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Keith B. Johns II<sup style="font-size:75%; vertical-align:top">(3)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">14,825</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">241,314</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">256,139</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Jason Richey<sup style="font-size:75%; vertical-align:top">(4)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Amounts shown reflect the grant date fair value of restricted stock units granted in 2024, calculated in accordance with FASB ASC Topic 718, excluding any estimates of forfeitures related to service-based vesting conditions. For information regarding assumptions underlying the valuation of equity awards, see Note 14 to our consolidated financial statements included in our 2024 Annual Report. The amounts reported in this column reflect the accounting cost for the restricted stock unit awards, and do not correspond to the actual economic value that may be recognized by holders upon the vesting or settlement of the applicable awards. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Ms.&#160;Alberti-Perez was appointed to our Board on March&#160;11, 2024. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Mr.&#160;Johns was appointed to our Board on September&#160;2, 2024. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Mr.&#160;Richey was appointed to our Board on December&#160;30, 2024. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(5)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The following table provides information regarding the number of shares of our common stock, underlying stock options, and restricted stock units held by our <span style="white-space:nowrap">non-employee</span> directors that were outstanding as of December&#160;31, 2024: </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:41%"/>

<td style="vertical-align:bottom;width:22%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:22%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">RSU&#160;Awards&#160;Outstanding<br/>at 2024 Year End<br/>(number of shares)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Option&#160;Awards<br/>Outstanding&#160;at&#160;2024&#160;Year<br/>End (number of shares)<sup style="font-size:75%; vertical-align:top">(1)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Omar Ishrak</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,206</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Krishna Gupta</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,050</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Davin</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,206</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6,456</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas Hudson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,206</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nicholas Lewin</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,206</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Milena Alberti-Perez</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Keith B. Johns II</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">13,044</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Jason Richey</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Amount reflects outstanding stock options awarded to Mr.&#160;Davin in his capacity as a <span style="white-space:nowrap">non-employee</span> director, all of which are vested. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="white-space:nowrap">Non-Employee</span> Director Compensation Policy </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective as of August 2023, our Board of Directors adopted a <span style="white-space:nowrap">non-employee</span> director compensation policy (the &#8220;Director Compensation Policy&#8221;) designed to enable us to attract and retain, on a long-term basis, highly </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">70 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
qualified <span style="white-space:nowrap">non-employee</span> directors. Effective as of October&#160;15, 2025, our Board of directors amended and restated the Director Compensation Policy (the &#8220;Amended Director Compensation Policy&#8221;). Under the Amended Director Compensation Policy, our <span style="white-space:nowrap">non-employee</span> directors are eligible to receive cash retainers (which are payable quarterly in arrears and prorated for partial years of service) and equity awards as set forth below. In addition, we reimburse <span style="white-space:nowrap">non-employee</span> directors for all reasonable <span style="white-space:nowrap"><span style="white-space:nowrap">out-of-pocket</span></span> expenses incurred in attending meetings of our Board of Directors or committees. We do not pay additional compensation for attending individual meetings of our Board of Directors. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:85%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Annual Retainer for Board Membership</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">25,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Additional Annual Retainer for <span style="white-space:nowrap">Non-Executive</span> Chair</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">25,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Additional Annual Retainer for Committee Membership</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Committee Chairperson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Committee Member (other than Chairperson)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation Committee Chairperson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">7,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation Committee Member (other than Chairperson)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominating and Corporate Governance Committee Chairperson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominating and Corporate Governance Committee Member (other than Chairperson)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Initial Award</span>: The Amended Director Compensation policy provides that an initial, <span style="white-space:nowrap">one-time</span> restricted stock unit award (the &#8220;Initial Award&#8221;) with a value to be determined by the Board will be granted to each new <span style="white-space:nowrap">non-employee</span> director upon his or her initial election or appointment to the Board of Directors. Each Initial Award shall vest in equal annual installments over three years from the date of grant, provided, however, that all vesting shall cease if the director resigns from the Board of Directors or otherwise ceases to serve as a director of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Annual Award</span>: On the date of each annual meeting of stockholders, or on such other date as determined by the Board, the Outside Directors as a whole will be allocated an aggregate award in an amount of restricted stock units (&#8220;RSUs&#8221;) equal to 0.5% of total shares of common stock then outstanding (the &#8220;Aggregate Annual Award&#8221;). From this Aggregate Annual Award, each Outside Director shall receive an individual annual award (&#8220;Annual Award&#8221;) equal to the total number of RSUs underlying the Aggregate Annual Award divided by the number of Outside Directors then serving on the Board, provided that no Outside Director shall be entitled to an award if he or she received an Initial Award within six (6)&#160;months prior to the date that the <span style="white-space:nowrap">non-employee</span> director would otherwise receive an Annual Award. Annual Awards shall vest in full upon the earlier of (i)&#160;the first anniversary of the date of grant or (ii)&#160;the date of the next annual meeting; provided, however, that all vesting shall cease if the director resigns from the Board of Directors or otherwise ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting; and provided, further, that if such Annual Award is not granted at an annual meeting, then in no event shall any grant be made: (i)&#160;during a Company blackout period or when any <span style="white-space:nowrap">non-employee</span> director is in possession of material <span style="white-space:nowrap">non-public</span> information or (ii)&#160;if such grant would otherwise constitute a &#8220;spring-loaded award&#8221; (as defined in the Staff Accounting Bulletin No.&#160;120). The vesting of all outstanding Initial Awards and Annual Awards held by a <span style="white-space:nowrap">non-employee</span> director will fully accelerate upon a &#8220;sale event&#8221; (as defined in our 2023 Plan). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of determining the size of each restricted stock unit award, the Director Compensation Policy defines &#8220;value&#8221; as the product of (A)&#160;the average closing market price on the NYSE (or such other market on which our common stock is then principally listed) of one share of our common stock over the trailing <span style="white-space:nowrap">30-day</span> period ending on the last day of the month immediately prior to the month of the grant date, and (B)&#160;the aggregate number of shares of our common stock underlying such award. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">71 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_17">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding the beneficial ownership of shares of our common stock, as of October&#160;31, 2025, in each case, by: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">each person who is known to us to be the beneficial owner of more than 5% of the issued and outstanding shares of our common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">each of our directors, director nominees and named executive officers; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">all of our directors and executive officers as a group. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options, restricted stock units, and warrants that are currently exercisable or releasable or exercisable or releasable within 60 days. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, we believe that all persons named in the table below have sole voting and investment power with respect to all shares of voting shares beneficially owned by them. Unless otherwise noted, the business address of each person listed in the table is c/o Allurion Technologies, Inc., 11 Huron Drive, Natick, MA 01760. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The beneficial ownership of the shares of our common stock is based on 7,770,047 shares of our common stock issued and outstanding as of October&#160;31, 2025. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:70%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name and Address of Beneficial Owner</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Number&#160;of<br/>Shares</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">% of<br/>Ownership</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Directors and Named Executive Officers:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shantanu Gaur<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">132,073</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1.7</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Krishna Gupta<sup style="font-size:75%; vertical-align:top">(2)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">242,243</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">3.1</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Omar Ishrak<sup style="font-size:75%; vertical-align:top">(3)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">160,127</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2.1</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Davin<sup style="font-size:75%; vertical-align:top">(4)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10,272</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas Hudson<sup style="font-size:75%; vertical-align:top">(5)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,208</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nicholas Lewin<sup style="font-size:75%; vertical-align:top">(6)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">1,208</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Jason Richey</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brendan M. Gibbons<sup style="font-size:75%; vertical-align:top">(7)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">11,006</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ojas Buch<sup style="font-size:75%; vertical-align:top">(8)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">10,740</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Keith B. Johns II<sup style="font-size:75%; vertical-align:top">(9)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">4,348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">*</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Current Directors and Executive Officers as a Group (11&#160;Persons)<sup style="font-size:75%; vertical-align:top">(10)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">655,338</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">8.1</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Five Percent Holders:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leavitt Equity Partners III, L.P.<sup style="font-size:75%; vertical-align:top">(11)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">462,762</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">6.0</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Armistice Capital<sup style="font-size:75%; vertical-align:top">(12)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">391,643</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">5.0</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RTW<sup style="font-size:75%; vertical-align:top">(13)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">2,542,603</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right">32.7</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> </div> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">*</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Less than one percent. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (i) 40,124 shares of common stock held by The Shantanu K. Gaur Revocable Trust Of 2021, of which Shantanu K. Gaur and Neha Gaur serve as trustees, (ii) 21,908 shares of common stock held by The Gaur Family Irrevocable Trust Of 2021, of which Steven M. Burke, Esq. and Neha Gaur serve as trustees and which Ms.&#160;Gaur has voting and dispositive control, and (iii) 70,041 shares of common stock issuable upon exercise of options within 60 days of October 31, 2025. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (i) 124,970 shares of common stock held by Romulus Growth Allurion L.P., (ii) 2,919 shares of common stock held by Romulus Capital I, L.P., (iii) 2,934 shares of common stock issuable upon exercise of a warrant held by Romulus Capital I, L.P., (iv) 35,252 shares of common stock held by Romulus Allurion </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">72 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="vertical-align:top;text-align:left">
Special Opportunity L.P., (v) 21,525 shares of common stock held by Samin Capital LLC, (vi) 49,866 shares of common stock held by Krishna Gupta, and (vii) 4,777 shares of common stock issuable upon vesting of restricted stock units held by Krishna Gupta within 60 days of October 31, 2025. Krishna Gupta is the general partner of Romulus Allurion Special Opportunity L.P., Romulus Growth Allurion L.P., and Romulus Capital I, L.P., and the manager of Samin Capital LLC. </td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (i) 29,014 shares held by Omar&#160;&amp; Helen Ishrak Living Trust, (ii) 130,509 shares held by the Sponsor, and (iii) 1,208 shares of common stock issuable upon vesting of restricted stock units held by Omar Ishrak within 60 days of October 31, 2025. Dr.&#160;Ishrak disclaims beneficial ownership over 54,743&#160;shares in excess of his pecuniary interest therein. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (i) 3,212 shares of common stock, (ii) 6,456 shares of common stock issuable upon exercise of options within 60 days of October 31, 2025, and (iii) 604 shares of common stock issuable upon vesting of restricted stock units held by Michael Davin within 60 days of October 31, 2025. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(5)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 604 shares of common stock and 604 shares of common stock issuable upon vesting of restricted stock units held by Douglas Hudson within 60 days of October 31, 2025. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(6)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 604 shares of common stock and 604 shares of common stock issuable upon vesting of restricted stock units held by Nicholas Lewin within 60 days of October 31, 2025. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(7)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 4,871 shares of common stock issuable upon exercise of options within 60 days of October 31, 2025, and 6,135 shares of common stock issuable upon vesting of restricted stock units within 60 days of October 31, 2025, held by Brendan Gibbons. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(8)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 4,605 shares of common stock issuable upon exercise of options within 60 days of October 31, 2025, and 6,135 shares of common stock issuable upon vesting of restricted stock units within 60 days of October&#160;31, 2025, held by Ojas Buch. </p></td></tr></table> <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(9)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 4,348 shares of common stock issuable upon vesting of restricted stock units held by Keith B. Johns II within 60 days of October 31, 2025. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(10)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">See footnotes 1 through 9 above. Also includes (i) 66,516 shares of common stock and (ii) 15,597 shares of common stock issuable upon exercise of options within 60 days of October 31, 2025, each held by Ram Chuttani. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(11)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Beneficial ownership is based solely on a Schedule 13G filed jointly on February 26, 2025 with the SEC by Leavitt Equity Partners III, LLC, and consists of 462,762 shares of common stock beneficially owned by Leavitt Equity Partners III, LLC, LEP Management LLC, Leavitt Legacy, LLC and Taylor Leavitt (collectively, the &#8220;Leavitt Funds&#8221;). The private placement warrants held by the Leavitt Funds are subject to a beneficial ownership exercise limitation which is currently set at 4.99%. The address and principal office of the Leavitt Funds is 95 South State Street, Suite 2190, Salt Lake City, UT 84111. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(12)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Beneficial ownership is based solely on a Schedule 13G filed jointly on May 15, 2025 with the SEC by Armistice Capital, LLC and consists of 391,643 shares of common stock held by Armistice Capital, LLC and Steven Boyd (collectively, &#8220;Armistice&#8221;). The address and principal office of Armistice is 510 Madison Avenue, 7<sup style="font-size:75%; vertical-align:top">th</sup> Floor, New York, New York 10022. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(13)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Beneficial ownership is based solely on a Schedule 13D/A filed jointly on April 17, 2025 with the SEC by RTW and Roderick Wong, M.D., which consists of 2,542,603 shares of common stock beneficially owned by RTW. RTW, in its capacity as the investment manager of those certain RTW entities, has the power to vote and the power to direct the disposition of the shares held by RTW. Accordingly, RTW may be deemed to be the beneficial owner of such securities. Roderick Wong, M.D., as the Managing Partner of RTW, has the power to direct the vote and disposition of the securities held by RTW. Dr.&#160;Wong disclaims beneficial ownership of the shares held by RTW, except to the extent of his pecuniary interest therein. The address and principal office of RTW is 40 10th Avenue, Floor 7, New York, NY 10014, and the address of Dr.&#160;Wong and each of the RTW entities is c/o RTW Investments, LP, 40 10th Avenue, Floor 7, New York, NY 10014. </p></td></tr></table> </div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">73 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_18">CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than the compensation agreements and other arrangements described under &#8220;<span style="font-style:italic">Executive and Director Compensation</span>&#8221; in this Proxy Statement and the transactions described below, since January&#160;1, 2023, there has not been and there is not currently proposed to be any transaction or series of similar transactions to which we were, or will be, a party in which the amount involved exceeded, or will exceed, $120,000 (or, if less, 1% of the average of our total assets at year-end for the last two completed fiscal years) and in which any director, executive officer, nominee for director, holder of five percent or more of any class of our capital stock or any member of the immediate family of, or entities affiliated with, any of the foregoing persons, had, or will have, a direct or indirect material interest. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">PIPE Investment </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain investors (&#8220;PIPE Investors&#8221;) related to Legacy Allurion entered into PIPE subscription agreements (&#8220;PIPE Subscription Agreements&#8221;), with Compute Health and us, pursuant to which they subscribed for shares of our common stock in connection with a private placement. The PIPE Investors made a private investment in the aggregate amount of $37.9&#160;million on the terms and conditions set forth in the PIPE Subscription Agreements. Such PIPE Investors who participated in the PIPE Investment include Michael Davin (1,233 shares), who is one of our directors, Omar Ishrak (28,410 shares), who is one of our directors, and RTW (85,230 shares), which has the right to designate two director nominees to be elected by our stockholders. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Gaur Contribution Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&#160;2, 2023, the Shantanu K. Gaur Revocable Trust of 2021 (the &#8220;Gaur Trust&#8221;) and we entered into a contribution agreement (the &#8220;Gaur Contribution Agreement&#8221;), pursuant to which, among other things, upon the terms and subject to the conditions set forth therein, the Gaur Trust agreed to contribute, as a contribution of capital, 3,170 shares of our common stock (the &#8220;Gaur Trust Contributed Shares&#8221;). The Gaur Trust&#8217;s contribution of the Gaur Trust Contributed Shares was effective immediately following the consummation of the Business Combination between us and Compute Health and the transactions contemplated thereby. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">RSU Forfeiture Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&#160;2, 2023, Krishna Gupta, a member of our Board, entered into a letter agreement with Legacy Allurion, pursuant to which, among other things, upon the terms and subject to the conditions set forth therein, Mr.&#160;Gupta agreed to forfeit 3,170 restricted stock units (the &#8220;Forfeited RSUs&#8221;). The Forfeited RSUs were terminated and cancelled without consideration therefor immediately following the consummation of the transactions contemplated by the Business Combination Agreement between Allurion and Compute Health and other parties thereto, dated as of February&#160;9, 2023, as amended from time to time. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">2023 Convertible Note Incremental Financing </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&#160;15, 2023, we sold a $13.0&#160;million convertible bridge note (the &#8220;HVL Bridge Note&#8221;) to Hunter Ventures Limited (&#8220;HVL&#8221;) and entered into a side letter agreement with HVL (the &#8220;Side Letter&#8221;). HVL is a limited partner of Romulus Growth Allurion L.P., which is a fund affiliated with Krishna Gupta (a member of our Board; in addition, entities affiliated with Krishna Gupta hold more than 5% of our outstanding capital stock) (the &#8220;Initial Financing&#8221;). In connection with the refinancing of the Initial Financing, we entered into a Termination Agreement with HVL, pursuant to which the Side Letter was terminated, effective as of May&#160;2, 2023 (the &#8220;HVL Termination Agreement&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The HVL Termination Agreement provided us, upon the terms and subject to the conditions set forth therein, the right to prepay, in one or more transactions, all or a portion of the outstanding principal amount, plus accrued interest, under the HVL Bridge Note, including by way of (a)&#160;a $2.0&#160;million prepayment, $1.5&#160;million of </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">74 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
which was deemed a prepayment penalty and (b)&#160;immediately prior to the consummation of the Business Combination, an additional payment of at least $6.0&#160;million under the HVL Bridge Note by way of (i)&#160;payment in cash by us and/or (ii)&#160;the sale and transfer of all or any portion of the HVL Bridge Note, equivalent in value to the portion of the additional payment to be repaid pursuant to this clause (b)(ii), to any person or persons designated in writing by us. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under the HVL Termination Agreement, upon the terms and subject to the conditions set forth therein, we agreed to issue to HVL 15,508 additional shares of our common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Revenue Interest Financing Agreement, Side Letter and PIPE Conversion Option </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&#160;9, 2023, concurrently with the execution of the Business Combination Agreement, we entered into the First RIFA with certain entities that engaged RTW. Pursuant to the First RIFA, at the closing of the Business Combination, RTW paid Allurion an aggregate of $40.0&#160;million (the &#8220;Investment Amount&#8221;). In exchange for the Investment Amount, we will remit revenue interest payments on all current and future products, digital solutions and services developed, imported, manufactured, marketed, offered for sale, promoted, sold, tested or otherwise distributed by us and our subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&#160;14, 2024, the First RIFA was amended pursuant to the RIFA Amendment, and was subsequently further amended on January&#160;7, 2025 pursuant to the Omnibus Amendment, to reflect certain modifications agreed between the parties thereto in connection with the Amended Note Purchase Agreement and the refinancing of our prior term loan facility with Fortress Credit Corp. Among other things, the RIFA Amendment waived the existing event of default under the First RIFA, increased the rate of revenue interest payments to be paid to RTW on all current and future products and digital solutions developed and to be developed by us (the &#8220;Royalty Rate&#8221;) for net sales less than or equal to $100&#160;million prior to December&#160;31, 2026 from 6% to 12%, and increased the Royalty Rate on net sales less than or equal to $100&#160;million on or after January&#160;1, 2027 from 10% to 12%, subject to the terms and conditions of the RIFA Amendment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, in connection with our entry into the RIFA Amendment, we, Compute Health, Legacy Allurion, Merger Sub II and RTW entered into a side letter (the &#8220;RTW Side Letter&#8221;) under which RTW was entitled to elect to convert up to $7.5&#160;million of its initial PIPE subscription into an additional revenue interest financing by forfeiting certain shares of our common stock acquired by the PIPE subscription (the &#8220;PIPE Conversion Option&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&#160;2, 2023, the parties amended and restated the RTW Side Letter in connection with a backstop agreement, pursuant to which, among other things, Allurion issued 10,000 shares of common stock to RTW immediately prior to the effective time of the Intermediate Merger. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&#160;14, 2024, the parties entered into the RTW Side Letter Amendment to reflect certain modifications to the RTW Side Letter in connection with the Amended Note Purchase Agreement (the &#8220;RTW Side Letter Amendment&#8221; and the amended RTW Side Letter, the &#8220;Amended and Restated RTW Side Letter&#8221;). The RTW Side Letter Amendment provides, among other things, that RTW may make a single election in certain circumstances to convert up to $7.5&#160;million of the purchase price that RTW paid for certain equity interests in Allurion into an amount of financing provided by RTW to Allurion pursuant to an additional revenue interest financing agreement with Legacy Allurion. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Amended and Restated RTW Side Letter, on October&#160;22, 2024, the Additional RIFA Investors notified us of their election to exercise the Investment Conversion in full. Accordingly, on October&#160;30, 2024, we and the Additional RIFA Investors entered into the Second RIFA. The Second RIFA has substantially identical terms and conditions as the First RIFA, except that the amount of financing provided under the Second RIFA is equal to the conversion amount of $7.5 million. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">75 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information, see the subsection entitled &#8220;<span style="font-style:italic">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Recent Developments&#8212;Amendment to Revenue Interest Financing Agreement, Additional Revenue Interest Financing Agreement, and Omnibus Amendment </span>&#8220;and Note 9, <span style="font-style:italic">Revenue </span><span style="font-style:italic">Interest Financing, Side Letter, and PIPE Conversion Option</span> in the notes to our annual consolidated financial statements for the years ended December&#160;31, 2024 and 2023 included in our 2024 Annual Report for further discussion. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Amended Note Purchase Agreement </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Amended Note Purchase Agreement, on April&#160;16, 2024, we issued and sold $48&#160;million of Notes to RTW in a private placement. Until the Notes are converted or repaid in full, RTW will be entitled to designate one representative who will serve as a <span style="white-space:nowrap">non-voting</span> board observer to the Board. RTW is also entitled to designate two directors to our Board, initially Nicholas Lewin and R. Jason Richey. Additionally, in August 2024, we expanded our Board from seven to eight members and in September 2024, we appointed Keith B. Johns II to our Board, which appointment was approved by RTW in satisfaction of certain obligations to RTW set forth in the Amended Note Purchase Agreement. For more information about the Amended Note Purchase Agreement, see the subsection entitled &#8220;<span style="font-style:italic">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Recent Developments&#8212;Amended Note Purchase Agreement</span>&#8221; in our 2024 Annual Report for further discussion. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Omnibus Amendment </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&#160;7, 2025, we and Allurion Technologies, LLC (&#8220;Allurion Opco&#8221;) entered into the Omnibus Amendment. The Omnibus Amendment requires (i)&#160;we and Allurion Opco to maintain certain minimum balances of unrestricted cash in controlled accounts in the U.S. in the amounts corresponding to the calculations set forth therein, and (ii)&#160;us to receive minimum trailing twelve-month consolidated Revenue (as defined in the Amended Note Purchase Agreement) in amounts set forth therein, tested quarterly beginning with the twelve-month period ending September&#160;30, 2025. The Omnibus Amendment also requires that (i)&#160;Allurion France will have successfully regained marketing authorization from the Agence Nationale de S&#233;curit&#233; du M&#233;dicament et des Produits de Sant&#233; to resume the Commercialization (as defined in the Existing Documents) of the Product (as defined in the Existing Documents) in France on or prior to December&#160;31, 2025, which condition was met as of February 2025, and (ii)&#160;Allurion OpCo shall have received Marketing Authorization from the U.S. Food and Drug Administration for the Commercialization of the Product (each as defined in the Omnibus Amendment) in the United States no later than June&#160;30, 2026. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Omnibus Amendment, the RIFA Investors and the Note Purchasers will receive a number of shares of the common stock, representing 5.0% of the fully-diluted shares outstanding (without regard to any beneficial ownership blockers) immediately after the closing of the offering and sale of Additional Shares (as defined in the Amended Note Purchase Agreement) to be consummated no later than February&#160;15, 2025, in connection with which we shall have raised at least $12,000,000 in aggregate net proceeds; provided that, in the event we cannot issue shares of common stock to the RIFA Investors and the Note Purchasers due to applicable law, we shall instead issue an equivalent <span style="white-space:nowrap">(as-converted)</span> number of shares of a newly created series of Series <span style="white-space:nowrap">A-1</span> <span style="white-space:nowrap">non-voting</span> preferred stock, par value $0.0001 per share (the &#8220;Series <span style="white-space:nowrap">A-1</span> Preferred Stock&#8221;), and we shall include a proposal in a definitive proxy statement on Schedule 14A seeking stockholder approval no later than December&#160;31, 2025 to allow the conversion of Series <span style="white-space:nowrap">A-1</span> Preferred Stock into common stock; provided further that, each share of Series <span style="white-space:nowrap">A-1</span> Preferred Stock outstanding on December&#160;31, 2026 will, except to the extent prohibited by Delaware law governing distributions to stockholders (including the Delaware General Corporation Law), be redeemed by us for cash in an amount equal to the <span style="white-space:nowrap">as-converted</span> value of the underlying common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Omnibus Amendment also provides that we will ensure that RTW and the RIFA Investors have the right to designate one director to the Board, which director is currently Nicholas Lewin, and as of the Amendment Effective Date (as defined in the Omnibus Amendment), also have the right to designate a second director to the Board, which additional director will initially be R. Jason Richey. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">76 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">July 2024 Public Offering and Concurrent Private Placement </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to an underwriting agreement, dated as of June 28, 2024 (the &#8220;Underwriting Agreement&#8221;), on July&#160;1, 2024, we issued and sold 576,261 shares of our common stock and 576,261 public warrants at an offering price of $30.00 per share and accompanying warrant. RTW purchased 9,594 shares of common stock and warrants to purchase 9,594 shares of common stock in this offering, for an aggregate purchase price of $0.3&#160;million. On July&#160;5, 2024, the underwriters partially exercised their over-allotment option to purchase an additional 77,091 shares of common stock, generating additional gross proceeds of approximately $2.2&#160;million to us, before deducting the underwriters&#8217; discounts and commissions and estimated offering expenses payable by us. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrently with the Underwriting Agreement, we issued and sold 2,260,159 shares of Series A Preferred Stock (which were automatically converted to 90,407 shares of common stock on December&#160;19, 2024 following stockholder approval and after giving effect to the reverse stock split we effected on January 3, 2025, by application of a reverse stock split ratio of 1-to-25) and 90,407 private warrants to funds affiliated with RTW, for an aggregate purchase price of approximately $2.7&#160;million, at an offering price of $30.00 per share of Series A Preferred Stock and accompanying private placement warrant. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about the offering and private placement, see the subsection entitled &#8220;<span style="font-style:italic">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;July 2024 Public Offering and Concurrent Private Placemen</span>t&#8221; in our 2024 Annual Report for further discussion. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">January 2025 RTW Private Placement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&#160;14, 2025, we entered into a subscription agreement with funds affiliated with RTW, pursuant to which we agreed to sell to RTW 841,751 shares of our common stock, for an aggregate purchase price of approximately $2.5&#160;million at a purchase price per share of $2.97. This private placement closed on January&#160;16, 2025. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">November 2025 Private Placement </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November 11, 2025, we entered into the Securities Purchase Agreement with the purchasers party thereto, which included funds managed by RTW, pursuant to which we agreed to sell to RTW 2,994,012 shares of our common stock and 2,994,012 accompanying warrants to purchase 2,994,012 shares of our common stock, at an offering price of $1.67 per share and accompanying warrant. The private placement closed on November 14, 2025, and resulted in gross proceeds of approximately $5 million, which includes approximately $3.1 million paid by RTW. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Exchange Agreement </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&#160;11, 2025, the Company entered into the Exchange Agreement with RTW, pursuant to which RTW has agreed to exchange all of the (i)&#160;principal amount of the Notes, purchased pursuant to the terms of the Amended Note Purchase Agreement, including interest accrued on the Notes; (ii)&#160;Company obligations under the First RIFA and (iii)&#160;Company obligations under the Second RIFA for shares of a newly issued class of Series&#160;B Preferred Stock. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Exchange Agreement, the Company has agreed, at the request of any holder of Series B Preferred Stock, to file a resale registration statement with the SEC to register the resale of the Series B Preferred Stock, the Common Stock issuable upon conversion thereof and other equity of the Company held by RTW as of the date of the Exchange Agreement, and to cause such registration statement to become effective within 90 days of the filing date. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">77 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div> <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the closing of the Exchange, RTW&#8217;s rights to appoint certain directors of the Company pursuant to the Amended Note Purchase Agreement and the RIFAs will terminate and be replaced by the rights set forth in the Certificate of Designations. Pursuant to the terms of the Certificate of Designations, for so long as RTW or its affiliates beneficially own at least: (i) 10% of the Company&#8217;s securities, RTW will have the right to nominate an individual for election to the Board and (ii) 30% of our securities, RTW will have the right to nominate a second individual for election to the Board, in each case subject to the recommendation of the Nominating Committee and the approval of the Board. Such individuals shall initially be Nicholas Lewin and R. Jason Richey, respectively, who currently serve on the Board. In addition, for so long as (x) a Specified Breach Event has occurred and is continuing and (y) RTW or its affiliates beneficially own at least 10% of the Company&#8217;s securities, RTW will have the right to nominate two additional individuals for election to the Board, in each case subject to the recommendation of the Nominating Committee and the approval of the Board. Notwithstanding the foregoing, if the appointment of such individuals would result in a majority of the Board being comprised of individuals nominated by RTW, then (i) such nomination right will be reduced so that all individuals nominated by RTW shall represent less than a majority of the Board, (ii) the Company will use its best efforts to increase the size of the Board to permit nomination of both individuals while all individuals nominated by RTW represent less than a majority of the Board, and (iii) the dividend rate of the Series B Preferred Stock will be increased by 2% during such period that at least one such individual cannot be appointed. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Investment by Former Chief Commercial Officer </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;24, 2023, Legacy Allurion sold a $200,000 bridge note to its former Chief Commercial Officer, Benoit Chardon. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Investor Rights Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the closing of the Business Combination, we and the Investors entered into the Investor Rights Agreement. Pursuant to the Investor Rights Agreement, upon the terms and subject to the conditions set forth therein, each Investor was granted certain registration rights with respect to such holder&#8217;s shares of our common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Investor Rights Agreement restricted the ability of certain Investors to transfer all or a portion of their respective shares of our common stock (or any securities convertible into or exercisable or exchangeable for shares of our common stock), subject to certain permitted transfers, for a period of either 18 months or 12 months following August&#160;1, 2023 (the &#8220;Closing Date&#8221;), as applicable. The foregoing <span style="white-space:nowrap">lock-up</span> restrictions did not apply to: (a)&#160;any shares of our common stock purchased pursuant to the PIPE Subscription Agreements, (b) 100 shares of our common stock held by each Investor, (c)&#160;shares issued to the Sponsor in the conversion of the loans made by the Sponsor to Compute Health, which balance was $3.7&#160;million at the time of the Business Combination and was converted into 21,023 shares of Allurion common stock, (d)&#160;certain incremental shares of PIPE Investors who were existing Allurion Stockholders or existing holders of Allurion Convertible Notes or shares issued upon conversion of securities issued in the Incremental Financing and (e)&#160;the Backstop Shares, the Sponsor Contributed Shares, the Gaur Trust Contributed Shares or the shares of our common stock issued to each of HVL, RTW, Fortress and the other holders of the $28.7&#160;million aggregate principal amount of convertible unsecured promissory notes sold in a private placement by Legacy Allurion to various investors from February&#160;15, 2023 until August&#160;1, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, pursuant to the Investor Rights Agreement, upon the terms and subject to the conditions set forth therein, the Board was to initially consist of seven directors, a majority of which shall be &#8220;independent&#8221; directors for purposes of NYSE rules, and the following persons have the following nomination rights with respect to our Board, subject to the limitations set forth in the Investor Rights Agreement: (i)&#160;one director and one independent director nominated by Shantanu Gaur; (ii)&#160;one director and one independent director nominated by Remus Capital; (iii)&#160;one director nominated by the Sponsor; and (iv)&#160;two independent directors nominated by Allurion (one of which shall be designated by RTW). </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">78 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Investor Rights Agreement terminates upon the earlier of (i)&#160;the seventh anniversary of the Closing Date of the Business Combination, (ii)&#160;a Change of Control (as defined in the Business Combination Agreement) or (iii)&#160;the date as of which there shall be no registrable securities outstanding; provided, that with respect to any Investor, such Investor will have no rights under the Investor Rights Agreement and all of our obligations to such Investor shall terminate upon the earlier of (x)&#160;the date at least one year after the Closing Date that such Investor ceases to hold at least one percent of the registrable securities outstanding on the Closing Date or (y)&#160;if such Investor is a one of our directors or executive officers, the date such Investor no longer serves as one of our directors or an executive officers. Notwithstanding the foregoing, (a)&#160;the piggy-back registration rights provided for in the Investor Rights Agreement terminate no later than the third anniversary of the Closing Date and (b)&#160;the obligations regarding the nomination of directors shall survive until the earlier of a termination of the Investor Rights Agreement in accordance with clauses (i)&#160;or (ii) above or with respect to any one Investor, at such time as such Investor is no longer entitled to nominate a director to our Board under the terms of the Investor Rights Agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Consulting Agreements with KKG Enterprises, LLC and Remus Group Management, LLC </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the first quarter of 2023, we entered into consulting agreements with KKG Enterprises and Remus Group Management to assist us in building out our AI platform, augment our AI advisory board, and provide advisory services related to the Business Combination. These agreements were tied to Board-related work by Krishna Gupta, who is a member of our Board, Chief Executive Officer of Remus Group Management, principal at KKG Enterprises, and affiliated with Romulus Capital, a stockholder. The agreements included payments of $0.2&#160;million to KKG Enterprises and $0.3&#160;million to Remus Group Management, and were terminated in June 2023. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Allurion Middle East Medical Instruments Trading, LLC </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Allurion Middle East Medical Instruments Trading, LLC (&#8220;Allurion Middle East&#8221;) is Allurion&#8217;s subsidiary in the United Arab Emirates (the &#8220;UAE&#8221;). Per the law of the UAE, the majority owner of a UAE limited liability company must be a UAE entity. Pursuant to the Second Restated Memorandum of Association of Allurion Middle East Medical Instruments Trading (the &#8220;MoA&#8221;), Shuraa Management&#160;&amp; Consultancy LLC is a 51% owner of Allurion Middle East; we own the remaining 49%. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Allurion Middle East was established to carry on the business of medical, surgical equipment, and instruments trading in the Middle East on our behalf. Allurion Middle East is permitted to enter into agreements and act as an agent on our behalf. Allurion Middle East&#8217;s capital is AED 300,000 divided into 300 <span style="white-space:nowrap">non-divisible</span> shares, par value AED 1,000. The capital is fully paid in cash and divided as follows: Shuraa Management&#160;&amp; Consultancy LLC received 153 shares at a value of AED 153,000 and holds 51% in capital. We hold 147 shares for a value of AED 147,000 and holds 49% in capital. New shares may be issued at any time to increase capital or by transferring the available reserve to share capital by a resolution of the board. Shares are assignable. Under the MoA, transfers are not permitted where they would reduce the UAE national partner&#8217;s hold in the capital below 51% unless the number of partners is reduced to below 2 or increased to above 50. Profits from Allurion Middle East are distributed 20% to Shuraa Management and Consultancy LLC and 80% to us. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&#160;2, 2022, Allurion Middle East entered into a <span style="white-space:nowrap">one-year</span> lease agreement with Shuraa Business Centre Branch (&#8220;SBCB&#8221;), an affiliate of Shuraa Management&#160;&amp; Consultancy LLC. On August&#160;29, 2022, Allurion Middle East entered into a second <span style="white-space:nowrap">one-year</span> lease agreement with SBCB. Under each lease, Allurion Middle East pays to SBCB AED 41,500 and AED 35,000 per year, respectively, plus an AED 3,000 refundable security deposit and 5% VAT. These leases automatically renew after one year, as agreed to by the parties. On February&#160;2, 2024, Allurion Middle East entered into a <span style="white-space:nowrap">six-month</span> lease agreement with SBCB in lieu of the second annual renewal of its <span style="white-space:nowrap">one-year</span> lease agreement entered into on February&#160;2, 2022. Cancellation of these contracts is not permitted until the seventh month and requires a two month notice period. Standard indemnity provisions exist. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">79 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Corporate Officer Agreement and Termination Agreement </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective as of September&#160;1, 2023, we entered into a corporate officer agreement with Benoit Chardon, then&#160;our Chief Commercial Officer, and Benoit Chardon Consulting, a French soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e that was solely owned by Mr.&#160;Chardon (&#8220;BCC&#8221;), pursuant to which BCC served as Managing Director of Allurion France (the &#8220;Corporate Officer Agreement&#8221;). The Corporate Officer Agreement provided that BCC would receive base consulting fees of &#8364;28,333.33 per&#160;month and additional variable compensation subject to the incentive plan terms issued annually by us and conditional on meeting Allurion France and personal performance goal attainment defined each year by us. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&#160;12, 2023, Mr.&#160;Chardon, BCC and Allurion France entered into a Termination Agreement (the &#8220;Termination Agreement&#8221;), pursuant to which the parties agreed to terminate the Corporate Officer Agreement as of December&#160;31, 2023 (the &#8220;Departure Date&#8221;). Pursuant to the Termination Agreement, BCC resigned from its duties as managing director of Allurion France effective as of the Departure Date and we paid BCC all amounts due to it under the Corporate Officer Agreement for monthly consulting fees through the Departure Date and its variable compensation due for the third quarter of 2023. In addition, we paid BCC a <span style="white-space:nowrap">lump-sum</span> termination fee of &#8364;156,740. The Termination Agreement contains a mutual release and <span style="white-space:nowrap">non-disparagement</span> provision as well as a <span style="white-space:nowrap">non-solicitation</span> provision by BCC in favor of Allurion France. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Paris Lease Agreement </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">LNMP JPBC Investment, a French entity, was the lessor under the 56 Rue des Petites Ecuries, Paris lease (the &#8220;56 Rue des Petites Ecuries Lease&#8221;), pursuant to which we leased certain space for Company purposes. LNMP JPBC Investment is partially owned by Benoit Chardon, our former Chief Commercial Officer. Under the 56 Rue des Petites Ecuries Lease, we paid monthly rent of &#8364;9,284. The 56 Rue des Petites Ecuries Lease had a three year term, which began in August 2022, and was renewable by agreement between us and LNMP JPBC Investment. This lease was terminated in February 2024. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Indemnification Agreements </p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We enter into indemnification agreements with our directors and executive officers. The indemnification agreements and our Charter and Bylaws require us to indemnify our directors and executive officers to the fullest extent permitted by law. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Executive Officer and Director Compensation Arrangements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See the section entitled &#8220;<span style="font-style:italic">Executive and Director Compensation</span>&#8221; above for information regarding compensation arrangements with our executive officers and directors, which include, among other things, employment, termination of employment and change in control arrangements, stock awards and certain other benefits. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Related Person Transaction Policy </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a written related person transaction policy that sets forth the following policies and procedures for the review and approval or ratification of related person transactions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our policy, a &#8220;Related Person Transaction&#8221; is any transaction in which we or any of our subsidiaries was, is or will be a participant, the amount of which involved exceeds $120,000, and in which any related person had, has or will have a direct or indirect material interest. A &#8220;Related Person&#8221; as defined in the policy means: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any person who is, or at any time during the applicable period was, one of our executive officers or a member of our Board of Directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any person who is known by us to be the beneficial owner of more than 5% of our voting stock; and </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">80 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any immediate family member of any of the foregoing persons, which means any child, stepchild, parent, stepparent, spouse, sibling, <span style="white-space:nowrap"><span style="white-space:nowrap">mother-in-law,</span></span> <span style="white-space:nowrap"><span style="white-space:nowrap">father-in-law,</span></span> <span style="white-space:nowrap"><span style="white-space:nowrap">son-in-law,</span></span> <span style="white-space:nowrap"><span style="white-space:nowrap">daughter-in-law,</span></span> <span style="white-space:nowrap"><span style="white-space:nowrap">brother-in-law</span></span> or <span style="white-space:nowrap"><span style="white-space:nowrap">sister-in-law</span></span> or any other person (other than a tenant or employee) sharing the household of such related person of a director, executive officer or a beneficial owner of more than 5% of our voting stock. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also have policies and procedures designed to minimize potential conflicts of interest arising from any dealings we may have with our affiliates and to provide appropriate procedures for the disclosure of any real or potential conflicts of interest that may exist from time to time. Specifically, the Audit Committee has the responsibility to review related person transactions. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">81 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc923025_19">ADDITIONAL INFORMATION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other Matters </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board is not aware of any matter to be presented for action at the Annual Meeting other than the matters referred to above and does not intend to bring any other matters before the Annual Meeting. However, if other matters should properly come before the Annual Meeting, it is intended that holders of the proxies named on our proxy card will vote thereon in their discretion consistent with applicable law. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Stockholder Proposals for the 2026 Annual Meeting of Stockholders </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stockholder Proposals under Rule <span style="white-space:nowrap">14a-8</span> </span></p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Rule <span style="white-space:nowrap">14a-8</span> of the Exchange Act, notice of proposals of stockholders for inclusion in the proxy statement and form of proxy, including director nominees, for our 2026 Annual Meeting of Stockholders must be received by us in writing at our principal executive offices no later than the close of business on July&#160;27, 2026. Such proposals must comply with applicable requirements of federal securities laws and the procedures as set forth in our Bylaws. Notices should be addressed to our Secretary at Allurion Technologies, Inc., 11 Huron Drive, Natick, Massachusetts 01760. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stockholder Proposals outside of Rule <span style="white-space:nowrap">14a-8</span> </span></p> <div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholders of record who do not submit a proposal for inclusion in our proxy materials under Rule <span style="white-space:nowrap">14a-8,</span> but instead intend to introduce an item of business at the 2026 Annual Meeting of Stockholders, must provide advance written notice in accordance with, and comply with all other relevant procedures as set forth in, our Bylaws. We must receive written notice of your intention to introduce a nomination or other mater of business at the 2026 Annual Meeting of Stockholders not later than the close of business on the 90<sup style="font-size:75%; vertical-align:top">th </sup>day prior to the <span style="white-space:nowrap">one-year</span> anniversary of the Annual Meeting, or September&#160;19, 2026, and no earlier than the close of business on the 120<sup style="font-size:75%; vertical-align:top">th</sup> day prior to such <span style="white-space:nowrap">one-year</span> anniversary, or August&#160;20, 2026. Notwithstanding the foregoing, if our 2026 Annual Meeting of Stockholders is first convened more than 30 before or more than 60 days after December&#160;18, 2026, notice from the stockholder must be received no later than the later of the close of business on the 90<sup style="font-size:75%; vertical-align:top">th</sup> day prior to the scheduled meeting date or the 10<sup style="font-size:75%; vertical-align:top">th</sup> day following the day we first publicly announce the date of the 2026 Annual Meeting of Stockholders. Notices should be addressed to our Secretary at Allurion Technologies, Inc., 11&#160;Huron Drive, Natick, Massachusetts 01760. </p> </div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Stockholder Solicitation of Proxies under Rule <span style="white-space:nowrap">14a-19</span> </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to satisfying the requirements under our Bylaws, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than our nominees must provide notice to us that sets forth the information required by Rule <span style="white-space:nowrap">14a-19</span> under the Exchange Act. Notices should be addressed to our Secretary at Allurion Technologies, Inc., 11 Huron Drive, Natick, Massachusetts 01760. If a stockholder fails to comply with any applicable requirements of the Exchange Act, including, but not limited to, Rule <span style="white-space:nowrap">14a-19,</span> such stockholder&#8217;s proposed nomination or proposed business shall be deemed to have not been made in compliance with our Bylaws and will be disregarded. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Additional Information </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We reserve the right to reject, rule out of order, or take other appropriate action with respect to any proposal that does not comply with the requirements outlined above or other applicable requirements. It is suggested that stockholders submit their proposals by certified mail, return receipt requested, or by electronic means that permit such stockholder to verify the date of delivery to us. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, if the nominating or proposing stockholder (or a qualified representative of the stockholder) does not appear at the 2026 Annual Meeting of Stockholders to present a nomination or any business, such </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">82 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
nomination or business shall be disregarded, notwithstanding that proxies in respect of such vote may have been received by us. To be considered a qualified representative of the proposing stockholder, a person must be authorized by a written instrument executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the meeting, and such person must produce such written instrument or electronic transmission, or a reliable reproduction, to the presiding officer at the 2026 Annual Meeting of Stockholders. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Expenses and Solicitations </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying proxy is solicited by and on behalf of our Board, whose Notice of Annual Meeting is attached to this Proxy Statement, and the entire cost of our solicitation will be borne by us. In addition to the use of mail, proxies may be solicited by personal interview, telephone, <span style="white-space:nowrap">e-mail</span> and facsimile by our directors, officers and other employees who will not be specially compensated for these services. We will also request that brokers, nominees, custodians and other fiduciaries forward soliciting materials to the beneficial owners of shares held by the brokers, nominees, custodians and other fiduciaries. We will reimburse these persons for their reasonable expenses in connection with these activities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we have engaged Innisfree M&amp;A Incorporated (&#8220;Innisfree&#8221;) to assist with the solicitation of proxies for the Annual Meeting. We will pay Innisfree a fee of $20,000 as compensation for its services and will reimburse it for its reasonable <span style="white-space:nowrap"><span style="white-space:nowrap">out-of-pocket</span></span> expenses. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain information contained in this Proxy Statement relating to the occupations and security holdings of our directors and officers is based upon information received from the individual directors and officers. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Householding </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC&#8217;s rules permit us to deliver a single set of proxy materials to one address shared by two or more of our stockholders with such stockholder&#8217;s consent, if required. This delivery method is referred to as &#8220;householding&#8221; and can result in significant cost savings. To take advantage of this opportunity, we will deliver only one set of proxy materials to multiple stockholders who share an address and who have consented to such delivery, if required, unless and until we receive contrary instructions from the impacted stockholders prior to the mailing date. <span style="font-weight:bold"><span style="font-style:italic">We agree to deliver promptly, upon written or oral request, a separate copy of the proxy materials, as requested, to any stockholder at the shared address to which a single copy of those documents was delivered.</span></span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you prefer to receive separate copies of the proxy materials, contact Innisfree, our proxy solicitor, toll-free at (877) <span style="white-space:nowrap">800-5192</span> or collect at (212) <span style="white-space:nowrap">750-5833.</span> Innisfree&#8217;s address is 501 Madison Avenue, 20th Floor, New York, New York 10022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are currently a stockholder sharing an address with another stockholder and wish to receive only one copy of future proxy materials for your household, please contact Innisfree at the above phone number or address. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Annual Report on Form <span style="white-space:nowrap">10-K</span> </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of our 2024 Annual Report, including financial statements and schedules thereto but not including exhibits, as filed with the SEC, will be sent to any stockholder of record as of the Record Date without charge upon written request addressed to: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Allurion Technologies, Inc. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Attention: Chief Legal and People Officer </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">11 Huron Drive </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Natick, Massachusetts 01760 </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A reasonable fee will be charged for copies of exhibits. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">83 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Where You Can Find More Information </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public from commercial document retrieval services and at the website maintained by the SEC at <span style="font-style:italic">www.sec.gov</span>. You may also access any document we file with the SEC on our website at <span style="font-style:italic"><span style="white-space:nowrap">investors.allurion.com/financials/sec-filings/default.aspx</span></span>. The inclusion of our website address in this Proxy Statement does not include or incorporate by reference the information on our website into this Proxy Statement, and you should not consider that information a part of this Proxy Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should rely on the information contained in this document to vote your shares at the Annual Meeting. We have not authorized anyone to provide you with information that is different from what is contained in this document. You should not assume that the information contained in this document is accurate as of any date other than the date of this Proxy Statement, and the provision of this document to stockholders at any time after that date does not create an implication to the contrary. This Proxy Statement does not constitute a solicitation of a proxy in any jurisdiction where, or to or from any person to whom, it is unlawful to make such proxy solicitations in such jurisdiction. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">WHETHER OR NOT YOU PLAN TO ATTEND THE ANNUAL MEETING ONLINE, WE URGE YOU TO VOTE YOUR SHARES VIA THE TOLL-FREE TELEPHONE NUMBER, OVER THE INTERNET, OR BY COMPLETING, SIGNING, DATING AND RETURNING THE PROXY CARD BY MAIL IN THE ENCLOSED POSTAGE-PAID RETURN ENVELOPE AS DESCRIBED IN THIS PROXY STATEMENT. WE ENCOURAGE YOU TO PROMPTLY VOTE YOUR SHARES. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">84 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:right">Appendix A </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ALLURION TECHNOLOGIES, INC. </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">AMENDED AND RESTATED </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">2023 EQUITY INCENTIVE PLAN </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">GENERAL PURPOSE OF THE PLAN; DEFINITIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The name of the plan is the Allurion Technologies, Inc. 2023 Amended and Restated Equity Incentive Plan (as amended from time to time, the &#8220;Plan&#8221;). The purpose of the Plan is to encourage and enable the officers, employees, <span style="white-space:nowrap">Non-Employee</span> Directors and Consultants of Allurion Technologies, Inc. (the &#8220;Company&#8221;) and its Affiliates upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business to acquire a proprietary interest in the Company. It is anticipated that providing such persons with a direct stake in the Company&#8217;s welfare will assure a closer identification of their interests with those of the Company and its stockholders, thereby stimulating their efforts on the Company&#8217;s behalf and strengthening their desire to remain with the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following terms shall be defined as set forth below: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Act&#8221;</span> means the Securities Act of 1933, as amended, and the rules and regulations thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Administrator&#8221;</span> means either the Board or the compensation committee of the Board or a similar committee performing the functions of the compensation committee and which is comprised of not less than two <span style="white-space:nowrap">Non-Employee</span> Directors who are independent. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-style:italic">Affiliate</span>&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule 405 of the Act. The Board will have the authority to determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Award&#8221;</span> or <span style="font-style:italic">&#8220;Awards,&#8221;</span> except where referring to a particular category of grant under the Plan, shall include Incentive Stock Options, <span style="white-space:nowrap">Non-Qualified</span> Stock Options, Stock Appreciation Rights, Restricted Stock Units, Restricted Stock Awards, Unrestricted Stock Awards, Cash-Based Awards, and Dividend Equivalent Rights. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Award Certificate&#8221;</span> means a written or electronic document setting forth the terms and provisions applicable to an Award granted under the Plan. Each Award Certificate is subject to the terms and conditions of the Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Board&#8221;</span> means the Board of Directors of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Cash-Based Award&#8221;</span> means an Award entitling the recipient to receive a cash-denominated payment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Code&#8221;</span> means the Internal Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations and interpretations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Consultant&#8221;</span> means a consultant or adviser who provides <span style="font-style:italic">bona fide</span> services to the Company or an Affiliate as an independent contractor and who qualifies as a consultant or advisor under Instruction A.1.(a)(1) of Form <span style="white-space:nowrap">S-8</span> under the Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Dividend Equivalent Right&#8221;</span> means an Award entitling the grantee to receive credits based on cash dividends that would have been paid on the shares of Stock specified in the Dividend Equivalent Right (or other award to which it relates) if such shares had been issued to and held by the grantee. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Exchange Act&#8221;</span> means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-style:italic">Exchange Agreement</span>&#8221; means the Securities Purchase and Exchange Agreement, November 11, by and between the Company and RTW Investments, LP. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Fair Market Value&#8221;</span> of the Stock on any given date means the fair market value of the Stock determined in good faith by the Administrator; provided, however, that if the Stock is listed on the National Association of Securities Dealers Automated Quotation System (&#8220;Nasdaq&#8221;), Nasdaq Global Market, The New York Stock Exchange or another national securities exchange or traded on any established market, the determination shall be made by reference to market quotations. If there are no market quotations for such date, the determination shall be made by reference to the last date preceding such date for which there are market quotations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-style:italic">Fully Diluted Shares</span>&#8221; means the sum of (i)&#160;the total aggregate number of issued and outstanding shares of Stock, (ii)&#160;the number of shares of Stock subject to outstanding Awards granted under the Plan (or Allurion Technologies, Inc. 2023 Stock Option and Incentive Plan prior to restatement), (iii) the number of shares of Stock remaining available under the Plan for the issuance of additional awards, and (iv)&#160;the number of shares of Stock issuable upon conversion or exercise of outstanding derivative securities, including any convertible debt securities, convertible preferred stock and warrants issued by the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Incentive Stock Option&#8221;</span> means any Stock Option designated and qualified as an &#8220;incentive stock option&#8221; as defined in Section&#160;422 of the Code. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="white-space:nowrap">&#8220;Non-Employee</span> Director&#8221;</span> means a member of the Board who is not also an employee of the Company or any Subsidiary. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="white-space:nowrap">&#8220;Non-Qualified</span> Stock Option&#8221;</span> means any Stock Option that is not an Incentive Stock Option. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Option&#8221;</span> or <span style="font-style:italic">&#8220;Stock Option&#8221;</span> means any option to purchase shares of Stock granted pursuant to Section&#160;5. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Prior Plans&#8221;</span> means each of the Allurion Technologies, Inc. 2010 Stock Incentive Plan, as amended, the Allurion Technologies, Inc. Amended and Restated 2020 Stock Option and Grant Plan, as amended, and Allurion Technologies, Inc. 2023 Stock Option and Incentive Plan prior to restatement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Restatement Effective Date&#8221;</span> means <span style="text-decoration:underline">&#8195;&#8195;&#8195;&#8195;</span>, the date on which the Company&#8217;s stockholders approved the Plan, as amended and restated. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Restricted Shares&#8221;</span> means the shares of Stock underlying a Restricted Stock Award that remain subject to a risk of forfeiture or the Company&#8217;s right of repurchase. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Restricted Stock Award&#8221;</span> means an Award of Restricted Shares subject to such restrictions and conditions as the Administrator may determine at the time of grant. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Restricted Stock Units&#8221;</span> means an Award of stock units subject to such restrictions and conditions as the Administrator may determine at the time of grant. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Sale Event&#8221;</span> means (i)&#160;the sale of all or substantially all of the assets of the Company on a consolidated basis to an unrelated person or entity, (ii)&#160;a merger, reorganization or consolidation pursuant to which the holders of the Company&#8217;s outstanding voting power and outstanding stock immediately prior to such transaction do not own a majority of the outstanding voting power and outstanding stock or other equity interests of the resulting or successor entity (or its ultimate parent, if applicable) immediately upon completion of such transaction, (iii)&#160;the sale of all of the Stock of the Company to an unrelated person, entity or group thereof acting in concert, or </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(iv)&#160;any other transaction in which the owners of the Company&#8217;s outstanding voting power immediately prior to such transaction do not own at least a majority of the outstanding voting power of the Company or any successor entity immediately upon completion of the transaction other than as a result of the acquisition of securities directly from the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-style:italic">Sale Price</span>&#8221; means the value as determined by the Administrator of the consideration payable, or otherwise to be received by stockholders, per share of Stock pursuant to a Sale Event. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Section</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;409A&#8221;</span> means Section&#160;409A of the Code and the regulations and other guidance promulgated thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Service Relationship&#8221; </span>means any relationship as an employee, director or Consultant of the Company or any Affiliate (e.g., a Service Relationship shall be deemed to continue without interruption in the event an individual&#8217;s status changes from full-time employee to part-time employee or Consultant). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Stock&#8221;</span> means the Common Stock, par value $0.0001 per share, of the Company, subject to adjustments pursuant to Section&#160;3. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Stock Appreciation Right&#8221;</span> means an Award entitling the recipient to receive shares of Stock (or cash, to the extent explicitly provided for in the applicable Award Certificate) having a value equal to the excess of the Fair Market Value of the Stock on the date of exercise over the exercise price of the Stock Appreciation Right multiplied by the number of shares of Stock with respect to which the Stock Appreciation Right shall have been exercised. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Subsidiary&#8221;</span> means any corporation or other entity (other than the Company) in which the Company has at least a 50&#160;percent interest, either directly or indirectly. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Ten Percent Owner&#8221;</span> means an employee who owns or is deemed to own (by reason of the attribution rules of Section&#160;424(d) of the Code) more than 10&#160;percent of the combined voting power of all classes of stock of the Company or any parent or subsidiary corporation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">&#8220;Unrestricted Stock Award&#8221;</span> means an Award of shares of Stock free of any restrictions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ADMINISTRATION OF PLAN; ADMINISTRATOR AUTHORITY TO SELECT GRANTEES AND DETERMINE AWARDS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Administration of Plan</span>. The Plan shall be administered by the Administrator. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Powers of Administrator</span>. The Administrator shall have the power and authority to grant Awards consistent with the terms of the Plan, including the power and authority: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">to select the individuals to whom Awards may from time to time be granted; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">to determine the time or times of grant, and the extent, if any, of Incentive Stock Options, <span style="white-space:nowrap">Non-Qualified</span> Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Restricted Stock Units, Unrestricted Stock Awards, Cash-Based Awards, and Dividend Equivalent Rights, or any combination of the foregoing, granted to any one or more grantees; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">to determine the number of shares of Stock to be covered by any Award; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">to determine and modify from time to time the terms and conditions, including restrictions, not inconsistent with the terms of the Plan, of any Award, which terms and conditions may differ among individual Awards and grantees, and to approve the forms of Award Certificates; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">to accelerate at any time the exercisability or vesting of all or any portion of any Award; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">subject to the provisions of Section<span style="text-decoration:underline"></span>&#160;5(c) or Section&#160;6(d), as applicable, to extend at any time the period in which Stock Options or Stock Appreciation Rights may be exercised; and </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">at any time to adopt, alter and repeal such rules, guidelines and practices for administration of the Plan and for its own acts and proceedings as it shall deem advisable; to interpret the terms and provisions of the Plan and any Award (including related written instruments); to make all determinations it deems advisable for the administration of the Plan; to decide all disputes arising in connection with the Plan; and to otherwise supervise the administration of the Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All decisions and interpretations of the Administrator shall be binding on all persons, including the Company and Plan grantees. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Delegation of Authority to Grant Awards</span>. Subject to applicable law, the Administrator, in its discretion, may delegate to a committee consisting of one or more officers of the Company, including the Chief Executive Officer of the Company, all or part of the Administrator&#8217;s authority and duties with respect to the granting of Awards to individuals who are (i)&#160;not subject to the reporting and other provisions of Section<span style="text-decoration:underline"></span>&#160;16 of the Exchange Act and (ii)<span style="text-decoration:underline"></span>&#160;not members of the delegated committee. Any such delegation by the Administrator shall include a limitation as to the amount of Stock underlying Awards that may be granted during the period of the delegation and shall contain guidelines as to the determination of the exercise price and the vesting criteria. The Administrator may revoke or amend the terms of a delegation at any time but such action shall not invalidate any prior actions of the Administrator&#8217;s delegate or delegates that were consistent with the terms of the Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Award Certificate</span>. Awards under the Plan shall be evidenced by Award Certificates that set forth the terms, conditions and limitations for each Award which may include, without limitation, the term of an Award and the provisions applicable in the event employment or service terminates. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Indemnification</span>. Neither the Board nor the Administrator, nor any member of either or any delegate thereof, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with the Plan, and the members of the Board and the Administrator (and any delegate thereof) shall be entitled in all cases to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including, without limitation, reasonable attorneys&#8217; fees) arising or resulting therefrom to the fullest extent permitted by law and/or under the Company&#8217;s articles or bylaws or any directors&#8217; and officers&#8217; liability insurance coverage which may be in effect from time to time and/or any indemnification agreement between such individual and the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Foreign Award Recipients</span>. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws in other countries in which the Company and its Subsidiaries operate or have employees or other individuals eligible for Awards, the Administrator, in its sole discretion, shall have the power and authority to: (i)&#160;determine which Subsidiaries shall be covered by the Plan; (ii)<span style="text-decoration:underline"></span>&#160;determine which individuals outside the United States are eligible to participate in the Plan; (iii)<span style="text-decoration:underline"></span>&#160;modify the terms and conditions of any Award granted to individuals outside the United States to comply with applicable foreign laws; (iv)<span style="text-decoration:underline"></span>&#160;establish subplans and modify exercise procedures and other terms and procedures, to the extent the Administrator determines such actions to be necessary or advisable (and such subplans and/or modifications shall be attached to this Plan as appendices); provided, however, that no such subplans and/or modifications shall increase the share limitations contained in Section<span style="text-decoration:underline"></span>&#160;3(a) hereof; and (v)<span style="text-decoration:underline"></span>&#160;take any action, before or after<span style="font-weight:bold"> </span>an Award is made, that the Administrator determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory exemptions or approvals. Notwithstanding the foregoing, the Administrator may not take any actions hereunder, and no Awards shall be granted, that would violate the Exchange Act or any other applicable United States securities law, the Code, or any other applicable United States governing statute or law. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">STOCK ISSUABLE UNDER THE PLAN; MERGERS; SUBSTITUTION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Stock Issuable</span>. Subject to adjustment as provided in this Section&#160;3, the maximum number of shares of Stock reserved and available for issuance under the Plan as of the Restatement Effective Date shall be 4,161,302 shares (the &#8220;Initial Limit&#8221;); provided, that upon consummation of the transactions contemplated by the Exchange Agreement, the Initial Limit shall be increased to twenty percent (20%) of the number of Fully Diluted Shares outstanding as of such date (the &#8220;Increased Initial Limit&#8221;). In addition, on January<span style="text-decoration:underline"></span>&#160;1,<span style="text-decoration:underline"></span>&#160;2026 and each January<span style="text-decoration:underline"></span>&#160;1 thereafter, the number of shares of Stock reserved and available for issuance under the Plan shall be cumulatively increased by (i)<span style="text-decoration:underline"></span>&#160;five percent (5%) of the number of Fully Diluted Shares outstanding as of the immediately preceding December<span style="text-decoration:underline"></span>&#160;31 or (ii)<span style="text-decoration:underline"></span>&#160;such lesser number of shares as determined by the Administrator (the &#8220;Annual Increase&#8221;). Subject to such overall limitation, the maximum aggregate number of shares of Stock that may be issued in the form of Incentive Stock Options shall not exceed the Initial Limit (or, upon consummation of the transactions contemplated by the Exchange Agreement, the lesser of the Increased Initial Limit or 9,000,000 shares of Stock), cumulatively increased on January&#160;1, 2026 and on each January&#160;1 thereafter by the lesser of the Annual Increase for such year or 3,000,000 shares of Stock, subject in all cases to adjustment as provided in Section<span style="text-decoration:underline"></span>&#160;3(b). For purposes of this limitation, the shares of Stock underlying any awards under the Plan or the Prior Plans that are forfeited, canceled, held back upon exercise of an option or settlement of an award to cover the exercise price or tax withholding, reacquired by the Company prior to vesting, satisfied without the issuance of Stock or otherwise terminated (other than by exercise) shall be added back to the shares of Stock available for issuance under the Plan and, to the extent permitted under Section&#160;422 of the Code and the regulations promulgated thereunder, the shares of Stock that may be issued as Incentive Stock Options. In the event the Company repurchases shares of Stock on the open market, such shares shall not be added to the shares of Stock available for issuance under the Plan. Subject to such overall limitations, shares of Stock may be issued up to such maximum number pursuant to any type or types of Award. The shares available for issuance under the Plan may be authorized but unissued shares of Stock or shares of Stock reacquired by the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Changes in Stock</span>. Subject to Section&#160;3(c) hereof, if, as a result of any reorganization, recapitalization, reclassification, stock dividend, extraordinary cash dividend, stock split, reverse stock split or other similar change in the Company&#8217;s capital stock, the outstanding shares of Stock are increased or decreased or are exchanged for a different number or kind of shares or other securities of the Company, or additional shares or new or different shares or other securities of the Company or other <span style="white-space:nowrap">non-cash</span> assets are distributed with respect to such shares of Stock or other securities, or, if, as a result of any merger or consolidation, sale of all or substantially all of the assets of the Company, the outstanding shares of Stock are converted into or exchanged for securities of the Company or any successor entity (or a parent or subsidiary thereof), the Administrator shall make an appropriate or proportionate adjustment in (i)<span style="text-decoration:underline"></span>&#160;the maximum number of shares reserved for issuance under the Plan, including the maximum number of shares that may be issued in the form of Incentive Stock Options, (ii)&#160;the number and kind of shares or other securities subject to any then outstanding Awards under the Plan, (iii)<span style="text-decoration:underline"></span>&#160;the repurchase price, if any, per share subject to each outstanding Restricted Stock Award, and (iv)<span style="text-decoration:underline"></span>&#160;the exercise price for each share subject to any then outstanding Stock Options and Stock Appreciation Rights under the Plan, without changing the aggregate exercise price (i.e., the exercise price multiplied by the number of shares subject to Stock Options and Stock Appreciation Rights) as to which such Stock Options and Stock Appreciation Rights remain exercisable. The Administrator shall also make equitable or proportionate adjustments in the number of shares subject to outstanding Awards and the exercise price and the terms of outstanding Awards to take into consideration cash dividends paid other than in the ordinary course or any other extraordinary corporate event. The adjustment by the Administrator shall be final, binding and conclusive. No fractional shares of Stock shall be issued under the Plan resulting from any such adjustment, but the Administrator in its discretion may make a cash payment in lieu of fractional shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Mergers and Other Transactions</span>. In the case of and subject to the consummation of a Sale Event, the parties thereto may cause the assumption or continuation of Awards theretofore granted by the successor entity, or the substitution of such Awards with new Awards of the successor entity or parent thereof, with appropriate adjustment as to the number and kind of shares and, if appropriate, the per share exercise prices, as such parties </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall agree. To the extent the parties to such Sale Event do not provide for the assumption, continuation or substitution of Awards, upon the effective time of the Sale Event, the Plan and all outstanding Awards granted hereunder shall terminate. In such case, except as may be otherwise provided in the relevant Award Certificate, all Awards with time-based vesting, conditions or restrictions shall become fully vested and exercisable or nonforfeitable as of the effective time of the Sale Event, and all Awards with conditions and restrictions relating to the attainment of performance goals may become vested and exercisable or nonforfeitable in connection with a Sale Event in the Administrator&#8217;s discretion or to the extent specified in the relevant Award Certificate. In the event of such termination, (i)&#160;the Company shall have the option (in its sole discretion) to make or provide for a payment, in cash or in kind, to the grantees holding Options and Stock Appreciation Rights, in exchange for the cancellation thereof, in an amount equal to the difference between (A)<span style="text-decoration:underline"></span>&#160;the Sale Price multiplied by the number of shares of Stock subject to outstanding Options and Stock Appreciation Rights (to the extent then exercisable at prices not in excess of the Sale Price) and (B)<span style="text-decoration:underline"></span>&#160;the aggregate exercise price of all such outstanding Options and Stock Appreciation Rights (provided that, in the case of an Option or Stock Appreciation Right with an exercise price equal to or greater than the Sale Price, such Option or Stock Appreciation Right shall be cancelled for no consideration); or (ii)<span style="text-decoration:underline"></span>&#160;each grantee shall be permitted, within a specified period of time prior to the consummation of the Sale Event as determined by the Administrator, to exercise all outstanding Options and Stock Appreciation Rights (to the extent then exercisable) held by such grantee. The Company shall also have the option (in its sole discretion) to make or provide for a payment, in cash or in kind, to the grantees holding other Awards in an amount equal to the Sale Price multiplied by the number of vested shares of Stock under such Awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Maximum Awards to <span style="white-space:nowrap">Non-Employee</span> Directors</span>. Notwithstanding anything to the contrary in this Plan, the value of all Awards awarded under this Plan and all other cash compensation paid by the Company to any <span style="white-space:nowrap">Non-Employee</span> Director in any calendar year for service as a <span style="white-space:nowrap">Non-Employee</span> Director shall not exceed $350,000, provided, however that such amount shall be $500,000 for the calendar year in which the applicable <span style="white-space:nowrap">Non-Employee</span> Director is initially elected or appointed to the Board. For the purpose of this limitation, the value of any Award shall be its grant date fair value, as determined in accordance with FASB ASC 718 or successor provision but excluding the impact of estimated forfeitures related to service-based vesting provisions. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ELIGIBILITY </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Grantees under the Plan will be such employees, <span style="white-space:nowrap">Non-Employee</span> Directors and Consultants of the Company and its Affiliates as are selected from time to time by the Administrator in its sole discretion; provided that Awards may not be granted to employees, Directors or Consultants who are providing services only to any &#8220;parent&#8221; of the Company, as such term is defined in Rule 405 of the Act, unless (i)&#160;the stock underlying the Awards is treated as &#8220;service recipient stock&#8221; under Section&#160;409A or (ii)&#160;the Company, in consultation with its legal counsel, has determined that such Awards are exempt from or otherwise comply with Section&#160;409A. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">STOCK OPTIONS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Award of Stock Options</span>. The Administrator may grant Stock Options under the Plan. Any Stock Option granted under the Plan shall be in such form as the Administrator may from time to time approve. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock Options granted under the Plan may be either Incentive Stock Options or <span style="white-space:nowrap">Non-Qualified</span> Stock Options. Incentive Stock Options may be granted only to employees of the Company or any Subsidiary that is a &#8220;subsidiary corporation&#8221; within the meaning of Section&#160;424(f) of the Code. To the extent that any Option does not qualify as an Incentive Stock Option, it shall be deemed a <span style="white-space:nowrap">Non-Qualified</span> Stock Option. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock Options granted pursuant to this Section&#160;5 shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Administrator shall deem desirable. If the Administrator so determines, Stock Options may be granted in lieu of cash compensation at the optionee&#8217;s election, subject to such terms and conditions as the Administrator may establish. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Exercise Price</span>. The exercise price per share for the Stock covered by a Stock Option granted pursuant to this Section&#160;5 shall be determined by the Administrator at the time of grant but shall not be less than 100<span style="text-decoration:underline"></span>&#160;percent of the Fair Market Value on the date of grant. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the exercise price of such Incentive Stock Option shall be not less than 110<span style="text-decoration:underline"></span>&#160;percent of the Fair Market Value on the grant date. Notwithstanding the foregoing, Stock Options may be granted with an exercise price per share that is less than 100<span style="text-decoration:underline"></span>&#160;percent of the Fair Market Value on the date of grant (i)<span style="text-decoration:underline"></span>&#160;pursuant to a transaction described in, and in a manner consistent with, Section<span style="text-decoration:underline"></span>&#160;424(a) of the Code, (ii)<span style="text-decoration:underline"></span>&#160;to individuals who are not subject to U.S. income tax on the date of grant, or (iii)<span style="text-decoration:underline"></span>&#160;if the Stock Option is otherwise compliant with Section<span style="text-decoration:underline"></span>&#160;409A. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Option Term</span>. The term of each Stock Option shall be fixed by the Administrator, but no Stock Option shall be exercisable more than ten years after the date the Stock Option is granted. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the term of such Stock Option shall be no more than five years from the date of grant. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Exercisability; Rights of a Stockholder</span>. Stock Options shall become exercisable at such time or times, whether or not in installments, as shall be determined by the Administrator at or after the grant date. The Administrator may at any time accelerate the exercisability of all or any portion of any Stock Option. An optionee shall have the rights of a stockholder only as to shares acquired upon the exercise of a Stock Option and not as to unexercised Stock Options. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Method of Exercise</span>. Stock Options may be exercised in whole or in part, by giving written or electronic notice of exercise to the Company, specifying the number of shares to be purchased. Payment of the purchase price may be made by one or more of the following methods except to the extent otherwise provided in the Option Award Certificate: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In cash, by certified or bank check or other instrument acceptable to the Administrator; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Through the delivery (or attestation to the ownership following such procedures as the Company may prescribe) of shares of Stock that are not then subject to restrictions under any Company plan. Such surrendered shares shall be valued at Fair Market Value on the exercise date; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By the optionee delivering to the Company a properly executed exercise notice together with irrevocable instructions to a broker to promptly deliver to the Company cash or a check payable and acceptable to the Company for the purchase price; provided that in the event the optionee chooses to pay the purchase price as so provided, the optionee and the broker shall comply with such procedures and enter into such agreements of indemnity and other agreements as the Company shall prescribe as a condition of such payment procedure; or </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to Stock Options that are not Incentive Stock Options, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment instruments will be received subject to collection. The transfer to the optionee on the records of the Company or of the transfer agent of the shares of Stock to be purchased pursuant to the exercise of a Stock Option will be contingent upon receipt from the optionee (or a purchaser acting in his stead in accordance with the provisions of the Stock Option) by the Company of the full purchase price for such shares and the fulfillment of any other requirements contained in the Option Award Certificate or applicable provisions of laws (including the satisfaction of any withholding taxes that the Company is obligated to withhold with respect to the optionee). In the event an optionee chooses to pay the purchase price by previously-owned shares of Stock through the attestation method, the number of shares of Stock transferred to the optionee upon the exercise of the Stock Option shall be net of the number of attested shares. In the event that the Company establishes, for itself or using the services of a third party, an automated system for the exercise of Stock Options, such as a system using an </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
internet website or interactive voice response, then the paperless exercise of Stock Options may be permitted through the use of such an automated system. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Annual Limit on Incentive Stock Options</span>. To the extent required for &#8220;incentive stock option&#8221; treatment under Section&#160;422 of the Code, the aggregate Fair Market Value (determined as of the time of grant) of the shares of Stock with respect to which Incentive Stock Options granted under this Plan and any other plan of the Company or its parent and subsidiary corporations become exercisable for the first time by an optionee during any calendar year shall not exceed $100,000. To the extent that any Stock Option exceeds this limit, it shall constitute a <span style="white-space:nowrap">Non-Qualified</span> Stock Option. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">STOCK APPRECIATION RIGHTS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Award of Stock Appreciation Rights</span>. The Administrator may grant Stock Appreciation Rights under the Plan. A Stock Appreciation Right is an Award entitling the recipient to receive shares of Stock (or cash, to the extent explicitly provided for in the applicable Award Certificate) having a value equal to the excess of the Fair Market Value of a share of Stock on the date of exercise over the exercise price of the Stock Appreciation Right multiplied by the number of shares of Stock with respect to which the Stock Appreciation Right shall have been exercised. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Exercise Price of Stock Appreciation Rights</span>. The exercise price of a Stock Appreciation Right shall not be less than 100&#160;percent of the Fair Market Value of the Stock on the date of grant. Notwithstanding the foregoing, Stock Appreciation Rights may be granted with an exercise price per share that is less than 100<span style="text-decoration:underline"></span>&#160;percent of the Fair Market Value of the Stock on the date of grant (i)<span style="text-decoration:underline"></span>&#160;pursuant to a transaction described in, and a manner consistent with, Section<span style="text-decoration:underline"></span>&#160;424(a) of the Code, (ii)<span style="text-decoration:underline"></span>&#160;to individuals who are not subject to U.S. income tax on the date of grant, or (iii)<span style="text-decoration:underline"></span>&#160;if the Stock Appreciation Right is otherwise compliant with Section<span style="text-decoration:underline"></span>&#160;409A of the Code. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Grant and Exercise of Stock Appreciation Rights</span>. Stock Appreciation Rights may be granted by the Administrator independently of any Stock Option granted pursuant to Section&#160;5 of the Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Terms and Conditions of Stock Appreciation Rights</span>. Stock Appreciation Rights shall be subject to such terms and conditions as shall be determined on the date of grant by the Administrator. The term of a Stock Appreciation Right may not exceed ten years. The terms and conditions of each such Award shall be determined by the Administrator, and such terms and conditions may differ among individual Awards and grantees. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RESTRICTED STOCK AWARDS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Nature of Restricted Stock Awards</span>. The Administrator may grant Restricted Stock Awards under the Plan. A Restricted Stock Award is any Award of Restricted Shares subject to such restrictions and conditions as the Administrator may determine at the time of grant. Conditions may be based on continuing employment (or other Service Relationship) and/or achievement of <span style="white-space:nowrap">pre-established</span> performance goals and objectives. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Rights as a Stockholder</span>. Upon the grant of the Restricted Stock Award and payment of any applicable purchase price, a grantee shall have the rights of a stockholder with respect to the voting of the Restricted Shares and receipt of dividends; provided that if the lapse of restrictions with respect to the Restricted Stock Award is tied to the attainment of performance goals, any dividends paid by the Company during the performance period shall accrue and shall not be paid to the grantee until and to the extent the performance goals are met with respect to the Restricted Stock Award. Unless the Administrator shall otherwise determine, (i)&#160;uncertificated Restricted Shares shall be accompanied by a notation on the records of the Company or the transfer agent to the effect that they are subject to forfeiture until such Restricted Shares are vested as provided in Section<span style="text-decoration:underline"></span>&#160;7(d) below, and (ii)<span style="text-decoration:underline"></span>&#160;certificated Restricted Shares shall remain in the possession of the Company until such Restricted Shares are vested as provided in Section<span style="text-decoration:underline"></span>&#160;7(d) below, and the grantee shall be required, as a condition of the grant, to deliver to the Company such instruments of transfer as the Administrator may prescribe. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Restrictions</span>. Restricted Shares may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as specifically provided herein or in the Restricted Stock Award Certificate. Except as may otherwise be provided by the Administrator either in the Award Certificate or, subject to Section&#160;16 below, in writing after the Award is issued, if a grantee&#8217;s employment (or other Service Relationship) with the Company and its Subsidiaries terminates for any reason, any Restricted Shares that have not vested at the time of termination shall automatically and without any requirement of notice to such grantee from or other action by or on behalf of, the Company be deemed to have been reacquired by the Company at their original purchase price (if any) from such grantee or such grantee&#8217;s legal representative simultaneously with such termination of employment (or other Service Relationship), and thereafter shall cease to represent any ownership of the Company by the grantee or rights of the grantee as a stockholder. Following such deemed reacquisition of Restricted Shares that are represented by physical certificates, a grantee shall surrender such certificates to the Company upon request without consideration. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Vesting of Restricted Shares</span>. The Administrator at the time of grant shall specify the date or dates and/or the attainment of <span style="white-space:nowrap">pre-established</span> performance goals, objectives and other conditions on which the <span style="white-space:nowrap">non-transferability</span> of the Restricted Shares and the Company&#8217;s right of repurchase or forfeiture shall lapse. Subsequent to such date or dates and/or the attainment of such <span style="white-space:nowrap">pre-established</span> performance goals, objectives and other conditions, the shares on which all restrictions have lapsed shall no longer be Restricted Shares and shall be deemed &#8220;vested.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RESTRICTED STOCK UNITS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Nature of Restricted Stock Units</span>. The Administrator may grant Restricted Stock Units under the Plan. A Restricted Stock Unit is an Award of stock units that may be settled in shares of Stock (or cash, to the extent explicitly provided for in the Award Certificate) upon the satisfaction of such restrictions and conditions at the time of grant. Conditions may be based on continuing employment (or other Service Relationship) and/or achievement of <span style="white-space:nowrap">pre-established</span> performance goals and objectives. The terms and conditions of each such Award shall be determined by the Administrator, and such terms and conditions may differ among individual Awards and grantees. Except in the case of Restricted Stock Units with a deferred settlement date that complies with Section&#160;409A, at the end of the vesting period, the Restricted Stock Units, to the extent vested, shall be settled in the form of shares of Stock (or cash, to the extent explicitly provided for in the Award Certificate). Restricted Stock Units with deferred settlement dates are subject to Section&#160;409A and shall contain such additional terms and conditions as the Administrator shall determine in its sole discretion in order to comply with the requirements of Section<span style="text-decoration:underline"></span>&#160;409A. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Election to Receive Restricted Stock Units in Lieu of Compensation</span>. The Administrator may, in its sole discretion, permit a grantee to elect to receive a portion of future cash compensation otherwise due to such grantee in the form of an award of Restricted Stock Units. Any such election shall be made in writing and shall be delivered to the Company no later than the date specified by the Administrator and in accordance with Section&#160;409A and such other rules and procedures established by the Administrator. Any such future cash compensation that the grantee elects to defer shall be converted to a fixed number of Restricted Stock Units based on the Fair Market Value of Stock on the date the compensation would otherwise have been paid to the grantee if such payment had not been deferred as provided herein. The Administrator shall have the sole right to determine whether and under what circumstances to permit such elections and to impose such limitations and other terms and conditions thereon as the Administrator deems appropriate. Any Restricted Stock Units that are elected to be received in lieu of cash compensation shall be fully vested, unless otherwise provided in the Award Certificate. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Rights as a Stockholder</span>. A grantee shall have the rights as a stockholder only as to shares of Stock acquired by the grantee upon settlement of Restricted Stock Units; provided, however, that the grantee may be credited with Dividend Equivalent Rights with respect to the stock units underlying his or her Restricted Stock Units, subject to the provisions of Section&#160;11 and such terms and conditions as the Administrator may determine. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Termination</span>. Except as may otherwise be provided by the Administrator either in the Award Certificate or, subject to Section&#160;16 below, in writing after the Award is issued, a grantee&#8217;s right in all Restricted Stock Units that have not vested shall automatically terminate upon the grantee&#8217;s termination of employment (or cessation of Service Relationship) with the Company and its Subsidiaries for any reason. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UNRESTRICTED STOCK AWARDS </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Grant or Sale of Unrestricted Stock</span>. The Administrator may grant (or sell at par value or such higher purchase price determined by the Administrator) an Unrestricted Stock Award under the Plan. An Unrestricted Stock Award is an Award pursuant to which the grantee may receive shares of Stock free of any restrictions under the Plan. Unrestricted Stock Awards may be granted in respect of past services or other valid consideration, or in lieu of cash compensation due to such grantee. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CASH-BASED AWARDS </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Grant of Cash-Based Awards</span>. The Administrator may grant Cash-Based Awards under the Plan. A Cash-Based Award is an Award that entitles the grantee to a payment in cash upon the attainment of specified performance goals. The Administrator shall determine the maximum duration of the Cash-Based Award, the amount of cash to which the Cash-Based Award pertains, the conditions upon which the Cash-Based Award shall become vested or payable, and such other provisions as the Administrator shall determine. Each Cash-Based Award shall specify a cash-denominated payment amount, formula or payment ranges as determined by the Administrator. Payment, if any, with respect to a Cash-Based Award shall be made in accordance with the terms of the Award and may be made in cash. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DIVIDEND EQUIVALENT RIGHTS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Dividend Equivalent Rights</span>. The Administrator may grant Dividend Equivalent Rights under the Plan. A Dividend Equivalent Right is an Award entitling the grantee to receive credits based on cash dividends that would have been paid on the shares of Stock specified in the Dividend Equivalent Right (or other Award to which it relates) if such shares had been issued to the grantee. A Dividend Equivalent Right may be granted hereunder to any grantee as a component of an award of Restricted Stock Units or as a freestanding award. The terms and conditions of Dividend Equivalent Rights shall be specified in the Award Certificate. Dividend equivalents credited to the holder of a Dividend Equivalent Right may be paid currently or may be deemed to be reinvested in additional shares of Stock, which may thereafter accrue additional equivalents. Any such reinvestment shall be at Fair Market Value on the date of reinvestment or such other price as may then apply under a dividend reinvestment plan sponsored by the Company, if any. Dividend Equivalent Rights may be settled in cash or shares of Stock or a combination thereof, in a single installment or installments. A Dividend Equivalent Right granted as a component of an Award of Restricted Stock Units shall provide that such Dividend Equivalent Right shall be settled only upon settlement or payment of, or lapse of restrictions on, such other Award, and that such Dividend Equivalent Right shall expire or be forfeited or annulled under the same conditions as such other Award. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Termination</span>. Except as may otherwise be provided by the Administrator either in the Award Certificate or, subject to Section&#160;16 below, in writing after the Award is issued, a grantee&#8217;s rights in all Dividend Equivalent Rights shall automatically terminate upon the grantee&#8217;s termination of employment (or cessation of Service Relationship) with the Company and its Subsidiaries for any reason. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transferability of Awards </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Transferability</span>. Except as provided in Section&#160;12(b) below, during a grantee&#8217;s lifetime, his or her Awards shall be exercisable only by the grantee, or by the grantee&#8217;s legal representative or guardian in the event of the grantee&#8217;s incapacity. No Awards shall be sold, assigned, transferred or otherwise encumbered or disposed of by a </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
grantee other than by will or by the laws of descent and distribution or pursuant to a domestic relations order. No Awards shall be subject, in whole or in part, to attachment, execution, or levy of any kind, and any purported transfer in violation hereof shall be null and void. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Administrator Action</span>. Notwithstanding Section&#160;12(a), the Administrator, in its discretion, may provide either in the Award Certificate regarding a given Award or by subsequent written approval that the grantee (who is an employee or director) may transfer his or her <span style="white-space:nowrap">Non-Qualified</span> Stock Options to his or her immediate family members, to trusts for the benefit of such family members, or to partnerships in which such family members are the only partners, provided that the transferee agrees in writing with the Company to be bound by all of the terms and conditions of this Plan and the applicable Award. In no event may an Award be transferred by a grantee for value. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Family Member</span>. For purposes of Section&#160;12(b), &#8220;family member&#8221; shall mean a grantee&#8217;s child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, <span style="white-space:nowrap"><span style="white-space:nowrap">mother-in-law,</span></span> <span style="white-space:nowrap"><span style="white-space:nowrap">father-in-law,</span></span> <span style="white-space:nowrap"><span style="white-space:nowrap">son-in-law,</span></span> <span style="white-space:nowrap"><span style="white-space:nowrap">daughter-in-law,</span></span> <span style="white-space:nowrap"><span style="white-space:nowrap">brother-in-law,</span></span> or <span style="white-space:nowrap"><span style="white-space:nowrap">sister-in-law,</span></span> including adoptive relationships, any person sharing the grantee&#8217;s household (other than a tenant of the grantee), a trust in which these persons (or the grantee) have more than 50<span style="text-decoration:underline"></span>&#160;percent of the beneficial interest, a foundation in which these persons (or the grantee) control the management of assets, and any other entity in which these persons (or the grantee) own more than 50<span style="text-decoration:underline"></span>&#160;percent of the voting interests. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Designation of Beneficiary</span>. To the extent permitted by the Company, each grantee to whom an Award has been made under the Plan may designate a beneficiary or beneficiaries to exercise any Award or receive any payment under any Award payable on or after the grantee&#8217;s death. Any such designation shall be on a form provided for that purpose by the Administrator and shall not be effective until received by the Administrator. If no beneficiary has been designated by a deceased grantee, or if the designated beneficiaries have predeceased the grantee, the beneficiary shall be the grantee&#8217;s estate. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TAX WITHHOLDING </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Payment by Grantee</span>. Each grantee shall, no later than the date as of which the value of an Award or of any Stock or other amount received thereunder first becomes includable in the gross income of the grantee for income tax purposes, pay to the Company, or make arrangements satisfactory to the Administrator regarding payment of, any Federal, state, or local taxes of any kind required by law to be withheld by the Company with respect to such income. The Company and its Subsidiaries shall, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the grantee. The Company&#8217;s obligation to deliver evidence of book entry (or stock certificates) to any grantee is subject to and conditioned on tax withholding obligations being satisfied by the grantee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Payment in Stock</span>. The Administrator may require the Company&#8217;s tax withholding obligation to be satisfied, in whole or in part, by the Company withholding from shares of Stock to be issued pursuant to any Award a number of shares with an aggregate Fair Market Value (as of the date the withholding is effected) that would satisfy the withholding amount due; provided, however, that the amount withheld does not exceed the maximum statutory tax rate or such lesser amount as is necessary to avoid liability accounting treatment. For purposes of share withholding, the Fair Market Value of withheld shares shall be determined in the same manner as the value of Stock includible in income of the grantees. The Administrator may also require the Company&#8217;s tax withholding obligation to be satisfied, in whole or in part, by an arrangement whereby a certain number of shares of Stock issued pursuant to any Award are immediately sold and proceeds from such sale are remitted to the Company in an amount that would satisfy the withholding amount due. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;409A awards </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Awards are intended to be exempt from Section&#160;409A to the greatest extent possible and to otherwise comply with Section&#160;409A. The Plan and all Awards shall be interpreted in accordance with such intent. To the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
extent that any Award is determined to constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Section&#160;409A (a &#8220;409A Award&#8221;), the Award shall be subject to such additional rules and requirements as specified by the Administrator from time to time in order to comply with Section&#160;409A. In this regard, if any amount under a 409A Award is payable upon a &#8220;separation from service&#8221; (within the meaning of Section&#160;409A) to a grantee who is then considered a &#8220;specified employee&#8221; (within the meaning of Section&#160;409A), then no such payment shall be made prior to the date that is the earlier of (i)&#160;six months and one day after the grantee&#8217;s separation from service, or (ii)&#160;the grantee&#8217;s death, but only to the extent such delay is necessary to prevent such payment from being subject to interest, penalties and/or additional tax imposed pursuant to Section&#160;409A. Further, the settlement of any 409A Award may not be accelerated except to the extent permitted by Section&#160;409A. The Company makes no representation that any or all of the payments or benefits described in the Plan will be exempt from or comply with Section&#160;409A of the Code and makes no undertaking to preclude Section&#160;409A of the Code from applying to any such payment. The grantee shall be solely responsible for the payment of any taxes and penalties incurred under Section&#160;409A of the Code. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TERMINATION OF SERVICE RELATIONSHIP, TRANSFER, LEAVE OF ABSENCE, ETC. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Termination of Service Relationship</span>. If the grantee&#8217;s Service Relationship is with an Affiliate and such Affiliate ceases to be an Affiliate, the grantee shall be deemed to have terminated his or her Service Relationship for purposes of the Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of the Plan, the following events shall not be deemed a termination of a Service Relationship: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a transfer to the employment of the Company from an Affiliate or from the Company to an Affiliate, or from one Affiliate to another; or </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">an approved leave of absence for military service or sickness, or for any other purpose approved by the Company, if the employee&#8217;s right to <span style="white-space:nowrap">re-employment</span> is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Administrator otherwise so provides in writing. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AMENDMENTS AND TERMINATION </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may, at any time, amend or discontinue the Plan and the Administrator may, at any time, amend or cancel any outstanding Award for the purpose of satisfying changes in law or for any other lawful purpose, but no such action shall materially and adversely affect rights under any outstanding Award without the holder&#8217;s consent. Except as provided in Section&#160;3(b) or 3(c), without prior stockholder approval, in no event may the Administrator exercise its discretion to reduce the exercise price of outstanding Stock Options or Stock Appreciation Rights or effect repricing through cancellation and <span style="white-space:nowrap">re-grants</span> or cancellation of Stock Options or Stock Appreciation Rights in exchange for cash or other Awards. To the extent required under the rules of any securities exchange or market system on which the Stock is listed, to the extent determined by the Administrator to be required by the Code to ensure that Incentive Stock Options granted under the Plan are qualified under Section&#160;422 of the Code, Plan amendments shall be subject to approval by Company stockholders. Nothing in this Section&#160;16 shall limit the Administrator&#8217;s authority to take any action permitted pursuant to Section&#160;3(b) or 3(c). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">STATUS OF PLAN </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to the portion of any Award that has not been exercised and any payments in cash, Stock or other consideration not received by a grantee, a grantee shall have no rights greater than those of a general creditor of the Company unless the Administrator shall otherwise expressly determine in connection with any Award or Awards. In its sole discretion, the Administrator may authorize the creation of trusts or other arrangements to meet the Company&#8217;s obligations to deliver Stock or make payments with respect to Awards hereunder, provided that the existence of such trusts or other arrangements is consistent with the foregoing sentence. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">GENERAL PROVISIONS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">No Distribution</span>. The Administrator may require each person acquiring Stock pursuant to an Award to represent to and agree with the Company in writing that such person is acquiring the shares without a view to distribution thereof. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Issuance of Stock</span>. To the extent certificated, stock certificates to grantees under this Plan shall be deemed delivered for all purposes when the Company or a stock transfer agent of the Company shall have mailed such certificates in the United States mail, addressed to the grantee, at the grantee&#8217;s last known address on file with the Company. Uncertificated Stock shall be deemed delivered for all purposes when the Company or a Stock transfer agent of the Company shall have given to the grantee by electronic mail (with proof of receipt) or by United States mail, addressed to the grantee, at the grantee&#8217;s last known address on file with the Company, notice of issuance and recorded the issuance in its records (which may include electronic &#8220;book entry&#8221; records). Notwithstanding anything herein to the contrary, the Company shall not be required to issue or deliver any evidence of book entry or certificates evidencing shares of Stock pursuant to the exercise or settlement of any Award, unless and until the Administrator has determined, with advice of counsel (to the extent the Administrator deems such advice necessary or advisable), that the issuance and delivery is in compliance with all applicable laws, regulations of governmental authorities and, if applicable, the requirements of any exchange on which the shares of Stock are listed, quoted or traded. Any Stock issued pursuant to the Plan shall be subject to any stop-transfer orders and other restrictions as the Administrator deems necessary or advisable to comply with federal, state or foreign jurisdiction, securities or other laws, rules and quotation system on which the Stock is listed, quoted or traded. The Administrator may place legends on any Stock certificate or notations on any book entry to reference restrictions applicable to the Stock. In addition to the terms and conditions provided herein, the Administrator may require that an individual make such reasonable covenants, agreements, and representations as the Administrator, in its discretion, deems necessary or advisable in order to comply with any such laws, regulations, or requirements. The Administrator shall have the right to require any individual to comply with any timing or other restrictions with respect to the settlement or exercise of any Award, including a window-period limitation, as may be imposed in the discretion of the Administrator. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Stockholder Rights</span>. Until Stock is deemed delivered in accordance with Section&#160;18(b), no right to vote or receive dividends or any other rights of a stockholder will exist with respect to shares of Stock to be issued in connection with an Award, notwithstanding the exercise of a Stock Option or any other action by the grantee with respect to an Award. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Other Compensation Arrangements; No Employment Rights</span>. Nothing contained in this Plan shall prevent the Board from adopting other or additional compensation arrangements, including trusts, and such arrangements may be either generally applicable or applicable only in specific cases. The adoption of this Plan and the grant of Awards do not confer upon any employee any right to continued employment with the Company or any Subsidiary. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Trading Policy Restrictions</span>. Option exercises and other Awards under the Plan shall be subject to the Company&#8217;s insider trading policies and procedures, as in effect from time to time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Clawback</span>. All Awards under the Plan shall be subject to reduction, cancellation, forfeiture or recoupment to the extent necessary to comply with (i)&#160;any clawback, forfeiture or similar policy adopted by the Board or the Administrator and as in effect from time to time; and (ii)<span style="text-decoration:underline"></span>&#160;applicable law. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EFFECTIVE DATE OF PLAN </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Plan, as amended and restated, shall become effective upon the Restatement Effective Date. No grants of Stock Options and other Awards may be made hereunder after the tenth anniversary of the Restatement Effective Date and no grants of Incentive Stock Options may be made hereunder after the tenth anniversary of the earlier of approval by the Board or the Company&#8217;s stockholders of the Plan (or any amendment to the Plan that constitutes the adoption of a new plan for purposes of Section&#160;422 of the Code). </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">GOVERNING LAW </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Plan and all Awards and actions taken thereunder shall be governed by, and construed in accordance with, the General Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other matters shall be governed by and construed in accordance with the internal laws of the State of Delaware, applied without regard to conflict of law principles. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">A-14 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:right">Appendix B </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">CERTIFICATE OF DESIGNATIONS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SERIES B PERPETUAL CONVERTIBLE PREFERRED STOCK </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ALLURION TECHNOLOGIES, INC. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned, Shantanu Gaur, Chief Executive Officer of Allurion Technologies, Inc. (the&#160;&#8220;<span style="text-decoration:underline">Company</span>&#8221;), a corporation organized and existing under the General Corporation Law of the State of Delaware (the&#160;&#8220;<span style="text-decoration:underline">DGCL</span>&#8221;), does hereby certify, in accordance with Sections 103 and 151 of the DGCL, that the following resolutions were duly adopted by its Board of Directors (the &#8220;<span style="text-decoration:underline">Board</span>&#8221;) on [&#8226;], 2025: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company&#8217;s Amended and Restated Certificate of Incorporation (as amended from time to time, the &#8220;<span style="text-decoration:underline">Certificate of Incorporation</span>&#8221;), authorizes 100,000,000 shares of preferred stock, par value $0.0001 per share (the &#8220;<span style="text-decoration:underline">Preferred Stock</span>&#8221;), issuable from time to time in one or more series, of which 2,260,159 shares are currently designated; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Certificate of Incorporation authorizes the Board to provide by resolution for the issuance of the shares of Preferred Stock in one or more series, and to establish from time to time the number of shares to be included in each such series, and to fix the designations, powers, including voting powers, full or limited, or no voting powers, preferences and the relative, participating, optional, conversion or other special rights of the shares of each series and any qualifications, limitations and restrictions thereof. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board desires, pursuant to its authority as aforesaid, to designate a new series of Preferred Stock, set the number of shares constituting such series, and the voting powers, designations, preferences and relative, participating, optional or other special rights, and the qualifications, limitations, and restrictions thereof. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, BE IT RESOLVED, that the Board hereby designates a new series of Preferred Stock, consisting of the number of shares set forth herein, with the voting powers, designations, preferences and relative, participating, optional or other special rights, and the qualifications, limitations, and restrictions relating to such series as follows: </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE I. NUMBER; DESIGNATION; RANK. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;1.1 This series of perpetual convertible preferred stock is designated as the &#8220;Series B Perpetual Convertible Preferred Stock&#8221; (the &#8220;<span style="text-decoration:underline">Series B Preferred Stock</span>&#8221;). The number of shares constituting the Series B Preferred Stock is [__________]<sup style="font-size:75%; vertical-align:top">1</sup> shares, par value $0.0001 per share. Such number of shares may be increased or decreased by resolution of the Board; <span style="font-style:italic">provided, however</span>, that no such decrease shall reduce the number of shares of Series B Preferred Stock to a number less than the number of such shares then outstanding. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;1.2 The Series B Preferred Stock ranks, with respect to the payment of dividends, rights (including as to the distribution of assets) upon liquidation, dissolution, or <span style="white-space:nowrap">winding-up</span> of the Company or otherwise senior in preference and priority to the Common Stock and each other class or series of Capital Stock of the Company (collectively with the Common Stock, the &#8220;<span style="text-decoration:underline">Junior Securities</span>&#8221;), except for any class or series of Capital Stock hereafter issued in compliance with the terms hereof and the terms of which expressly provide that it will rank senior to or on parity with the Series B Preferred Stock with respect to the payment of dividends, rights (including as to the distribution of assets) upon liquidation, dissolution, or <span style="white-space:nowrap">winding-up</span> of the Company, or otherwise. </p><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><sup style="font-size:75%; vertical-align:top">1</sup>&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">NTD: The number is to be calculated and filled in on the closing date after taking into account accrued interest through the closing date. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE II. DIVIDENDS. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;2.1 <span style="text-decoration:underline">Dividend Accruals</span>. From the Issue Date, dividends (&#8220;<span style="text-decoration:underline">Preferred Dividends</span>&#8221;) shall accrue on a daily basis at the Dividend Rate per annum on the Accrued Value (calculated as of the beginning of the relevant Dividend Period) (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Preferred Shares), whether or not declared; <span style="font-style:italic">provided, however</span>, that such Preferred Dividends shall be payable on each Dividend Payment Date only (i)&#160;in cash (except as otherwise expressly provided in this Section&#160;2.1), (ii)&#160;when, as, and if declared by the Board and (iii)&#160;out of funds legally available therefor. Notwithstanding the foregoing, until the second-year anniversary of the Issue Date, the Company shall pay Preferred Dividends, in lieu of cash, by increase of the Accrued Value (&#8220;<span style="text-decoration:underline">Accrued Dividends</span>&#8221;). Dividends will be computed on the basis of a <span style="white-space:nowrap">360-day</span> year comprised of twelve <span style="white-space:nowrap">30-day</span> months. Dividends paid on the Preferred Shares in an amount less than the total amount of the Preferred Dividends at the time accrued on such shares shall be allocated pro rata on a <span style="white-space:nowrap"><span style="white-space:nowrap">share-by-share</span></span> basis among all such Preferred Shares at the time outstanding. The Board may fix a record date for the determination of holders of Preferred Shares entitled to receive payment of a dividend declared thereon, which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than sixty (60)&#160;days prior to such payment. On any Dividend Payment Date on which the Company is not legally permitted to pay cash dividends, the Company shall pay Preferred Dividends in the form of Accrued Dividends by increase of the Accrued Value on such Dividend Payment Date. Following an increase in the Accrued Value of the Preferred Shares as a result of Accrued Dividends, the Preferred Dividends shall be calculated on the basis of such increased Accrued Value from and after the date of such increase. Accrued Dividends shall increase the Accrued Value to, but excluding, the date of any conversion of Preferred Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;2.2 <span style="text-decoration:underline">Dividend Blocker</span>. Except with respect to (i)&#160;a dividend on shares of Common Stock payable in the form of shares of Common Stock or (ii)&#160;a dividend in the form of rights issued to all holders of the Common Stock pursuant to a rights plan, where such rights are not presently exercisable, trade with the Common Stock and the plan provides that the holders of Preferred Shares will receive such rights along with any Common Stock received upon conversion of the Preferred Shares), the Company shall not declare, pay or set aside any dividends on Junior Securities if at such time there are any accrued and unpaid Preferred Dividends with respect to completed Dividend Periods. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;2.3 <span style="text-decoration:underline">Participating Dividends</span>. If the Company declares, makes or pays any dividend or distribution in respect of the Common Stock, other than a dividend or distribution to which Section&#160;5.4(b) or (c)&#160;applies (a &#8220;<span style="text-decoration:underline">Common Dividend</span>&#8221;), each Holder shall first receive a dividend (in addition to the dividends provided for by Section&#160;2.1) in respect of each Preferred Share held thereby, in an amount equal to the product of (x)&#160;the amount of such Common Dividend paid per share of Common Stock, multiplied by (y)&#160;the number of shares of Common Stock (or Reference Property, to the extent applicable) issuable if such Preferred Share had been converted into shares of Common Stock immediately prior to the record date for such Common Dividend(such amount per share of Preferred Stock, the &#8220;<span style="text-decoration:underline">Participating Dividend</span>&#8221;). In calculating the amount of Participating Dividends due to a Holder, the Beneficial Ownership Limitation set forth in Section&#160;5.5 shall be disregarded, except that no Participating Dividend shall be paid or payable to a Holder to the extent such Participating Dividend would result in such Holder owning in excess of the Beneficial Ownership Limitation. Participating Dividends shall be payable to Holders on the record date for such Common Dividend at the same time and in the same manner as the Common Dividend triggering such Participating Dividend is paid. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE III. LIQUIDATION PREFERENCE. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;3.1 Upon any liquidation, dissolution or <span style="white-space:nowrap">winding-up</span> of the Company, the holders of Preferred Shares then outstanding shall be entitled to receive and to be paid out of the assets of the Company legally available for distribution to the Company&#8217;s stockholders, before any distribution or payment may be made to a holder of any Junior Securities, an amount per share equal to the greater of (i)&#160;the Accrued Value as of such </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
determination date and (ii)&#160;an amount equal to the amount the Holders of Preferred Shares would have received upon such liquidation, dissolution or <span style="white-space:nowrap">winding-up</span> of the Company had all such Holders converted such Preferred Shares into Common Stock (or Reference Property, to the extent applicable) immediately prior thereto (disregarding, for this purpose, the Beneficial Ownership Limitation set forth in Section&#160;5.5) (the &#8220;<span style="text-decoration:underline">Participating Liquidation Preference</span>,&#8221; and such greater amount, the &#8220;<span style="text-decoration:underline">Liquidation Preference</span>&#8221;), and no more. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;3.2 If upon any liquidation, dissolution or winding up of the Company, the cash legally available for distribution to the Company&#8217;s stockholders is insufficient to pay the Holders the full Liquidation Preference and the holders of all Parity Securities the full cash liquidation preferences to which they are entitled, the Holders and the holders of such Parity Securities will share the cash legally available for distribution to the Company&#8217;s stockholders ratably in proportion to the full respective amounts of cash to which they are entitled. If upon any such liquidation, dissolution or winding up of the Company, the assets of the Company legally available for distribution to the Company&#8217;s stockholders are insufficient to pay the Holders the full Liquidation Preference and the holders of all Parity Securities the full liquidation preferences to which they are entitled, the Holders and the holders of such Parity Securities will share ratably in any such distribution of the assets of the Company in proportion to the full respective amounts to which they are entitled. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;3.3 After payment to the Holders of the full Liquidation Preference to which they are entitled, the Holders as such will have no right or claim to any of the assets of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;3.4 No holder of Junior Securities shall receive any assets upon any liquidation, dissolution or <span style="white-space:nowrap">winding-up</span> of the Company unless the entire Liquidation Preference in respect of the Preferred Shares has been paid. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;3.5 The amount deemed paid or distributed to the holders of Capital Stock of the Company upon any such liquidation, dissolution or winding up of the Company shall be (i)&#160;in the case of cash, the amount of cash paid and (ii)&#160;in the case of any other assets, the value of such other assets as determined in good faith by the Board. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE IV. VOTING RIGHTS. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;4.1 <span style="text-decoration:underline">Voting Rights</span>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Holders shall be entitled to vote on all matters on which the holders of shares of Common Stock are entitled to vote and, except as otherwise provided in the Certificate of Incorporation (including, for the avoidance of doubt, this Certificate of Designations and any other certificate of designations in respect of a series of Preferred Stock), or by law, the Holders shall vote together with the holders of shares of Common Stock and any other shares of Capital Stock of the Company entitled to vote thereon as a single class. As of any record date or other determination date, on each matter on which Holders are entitled to vote as a single class with the holders of Common Stock and any other shares of Capital Stock of the Company, each Holder shall be entitled to a number of votes equal to the number of votes such Holder would have had if all Preferred Shares held by such Holder on such date had been converted into shares of Common Stock immediately prior thereto (and, for the avoidance of doubt, a Holder shall have no votes with respect to any Preferred Shares held thereby that, as of such record date or other determination date, are not convertible as a result of the Beneficial Ownership Limitation set forth in Section&#160;5.5). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that any Holder would be required to file any Notification and Report Form pursuant to the HSR Act as a result of any increase in the number of shares of Common Stock issuable upon conversion of the Preferred Shares, the voting rights of such Holder pursuant to this Section&#160;4.1 shall not be increased as a result of such events unless and until such Holder and the Company shall have made their respective filings under the HSR Act and the applicable waiting period shall have expired or been terminated in connection with such filings. The Company shall make all required filings and reasonably cooperate with and assist such Holder in connection with the making of such filing and obtaining the expiration or termination of such waiting period. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;4.2 <span style="text-decoration:underline">Approval Rights</span>. In addition to the voting rights provided for by Section&#160;4.1 and any voting rights to which the Holders may be entitled to under law, for so long as any Preferred Shares are outstanding, the Company may not, directly or indirectly, take any of the following actions (including by means of merger, consolidation or otherwise) without the prior written consent of the Majority Holders: </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) amend the Company&#8217;s Certificate of Incorporation (excluding for this purpose this Certificate of Designations) or the <span style="white-space:nowrap">by-laws</span> of the Company (including by means of merger, consolidation, reorganization, recapitalization or otherwise), in each case, in a manner that is disproportionately adverse to the Holders; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) amend, repeal, alter or add, delete or otherwise change the terms, powers, rights, preferences or privileges of the Series B Preferred Stock; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) create (by reclassification or otherwise) or amend any Senior Securities or Parity Securities; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) issue, or authorize for issuance, or designate any shares of Preferred Stock that were not issued and outstanding on the Issue Date (other than the Preferred Shares to be issued to the RTW Investor on the Issue Date) unless such shares of Preferred Stock are Junior Securities; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) reduce the number of authorized shares of Common Stock; or </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) (i) effect any Fundamental Change, (ii)&#160;approve, engage in or participate in any transaction that would result in a Fundamental Change or (iii)&#160;enter into any agreement for a transaction that would constitute a Fundamental Change. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE V. CONVERSION. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;5.1 <span style="text-decoration:underline">Conversion Privilege</span>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <span style="text-decoration:underline">General</span>. Subject to the provisions of this Article V (including the Beneficial Ownership Limitation set forth in Section&#160;5.5), each Holder shall be entitled to convert, at any time and from time to time, at the option and election of such Holder, any or all outstanding Preferred Shares held by such Holder into such number of shares of Common Stock (or Reference Property, to the extent applicable) as set out in Section&#160;5.2. Notwithstanding anything to the contrary set forth in this Article V, no Preferred Share shall be convertible to the extent that, and only to such extent, that the number of Conversion Shares issuable upon conversion of a Converted Share would result in the aggregate number of issued and outstanding shares of Common Stock exceeding the total number of authorized shares of Common Stock set forth in the Certificate of Incorporation. In the event that there is an insufficient number of authorized shares to permit such conversion, such conversion shall be held in abeyance until there are sufficient authorized shares to permit such conversion, as a result of an amendment of the Certificate of Incorporation, reduction in the number of shares outstanding, or otherwise. Notwithstanding anything to the contrary set forth in this Certificate of Designations, in no event shall the total number of shares of Common Stock issuable upon conversion of the Preferred Shares exceed [&#8226;] shares of Common Stock, subject to adjustment for subdivisions or combinations (as set out in section 5.4(b)) to the same extent that all of the shares of Common Stock or Reference Property are adjusted, as set forth in this Certificate of Designations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <span style="text-decoration:underline">Deliveries Required for Holder Conversion</span>. Such conversion right shall be exercised by the surrender of the certificate or certificates for such Preferred Shares to be converted (the &#8220;<span style="text-decoration:underline">Converted Shares</span>&#8221;) to the Company (or a transfer agent on behalf of the Company, as applicable) (or, if the Holder whose shares are to be converted (the &#8220;<span style="text-decoration:underline">Converting Holder</span>&#8221;) alleges that such certificate has or certificates have been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Company or such transfer agent to indemnify the Company against any claim that may be made against the Company on account of the alleged </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
loss, theft or destruction of such certificate) at the office of the Company&#8217;s transfer agent for the Preferred Stock (or at the principal office of the Company, if the Company serves as its own transfer agent), together with (x)&#160;written notice (a &#8220;<span style="text-decoration:underline">Holder Conversion Notice</span>&#8221;) that such Holder elects to convert all or part of the Preferred Shares represented by such certificates as specified therein, which notice shall specify the name or names (with address) in which a certificate or certificates for shares of Common Stock (or Reference Property) to be issued in a conversion (the &#8220;<span style="text-decoration:underline">Conversion Shares</span>&#8221;) are to be issued and a statement setting forth the amount of each class or series of Capital Stock of the Company Beneficially Owned by such Converting Holder, (y)&#160;a written instrument or instructions of transfer or other documents and endorsements reasonably acceptable to the transfer agent or the Company, as applicable (if reasonably required by the transfer agent or the Company, as applicable), and (z)&#160;funds for any stock transfer, documentary, stamp or similar taxes, if payable by the Holder pursuant to Section&#160;5.3(b). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;5.2 <span style="text-decoration:underline">Received Upon Conversion</span>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <span style="text-decoration:underline">Conversion Amount</span>. Subject to subsection (b)&#160;hereof, upon a conversion of the Preferred Shares in accordance with this Article V, the Converting Holder shall receive in respect of each Converted Share a number of Conversion Shares equal to the amount (the &#8220;<span style="text-decoration:underline">Conversion Amount</span>&#8221;) determined by dividing (i)&#160;the Accrued Value by (ii)&#160;the Conversion Price in effect at the time of conversion. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <span style="text-decoration:underline">Fractional Shares</span>. No fractional shares of Common Stock (or fractional shares in respect of Reference Property, to the extent applicable) will be issued upon conversion of the Preferred Shares. In lieu of fractional shares, the Company shall pay cash in respect of each fractional share equal to such fractional amount multiplied by the Thirty Day VWAP as of the closing of business on the Business Day immediately preceding the Conversion Date. If more than one Preferred Share is being converted at one time by the same Holder, then the number of full shares issuable upon conversion will be calculated on the basis of the aggregate number of Preferred Shares converted by such Holder at such time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <span style="text-decoration:underline">HSR Compliance</span>. Notwithstanding the foregoing, in the event any Holder would be required to file any Notification and Report Form pursuant to the HSR Act as a result of the conversion of any Preferred Shares into the property described above in this Section&#160;5.2, at the option of such Holder upon written notice to the Company, the effectiveness of such conversion shall be delayed (only to the extent necessary to avoid a violation of the HSR Act), until such Holder shall have made such filing under the HSR Act and the applicable waiting period shall have expired or been terminated; <span style="font-style:italic">provided, however</span>, that in such circumstances such Holder shall use commercially reasonable efforts to make such filing and obtain the expiration or termination of such waiting period as promptly as reasonably practical and the Company shall make all required filings and reasonably cooperate with and assist such Holder in connection with the making of such filing and obtaining the expiration or termination of such waiting period and shall be reimbursed by such Holder for any reasonable and documented <span style="white-space:nowrap"><span style="white-space:nowrap">out-of-pocket</span></span> costs incurred by the Company in connection with such filings and cooperation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;5.3 <span style="text-decoration:underline">Mechanics of Conversion</span>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) On and after the Conversion Date for a Preferred Share, the Preferred Share so converted shall cease to be outstanding, dividends and distributions on such Preferred Share shall cease to accrue or be due, and all rights in respect of such Preferred Share shall terminate, other than the right to receive, upon compliance with this Article V, the amounts due upon conversion. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Converting Holder shall pay any documentary, stamp, or similar issue or transfer tax due on the issue of Conversion Shares in the name of any Person other than the Converting Holder or due upon the issuance of a new certificate for any Preferred Shares not converted in the name of any Person other than the Converting Holder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For the purpose of effecting the conversion of Preferred Shares, the Company shall at all times reserve and keep available, free from any preemptive rights, out of its treasury or authorized but unissued shares </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Common Stock (or Reference Property, to the extent applicable) the full number of shares of Common Stock (or Reference Property, to the extent applicable) deliverable upon the conversion of all outstanding Preferred Shares after taking into account any adjustments to the Conversion Price from time to time pursuant to the terms of this Section&#160;5 and assuming for the purposes of this calculation that all outstanding Preferred Shares are held by one holder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) All shares of Common Stock (or Reference Property, to the extent applicable) issued upon conversion of the Preferred Shares will, upon issuance by the Company, be duly and validly issued, fully paid, and nonassessable. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;5.4 <span style="text-decoration:underline">Adjustment to Conversion Price and Number of Conversion Shares</span>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In order to prevent dilution of the conversion rights granted under this Section&#160;5, the Conversion Price and the number of Conversion Shares issuable on conversion of the Preferred Shares shall be subject to adjustment, without duplication, from time to time as provided in this Section&#160;5.4, except that the Company shall not make any adjustment to the Conversion Price if each Holder participates, at the same time and upon the same terms as all holders of Common Stock and solely as a result of holding Series B Preferred Stock, in any transaction described in this Section&#160;5.4, without having to convert its Series B Preferred Stock, as if each such holder held a number of shares of Common Stock that would be issuable upon conversion of such Series B Preferred Stock (without giving effect to the proposed adjustment). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <span style="text-decoration:underline">Subdivisions and Combinations</span>. In case the outstanding shares of Common Stock shall be subdivided (whether by stock split, reclassification, recapitalization or otherwise) into a greater number of shares of Common Stock or combined (whether by consolidation, reverse stock split, reclassification or otherwise) into a lesser number of shares of Common Stock, then the Conversion Price in effect at the opening of business on the day following the day upon which such subdivision or combination becomes effective shall be adjusted to equal the product of the Conversion Price in effect on such date and a fraction the numerator of which shall be the number of shares of Common Stock outstanding immediately prior to such subdivision or combination, and the denominator of which shall be the number of shares of Common Stock outstanding immediately after such subdivision or combination. Such adjustment shall become effective retroactively to the close of business on the day upon which such subdivision or combination becomes effective. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <span style="text-decoration:underline">Stock Dividends or Distributions</span>. If the Company shall issue shares of Common Stock as a dividend or distribution on all or substantially all shares of Common Stock or if the Company effects a stock split or combination of the Common Stock (other than as set forth in Section&#160;5.4(b)), the Conversion Price shall be adjusted based on the following formula: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:42%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:1%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:2%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:39%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td rowspan="2" style="vertical-align:bottom"/>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:right" rowspan="2">CP<sub style="font-size:75%; vertical-align:bottom">1</sub></td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">=</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">CP<sub style="font-size:75%; vertical-align:bottom">0</sub></td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">&#215;&#8201;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">OS<sub style="font-size:75%; vertical-align:bottom">0</sub></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center">OS<sub style="font-size:75%; vertical-align:bottom">1</sub></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">where, </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CP1 = the Conversion Price in effect immediately after the open of business on the <span style="white-space:nowrap">Ex-Dividend</span> Date for such dividend or distribution or the effective date of such share split or share combination, as the case may be; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CP0 = the Conversion Price in effect immediately prior to the open of business on the <span style="white-space:nowrap">Ex-Dividend</span> Date for such dividend or distribution or the effective date of such share split or share combination, as the case may be; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">OS0 = the number of shares of Common Stock outstanding immediately prior to the open of business on the <span style="white-space:nowrap">Ex-Dividend</span> Date for such dividend or distribution or the effective date of such share split or share combination, as the case may be; and </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">OS1 = the number of shares of Common Stock that would be outstanding immediately after giving effect to such dividend, distribution, share split or share combination, as the case may be. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any adjustment made under this clause (c)&#160;shall become effective immediately after the open of business on such <span style="white-space:nowrap">Ex-Dividend</span> Date for such dividend or distribution, or immediately after the open of business on the effective date for such share split or share combination, as applicable. If any dividend or distribution of the type described in this clause (c)&#160;is declared but not so paid or made, the Conversion Price shall be immediately readjusted, effective as of the date the Board determines not to pay such dividend or distribution, to the Conversion Price that would then be in effect if such dividend or distribution had not been declared or announced. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <span style="text-decoration:underline">Distributions of Rights, Options or Warrants</span>. If the Company shall distribute to all or substantially all holders of its Common Stock any rights, options or warrants (other than rights, options or warrants distributed in connection with a stockholders&#8217; rights plan, in which case the provisions of Section&#160;5.4(h) shall apply) entitling them to purchase, for a period of not more than 45 calendar days from the announcement date for such distribution, shares of the Common Stock at a price per share less than the average of the Last Reported Sale Prices of the Common Stock for the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement date for such distribution, the Conversion Price shall be decreased based on the following formula: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:38%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:1%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:2%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:35%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td rowspan="2" style="vertical-align:bottom"/>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:right" rowspan="2">CP<sub style="font-size:75%; vertical-align:bottom">1</sub></td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">=</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">CP<sub style="font-size:75%; vertical-align:bottom">0</sub></td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">&#215;&#8201;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">OS<sub style="font-size:75%; vertical-align:bottom">0</sub> + X</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center">OS<sub style="font-size:75%; vertical-align:bottom">0</sub>+ Y</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">where, </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CP1 = the Conversion Price in effect immediately after the open of business on the <span style="white-space:nowrap">Ex-Dividend</span> Date for such distribution; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CP0 = the Conversion Price in effect immediately prior to the open of business on the <span style="white-space:nowrap">Ex-Dividend</span> Date for such distribution; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">OS0 = the number of shares of the Common Stock outstanding immediately prior to the open of business on the <span style="white-space:nowrap">Ex-Dividend</span> Date for such distribution; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">X = the number of shares of the Common Stock equal to the aggregate price payable to exercise such rights, options or warrants, divided by the average of the Last Reported Sale Prices of the Common Stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the announcement date of such distribution; and </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Y = the total number of shares of the Common Stock issuable pursuant to such rights, options or warrants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any decrease made under this clause (d)&#160;shall be made successively whenever any such rights, options or warrants are distributed and shall become effective immediately after the open of business on the <span style="white-space:nowrap">Ex-Dividend</span> Date for such distribution. To the extent that shares of the Common Stock are not delivered after the expiration of such rights, options or warrants, the Conversion Price shall be increased to the Conversion Price that would then be in effect had the increase with respect to the distribution of such rights, options or warrants been made on the basis of delivery of only the number of shares of the Common Stock actually delivered. If such rights, options or warrants are not so distributed, the Conversion Price shall be increased to the Conversion Price that would then be in effect if such record date for such distribution had not occurred. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this clause (d), in determining whether any rights, options or warrants entitle the holders to subscribe for or purchase shares of the Common Stock at a price per share less than such average of the Last Reported Sale Prices of the Common Stock for the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the announcement date for such distribution, and in determining the aggregate offering price of such shares of the Common Stock, there shall be taken into account any consideration </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
received by the Company for such rights, options or warrants and any amount payable upon exercise or conversion thereof, the value of such consideration, if other than cash, as reasonably determined by the Company in good faith. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <span style="text-decoration:underline">Distributions of Equity Securities, Indebtedness, other Securities, Assets or Property</span>. If the Company distributes shares of its Equity Securities, evidences of its Indebtedness, other assets or property of the Company or rights, options or warrants to acquire its Equity Securities or other securities to all or substantially all holders of Common Stock, excluding: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) dividends or distributions as to which adjustment is required to be effected pursuant to clause (b)&#160;or (c) above; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) rights issued to all holders of the Common Stock pursuant to a rights plan, where such rights are not presently exercisable, trade with the Common Stock and the plan provides that the holders of Preferred Shares will receive such rights along with any Common Stock received upon conversion of the Preferred Shares; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) dividends or distributions in which Series B Preferred Stock participates on an <span style="white-space:nowrap">as-converted</span> basis pursuant to Section&#160;2.3; and </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Spin-Offs described below in this clause (d), </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">then the Conversion Price shall be decreased based on the following formula: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:38%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:1%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:2%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:35%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td rowspan="2" style="vertical-align:bottom"/>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:right" rowspan="2">CP<sub style="font-size:75%; vertical-align:bottom">1</sub></td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">=</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">CP<sub style="font-size:75%; vertical-align:bottom">0</sub></td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">&#215;&#8201;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">SP<sub style="font-size:75%; vertical-align:bottom">0</sub> &#8211; FMV</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center">SP<sub style="font-size:75%; vertical-align:bottom">0</sub></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">where, </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CP1 = the Conversion Price in effect immediately after the open of business on the <span style="white-space:nowrap">Ex-Dividend</span> Date for such distribution; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CP0 = the Conversion Price in effect immediately prior to the open of business on the <span style="white-space:nowrap">Ex-Dividend</span> Date for such distribution; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SP0 = the average of the Last Reported Sale Prices of the Common Stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the <span style="white-space:nowrap">Ex-Dividend</span> Date for such distribution; and </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FMV = the fair market value (as determined by the Board in good faith) of the shares of Equity Securities, evidences of Indebtedness, securities, assets or property distributed with respect to each outstanding share of the Common Stock immediately prior to the open of business on the <span style="white-space:nowrap">Ex-Dividend</span> Date for such distribution. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any decrease made under the portion of this clause (e)&#160;above shall become effective immediately after the open of business on the <span style="white-space:nowrap">Ex-Dividend</span> Date for such distribution. If such distribution is not so paid or made, the Conversion Price shall be increased to be the Conversion Price that would then be in effect if such distribution had not been declared. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if &#8220;FMV&#8221; (as defined above) is equal to or greater than &#8220;SP0&#8221; (as defined above), in lieu of the foregoing decrease, each holder of Preferred Shares may elect to receive at the same time and upon the same terms as holders of shares of Common Stock without having to convert its Series B Preferred Stock, the amount and kind of the Equity Securities, evidences of the Company&#8217;s Indebtedness, other assets or property of the Company or rights, options or warrants to acquire its Equity Securities or other securities of the Company that such holder would have received as if such holder owned a number of shares of Common Stock </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
into which the Preferred Share was convertible at the Conversion Price in effect on the <span style="white-space:nowrap">Ex-Dividend</span> Date for the distribution. If the Board of Directors determines the &#8220;FMV&#8221; (as defined above) of any distribution for purposes of this clause (e)&#160;by reference to the actual or when-issued trading market for any securities, it shall in doing so consider the prices in such market over the same period used in computing the Last Reported Sale Prices of the Common Stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the <span style="white-space:nowrap">Ex-Dividend</span> Date for such distribution. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to an adjustment pursuant to this clause (e)&#160;where there has been a payment of a dividend or other distribution on the Common Stock in shares of Equity Securities of any class or series, or similar equity interests, of or relating to a Subsidiary or other business unit of the Company that will be, upon distribution, listed on a U.S. national or regional securities exchange (a &#8220;<span style="text-decoration:underline"><span style="white-space:nowrap">Spin-Off</span></span>&#8221;), the Conversion Price shall be decreased based on the following formula: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:38%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:1%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:2%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:12%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:35%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td rowspan="2" style="vertical-align:bottom"/>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:right" rowspan="2">CP<sub style="font-size:75%; vertical-align:bottom">1</sub></td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">=</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">CP<sub style="font-size:75%; vertical-align:bottom">0</sub></td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">&#215;&#8201;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">MP<sub style="font-size:75%; vertical-align:bottom">0</sub></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center">FMV + MP<sub style="font-size:75%; vertical-align:bottom">0</sub></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">where, </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CP1 = Conversion Price in effect immediately after the end of the Valuation Period; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CP0 = the Conversion Price in effect immediately prior to the end of the Valuation Period; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FMV = the average of the Last Reported Sale Prices of the Equity Securities or similar equity interest distributed to holders of the Common Stock applicable to one share of the Common Stock (determined by reference to the definition of Last Reported Sale Price as if references therein to Common Stock were to such Equity Securities or similar equity interest) over the first 10 consecutive Trading Day period after, and including, the <span style="white-space:nowrap">Ex-Dividend</span> Date of the <span style="white-space:nowrap">Spin-Off</span> (the &#8220;<span style="text-decoration:underline">Valuation Period</span>&#8221;); and </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MP0 = the average of the Last Reported Sale Prices of the Common Stock over the Valuation Period. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any adjustment to the Conversion Price under the preceding paragraph of this clause&#160;(e) shall be made immediately after the close of business on the last Trading Day of the Valuation Period. If the Conversion Date for any Preferred Share to be converted occurs on or during the Valuation Period, then, notwithstanding anything to the contrary in this Certificate of Designations, the Company will, if necessary, delay the settlement of such conversion until the second (2nd) Business Day after the last Trading Day of the Valuation Period. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if the &#8220;FMV&#8221; (as defined above) is equal to or greater than the Daily VWAP of the Common Stock over the Valuation Period, in lieu of the foregoing decrease, each holder of Preferred Shares may elect to receive at the same time and upon the same terms as holders of shares of Common Stock without having to convert its Preferred Shares, the amount and kind of Equity Securities or similar equity interest that such holder would have received as if such holder owned a number of shares of Common Stock into which the Series B Preferred Stock was convertible at the Conversion Price in effect on the <span style="white-space:nowrap">Ex-Dividend</span> Date for the distribution. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <span style="text-decoration:underline">Tender Offer, Exchange Offer</span>. If the Company or any of its Subsidiaries makes a payment in respect of a tender offer or exchange offer for the Common Stock, to the extent that the cash and value of any other consideration included in the payment per share of the Common Stock exceeds the average of the Last Reported Sale Prices of the Common Stock over the 10 consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the last date (the &#8220;<span style="text-decoration:underline">Expiration Date</span>&#8221;) on which tenders or exchanges may be made pursuant to such tender or exchange offer (as it may be amended), the Conversion Price shall be decreased based on the following formula: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:37%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:1%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:2%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:15%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:33%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td rowspan="2" style="vertical-align:bottom"/>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:right" rowspan="2">CP<sub style="font-size:75%; vertical-align:bottom">1</sub></td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">=</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">CP<sub style="font-size:75%; vertical-align:bottom">0</sub></td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td style="vertical-align:middle;text-align:center" rowspan="2">&#215;&#8201;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">SP<sub style="font-size:75%; vertical-align:bottom">1</sub> &#215; OS<sub style="font-size:75%; vertical-align:bottom">0</sub></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center">AC + ( SP<sub style="font-size:75%; vertical-align:bottom">1</sub> &#215; OS<sub style="font-size:75%; vertical-align:bottom">1</sub>)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">where, </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CP1 = the Conversion Price in effect immediately after the close of business on the 10th Trading Day immediately following, and including, the Trading Day next succeeding the Expiration Date; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CP0 = the Conversion Price in effect immediately prior to the close of business on the 10th Trading Day immediately following, and including, the Trading Day next succeeding the Expiration Date; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">AC = the aggregate value of all cash and any other consideration (as determined by the Board in good faith) paid or payable for shares purchased or exchanged in such tender or exchange offer; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SP1 = the average of the Last Reported Sales Prices of the Common Stock of over the ten (10)&#160;consecutive Trading Day period beginning on, and including, the Trading Day next succeeding the Expiration Date; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">OS1 = the number of shares of the Common Stock outstanding immediately after the close of business on the Expiration Date (adjusted to give effect to the purchase or exchange of all shares accepted for purchase in such tender offer or exchange offer); and </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">OS0 = the number of shares of the Common Stock outstanding immediately prior to the Expiration Date (prior to giving effect to such tender offer or exchange offer); </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">provided, however</span>, that the Conversion Price will in no event be adjusted up pursuant to this Section&#160;5.4(e), except to the extent provided in the immediately following paragraph. The adjustment to the Conversion Price pursuant to this Section&#160;5.4(f) will be calculated as of the close of business on the tenth (10<sup style="font-size:75%; vertical-align:top">th</sup>) Trading Day immediately following, and including, the Trading Day next succeeding the Expiration Date. If the Conversion Date for any Preferred Share to be converted occurs on the Expiration Date or during the Tender/Exchange Offer Valuation Period, then, notwithstanding anything to the contrary in this Certificate of Designations, the Company will, if necessary, delay the settlement of such conversion until the second (2nd) Business Day after the last Trading Day of the Tender/Exchange Offer Valuation Period. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <span style="text-decoration:underline">Adjustment for Reorganization Events</span>. If there shall occur any reclassification, statutory share exchange, reorganization, recapitalization, consolidation or merger involving the Company with or into another Person in which all of the outstanding shares of Common Stock (but not the Series B Preferred Stock) is converted into or exchanged for securities, cash or other property (excluding a merger solely for the purpose of changing the Company&#8217;s jurisdiction of incorporation) including a Fundamental Change (without limiting the rights of holders of Series B Preferred Stock or the Company with respect to any Fundamental Change) (a &#8220;<span style="text-decoration:underline">Reorganization Event</span>&#8221;), then, subject to Article III (Liquidation Preference), following any such Reorganization Event, each Preferred Share shall remain outstanding and be convertible into the number, kind and amount of securities, cash or other property which a holder of such Preferred Share would have received in such Reorganization Event had such holder converted its Preferred Shares into the applicable number of shares of </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Common Stock immediately prior to the effective date of the Reorganization Event using the Conversion Price applicable immediately prior to the effective date of the Reorganization Event; and, in such case, appropriate adjustment (as determined in good faith by the Board) shall be made in the application of the provisions in this Section&#160;5.4(g) set forth with respect to the rights and interest thereafter of the holders of Series B Preferred Stock, to the end that the provisions set forth in this Section&#160;5.4(g) (including provisions with respect to changes in and other adjustments of the Conversion Price) shall thereafter be applicable, as nearly as reasonably practicable, in relation to any shares of stock or other property thereafter deliverable upon the conversion of the Series B Preferred Stock. Without limiting the Company&#8217;s obligations with respect to a Fundamental Change, the Company (or any successor) shall, no less than twenty (20)&#160;calendar days prior to the occurrence of any Reorganization Event, provide written notice to the holders of Series B Preferred Stock of the expected occurrence of such event and of the kind and amount of the cash, securities or other property that each Preferred Share is expected to be convertible into under this Section&#160;5.4(g). Failure to deliver such notice shall not affect the operation of this Section&#160;5.4(g). The Company shall not enter into any agreement for a transaction constituting a Reorganization Event unless, to the extent that the Company is not the surviving corporation in such Reorganization Event, or will be dissolved in connection with such Reorganization Event, proper provision shall be made in the agreements governing such Reorganization Event for the conversion of the Series B Preferred Stock into stock of the Person surviving such Reorganization Event or such other continuing entity in such Reorganization Event. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <span style="text-decoration:underline">Stockholders&#8217; Rights Plan</span>. To the extent that any stockholders&#8217; rights plan adopted by the Company is in effect upon conversion of the Preferred Shares, the holders of Preferred Shares will receive, in addition to any Common Stock due upon conversion, the appropriate number of rights, if any, under the applicable rights agreement (as the same may be amended from time to time). However, if, prior to any conversion, the rights have separated from the shares of the Common Stock in accordance with the provisions of the applicable stockholders&#8217; rights plan, the Conversion Price will be adjusted at the time of separation as if the Company distributed to all holders of the Common Stock, shares of Equity Securities, evidences of Indebtedness, securities, assets or property as described in clause (e)&#160;above, subject to readjustment in the event of the expiration, termination or redemption of such rights. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <span style="text-decoration:underline">Other Issuances</span>. Except as stated in this Section&#160;5.4, the Company shall not adjust the Conversion Price for the issuances of shares of Common Stock or any securities convertible into or exchangeable for shares of Common Stock or rights to purchase shares of Common Stock or such convertible or exchangeable securities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <span style="text-decoration:underline">Adjustment at the Discretion of the Board</span>. The Company shall be permitted to decrease the Conversion Price by any amount for a period of at least twenty (20)&#160;Business Days if the Board determines in good faith that such decrease would be in the best interest of the Company. In addition, to the extent permitted by applicable law and subject to the applicable rules of any exchange on which any of the Company&#8217;s securities are then listed, the Company also may (but is not required to) decrease the Conversion Price to avoid or diminish income tax to holders of Common Stock or rights to purchase shares of Common Stock in connection with a dividend or distribution of shares (or rights to acquire shares) or similar event. Whenever the Conversion Price is decreased pursuant to either of the preceding two sentences, the Company shall deliver to the holders of the Series B Preferred Stock a notice of the decrease at least fifteen (15)&#160;days prior to the date the decreased Conversion Price takes effect, and such notice shall state the decreased Conversion Price and the period during which it will be in effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <span style="text-decoration:underline">Adjustment After a Make-Whole Fundamental Change</span>. From and after the time a Make-Whole Fundamental Change occurs, when a Holder elects to convert its Preferred Shares, the number of shares of Common Stock issuable in connection with such conversion shall be [&#8195;&#8195;]% of the number of shares of Common Stock otherwise provided for in this Certificate of Designations. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) subject to adjustments in the same manner as the Conversion Rate is required to be adjusted as set forth in Section&#160;5.4 hereof. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <span style="text-decoration:underline">Rounding; Par Value; <span style="white-space:nowrap">De-minimis</span> Adjustments</span>. All calculations under this Section&#160;5.4 shall be made to the nearest 1/10,000th of a cent or to the nearest 1/10,000th of a share, as the case may be. No adjustment in the Conversion Price shall reduce the Conversion Price below the then par value of the Common Stock. If an adjustment to the Conversion Price otherwise required by this Section&#160;5.4 would result in a change of less than one percent (1%) to the Conversion Price, then, notwithstanding anything to the contrary in this Section&#160;5.4, the Company may, at its election, defer and carry forward such adjustment, except that all such deferred adjustments must be given effect (i)&#160;when all such deferred adjustments would result in an aggregate change to the Conversion Price of at least one percent (1%), (ii) on the Conversion Date of any Preferred Share, (iii)&#160;on the effective date of any Fundamental Change and/or Make-Whole Fundamental Change and (iv)&#160;in connection with dividends paid on the Common Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <span style="text-decoration:underline">Treatment of <span style="white-space:nowrap">Pre-Record</span> Date Adjustments</span>. Notwithstanding this Section&#160;5.4 or any other provision of this Certificate of Designations to the contrary, if a Conversion Price adjustment becomes effective on any <span style="white-space:nowrap">Ex-Dividend</span> Date, and a holder that has converted its Series B Preferred Stock on or after such <span style="white-space:nowrap">Ex-Dividend</span> Date and on or prior to the related record date would be treated as the record holder of the shares of Common Stock as of the related Conversion Date based on an adjusted Conversion Price for such <span style="white-space:nowrap">Ex-Dividend</span> Date, then, notwithstanding the Conversion Price adjustment provisions in this Section&#160;5.4, the Conversion Price adjustment relating to such <span style="white-space:nowrap">Ex-Dividend</span> Date shall not be made for such converting holder. Instead, such holder shall be treated as if such holder were the record owner of the shares of Common Stock on an unadjusted basis and participate in the related dividend, distribution or other event giving rise to such adjustment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) Notwithstanding anything to the contrary in this Section&#160;5.4, the Conversion Price shall not be adjusted: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) upon the issuance of any shares of Common Stock pursuant to any present or future plan providing for the reinvestment of dividends or interest payable on the Company&#8217;s securities and the investment of additional optional amounts in shares of Common Stock under any plan; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) upon the issuance of any shares of Common Stock or options or rights to purchase those shares pursuant to any present or future employee, director or consultant benefit plan or program of or assumed by the Company or any of the Company&#8217;s Subsidiaries; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) upon the issuance of any shares of the Common Stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible security not described in clause (ii)&#160;of this subsection and outstanding as of Issue Date; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) upon the repurchase of any shares of Common Stock pursuant to an open market share repurchase program or other <span style="white-space:nowrap">buy-back</span> transaction, including structured or derivative transactions, that is not a tender or exchange offer of the kind described in Section&#160;5.4(f); </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) solely for a change in the par value of the Common Stock or to the extent the Conversion Price would be reduced below such par value; or </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) for accrued and unpaid Preferred Dividends, if any. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) <span style="text-decoration:underline">Reference Property</span>. In the case of any recapitalization, reclassification, or change of the Common Stock (other than changes resulting from a subdivision, combination or reclassification described in Section&#160;5.4(b)), or consolidation or merger involving the Company, in each case as a result of which all of the outstanding shares of Common Stock (but not the Series B Preferred Stock) would be converted into, or exchanged for, stock, other securities, other property or assets (including cash or any combination thereof) (any of the foregoing, a &#8220;<span style="text-decoration:underline">Reference Transaction</span>&#8221;), then, at the effective time of the Reference Transaction, the right to convert each Preferred Share will be changed into a right to convert such Preferred Share into the kind and amount of shares of stock, other securities, or other property or assets (including cash or any combination thereof) (the &#8220;<span style="text-decoration:underline">Reference Property</span>&#8221;) that a Holder would have received in respect of the Common Stock issuable upon conversion of such Preferred Share immediately prior to such Reference Transaction (disregarding, for </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purpose of this determination, the Beneficial Ownership Limitation set forth in Section&#160;5.5); and, in such case, appropriate adjustment (as determined in good faith by the Board) shall be made in the application of the provisions of this Certificate of Designation with respect to the rights and interests thereafter of the holders of Series B Preferred Stock, to the end that the provisions set forth in this Certificate of Designations shall thereafter be applicable, as nearly as reasonably may be, in relation to such Reference Property. In the event that holders of Common Stock have the opportunity to elect the form of consideration to be received in the Reference Transaction, the Company shall make adequate provision whereby the Holders shall have a reasonable opportunity to determine the form of consideration into which all of the Preferred Shares, treated as a single class, shall be convertible from and after the effective time of the Reference Transaction. Any such election shall be made by the Majority Holders. Any such determination by the Holders shall be subject to any limitations to which all holders of Common Stock are subject, such as pro rata reductions applicable to any portion of the consideration payable in the Reference Transaction, and shall be conducted in such a manner as to be completed at approximately the same time as the time elections are made by holders of Common Stock. The provisions of this Section&#160;5.4(o) and any equivalent thereof in any such securities similarly shall apply to successive Reference Transactions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) <span style="text-decoration:underline">No Duplication</span>. If any action would require adjustment of the Conversion Price pursuant to more than one of the provisions described in this Article V in a manner such that such adjustments are duplicative, only one adjustment (which shall be the adjustment most favorable to the Holders) shall be made. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) <span style="text-decoration:underline">Notice of Record Date</span>. In the event of: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any event described in Section&#160;5.4(b) or (c); </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any Reference Transaction to which Section&#160;5.4(o) applies; or </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the dissolution, liquidation, or <span style="white-space:nowrap">winding-up</span> of the Company, </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the Company shall mail to the Holders at their last addresses as shown on the records of the Company, at least twenty (20)&#160;days prior to the record date specified in (i)&#160;below or twenty (20)&#160;days prior to the date specified in (ii)&#160;below, as applicable, a notice stating: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the record date for the dividend, other distribution, stock split, or combination or, if a record is not to be taken, the date as of which the holders of Common Stock of record are to be entitled to such dividend, other distribution, stock split, or combination; or </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the date on which such reclassification, change, dissolution, liquidation, <span style="white-space:nowrap">winding-up,</span> or other event constituting a Reference Transaction is estimated to become effective or otherwise occur, and the date as of which it is expected that holders of Common Stock of record will be entitled to exchange their shares of Common Stock for Reference Property, other securities or other property deliverable upon such reclassification, change, liquidation, dissolution, <span style="white-space:nowrap">winding-up,</span> or Reference Transaction. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) <span style="text-decoration:underline">Certificate of Adjustments</span>. Upon the occurrence of each adjustment or readjustment of the Conversion Price pursuant to this Section&#160;5.4, the Company at its expense shall as promptly as reasonably practicable compute such adjustment or readjustment in accordance with the terms hereof and furnish to each Holder a certificate, signed by an officer of the Company (in his or her capacity as such and not in an individual capacity), setting forth (A)&#160;the calculation of such adjustments and readjustments in reasonable detail, (B)&#160;the facts upon which such adjustment or readjustment is based, (C)&#160;the Conversion Price then in effect, and (D)&#160;the number of shares of Common Stock (or Reference Property, to the extent applicable) and the amount, if any, of Capital Stock, other securities or other property (including, but not limited to, cash and evidences of indebtedness) which then would be received upon the conversion of a Preferred Share.<span style="text-decoration:line-through"> </span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;5.5 <span style="text-decoration:underline">Beneficial Ownership Limitation</span>. No Holder shall have the right to convert any Preferred Share to the extent that, after giving effect to the conversion, such Holder (together with such Holder&#8217;s Affiliates, and </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any Persons acting as a group together with such Holder or any of such Holder&#8217;s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by such Holder and its Affiliates and such other Persons shall include the number of shares of Common Stock issuable upon conversion of the Preferred Shares with respect to which such determination is being made, but shall exclude the number of Conversion Shares which are issuable upon (i)&#160;conversion of the remaining, unconverted Preferred Shares beneficially owned by such Holder or any of its Affiliates or such other Persons and (ii)&#160;exercise or conversion of the unexercised or unconverted portion of any other securities of the Company subject to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, the Preferred Shares) beneficially owned by such Holder or any of its Affiliates or such other Persons. Except as set forth in the preceding sentence, for purposes of this Section&#160;5.5, beneficial ownership and a determination as to any group status shall be calculated in accordance with Section&#160;13(d) of the Exchange Act and the rules and regulations promulgated thereunder. Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to such Holder the number of shares of Common Stock then outstanding. The &#8220;Beneficial Ownership Limitation&#8221; shall initially be nine and nine-tenths percent (9.9%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Shares held by the applicable Holder. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&#160;5.5 to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of Preferred Shares. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE VI. COVENANTS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;6.1 <span style="text-decoration:underline">Maintenance of Cash Balance</span>. Unless (and only to the extent) waived by the Majority Holders from time to time, the Company shall at all times maintain a minimum aggregate balance of three million ($3,000,000) in unrestricted cash maintained with one or more commercial banks or similar deposit-taking institutions in the United States. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;6.2 <span style="text-decoration:underline">Marketing Authorization</span>. The Company and its Subsidiaries shall execute, deliver and file any and all agreements, documents or instruments that are necessary or desirable to secure and maintain, and shall obtain, a Marketing Authorization for the Products from the FDA no later than December&#160;31, 2026. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE VII. DIRECTOR APPOINTMENTS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;7.1 <span style="text-decoration:underline">First Director</span>. For so long as RTW or its Affiliates owns the Lower Ownership Threshold, RTW shall have the right to designate an individual to be nominated for election to the Board (the&#160;&#8220;<span style="text-decoration:underline">First Director Designee</span>&#8221;) at any annual meeting of stockholders at which such First Director Designee is to be elected; <span style="font-style:italic">provided</span> that such nomination shall be subject to the recommendation by the Nominating Committee and the approval by the Board (such recommendation and approval not to be unreasonably withheld or delayed); <span style="font-style:italic">provided, further</span>, that if any First Director Designee ceases to be a director of the Company for any reason, RTW shall have the right to designate a different individual to be nominated for election as the First Director Designee (the nomination of which shall be subject to the procedures immediately preceding this proviso). At each meeting of the stockholders of the Company at which the First Director Designee is to be elected or <span style="white-space:nowrap">re-elected,</span> the Board shall nominate the individual designated and approved for nomination as such First Director Designee in accordance with this Section&#160;7.1 for election or <span style="white-space:nowrap">re-election,</span> as the case may be, as a director, and shall support the First Director Designee for election or <span style="white-space:nowrap">re-election</span> in a manner no less rigorous and favorable than the manner in which the Company supports other nominees. The individual serving as First Director Designee shall serve for a term commencing upon his or her election or appointment and expiring upon the earlier of (i)&#160;the time at which </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-14 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
RTW delivers a notice to the Company indicating that it desires to designate a different individual as such First Director Designee, in which case such individual shall cease to be qualified as, and no longer be, a director, and (ii)&#160;the time at which RTW or its Affiliates ceases to own the Lower Ownership Threshold, in which case such individual shall cease to be qualified as, and no longer be, a director. The individual serving as First Director Designee shall be eligible to serve as a member of any committee of the Board, except for special&#160;committees&#160;established for potential conflict of interest situations the nature of which is such that membership thereon by the First Director&#160;Designee&#160;would be inappropriate, as determined in good faith by the Board, and&#160;except that only First Director Designees who qualify under the applicable rules and regulations of the applicable securities exchange and the SEC may serve on&#160;committees&#160;where such qualification is required. The First Director Designee shall initially be Nicholas Lewin. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;7.2 <span style="text-decoration:underline">Second Director</span>. For so long as RTW or its Affiliates owns the Higher Ownership Threshold, RTW shall have the right to designate an additional individual to be nominated for election to the Board (the&#160;&#8220;<span style="text-decoration:underline">Second Director Designee</span>&#8221;) at any annual meeting of stockholders at which such Second Director Designee is to be elected; <span style="font-style:italic">provided</span> that such nomination shall be subject to the recommendation by the Nominating Committee and the approval by the Board (such recommendation and approval not to be unreasonably withheld or delayed); <span style="font-style:italic">provided, further</span>, that if any Second Director Designee ceases to be a director of the Company for any reason, RTW shall have the right to designate a different individual to be nominated for election as the Second Director Designee (the nomination of which shall be subject to the procedures immediately preceding this proviso). At each meeting of the stockholders of the Company at which the Second Director Designee is to be elected or <span style="white-space:nowrap">re-elected,</span> the Board shall nominate the individual designated and approved for nomination as such Second Director Designee in accordance with this Section&#160;7.2 for election or <span style="white-space:nowrap">re-election,</span> as the case may be, as a director, and shall support the Second Director Designee for election or <span style="white-space:nowrap">re-election</span> in a manner no less rigorous and favorable than the manner in which the Company supports other nominees. The individual serving as Second Director Designee shall serve for a term commencing upon his or her election or appointment and expiring upon the earlier of (i)&#160;the time at which RTW delivers a notice to the Company indicating that it desires to designate a different individual as such Second Director Designee, in which case such individual shall cease to be qualified as, and no longer be, a director, and (ii)&#160;the time at which RTW or its Affiliates ceases to own the Higher Ownership Threshold, in which case such individual shall cease to be qualified as, and no longer be, a director. The individual serving as Second Director Designee shall be eligible to serve as a member of any committee of the Board, except for special&#160;committees&#160;established for potential conflict of interest situations the nature of which is such that membership thereon by the Second Director&#160;Designee&#160;would be inappropriate, as determined in good faith by the Board, and&#160;except that only Second Director Designees who qualify under the applicable rules and regulations of the applicable securities exchange and the SEC may serve on&#160;committees&#160;where such qualification is required. The Second Director Designee shall initially be R. Jason Richey. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;7.3 <span style="text-decoration:underline">Breach Event Directors</span>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If and for so long as (x)&#160;a Specified Breach Event (as defined below) is ongoing and (y)&#160;RTW or its Affiliates owns the Lower Ownership Threshold, RTW shall have the right to designate to be nominated for election to the Board (in addition to the First Director Designee and the Second Director Designee) two (2)&#160;individuals (&#8220;<span style="text-decoration:underline">Breach Director Designees</span>&#8221;); <span style="font-style:italic">provided</span> that such nomination shall be subject to the recommendation by the Nominating Committee and the approval by the Board (such recommendation and approval not to be unreasonably withheld or delayed); <span style="font-style:italic">provided, further</span>, that if any Breach Director Designee ceases to be a director of the Company for any reason, RTW shall have the right to designate a different individual to be nominated for election to the Board as such Breach Director Designee (the nomination of which shall be subject to the procedures immediately preceding this proviso). At each meeting of the stockholders of the Company at which a Breach Director Designee is to be elected, the Board shall nominate each individual designated and approved for nomination as a Breach Director Designee in accordance with this Section&#160;7.3 for election or <span style="white-space:nowrap">re-election,</span> as the case may be, as a director, and shall support each Breach Director Designee for election or <span style="white-space:nowrap">re-election</span> in a manner no less rigorous and favorable than the manner in which the Company supports other nominees. Notwithstanding the foregoing, if the election of either or both of the Breach Director </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-15 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Designees would result in a majority of the Board then in office being comprised of RTW Designees (the&#160;&#8220;<span style="text-decoration:underline">Majority Condition</span>&#8221;), then (1)&#160;the number of Breach Director Designees shall be reduced so that all RTW Designees represent less than a majority of the Board (and, if necessary, the Breach Director Designee(s) then in office shall cease to be qualified as, and shall cease to serve as, directors (it being understood that, if there are two (2)&#160;Breach Director Designees in office and the disqualification of only one (1)&#160;such director is required to comply with the Majority Condition, the disqualification shall occur in the reverse order in which such Breach Director Designees were designated)), (2)&#160;the Company will undertake best efforts to increase the size of the Board and/or fill any resulting vacancy or vacancies or newly created directorships as necessary so that both Breach Director Designees can be appointed and RTW Designees will remain less than a majority of the Board and (3)&#160;the Dividend Rate shall be increased by two percentage points (2.0%) during such period that at least one (1)&#160;Breach Director Designee cannot be elected or is unable to serve as a result of the Majority Condition. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Breach Director Designee shall serve for a term expiring upon the earliest of (i)&#160;the time at which RTW delivers a notice to the Company indicating that it desires to designate a different individual to the seat of such Breach Director Designee, in which case such individual shall cease to be qualified as, and no longer be, a director, (ii)&#160;the time at which RTW or its Affiliates ceases to own the Lower Ownership Threshold, in which case such Breach Director Designees shall cease to be qualified as, and no longer be, a director, and (iii)&#160;the time at which the Specified Breach Event giving rise to the designation rights in respect of such Breach Director Designee is no longer ongoing, in which case such individual shall cease to be qualified as, and no longer be, a director. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each individual serving as Breach Director Designee shall be eligible to serve as a member of any committee of the Board, except for special&#160;committees&#160;established for potential conflict of interest situations the nature of which is such that membership thereon by the Breach Director&#160;Designee&#160;would be inappropriate, as determined in good faith by the Board, and&#160;except that only Breach Director Designees who qualify under the applicable rules and regulations of the applicable securities exchange and the SEC may serve on&#160;committees&#160;where such qualification is required. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) For purposes of this Section&#160;7.3, the term &#8220;Specified Breach Event&#8221; means a failure to satisfy either of the covenants in Article&#160;6, which has not been cured. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;7.4 <span style="text-decoration:underline">Vacancy Appointment</span>. If at any time RTW is entitled to nominate for election any director pursuant to this Article&#160;7 and there is a vacancy in such director position between annual meetings of stockholders, then the Company will use reasonable best efforts to promptly fill such vacancy in accordance with the procedures set forth in this Article&#160;7. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;7.5 <span style="text-decoration:underline">Other Requirements</span>. Notwithstanding anything to the contrary contained in this Article&#160;7, neither the Company nor the Board shall be under any obligation to nominate or appoint any First Director Designee, Second Director Designee or Breach Director Designee, as applicable, to the Board, or solicit votes for or otherwise support the election or <span style="white-space:nowrap">re-election</span> of any such person pursuant to this Article&#160;7, in the event that the Board in good faith determines that such person (i)&#160;has been the subject of any event required to be disclosed pursuant to Item&#160;401(f) of Regulation <span style="white-space:nowrap">S-K</span> of the Securities Act of 1933, as amended (for the avoidance of doubt, excluding bankruptcies), involving an act of moral turpitude by such individual, (ii)&#160;is subject to any order, decree or judgment of any governmental entity prohibiting service as a director of any public company, or (iii)&#160;fails to complete reasonable and customary onboarding documentation, including providing reasonably required information to the Company, in each case, to the extent such requirements are consistent with those applicable to the other members of the Board. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-16 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE VIII. ADDITIONAL DEFINITIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;8.1 For purposes of these resolutions, the following terms shall have the following meanings: </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Accrued Value</span>&#8221; means, for a Preferred Share, (i)&#160;the Initial Stated Value plus (ii)&#160;all increases in the Accrued Value resulting from Accrued Dividends as set forth in Section&#160;2.1 plus (iii)&#160;the amount of any accrued but unpaid Preferred Dividends existing since the most recent past Dividend Payment Date to but excluding the date of determination. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Affiliate</span>&#8221; means, with respect to any Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with, such specified Person. Notwithstanding the foregoing, none of the Company, its Subsidiaries or its other controlled Affiliates shall be considered Affiliates of the RTW Investor. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Beneficial Owner</span>&#8221; has the meaning assigned to such term in Rule <span style="white-space:nowrap">13d-3</span> and Rule <span style="white-space:nowrap">13d-5</span> under the Exchange Act, except that in calculating the beneficial ownership of any particular &#8220;person&#8221; (as that term is used in Section&#160;13(d)(3) of the Exchange Act), such &#8220;person&#8221; shall be deemed to have beneficial ownership of all securities that such &#8220;person&#8221; has the right to acquire by conversion or exercise of other securities, whether such right is currently exercisable or is exercisable only upon the occurrence of a subsequent condition (including, for the avoidance of doubt, by conversion of the Preferred Shares and exercise of warrants). The terms &#8220;Beneficially Owns&#8221; and &#8220;Beneficially Owned&#8221; shall have a corresponding meaning. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Business Day</span>&#8221; shall mean any day, other than a Saturday, Sunday and any day which is a legal holiday under the laws of the State of New York or is a day on which banking institutions located in the State of New&#160;York are authorized or required by law or other governmental action to close. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Capital Stock</span>&#8221; means, with respect to any Person, any and all shares of stock, partnership interests or other equivalent interests (however designated, whether voting or <span style="white-space:nowrap">non-voting)</span> in such Person&#8217;s equity, entitling the holder to receive a share of the profits and losses, and a distribution of assets, after liabilities, of such Person. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Certificate of Designations</span>&#8221; means this certificate of designations for the Series B Preferred Stock, as such shall be amended from time to time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Common Stock</span>&#8221; means the shares of Common Stock, par value $0.0001 per share, of the Company or any other Capital Stock of the Company into which such Common Stock shall be reclassified or changed. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Common Equity</span>&#8221; of any Person means the Capital Stock of such Person that is generally entitled (a)&#160;to vote in the election of directors of such Person or (b)&#160;if such Person is not a corporation, to vote or otherwise participate in the selection of the governing body, partners, managers or others that will control the management or policies of such Person. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">control</span>&#8221; (including, with correlative meanings, the terms &#8220;controlling,&#8221; &#8220;controlled by,&#8221; and &#8220;under common control with&#8221;) with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract, or otherwise. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Conversion Date</span>,&#8221; with respect to any Converted Shares, shall mean the first date on which each of the following has occurred: (i)&#160;a conversion has been requested pursuant to Section&#160;5.1, and (ii)&#160;the Company or its transfer agent, as applicable, has received, or waived the requirements to provide, the certificates, notice and other documents and amounts required to be delivered or paid under Section&#160;5.3(b). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Conversion Rate</span>&#8221; shall mean the quotient obtained by dividing $1,000 by the Conversion Price. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-17 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Conversion Price</span>&#8221; means initially $3.37, as adjusted from time to time as provided in Section&#160;5. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Daily VWAP</span>&#8221;, with respect to any Trading Day, means the volume-weighted average price per share of Common Stock (or per minimum denomination or unit size in the case of any security other than Common Stock) as displayed under the heading &#8220;Bloomberg VWAP&#8221; on the Bloomberg page for the &#8220;&lt;equity&gt; AQR&#8221; page corresponding to the &#8220;ticker&#8221; for such Common Stock or unit (or its equivalent successor if such page is not available) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session on such Trading Day (or if such volume-weighted average price is unavailable, the Market Value of one share of such Common Stock (or per minimum denomination or unit size in the case of any security other than Common Stock)) on such Trading Day. The &#8220;volume weighted average price&#8221; shall be determined without regard to after-hours trading or any other trading outside of the regular trading session trading hours. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Dividend Payment Date</span>&#8221; means [&#8226;], [&#8226;], [&#8226;] and [&#8226;] each year beginning [&#8226;], 2026; <span style="font-style:italic">provided</span> that, if any such Dividend Payment Date would otherwise occur on a day that is not a Business Day, such Dividend Payment Date shall instead be the immediately succeeding Business Day.<sup style="font-size:75%; vertical-align:top">2</sup> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Dividend Period</span>&#8221; means a period commencing on [&#8226;], [&#8226;], [&#8226;] or [&#8226;] (other than the initial Dividend Period, which shall commence on and include the Issue Date) and ending on and including [&#8226;], [&#8226;], [&#8226;] and [&#8226;] preceding the next Dividend Payment Date, as applicable.<sup style="font-size:75%; vertical-align:top">3</sup> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Dividend Rate</span>&#8221; means 8.25% per annum, or such higher amount as set forth in Section&#160;7.3(a)(3). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Effective Date</span>&#8221; means, with respect to a Fundamental Change or a Make-Whole Fundamental Change, as applicable, the date such Fundamental Change or Make-Whole Fundamental Change, as applicable, occurs or becomes effective. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Equity Securities</span>&#8221; shall mean, with respect to any Person, (i)&#160;shares of capital stock of, or other equity or voting interest in, such Person, (ii)&#160;any securities convertible into or exchangeable for shares of capital stock of, or other equity or voting interest in, such Person, (iii)&#160;options, warrants, rights or other commitments or agreements to acquire from such Person, or that obligates such Person to issue, any capital stock of, or other equity or voting interest in, or any securities convertible into or exchangeable for shares of capital stock of, or other equity or voting interest in, such Person, (iv)&#160;obligations of such Person to grant, extend or enter into any subscription, warrant, right, convertible or exchangeable security or other similar agreement or commitment relating to any capital stock of, or other equity or voting interest (including any voting debt) in, such Person and (v)&#160;the capital stock of such Person. Unless otherwise specified, &#8220;Equity Security&#8221; means an Equity Security of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Exchange</span>&#8221; means The New York Stock Exchange or other principal national securities exchange on which the Common Stock (or Reference Property, to the extent applicable). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Exchange Act</span>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Excluded Parties</span>&#8221; means (x)&#160;the RTW Investor and its Affiliates and (y)&#160;any &#8220;group&#8221; (within the meaning of Section&#160;13(d)(3) of the Exchange Act) of which any Person referred to in clause (x)&#160;of this definition is a member. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline"><span style="white-space:nowrap">Ex-Date</span></span>&#8221; means the first date on which the Common Stock trades on the applicable Exchange or in the applicable market, regular way, without the right to receive the issuance, dividend, or distribution in question </p><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><sup style="font-size:75%; vertical-align:top">2</sup>&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">NTD: To be determined by the parties at the time of closing. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><sup style="font-size:75%; vertical-align:top">3</sup>&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">NTD: To be determined by the parties at the time of closing. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-18 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
from the Company or, if applicable, from the seller of the Common Stock on such Exchange or market (in the form of due bills or otherwise) as determined by such Exchange or market. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A &#8220;<span style="text-decoration:underline">Fundamental Change</span>&#8221; shall be deemed to have occurred at the time after the Issue Date when any of the following the consummation of (A)&#160;any recapitalization, reclassification or change of the Common Stock (other than changes resulting from a subdivision or combination) pursuant to which all of the outstanding shares of the Common Stock (<span style="font-style:italic">i.e.</span> 100% of all Common Stock) would be converted into, or exchanged for, or represent solely the right to receive, shares, stock, other securities, other property or assets (including cash or any combination thereof), (B) any share exchange, consolidation, merger, amalgamation or similar event involving the Company pursuant to which all of the outstanding shares of the Common Stock will be converted into, or exchanged for, or represent solely the right to receive, shares, stock, other securities, other property or assets (including cash or any combination thereof), or (C)&#160;any sale, lease or other transfer in one transaction or a series of transactions of all of the consolidated assets of the Company and its Subsidiaries, taken as a whole, to any Person other than one or more of the Company&#8217;s wholly owned Subsidiaries (without consideration of any director&#8217;s qualifying shares) (any such share exchange, consolidation, merger, amalgamation or similar event, transaction or series of transactions being referred to in this definition as an &#8220;<span style="text-decoration:underline">Event</span>&#8221;); <span style="font-style:italic">provided, however</span>, that any such Event described in clause (A)&#160;or (B) above where the Persons that &#8220;beneficially owned,&#8221; directly or indirectly, the Company&#8217;s Common Equity immediately prior to such Event &#8220;beneficially own&#8221;, directly or indirectly, more than 50.0% of the total voting power of all outstanding classes of the Company&#8217;s Common Equity of the continuing or surviving Person or transferee or the parent thereof immediately after such Event and such holders&#8217; proportional voting power immediately after such transaction <span style="white-space:nowrap"><span style="white-space:nowrap">vis-&#224;-vis</span></span> each other with respect to the securities such holders receive in such transaction will be in substantially the same proportions as their respective voting power <span style="white-space:nowrap"><span style="white-space:nowrap">vis-&#224;-vis</span></span> each other immediately prior to such transaction will not constitute a &#8220;Fundamental Change&#8221;; <span style="font-style:italic">provided, however</span>, that a transaction or event will not constitute a Fundamental Change if at least ninety percent (90%) of the consideration received or to be received by the holders of Common Stock (excluding cash payments for fractional shares or pursuant to dissenters&#8217; rights), in connection with such transaction or event, consists of shares of common stock or other corporate Common Equity interests listed (or depositary receipts representing shares of common stock or other corporate Common Equity interests, which depositary receipts are listed) on any Exchange (or any of their respective successors), or that will be so listed when issued or exchanged in connection with such transaction or event, and such transaction or event constitutes a Reference Transaction whose Reference Property consists of such consideration. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any transaction in which the Common Stock is replaced by the Common Equity of another entity occurs, following completion of any related Make-Whole Fundamental Change (or, in the case of a transaction that would have been a Make-Whole Fundamental Change but for the proviso immediately following numbered clause (4)&#160;to this definition, following the effective date of such transaction), references to the Company in this definition of &#8220;Fundamental Change&#8221; will apply to such other entity instead. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this definition, whether a Person is a &#8220;beneficial owner,&#8221; whether shares are &#8220;beneficially owned,&#8221; and percentage beneficial ownership, will be determined in accordance with Rule <span style="white-space:nowrap">13d-3</span> under the Exchange Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Governmental Entity</span>&#8221; shall mean any United States or <span style="white-space:nowrap">non-United</span> States federal, state, or local government, or any agency, bureau, board, commission, department, tribunal, or instrumentality thereof or any court, tribunal, or arbitral or judicial body. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">hereof</span>,&#8221; &#8220;<span style="text-decoration:underline">herein</span>,&#8221; and &#8220;<span style="text-decoration:underline">hereunder</span>&#8221; and words of similar import refer to this Certificate of Designations as a whole and not merely to any particular clause, provision, section, or subsection. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Higher Ownership Threshold</span>&#8221; means that RTW and its Affiliates, taken as a whole, Beneficially Own securities of the Company or its Subsidiaries (including (i)&#160;Series B Preferred Stock, (ii)&#160;shares of Common Stock or Preferred Stock other than the Series B Preferred Stock and (iii)&#160;convertible notes, warrants or other </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-19 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
securities convertible into or exercisable or exchangeable for Common Stock or Preferred Stock) at least thirty percent (30%) of the Common Stock; <span style="font-style:italic">provided</span>, that in making such determination the Beneficial Ownership Limitation set forth in Section&#160;5.5 shall be disregarded and any analogous to limitation contained in other convertible, exercisable or exchangeable securities shall also be disregarded. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Holders</span>&#8221; means the holders of outstanding Preferred Shares as they appear in the records of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">HSR Act</span>&#8221; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the regulations promulgated thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Initial Stated Value</span>&#8221; means $1,000 per Preferred Share, subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series B Preferred Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Issue Date</span>&#8221; means the date on which the Series B Preferred Stock is first issued by the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Lower Ownership Threshold</span>&#8221; means that RTW and its Affiliates, taken as a whole, Beneficially Own securities of the Company or its Subsidiaries (including (i)&#160;Series B Preferred Stock, (ii)&#160;shares of Common Stock or Preferred Stock other than the Series B Preferred Stock and (iii)&#160;convertible notes, warrants or other securities convertible into or exercisable or exchangeable for Common Stock or Preferred Stock) at least ten percent (10%) of the Common Stock; <span style="font-style:italic">provided</span>, that in making such determination the Beneficial Ownership Limitation set forth in Section&#160;5.5 shall be disregarded and any analogous to limitation contained in other convertible, exercisable or exchangeable securities shall also be disregarded. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Majority Holders</span>&#8221; means Holders of Preferred Shares owning of record Preferred Shares representing more than 50% of the Accrued Value of all issued and outstanding Preferred Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Make-Whole Fundamental Change</span>&#8221; means any event that is a Fundamental Change (subject to any exceptions or exclusions to the definition other than the exclusion in the proviso to the definition of &#8220;Fundamental Change&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Market Disruption Event</span>&#8221; means the occurrence or existence for more than one half hour period in the aggregate on any scheduled Trading Day for the Common Stock (or Reference Property, to the extent applicable) of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the applicable Exchange or otherwise) in the Common Stock (or Reference Property, to the extent applicable) or in any options, contracts, or future contracts relating to the Common Stock (or Reference Property, to the extent applicable), and such suspension or limitation occurs or exists at any time before 4:00 p.m., New York City time, on such day. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Market Value</span>&#8221; on any date means the closing sale price per share (or if no closing sale price is reported, the average of the closing bid and ask prices or, if more than one in either case, the average of the average closing bid and the average closing ask prices) on such date as reported on the principal Exchange on which shares of the Common Stock are then listed. If the Common Stock is not so listed or traded, the Market Value will be an amount reasonably determined by the Board in good faith to be the fair value of the Common Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Nominating Committee</span>&#8221; means the Nominating and Corporate Governance Committee of the Board or its successor. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Parity Securities</span>&#8221; means any class or series of Preferred Stock or any other Capital Stock of the Company hereafter issued in compliance with the terms hereof and the terms of which expressly provide that it will rank on parity with the Series B Preferred Stock with respect to the payment of dividends, redemption payments, rights (including as to the distribution of assets) upon liquidation, dissolution or winding up of the Company, or otherwise. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-20 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Person</span>&#8221; means any individual, corporation, limited liability company, limited or general partnership, joint venture, association, joint-stock company, trust, unincorporated organization, or other entity, or any Governmental Entity, any agency or political subdivisions thereof, or other &#8220;Person&#8221; as contemplated by Section&#160;13(d) of the Exchange Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Preferred Shares</span>&#8221; means the shares of Series B Preferred Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Products</span>&#8221; means (a)&#160;the gastric balloon for weight loss owned or controlled by the Company or its Subsidiaries and any derivatives, modifications and improvements thereto, (b)&#160;a suite of related and complementary digital products, and (c)&#160;any and all current and future products, digital solutions, and services developed, imported, manufactured, marketed, offered for sale, promoted, sold, tested or otherwise distributed by the Company or any of its Subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">RTW</span>&#8221; means RTW Investments, LP., a Delaware limited partnership, or its successor. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">RTW Designees</span>&#8221; means the First Director Designee, the Second Director Designee and the Breach Director Designees, if any. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">RTW Investor</span>&#8221; means RTW and its Affiliates. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Senior Securities</span>&#8221; means any class or series of Preferred Stock or any other Capital Stock of the Company hereafter issued in compliance with the terms hereof and the terms of which expressly provide that it will rank senior in preference or priority to the Series B Preferred Stock with respect to the payment of dividends, redemption payments, rights (including as to the distribution of assets) upon liquidation, dissolution or winding up of the Company, or otherwise. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Subsidiary</span>&#8221; of any Person shall mean any other Person in which such Person, directly or indirectly, owns or has the power to vote or control more than fifty percent (50%) of the voting stock or other interests the holders of which are generally entitled to vote for the election of the board of directors or other applicable governing body of such other Person (or, in the case of a partnership, limited liability company or other similar entity, control of the general partnership, managing member or similar interests). Unless otherwise specified, &#8220;Subsidiary&#8221; means a Subsidiary of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Thirty Day VWAP</span>&#8221; means, with respect to a security, the average of the Daily VWAP of such security for each day during a thirty (30) consecutive Trading Day period ending immediately prior to the date of determination. Unless otherwise specified, &#8220;Thirty Day VWAP&#8221; means the Thirty Day VWAP of the Common Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Total Current Voting Power</span>&#8221; shall mean, with respect to any entity, at the time of determination of Total Current Voting Power, the total number of votes which may be cast in the general election of directors of such entity (or, in the event the entity is not a corporation, the governing members, board or other similar body of such entity and, in the case of the Company). Unless otherwise specified, &#8220;Total Current Voting Power&#8221; means Total Current Voting Power of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">Trading Day</span>&#8221; means any day on which (i)&#160;there is no Market Disruption Event and (ii)&#160;the Exchange is open for trading or, if the Common Stock (or Reference Property, to the extent applicable) is not listed, admitted for trading or quoted on an Exchange, any Business Day. A Trading Day only includes those days that have a scheduled closing time of 4:00 p.m., New York City time, or the then-standard closing time for regular trading on the relevant Exchange or trading system. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">U.S. Marketing Authorization</span>&#8221; means, with respect to a Product, the U.S. Regulatory Approvals required by applicable law to commercially distribute such Product in the United States, including, to the extent required by applicable law for the commercial distribution of such Product, all pricing approvals and government reimbursement approvals. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-21 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="text-decoration:underline">U.S. Regulatory Approvals</span>&#8221; means, collectively, all regulatory approvals, registrations, certificates, clearances, authorizations, permits and supplements thereto, as well as associated materials (including the product dossier) pursuant to which any Product may be researched, tested, developed, manufactured, marketed, sold and distributed in the United States, issued by the U.S. Food and Drug Administration (or any successor agency or authority thereto) or other appropriate governmental entity with responsibility for the approval of the marketing and sale of medical devices or other regulation of medical devices in the United States. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;8.2 Each of the following terms is defined in the Section set forth opposite such term: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:88%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:11%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Term</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Section</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Accrued Dividends</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">2.1</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Board</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Preamble</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Certificate of Incorporation</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Recitals</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Common Dividend</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">2.2</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Company</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Preamble</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Conversion Amount</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">5.3(a)(i)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Conversion Date</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">5.1(c)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">DGCL</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Preamble</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Junior Securities</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">1.2(a)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Participating Dividend</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">2.2</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Participating Liquidation Preference</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">3.1</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Preferred Dividend</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">2.1(a)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Preferred Stock</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Recitals</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Reference Property</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">5.4(e)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Reference Transaction</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">5.4(e)</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Series B Preferred Stock</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">1.1</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Stock Price</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">5.5(c)</td></tr>
</table> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">ARTICLE IX. MISCELLANEOUS. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;9.1 <span style="text-decoration:underline">Share Certificates</span>. If any certificates representing Preferred Shares shall be mutilated, lost, stolen, or destroyed, the Company shall issue, in exchange and in substitution for and upon cancellation of the mutilated certificate, or in lieu of and substitution for the lost, stolen, or destroyed certificate, a new Preferred Share certificate of like tenor and representing an equivalent number of Preferred Shares, but only upon receipt of evidence of such loss, theft, or destruction of such certificate and indemnity by the holder thereof, if requested, reasonably satisfactory to the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;9.2 <span style="text-decoration:underline">Availability and Reservation of Shares of Common Stock</span>. For the purpose of effecting the conversion of Preferred Shares, the Company shall at all times reserve and keep available, free from any preemptive rights, out of its treasury or authorized but unissued shares of Common Stock the full number of shares of Common Stock deliverable upon the conversion of all outstanding Preferred Shares after taking into account any adjustments to the Conversion Price from time to time. If the Company reasonably expects that, on or any time after the tenth (10<sup style="font-size:75%; vertical-align:top">th</sup>) anniversary of the Issue Date, it will not legally be permitted to pay cash dividends and therefore will pay Preferred Dividends in the form of Accrued Dividends in the manner set forth in Section&#160;2.1, then the Company agrees to periodically amend its certificate of incorporation as necessary to ensure that at all times there are sufficient authorized but unissued shares of Common Stock available to allow for the issuances of Conversion Shares with respect to Accrued Dividends. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;9.3 Without prejudice to any other remedy at law or in equity any Holder may have as a result of such default, take all actions reasonably required to amend its Certificate of Incorporation, as expeditiously as reasonably practicable, to increase the authorized and available amount of Common Stock (or Reference </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-22 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Property, to the extent applicable) if at any time such amendment is necessary in order for the Company to be able to satisfy its obligations under Section&#160;5. Before taking any action which would cause an adjustment reducing the Conversion Price below the then par value of the shares of Common Stock (or Reference Property, to the extent applicable) issuable upon conversion of the Series B Preferred Stock, the Company will take any corporate action which may be necessary in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock (or Reference Property, to the extent applicable) upon the conversion of all outstanding Preferred Shares at such adjusted Conversion Price. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;9.4 <span style="text-decoration:underline">Status of Cancelled Shares</span>. Preferred Shares which have been converted, redeemed, repurchased, or otherwise cancelled shall be automatically retired and resume the status of authorized and unissued shares of Preferred Stock, without designation as to series, until such shares are once more designated by the Board as part of a particular series of Preferred Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;9.5 <span style="text-decoration:underline">Severability</span>. If any right, preference, or limitation of the Series B Preferred Stock set forth in this Certificate of Designations is invalid, unlawful, or incapable of being enforced by reason of any rule of law or public policy, all other rights, preferences, and limitations set forth in this Certificate of Designations which can be given effect without the invalid, unlawful, or unenforceable right, preference, or limitation shall, nevertheless, remain in full force and effect, and no right, preference, or limitation herein set forth shall be deemed dependent upon any other such right, preference, or limitation unless so expressed herein. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;9.6 <span style="text-decoration:underline">Headings; Interpretation</span>. The headings of the various subdivisions hereof are for convenience of reference only and shall not affect the interpretation of any of the provisions hereof. When this Certificate of Designations refers to a specific agreement or other document or a decision by any body or Person that determines the meaning or operation of a provision hereof, the Secretary of the Company shall maintain a copy of such agreement, document or decision at the principal executive offices of the Company and a copy thereof shall be provided free of charge to any stockholder who makes a request therefor. Unless otherwise expressly provided herein, a reference to any specific agreement or other document shall be deemed a reference to such agreement or document as amended from time to time in accordance with the terms of such agreement or document. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;9.7 <span style="text-decoration:underline">Notices</span>. All notices or communications in respect of Preferred Stock shall be in writing and shall be deemed delivered (a)&#160;three (3)&#160;Business Days after being sent by registered or certified mail, return receipt requested, postage prepaid, (b)&#160;one (1)&#160;Business Day after being sent via a reputable nationwide overnight courier service guaranteeing next business day delivery, (c)&#160;on the date of delivery if delivered personally, or (d)&#160;if by facsimile, upon written confirmation of receipt by facsimile. Notwithstanding the foregoing, if Preferred Stock is issued in book-entry form through The Depository Trust Company or any similar facility, such notices may be given to the beneficial holders of Preferred Stock in any manner permitted by such facility. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;9.8 <span style="text-decoration:underline">Other Rights</span>. The shares of Preferred Stock shall not have any rights, preferences, privileges, or voting powers or relative, participating, optional, or other special rights, or qualifications, limitations, or restrictions thereof, other than as set forth herein or in the Certificate of Incorporation or as provided by applicable law and regulation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;9.9 <span style="text-decoration:underline">Waiver</span>. The terms of this Certificate of Designations may be waived upon the written consent of the Majority Holders and the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="font-style:italic">[Rest of page intentionally left blank.] </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-23 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">IN WITNESS WHEREOF</span>, the Company has caused this Certificate of Designations to be executed by a duly authorized officer of the Company as of __________, 2025. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0;margin-left:auto">


<tr>

<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:87%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">ALLURION TECHNOLOGIES, INC.</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">A Delaware corporation</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Shantanu Gaur</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Executive Officer</td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="font-style:italic">[SIGNATURE PAGE TO CERTIFICATE OF DESIGNATIONS</span>] </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">B-24 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:right">Appendix C </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">CERTIFICATE OF AMENDMENT </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">TO </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">AMENDED AND RESTATED </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">CERTIFICATE OF INCORPORATION </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">OF </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">ALLURION TECHNOLOGIES, INC. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ALLURION TECHNOLOGIES, INC., a corporation organized and existing under the laws of the State of Delaware (the &#8220;Corporation&#8221;), hereby certifies as follows: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. The name of the Corporation is Allurion Technologies, Inc.&#160;The date of the filing of its original Certificate of Incorporation with the Secretary of State of the State of Delaware was January&#160;25, 2023 under the name Allurion Technologies Holdings, Inc. The Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on July&#160;31, 2024, and has been amended by a Certificate of Designations of Preferences, Rights and Limitations of Series A <span style="white-space:nowrap">Non-Voting</span> Convertible Preferred Stock filed with the Secretary of State of the State of Delaware on June&#160;28, 2024 and a Certificate of Amendment filed with the Secretary of State of the State of Delaware on December&#160;31, 2024 (the Amended and Restated Certificate of Incorporation, as so amended, the &#8220;Certificate of Incorporation&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. This Certificate of Amendment hereby amends Article IV of the Certificate of Incorporation by adding the following paragraphs after the fourth paragraph of Article IV, as follows: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#8220;Effective as of&#8195;&#8195;&#8195;&#8195;Eastern time on&#8195;&#8195;&#8195;&#8195;, 2025 (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Effective Time</span></span>&#8221;), each&#8195;&#8195;&#8195;&#8195;(&#8195;&#8195;&#8195;&#8195;) shares of Common Stock issued and outstanding (or held in treasury) immediately prior to the Effective Time (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Old Common Stock</span></span>&#8221;) shall automatically without further action on the part of the Corporation or any holder of Old Common Stock, be reclassified, combined, converted and changed into one (1)&#160;fully paid and nonassessable share of Common Stock (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">New Common Stock</span></span>&#8221;), subject to the treatment of fractional share interests as described below (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">reverse stock split</span></span>&#8221;). The reverse stock split shall not affect the total number of shares of capital stock, including the Common Stock, that the Corporation is authorized to issue, which shall remain as set forth under this Article IV. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The conversion of the Old Common Stock into New Common Stock will be deemed to occur at the Effective Time without any further action on the part of the Corporation or the holders of shares of New Common Stock and whether or not certificates representing such holders&#8217; shares prior to the reverse stock split are surrendered for cancellation. Upon the Effective Time, all references to &#8220;Common Stock&#8221; in this Certificate of Incorporation shall be to the New Common Stock. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The reverse stock split will be effectuated on a <span style="white-space:nowrap"><span style="white-space:nowrap">stockholder-by-stockholder</span></span> (as opposed to <span style="white-space:nowrap"><span style="white-space:nowrap">certificate-by-certificate)</span></span> basis, except that the reverse stock split will be effectuated on a <span style="white-space:nowrap"><span style="white-space:nowrap">certificate-by-certificate</span></span> basis for shares held by registered holders, as applicable.&#160;From and after the Effective Time, certificates representing the Old Common Stock shall represent the number of shares of New Common Stock into which such Old Common Stock shall have been converted pursuant to this Certificate of Amendment. The Corporation shall not be obligated to issue new certificates evidencing the shares of New Common Stock outstanding as a result of the reverse stock split unless and until the certificates evidencing the shares held by a holder prior to the reverse stock split are either delivered to the Corporation or its current transfer agent, or the holder notifies the Corporation or such transfer agent that such certificates have been lost, stolen or destroyed and executes an agreement satisfactory to the Corporation to indemnify the Corporation from any loss incurred by it in connection with such certificates. Holders who otherwise would be entitled to receive fractional share interests of New Common Stock upon the effectiveness of the reverse stock split shall be entitled to receive a whole share of New Common Stock in lieu of any fractional share created as a result of such reverse stock split.&#8221; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. The stockholders of the Corporation have duly approved the foregoing amendment in accordance with the provisions of Section&#160;211 and 242 of the General Corporation Law of the State of Delaware. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be duly adopted and executed in its corporate name and on its behalf by its duly authorized officer as of this <span style="text-decoration:underline">&#8195;&#8195;&#8195;</span> day of <span style="text-decoration:underline">&#8195;&#8195;&#8195;</span>, 2025. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0;margin-left:auto">


<tr>

<td style="width:7%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">ALLURION TECHNOLOGIES, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Name:&#160;Shantanu Gaur</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Title: Chief Executive Officer</td></tr>
</table></div>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g923025dsp007.jpg" alt="LOGO"/>
 </p> </div> <p style="font-family:Times New Roman; font-size:0.5pt"><span style="color:#FFFFFF">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: V81047-P40645 KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY ALLURION TECHNOLOGIES, INC. The Board of Directors recommends you vote FOR the following proposals: 1. Election of Directors For Withhold Nominees: 1a. Omar Ishrak ! ! 1b. R. Jason Richey ! ! For Against Abstain 1c. Douglas Hudson ! ! 5. To approve the issuance of shares of common stock upon the ! ! ! conversion of the Company&#8217;s Series B convertible preferred stock in accordance with NYSE Listing Rule 312.03(b)(i), 312.03(c) and For Against Abstain 312.03(d). 2. To ratify the appointment of Deloitte &amp; Touche LLP as the ! ! ! 6. To approve the issuance of shares of common stock upon the ! ! ! Company&#8217;s independent registered public accounting firm for the exercise of certain private placement warrants for purposes of fiscal year ending December 31, 2025. complying with NYSE Listing Rule 312.03(c). 3. To approve an amendment and restatement of the Allurion 7. To approve an amendment to the Company&#8217;s Amended and Technologies, Inc. 2023 Stock Option and Incentive Plan to (i) ! ! ! Restated Certificate of Incorporation, as amended, to combine ! ! ! increase the number of shares of common stock of the Company outstanding shares of the Company&#8217;s common stock into a lesser authorized for issuance thereunder (with a corresponding increase number of outstanding shares, by a ratio of not less than 1-for-1.5 to the number of shares of common stock that may be issued in and not more than 1-for-20, with the exact ratio to be set within respect of incentive stock options), (ii) amend the definition of this range by the Board of Directors of the Company in its sole Fully-Diluted Shares Outstanding, (iii) lower the non-employee discretion. director compensation limit, and (iv) extend the term of the plan. 8. To approve an adjournment of the Annual Meeting, if necessary, 4. To approve the repricing of certain outstanding stock options that ! ! ! to permit further solicitation and vote of proxies in the event that ! ! ! have been granted under the Allurion Technologies, Inc. 2023 there are insufficient votes in favor of Proposals 3, 4, 5, 6 and 7. Stock Option and Incentive Plan. Note: The proxy holders are hereby authorized to vote in their discretion upon such other matters as may properly come before the meeting and any postponements, continuations, or adjournments thereof. Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date </span></p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>
<h5 style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g923025dsp008.jpg" alt="LOGO"/>
 </p> </div> <p style="font-family:Times New Roman; font-size:0.5pt;text-align:center"><span style="color:#FFFFFF">Allurion Technologies, Inc. ANNUAL MEETING OF STOCKHOLDERS December 18, 2025 - 12:00 P.M. EASTERN TIME THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The stockholder(s) hereby appoint(s) Shantanu Gaur and Brendan Gibbons, or either of them, as proxies, each with the power to appoint such proxy&#8217;s substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of Common Stock of Allurion Technologies, Inc. that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held at 12:00 P.M. Eastern Time, on December 18, 2025, via live audio webcast at www.virtualshareholdermeeting.com/ALUR2025, and any adjournment or postponement thereof. This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors&#8217; recommendations. CONTINUED AND TO BE SIGNED ON REVERSE SIDE Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Proxy Statement is available at www.proxyvote.com. </span></p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>alur-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 20-November-2025 [10:15:17] {PM}-->
<schema targetNamespace="http://www.allurion.com/20241231" elementFormDefault="qualified" xmlns:alur="http://www.allurion.com/20241231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31">
  <annotation>
    <appinfo />
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <import namespace="http://xbrl.sec.gov/dei-sub/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
  <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <import namespace="http://xbrl.sec.gov/ecd-sub/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd" />
  <import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd" />
  <import namespace="http://www.xbrl.org/2006/ref" schemaLocation="http://www.xbrl.org/2006/ref-2006-02-27.xsd" />
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <import namespace="http://fasb.org/srt-roles/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd" />
  <element name="InsiderTradingPoliciesandProceduresAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="alur_InsiderTradingPoliciesandProceduresAbstract" substitutionGroup="xbrli:item" />
  <element name="AwardTimingDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="alur_AwardTimingDisclosureAbstract" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g923025dsp007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923025dsp007.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !D
M  #_X0-E:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 V+C M8S P,B W.2XQ-C0T.#@L(#(P,C O,#<O,3 M
M,C(Z,#8Z-3,@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;7!-33I/
M<FEG:6YA;$1O8W5M96YT240](GAM<"YD:60Z.#E!-4)#-C,S1$(Y13 Q,3@V
M138Y,3,S-C(Q-44T038B('AM<$U-.D1O8W5M96YT240](GAM<"YD:60Z-3,S
M-CDP14)#-C1",3%&,$%!-D1!0D%&,D(W0T5&-4,B('AM<$U-.DEN<W1A;F-E
M240](GAM<"YI:60Z-3,S-CDP14%#-C1",3%&,$%!-D1!0D%&,D(W0T5&-4,B
M('AM<#I#<F5A=&]R5&]O;#TB07-P;W-E(%!T>2!,=&0N(CX@/'AM<$U-.D1E
M<FEV961&<F]M('-T4F5F.FEN<W1A;F-E240](G5U:60Z96%E9C%B8S0M,&5C
M-2TT,V9B+3EF8C<M,# S,#0Q,&8T-#4Y(B!S=%)E9CID;V-U;65N=$E$/2)X
M;7 N:60Z-S!F8V-D,C@M868V,RTY9C0U+6$Q86$M,S(P,#0S,S%C8C<V(B\^
M(#PO<F1F.D1E<V-R:7!T:6]N/B \+W)D9CI21$8^(#PO>#IX;7!M971A/B \
M/WAP86-K970@96YD/2)R(C\^_^X #D%D;V)E &3      ?_; (0  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0(" @(" @("
M @(" P,# P,# P,# P$! 0$! 0$" 0$" @(! @(# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#_\  $0@#< *H P$1
M  (1 0,1 ?_$ +L  0 !!0$! 0$!           '! 4&" D# @$*"P$! 0$!
M 0                $" P00  $$ P ! P("!@4( PL#%04" P0&  $'"!$2
M$Q0)%18AUA>8&5DQ(B.W.5'14B1TEUAX03(*<9'2TR4U595V-QAALC.T=;4F
MMD(TU5:65[B!4\;7*#AI>1H1 0 " @ $!04  P$! 0$!   !$0(2(3%!46&1
M(E(#<8&A,C/PL1/!X='Q0O_:  P# 0 "$0,1 #\ _OXP& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P/X<ON[_\ :(?/+PW^X'W?QEX>
M/X"*YMR9RBB0[MTH)VTV8Q+/<\JUS+%291%V"14[5.LRF&F&8R$-,,(]=K6I
M2MQWP^+'+&YYM6N:_P#:4_N#WI4E-F\M?MQ<@TP!K1=M70>!>2\_4L@=T2_$
MZPQ^ST+==Z-T_P"A:T16OVP7/K&OHY$K6GOBJS\>,=,OPA6Q?]JG^Y^$L!P,
M-M'B%;1PDL0&P+4 XS<V 5EAPI3L>,>#,6"\!#S(LJTWI]A,V'$EI:7K3K+:
M_5&HU_QP\7]='V%_N']P^Y/X<6SL_D$,H,*_T[N=NY?]=SH,2KX,V#%U>DVD
M60D!B1D\J&3:_-SD9S;4CX76V$+TA*E*]:X_)C&&51R=M,.9@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#@)X&5*IVK[O'
MWS4VBKUNR:A73P=W"V?!"S"H?S>/QCY]1%D8DE<9+_L3\FD;3I>T)VKU]NO0
MWE^F/W_V[;_LAY-_^B_G?_YE5K_\69;E@_9#R;_]%_.__P RJU_^+,ER.0OV
M4XD2!*^ZQ!@1(L"##^[QY;QH<&#&8APH<9F!SE#,:)$C(:CQH[*-:2AM"4H2
MG7IK6M8ZMY?KC]';[#!@8=T/H%-Y10KIT_HM@@5.@\\JQZZW2S$U.)'@*O61
MDDP<+R_A;>?4Q &PW'-I;0MQ?M]J$J5O6MB(N:CFX><1_P"T4>&W=^F<[H]:
MXEYL!*7UWH8#E_,>]VCQT)0^)6JV6>P,58,SJVCCY24)@3#LE#&WI41OZ=2O
M]82QM*](.D_'E$7P3?YI?>]\-/"_L3?C@0@=H\A_(W4-B>5XEXP<W?ZI<ZQ'
ME18\^(FU;T3#"!4Z2-DHDZA(DOSVX[C;KK#;3K2UK,?CRRB^$0V#\!ON/\2^
MX<"Z9/Y53.W\TLW&SH"N=+YSWWF<_F5YK)*SC9A0&I0V1,)PI\(A%'2/8ZQ(
M7M.VMZ6E&]I]3.6,X\T*\$^]7X0^1_F_>? +G)J_*[92"O20*#1JL"X/,KF=
MY/*5'N0>C6R+92$LW-B-Q)K[/R08R)$<=)<0K>D)]Y9^/*,=IY,\\DONT>'O
MB3Y?\9\+N]6&V4;HG<JV%LU2O4\#!UQX4Q9+#9:G7H%QNKAMJ56YIBQUER(A
MQV J$TN0PI^0TVM:T",,LL=HY0D;R-^X7PCQ>\E?$[Q5Z0.Z)*Z9YE6$S6N2
MRZM6QQ:IPB(.6&AS570O*/C)8.*IXZS\:V8LS:DZ5O>M>FO4D8S,3E'*&3>:
M7FC2O!_GE9Z1>>3^1'7AMHN<>DQ0/C;R,IV*WCITD*9.)+F@ J= ?&UMM@(M
ME<Q2MH3)>9;]/5S6]#'';LY453_M*/AM>B]B 4GQB^XY<#=.+L@+H)JOB5.L
M9*E&GI$F*@5<1X2ZSIE7(Z?A/IW'G-L/:VP[KV^K:]:-?\LN\>::_*?[\OAK
MXT=L.>. "G>1GE)V^F1D2>D4+Q6Y*_U.5S)?L;=EC+J3V8"BXAL8V\CZR)%=
MEK@N*^&3ME[6V]+(^/*8OA$-O? S[DOBK]QRCV2X>-]N,/E:(4:"=)YE>P+]
M-ZGS<M)5+3"BV^I2WI*H[!#<%_4>7%?EPGG&'6DO;>9>;;,Y898\V^>&3 U<
M\T_*,!X6>,/5_*"TU&P7NN\C%@S)BI5-\>Q9C,$M; %8>9!;*NQQSY1C1SYF
M6'G642%MZ:^1OW^])<8VFH6GQ/\ .7QJ\T01DCPZ^ZF6JGR-#NE\AN(LA1.W
M<D.I]B'P'4.469F!<*@08?7\:7'HVX4E6MJC/O(]%[$XSCS;<X0P& P& P&
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MLA9L*T,IB)C$2=P;DPG6[29/K][T^5-T\[+>=6IS>_7 _C$\XV]>._)/OR>
MG/G'97C#Q\MX=]]XY279#T^N<;+]AZ=S4W=N95IE]Q](FJRR9?YXHU&]-1=1
M%;;3K:W=J#N[TO[6/AY9/M=W\9=N,4*R==.^-)WL%G[X2K8F9V$GW#]F;US>
MOV^B/Q%6I*6+.RE,>!J5J"P+;1!0UJ,G2,#9K[)?6+EVO[6/AM?[^8G6"V2.
M9S*T3-DY"Y9$HS0KA9:*(ESI3JEO2IBPM<C:==<4IQUS6U*WM6][P.I^ P&
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M:F>BE"^A]O[G#I<&BZJ820TM!R9 >>D>UA$5?O3O9=)OG%P\F//+P!Y;Y/\
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MKUWO6O52]ZUK_+O?I@?6 P& P& P& P& P& P& P& P& P& P& P& P& P&
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M;TE&E*KEGGO-NMF&# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M%%J_S]P<BS+KX0\<(1VRY7805.'"!PQ\F=$$R;;K4>=!:D0G]QWMMNJTR[M
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M,-()%9"&T;0E+BS,S:<\(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MQP[\B*EK?I BOITF2SIW8C*8Y/>I^"?C!3(O=Q0?FT1=<\D8%@%=6JY">0G
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M X@P="J-\4+@JG,DA3_6>AN#+>%**XPHI5;S T?1&MU4)J\?JGN3 FI=8?\
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MT1<]W7RKID1R'#YM'Z#%L'0+U)KMK*5B[!(=>JLKJW9(54&6KWRI$O44V&
M&!LQEEO0F"58<?CS=)0J0_T5"<^TWGO=<ZK207+0D,E7#M*M\D[-.U4Y8*R&
M-A!1FP#'7I5>>$S]%"SX5D7'97.99W]?MSXW'4MMJ)%5Q0+OR2\KQ<@HQ^R&
M-8W7]=(LHZ-.I5UKNAT$?41%EIO.F9L=Z?\ C5EALS_E=F)8]IGW*B,M1)++
MVT%K%EET[SY4TI!Q7[*J_:X[)PY7H!$!3+XPP&B5LWS 5)OQJ+(L,E1FNFX]
MQ*R8L&(\P\TP*VY]5(3J3\ J&<P+YY#SN2^3Q25&#C^IU.(9G\E#PJ!8B0V
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MRBY0?#L$]UUS=E-$')BDNQF"$%"T09:G'(VM()-<H;580P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MH5K\@:=<_(\I2ZY=K00>*TJ#R6&L1>BU4'!'.?T!TF38BIW,I$L8JZM%(TE
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MG[,SI&8A\^1Z&U:-S4';!4%Q9E&371;;26([\*6R1:?U(D)<_JCTL+%](\W
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M@,!@,!@,!@<Y[@=\[] @T6C5PLJY[F6IZV3SVN-*I;<MQI$,<*IL!E^(;<J
MQM_4\3.(35$Y;S>V)S6];4ALUZ621*OY+N]'N\TX]:+)&"<2[C4J<4+-<O&4
MTS83I3F$GE[X^'79(P]*L1L?7)[IM1.&P.@S/>U$4U'<3IP<*'ZSY463E?;J
ME99RI16U\FOPVD1XVZ.-=J5U?L]]#TX0'E!'X,AR,_0% 9SCI20_O<M2M_.S
M[ELH'!;+A)\ZXQ]VMTQAR8$A2+Q"CW\JWR>0^<"SV[*NH&Y 5N.%;'6BLSF1
M;2$)9U"(19*]OQ$K9<=4/32]! _DZ0[;S1N\NV(E1Z1TBZSDE(7[+80 G06Z
M1W2HUFRWM(N0.MCM]-3S !:(8R$V%U'=T\J,S(:>U''"O%B92M^;5SDMU>R/
M0Z_6G+QS@J[;JSJ@-'68?+.P5$,3*-1WW)C#JNH5>&NZM,OQ7D#X\!0EUG:G
MOI5E]//JK@#7GF8L,479S4.J5]1&DP)Q<&#YN1);K"=@DV2R0I<],\=!N3[\
M0HB?%<@S8.F9,5R"PUMI:'2>E>;O<O+.'&XQ4:HR$>Z7;^/FCG1(CT"NNL56
MWT46*F3)S*U25"=MWX\82'92N1]#%DZ;<2M+7S+T(B.<\EYH9SRUU=:R,M%>
M-2J&3M4.0JQ'6.61#POGT&)UK9%'0(U9+,QV;H5(.U)++82(['^G2I6_@7J8
MA(]->+'XIWS6EW.TKGUF>'I#EEG*ID:$OE94E'F)V8B@A-C(.KCN2.0R518L
MDG-C0TV9GZI#4=:TH>>0/2L3\SS:>=6\*?/#!">>0YBW2]4XT9MA>_1R)5JS
MAW&P!2'7PTA$AN"P%F>Z?!;#+==D1YLU'Z!Z6=M(\H;)R;H48XB\5F\P^B4@
MS59H.;RF+895*C6NJ'K;4@C#$27774"@#! 0J9/?VL\K2I#6H2)"(S X6CRH
M5SS9HHWC%+&E$SJM$$<YW=#9X=1"Y>ODMM2(UDIKD>#(A22=+&PH"-/SDOO&
MOJY+;C<UYG3K:!.LVD+H,GS8:OEG@\YAU>32T2R(^IF#FJLTV\@N!B746>)L
M)DZ+H'U(U5Y5-<8TUJ1,_,[!'T4F"XX@1K7'FP;E8KS"B=8 V:\_C;XRS ^>
MC[8Y+A<RA5=@.!.=P>LHZS11Q5VPQ;J+BV !^'2P,:..):6CZA"]-O[:$ZUP
M?I<7YC%;&D@SNR-1*OT!Y\87C*YC7UW6M?F\4X. E ##Q&6+H$0=,6V00N8\
M6G18#DMJ0EUUF'H>FF5R2?F;%\:TO1QVC'D$0.2V6TQXW/ACE8AH%2Y,71.'
M-><J-G'NVF$W"]\94![\+GMR%+TY&==='IOP1K?!GG@2Y_81CCQ<I(N%/O""
M@^I1.-1#]9L1)7715.JU3D&I0X8NKO1GJJHI-G2I!%IO3CL>2RM;^F"^FTB7
M&A]Y WUB\T^1<GH.^1<?H!"-6OV7&3X9T6KL)*Y*I,*_LM#5D9EI74$EWB$I
M;4D5MW<?6Y$=I3!+BD6TRH>9M,8LA90R=&LUOGG2LY%9)T:PB'+M)L%V-5R&
M^S=BKZ O('IU@5^*N0-(.LQ-0VXWM]CWL+Z4^\HF>5Z^B31_9%@1//?PAIL2
M;'?D_4XI9P,NT460/9C1Y#\QN/T./#'WB'M3'O@(D?ACFD[0ZSHDU7!K_5*;
MYOTBJDC08K9K%<3,6DA+(/ODKEI"9)=K?+ZV)ME]$SQ[/TKEJF6<-*CBFE[2
M+E)6T_,A;6ZX\DLSC,^"?"X3R@*3>,,0SZ SDJFQ(77+V$ TADO!)J9>G2T#
M0%H<L N')F38T9M[3468PVI2]MZ2GT]I."&E,>=I9D23ER[8)L4",?AK:$,<
M=AU)9NU4D2N+]95YCY67/!<YL,.8W&GNE)*R,R0T[N.W'^5E ]*2GS'ENFX-
MAY8:TM\_"V(F..VZOQN.2+A8@TFZ]+>J!:I0"LUT4J.S3?RHT?5+'Q7F_DE?
M1,;?0XML>E']7&>:-8A1(+GYK,2F8FH*K"5WR0J<L=T'FGT#-W>2[(B1FN.R
M!;TGZB4*8CV-#.HFF4I<^5.R^E(=,7Y@"[/S=NYR2=G 3GZS)O+3 WE8A$)X
M[66EV^/(,0$*>C5[G]@C;^CAQ8;Q$M]2K6R6DLHTX2=7@!B^5H.]O#7IET-5
M9[KQV?#G&-<IG@W:0:ZO,)DH1Z<C<*U#JM7^+RXK=8;&LZ):L#<A@AM<9MC2
MQZ6']3#>5AZ[!YT*!>U :;U6P6%,FHP^(?5BZ]N+=J]09'+]6LFPX?;(5$XQ
MNV,V72ELD5:V.1\:-^T13'#,?SU'A9H$6,(V<V<L]H+6,@9)<PF4O06PU2LQ
MTTZJQW5B; .KE>(RI[P]YU_4K<II3#R9#"DNX7TIB'S?)>JU'K%EOUB@QG(7
M.;=:*N2)BJ*F!4K*%O%_D ZTP@ QJ7.KQ#GT,#N2Y.5+?^93BT/-NJ4RV3@P
M^OVGS8F.5^SE*P3;BD9-3N%@IC,'F38H5SLP[2;&;I(.5-(0+9*[-7M2S8)_
M4UUH._"B(D-K;F+:<<'I3[X[,]P=$6<OW!&Q!4F5$+ 5-F)268P@<JJ@IQB;
M)F5'<Q4XY.MA @Q*4[,>9UJ(W\"?;O;SQ)KHV+PA@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<[E<
M]\VHD]EQ/1YI >JF,R"<1J=4?JYYV9;34NZUP>:E1846M%I%7?@MU<BD1/CP
M78WQREMI6\Z\:O%>FJ'Y;S[/!;8N-BK=66<'R#CY2UU J^]48\H++JX0/'A@
M9LT?80@^+,AVR4I]6C3TC;L-]6E-KB"X6+@_,/**H]>7:[Q)-RZY:2[+UWCF
MKO42D.0Z/Y#4:[(M;:JX+%$Y$R3?0<EL4(<CNPF!$CYUN0GVT1-B9BN"HU1/
M-<U<.AE9MS55*VTQ<#O.:Z$L@*3%7=F)\1%.@%)A,0;)3^?2QT)#KL9Q0_?R
MO/H7&:3[=K%XO"'Q;R))USR2<L)>T1+I>:5R\+6#XSI(@:7+V.BV"_G;,[3"
ME?""U\^J)W\P,,BHLQ3K\=I]Q#^VTZ5O9;CAV22!K7E2T)[5J58=,&R@"6WS
M]TR:KQ&%^<%'+-(8)5-$$&[JHU[5/D"H3<<FW/4T386\MIY*77YQ.#"VJ!Y=
M-V*LE1%WL@VJ.W[4TC5[4;J%I.B*B-KW-$ AI4C!<&098XD4AV]HRZU(+3M.
M%(4AAI[45I# O%@<7F?G$X/(6&=:B<:VS09\/!$Q;Q"DA00:;T#DMGFP&@[Q
M)H>4MTBNQ[8,!FG9Z)$9A4;3SL/3FM1Q>*7NN5KR^G#.5"^76:#'*": 78OM
MRER0@F2;NDNF3A"%SZTXHJ!@;;L*XQ"(Y&;)M-R4N-JVTPG2I BE?<Z/Y/L<
MUW6:/?9RCL'L$]Z/99[P Q<IG('1I109.Y$S=5#3#@NURH4F0T^]'^H%Q'8R
MEN[7\;HX6B6N\D\PZDNQC85M;;J;'UTP17JK)K@]PN+.]/CV*V#QYXU,=76.
MB31$LN_ EJ'N0$MSV8ZYC"V$.-%O%=HG)?*$.3O\L=<NCNUR4>:,B:_+Z;6R
M)PR)L=F#$;,,!ERXN6BL' E1BJ'0=+DLCFI7U2V=IV\S-:)</0=S/S4W^%S3
M/01)4I),#'",,S*K9&LA( +]C<JO38(Z/48#SAAJ;!M:RDAGXW9CKJ5,_"A4
M1$8MXI1F5CR/>YAS>'5#9>O7[\?6(Z0]>;'6;/(9KYUN0P>MXR>($;&$Y]?G
MM-3 T)MJ"A49Q3+K;._1#9GA?@A5OE/ET1(5LV9/G9,H8U)%O"2U^K) +^+3
MS''C5EM1,/# Q0AJL2WZ@=37(KK"R87<Y"DICI=VU$-7BQ^QB?,.AKYJ+(7J
M[6V29/<O8;:K\P+.*JLK\SC*^M$+9*CT-0=SG$&(U;?BA^^$IEF1\C.TI2RY
M '"4U7+G'DU,N_13]2O<ZM@EG*^0H@JO2:6TB;'FDZ0+N<T\/-5E]DL8ATR$
M5T,1/D[C_6;9VYO^JVIHEPC@5R3R_4\1GHO%FKQ@U483CDB9T: ;#1['7.?=
M7KU;B/A9PVPZ"/E+I.KALT@<Y)C.*TIC4N6U'5I\MPOUQI'E;T,)T:&6?MU4
M9MM:Z2QST93.H5JND**6E)+?EQBXFA(YN61_%8*8#(]T;*D)$R?J=O\ R)<0
M^@D3C"@F\X\QW?HQX&US:JS+,-.O3X5BI&AP:@$+@=FV,(Z)_*\U<SK3\*;$
MDQS2$NP=,-K;4KYODU++>+-[[QSN-@KG+WQMJ?F7OE=L[R3 F"QT?MN7!+ N
MFU7C12P-*!/C35D'UTR)2J2[%5N)-6[(=0_O3B'"1,0Q#7,?,,I%*+WTFT5R
M&K26:B)<MM-F6(0':&=FG18]M-,5&?!,V95H>IK<F4TM]K8QIQE+BUIE/R1<
M-I..">GUJ$;K_124^T-M$VY]=M1(D&G$71TL#75D!1/0P>'4J0Q;EEG&-ZC:
M:;@J8:2KT0E.B371-&$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"!:]Y'<Z/7
M'5*>V;KDXB=N5=IQ.S0(PT#T0KSVRN5"YQJ21:GR]D7P1]K;2V9#<60^UK<A
MAMV.E3J2U+RD>4OC_'7I6NK4>1!3(^BE%(MF"/08A-Q@%)@B?34_4R>5),V2
M$IEB&S)<UJ0W\FD?(U[Q4LO!=IY3:[!)J52O]4M5KC!)-B37:^=&$BDL-$0(
M7)(0&V97PS(L95@'H>=0O;;#DZ.EU2-O(]PJ4/TGS)Y%;K##K13\;YM/(AK
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M(N&MMD%:<#DXQZ XPM/N4Z@A%4G6]26-N#6>R,'/N*>'R[01J@KM-1.2:_\
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M+$<O7VK -Y\!"$NR$(U(I(2QGS .+2)#??K5$?@D(Q)2XA!"4NH<C1W6R_\
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M>/*_3U0R6E,$9L.7MEZ%"5.:;1I6XJ14771B8[OWD]/"P;)/Y,(J\"<+)DR
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MC&^NC^7TKI-. SYW0;1Y!]=L/240Z9=:T>Z70J:9\@K!S.O:0>(Q;31Z?8G
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M 8# 8# 8'.-9OS;$5N<1;%K96AV:/A5B#5P1F=&A#0?.S4:= )R#AJ>HU;+
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M:(]:$-\.Z2F$JAWN.'M,]FTIGCC)EE0D$/ RK0^ED)72$^1OZ'6H@^!(E/\
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MNY(EGZA,73RTQ<&K9*X]@)5#QWM/;V:T+MQ:N\W-7F%4JW9);(JS$!HJ20@
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M:,9L=$UN684%=,1)#%., XTP"8EU^+)F"WD+&RI:%2'6%ONNN+%SR78;PWE
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MG296Y_01-?"R#+@FE1KJ2])93\%9'JG3$(?=VIY"%I%RN<GQ[Y$^_;)<>K2
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M]W:(W/9AQ"BX /3*"MV4..I'2W9$U,5EIU+:GU.E$3U9K=_'_H5^I/B>-!-
M72O"N<-,7$'/L%;MA^09"&>'NZ#56[RI2'ZS:#0VE%DCK7&:T]"<VA#B642G
M/8+J98S1.,66J!ZM$Z'RBNW\/6>@=9(7?EKCO#P.K>2MDQ+E(Z+N,N^O5GI4
MRH0V9D7>[8\*)H2:5(0SM^(VE0N^2Z6OA-^M9>],5>AA5W$G:>HV6-VF+=JG
M]3,YA:^0V:J5#B;L:&6<L\%L02*#PWX:N.FLQFAFC#,I4[V-X+B$7#_&.]U;
M\=J<FD4:S'W:@<K?/.ICSO-:)7>17@K:85B$]$ U2"9U9N<*J#;['U$&NQ)C
MA4P&DO.+2V0TO1;B6]/C132=)L798+ &.-I1>U-6.O%S<F@DNDGS9HI:)UK>
MLAZA%B_YEJ,=;\-=?EG%-6%MJ1)BRT;1'8<<,Y-M,,F P&!!O:O&7QW\CVJX
MQW[B/+NS,5!TH_56NETD!<FZZ^:;A-%W0R#L&:D>X3;&QTO[:]NW=,HTKU]N
MO0L3,<D,!OML_;\KID/8@/A=XRASU?*C3H,P-XS1(9$09#S6"(HH.F,!4/Q)
MXZ?&;>9=1O2VW4)4G>MZUO"[9=Y2]VGQ9\;/(]^NR>_<(Y1V:146B;%7?Z71
M:[<G:\R:5!67:#K.P)JAZ"2QD?;^FO;IS;"/=Z^W7H2)F.4TBJL_;E\!Z98P
M%PJ7AOXV5NU54T,L=:L03CM&&F0)X-,9("3 DA%#-2H)(;.CH>8>;4E;;B-*
M3O6]:PNV7>4F=G\3/&'R,)@C7?. <A[(7K$&8+KI+I-!K=QF@QQ"0S+G01<D
MX/FNP8LR3';<<0WM*5K1K>];WK6$B9CE,PCNG_;P\$.?6NNWJC>'WCC4;G4#
M$*P5:TUWD-($GJ\<&O:D#RX<I"#LS!Y&$^G2VGFEI6A6O76];PNV4\)F6>]E
M\0O%CR).B;/WGQXXYV*Q@1*@(0YTCGM9N!02%7,=(+%#YQP=,D1!ZISZWMM(
M5I&W%[5Z>N\)&64<IEA-'^WUX,\RM]>Z!SOQ%\=J1>*D026K%NJ_)*4$L-?*
M(:=800$%H AB:/F)8?6C3C2TJTE>]>OZ<+ME/.99=V'PW\3_ "$LL*Y]T\<>
M+=>MHT,Q71]DZ+SJKVXU" QIDTA'#Q21L;,E,C6)Q&0\EE*M-I<>6K6O56][
M)&64<(F6-<\\!O"/DMS!=%Y?XG>/O/[[5WY$JN7&H<IIH"R Y,N#*&2GQ1@:
M)CSH+L@=->86IM:=J:=4G?Z%;UA9RRGA,S2^=;\*_$3OEL3?.V^-'$.L75(F
M$!3:^@\UJEKL"0HUV6^/%:*F1DN9H?">GO+::]_L0IU>]:U[MX2,LHY3*V\S
M\$O"[B]U$]'Y)XK<#YK?P*"#82YTGEM/K=E$ME1\D430/,BA4:=$3/&3'8[V
MD+U\C3BD[]=;WK!.64\)F55U7P@\.NYW&3T/LWC!PKJ5[FP!XN7<+YS*I6BQ
MR1HEM;(R"^7+BY4UR) :<4EEO:]I;UO>M:U@C+*.$3+XY9X.>&_#[G"Z+QSQ
M>X1R^^C89$>/N-$YA4:Q9(4$O'W$*0XQ@0+BSF8Q"+OXWD)7I+B/T*]=8)RR
MGA,S3SZ?X+^&7;+H3Z/U_P 6N"]-OYI@=&+W.\<NJ%ELI..(@L#!3$XR6%2I
MTEH<.C-L,I6O>FVD)2GTUK6L$991PB9I6<F\)_$'@UN3?^*>,O#N4W= N<$3
M;:!S2IU6PI#DU1ED1FBP<9$FZ@SEPVMNM>_V+VVGUUOTU@G+*>$S-+5T;P+\
M*.OW0WT;JGBCX_\ 1+]9'(CM@N5RY53K#933D"!%%07"9@F)D3IJX@V"RPWM
MQ:MH::2G7Z$ZU@C+*.$3*^\@\,_$OQ^M$F[<-\;N*<CN$T-)KTNS\[YQ5JD<
MD@IDJ%.EAWR84;#EN#I,P='=6SM6T*<90K>O5.O03EE/.98S?/M_>#O4KC8.
MA=(\2/'F]7JUS4DK-;[7R:EG+&?()C,0TS2Y<B(?FSY*8D5MO2W%J5[&TZ]?
M36L+ME'")FF7\;\/_%;QWL!2U\'\=N-<>LQL/NO&#_..>5BH%B8+<V,2V(G3
MP@Z')DCMD(3+WPK5M'RM)5Z>NM;PDY93SF6$7/[>?@GT6V6*^7WQ!\<[C=;<
M5DG;3:[)R*DF#]A,S5:5+*F"LX.],(3Y*DZVMUU:EJWK].\+ME'")FF?<8\2
M/%[QT+FC_!/'WC_'#=D'1A%@+<VH%:IY T*AR538HXG+!CX;TR''EKVZAMS:
MDI7OUUKUPDS,\YE'5J^W5X%WFS6&Z7+PZ\;K1;K89(V*SV4]Q^CE#=@/%Y3D
MTH8+DI89V7/)$)CRG7GG5*6XM6U*WO>\+ME'")E)W%_%3QH\<9=@G\"X+R;C
M4VUQQT2S2^:T2NTZ0?BB');PN.7=!0(2Y[(]V>^IE+FU:;4ZO:?3W;PDS,\Y
M:F]A\6_M$TFV2R'?.-^!M,N]XD%[G,D]9!<4K%DM<@D4>?.6=S=MU (&-S#,
MEQ4F7_::5(7OWJ]V]X:B<YY6GOC'.?"#QL@GR/!*SXV<6&W,Z]7++.YNUSRE
MP;+9:"*L!J6!*R@BX+!,Y3@;)26]%<4N1 B-R75I0VAQ6B3.4\[0HCPM^U!=
M;T[7V?';P@M/2K0(5TQT!'I7'S-U/U^Q/))*OOX0S&D&R0,T^1T_HGIM<>0I
M_2M.*]^M[&V?>:2CR.#]OSQ?:ZV(XE)\4.%LUJ8*F=S'4$SRRB)K,^')V #2
M.HQ1,X?^ 26)I'Z*.HIIE6GG_B3_ %E^W8G:>=RA0[X>_9^&5@+TRR<%\!QM
M+O4]'Y<OYJJ\2A56X$RSK[S:0=IG--"#TTB^EQ2=1WW5NJTK>O7>MX7;/E<M
MF>7<\\./&,3?:KR&M>/O#0VI55-]- 4MBB42"S+N>M5RDE+H/'*'-1GK9]/]
M"*=FI3N?M'Q,;<WKVX9F<IYV@ 5X%_:AL&ZNH'XN>$9O=Z;.2J7L5SOD1+=Q
M9KB]:LLBK[AP7OS"T!<7K4Y<3YM1=[_M=I]<+MGWEL!Q^A>'/&YEO\<>%U_Q
M\YT4(,RK=>^'\X;H@ S(C%!PT-,LEGYX"6P3^EGBOI(RY<F)I#C.VD;5O6TZ
MPDSE/&;:K%O$#[-=;I]>OQWA'V^@- M,U8FJ74M6>&"Z?8R+"Y;#@VO6.8A@
M*8FLNCWT*9C/..)4PYK>O5"O0UM\G>;;,<VKGA'R5@MXJ<HB>-G/]7&.3.&O
M'JERN=@9MDB6^OQFBQ>=S(5(CSB<6QUB.U\SZH:T282$[VI3>M;PD[3ZIM!=
MF\#?M-45!K5Q\7O!ZG-U:NP[78OS-SSD%?17:G-(R H^RFOQ6%$T(KLLM#=B
M,S'_ (XSDAI;25[6G:=#;.>LMD:!S#Q*H7*A'&N9T_A-6XSVJ+8VZ]SBH0:6
M-H/585NKDHM:D@*Z+^,-=(]@J;3\J;]*W)3('H6ZOU:TI6B7E=S=PUQ@>!GV
MGB18571?BYX0D#IMRVQP@*!SOD,LN7>Y^20%O3 H9'@N3)[E),.)B%DLH7L;
M)5IJ1IM>])PNV?>6P=:YYX=5+B2>,U.M>/U?\>KQ,O%);YR%8HL#EEL(RE66
M5T:J, 8JFZZ:(*4$,.%X2$..I^CE[?1KX7O:+RNYNVNG/?!C[2G6Q<HWRCQF
M\&>FA8$OZ"<7Y[0N.W07"G?'IWZ*5/K<0E$CR_B5I7QK7I?MWZ^GI@G+..<R
MGT-3O"F/S^Z>(@ 3XXM\VIU<+;Z'XYBG.??ERJ50K.=/&W+ES.,]N.! SB,]
M<N0N;$:86Z]MQ6_57KLGJYS=M?&_"'[1;L,81:\;O!-P>;"5RRAIS='XRN&6
MKEQ-1*U4; ,E)C;8GA+38Y[ \=+:4MB=->;894MU:4[+MGWELDQSOP\E<8B>
M.4:L^/\ (X'/L!'D$#C;#%&>YM-M84L2L)?F42G-J4#DV42:"S)DD.AE4MB1
M$><6TE32]I)>5WU:ZZ\%?M+;GB!6O&3P;V3L%I/48".U0>/;GF[M5D2W+/3A
M$/4/Z@E::XW ?5/'LI7+AZ9<VZVC2%>AK;/O*>)M5\)#W"9W$)X_QM+>.%2K
M%?>)\SD/\[F<FK=.B66:S6))"O*?76A%=9M]6DMPG'6VX_X@.=0WOY6%Z29]
M5WQMJZ]XG_9?8-V:L2.*_;Q9LE+E1X-RKSP'@[9NIS9AN#68D.S"5^D\#*E6
M,G&'MMRFVEKG2&F-:VZXE&S5_)WG\MQ[!R'Q5O''"7#;-0^)6GA'+DB:\:Y>
M5$U KS?GR:*.%V ,&,5I]#P*K[J8ER%-98D-,;AQELO:2E"D*V9O*)OC;5:O
M>$?VA[B.@%:IXX>"%J$EZ\=M@PE7:3Q@X.*52L$6@UFLL"8-C2HTVO5XM(;B
M3YK:E1HDE:6G5H6K2=EVS[RG.>.\#_(+E=(XW.=\7.R<:_'!M*YUSG17F5YH
M3MEYU7_KA=3J%>9F$@T@[2ZNS\[<&(VJ1!@I^3V(:UZX/5$WQMKJ[XA?9IT:
MJ=5?X5]OC5CZ&VG\BUMVM<+T;O#;Q.>#3NI"%(U/LJ'3(R5#U]&V_K<J.ZU_
MUVUIT7;Y.\MGY%3\*O+CGK'*U#?''R/YAS8@";:H<)[GW4ZA1RH$;,#5QM0*
M \:&5^<*%.2(T1*FVG&F=K0C6D^[6&?5CQXQ*$)?@!]J>-.MH:=XI^%$<G10
M,6S7H5*YKR5F?3JP0CD9,*PVR$Z/3(KP&;$$RW&I<Q+,=QN*\I*]Z;7M)=L^
M\IB[B%\&.H<W""?(I'C'=.35(73NA5^)U@AS8I1*^$LK)"KT"[#=V:4L(/#V
M%E4J ((HVEB9KY68[B_12<$;1/"[0\UX#?:H52OVG,^*_A0KG3(ARR[Z$WS?
MDJJ4T!AH7(>/[MB8&P2 \9ME2UROJ/A0E.][5K6MX-L^5S::>F5/PC\I>50;
MCU@;XV]ZXGS]XI88-NN#_.^@<QISPP<N&:,M6.>^2K 10X4M3<I_YV_A8WO2
M]Z3@C:)X7$M9'_%G[,U=O JE2N.?;U"=(<FUQX+4907A ZZND#;$,S4W!M>>
MVT<=E&(TAB4/^-G:I+;C;C/N2I.]EOY.\TESLQ_[:/DG609CO5O\+^TT^FVB
M2#KQ;I%RXW=*Y6[H=&(DR@HP@;+3AHRS%@P]+BHR%HE/1F?=[=H3ZZ)&\<KA
M5@_MN?;MB20MFKGACXM,RH<D98*^=$<<Y_IQB5$>8)AS HA%#?U76'VFWX[[
M2OT*TE:=_P!&\&V7>4W]I\7_ !R\C_R[^W[AO*^S?E#9/=6_:71Z_<OR]LUJ
M#HOL-^.P9OX?LGH9'^?XO;\OP(]WK[=>A(F8Y(@ _;>\ *L="6>M^&/C0"L=
M;+C3]?.">-T6"5"FPTUDB)+#)T<*W(A$!L^,V\RZVI*VW$:4G>MZUA=LN\I6
M[1XI^,_D;, $>^\$Y+V6?5(Q"%6IG2J'7+C) Q"SL5\G&$O'8$U<!B>]!94\
MEO:=.*:3O?K[=82)F.2,JI]NOP+HMGKUUIGAUXW5:WU(R.L58LP'C]'%G*^>
M$26YHLP')PPS4L>2'RVDN,O-*2MM:=;3O6]87;*>$S*1>S>)'B[Y%EPM@[UX
M^\?[&<K@V0' %ND\_K5P(!A4N5J;*'#99P?,>API$Q.G5MM[2E2]>[>O7"1,
MQREJ!;O$7Q2X+U7E1+@'@IXC1>D0170>HA[3*I]<YP6KKG+-TY*4U>S :"??
M$6$DNYZTQ-=TTQ%TSO:MJ]_Z#43E,<9FD2]8E</\N!]M[/=O$'QF[--YS.YK
M1:E,[Q3316U,4WH,VJSH;3UEG\S-@(:8I3HFI2AHN:0TUO3ORJ;<7^@1>/"Y
MA0<[K'@ES/L-L_97X4>)];[3RFSTVO<AM-"#4(&7,WTS>QG!^B2UD!M059N:
MA^<=2M*!4J4MF5,F0)'R,,+<<3'47U3'&9I)'DY7O%NR]"1_\6OB+X_]A[2/
MH/&VAEB*\^E=$C21?0^TW&@1*VQ;C?-YKM>#UM+'XBC\0<C-/2ISS:-:2A;^
MR1?_ /F9B'A+Y_X!^*OE%1@'+_$7QDI71QM1/FXG0JI6^=4R\T^XV"I7LC0Z
MR&'CP:;%(9OU5Y]:8\R;'<1]$OZ!C;;VB2?C%Y3'&9I'5G9\>_,7H',Y]W\$
M?&2_]]NU&H,>YS>[#P]AGTDDNI]BMLR@2+3'YU8S)(0,BT)B0%GZCH9G"S[4
MU,="=I:=+QQCA,TO8$)X<>/1;Q5[3P+PD\>^>7OLXR?L.8KU$%U>\ 7317GM
M#)4ZJVFD4,I _$CKG276&YI&6)"2V8OQKE(U+:WH>J;B9EXVOGO"_*0[2^R=
M!\+?#[I]LZAU][C1.U]0HYPE;H0JM";4\#?D'[/R=*K0Y"$4QYA*8CJQS:WF
MTM25(0O>R7./")FEO$K\1O%P;RGO'%/"[QOY!>KURH9:V[O7Z6T$FU +;[-6
M*X<$O$.:\V-W0D*7 +_*ZJ'"7MSX4Z6UIOW+07U3PF9E=I=<\/?)7N*9'>_
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MF/XEQ?C=,Z!JT$G]!*#T3H,#E^B,^*7W]-&*+<0^E<1>O=69RC:)QZ-2;?\
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M8\)\^6X_8WRIEV,UI+2R9)]U2WWMZ][JU;4K>][WO)U=<_YXOZ!LKD8# 8'
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MN8.F]1>L!>]./6/K=/A]:@OME-P(,+XZT*BH@MKAHF;.DYQTC@\GOM0]2(=
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MW=_\KD8# 8' #[J7^*7]@C_F'\JO[EJOATQ_3+Z0[_X<S B?F/125Z(=3&F
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MN&<L=:=%L,F P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M]RBUBH_C(.#J7'9G"MP8\$=J/"3$D.?43W3,S$\FY6&3 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8'YK>M_T;UO_ +F_7 _<!@,!@,!@?F]ZUZ:WO6M[_HUO?]/_
M ',#]P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M&!;B@<2<B_0FA8XO"^9F1]&4A1B$7YXZ].QW_IY;3S7S,.:TI"O3W)5KUUO6
M\"XX# X ?;Y_QN/OE_[+X)?W-6#(ZY?SQ^[O_E<C 8# X ?=2_Q2_L$?\P_E
M5_<M5\.F/Z9?2'?_  YF P&!&73^BO<WB4N:BM3+%'M?2Z)SR:[$(CAZ:ZU>
MCL>O1K%+3.<2\0BP24UA"H\9#CZ_EUOT2A*UI+$6<NZ]1NQC;&5HA)9.)5+:
M2I)I:V?C2P=&P1992([Z%O1)\.6'.0Y;#[#CC3C,E'Z=+TI"1,3'-)N$:2?_
M !MU,)""V"_4FS5JHWNLF+SS$L!]_0"]CIE>4]).E+)5ZT/63ILX97]-E7(^
M]SF]0EK1M_4MER*DUKT961\T.(BIP0/-E6UNQV!R= &51JG&95K<L(^[HY\]
M5I%=BLO%8)YRQ*5II#S3;#L=M;R7=MHWO1-9>70/+JIT"PWFHR:G:B]GI]B
MA80H7#>?U:(Q<=R C*>"RVXKK+YR$CKC*&Q+?RS7MPE.*TRPZAW18QF5NL?G
M#Q0%79Y]MZPOZ9D0@X]H@!(@HQ&V%:D+M<"LIED(VGM2&$V$7"(OLL26!<TD
MRW(VG>U>T:RV)Y=T0%UKGU2Z35_G77+H$@V ')?8D,(GBR+"9$(E!W)8C/2A
M1%A:7HDC;:$R8RT.IU[5IPDQ4TSW"& P& P& P& P& P& P& P& P.='W)1
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M]I^K9G"& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M5?H85IKT>W_U/7"U,\DTZWK>M;UO6];UK>MZWZZWK?Z=;UO7Z-ZWK"/W 8#
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M!!MD#RG-(8>4Z@JQM.M(5[]%TGHSBH><E#N5M!U*!1;W'=+(IDV:7=DT.8)
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MQ3J]A\W8MN' J57RK5?E6WHHV)9JZSR4BDM$F"NAV7EBW6[1(D*K]< ,"Q$
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M/37KZ^FO7_+Z?I_[^!^X# X ?;Y_QN/OE_[+X)?W-6#(ZY?SQ^[O_E<C 8#
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MTF7YTZKO%HW-1%3W:$4S;O9"I&=3E!Y%K6 5%FPHPR9IJ3$EQRJ=2QL@>\]
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MT;VT\XC_ "*WAA6X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8' #[?/^-Q]\O_9?!+^YJP9'7+^>/W=_\KD8# 8' #[J7^*7]@C_ )A_*K^Y
M:KX=,?TR^D._^',P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M7.LA/2!L0/"BH'!&95H?;@C]*7'&PFV8['HA'JHDS:?,(8# 8# 8# 8# 8#
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M[_X<S 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M)L,?'5+GRXT&*A;+:Y,Q]J-'0Y(>;CQT*>>6AM*WY#J&T:WOU4M6DZ]=[UK
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MA6E8*F'I6.X<@N<V",K/2*>6*E"UO!C!#1R$R7)%:">+5BX0QXF4XP1G*!'
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MYL(=*KS@0DY8;BAK0.'>T5EYDQIE#^QB2469&T^N(Y!V](+MCV7PIX;= LO
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M:&HCKC-1(LI"Y.GHJ6TI%R\('4/$"?;T1:G<@=7N%0&]/L+3-<(!*\ZY8[1
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M6&L>=^# N2\WC>.?GJ'X_P ]O?:BG,>B^(G1NE6&G]7[CUGN,!J^\_[+R.K
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M1RGUHP0>;;0RV[.)!84V6XVRWK3;2%R'E;TE.O1.M^FOT88GFS#". 'V^?\
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MI>])3I.MK7O:EJWZ:UZJ4K?KO?\ 3O>!]8# 8# 8# 8# 8# 8# 8# 8# 8#
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M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<
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MZ9?2'?\ PYF P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M<?%XUXK*KB/F4+5&*,]=-64]'I88/$U.Z"W ".6+Y..6"SJL@R)2H$1\09M
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M\4$5%9TY*DS[K6M1 &Q5[(!D2XEQIZX;RITN*QM*].-K6WO;B1JIB?G53XD
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M^"7]S5@R.N7\\?N[_P"5R,!@,#@!]U+_ !2_L$?\P_E5_<M5\.F/Z9?2'?\
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ML#]P&;"AC!\*8&W]#ZBY42 %AL-.,>Q;;,1E"=Z2TC227*D;Y1RUI(]#7-:
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M@,!@,!@,!@8 -_\ >E<O_8'FO_W0]6PO1G^$,!@,",Z]_P"]+I7_ -8N=?\
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M*2CX;#']N_3T5OW:U_1O(NOC'FRC^*A7/^!'[I/[BO4?_#RIKXQYG\5&N?\
M C]TC]Q7J/\ X>#7QCS/XJ-<_P"!'[I'[BO4?_#P:^,>9_%1KG_ C]TC]Q7J
M/_AX-?&/-L9XM=Q3Y"E.I=#B\:\A^,#69-.J\</Y'<>L/&K.8E"1I4A,*  =
MB6N46KR&S;+/UB/1'U2'6O3U;WO9)BNS;["& P& P& P& P& P&!2SFEOPI;
M#?IMQZ+(:1K>_36UN-+0GUW_ -&O=O Y1U/[F06L5:MUJ?X,?<]=FUT$( S7
MH?@SU.3">EAX$<=)=AR6_5N3$=>C*4TXG^JXC>E:_1O#<X\><>:__P 4ZM?\
M"OW1?W%.J_YL)KXQYG\4ZM?\"OW1OW%.K?YL&OC'F?Q3JU_P*_=%_<4ZK_FP
M:^,>9_%.K?\ P*_=&_<3ZM_FP:^,>9_%.K7_  *_=&_<4ZM_FP:^,>9_%.K?
M_ K]T;]Q/JW^;!KXQYG\4ZM?\"OW1OW%.K?YL&OC'F?Q3JU_P*_=%_<4ZK_F
MP:^,>9_%.K7_  *_=&_<4ZM_FP:^,>9_%.K7_ K]T;]Q3JW^;!KXQYG\4ZM?
M\"OW1?W%.J_YL&OC'F?Q3JU_P*_=%_<4ZK_FP:^,>9_%.K7_  *_=%_<4ZK_
M )L&OC'F?Q3JU_P*_=%_<4ZK_FP:^,>9_%.K7_ K]T7]Q3JO^;!KXQYG\4ZM
M?\"OW1?W%.J_YL&OC'F?Q3JU_P "OW1?W%.J_P";!KXQYG\4ZM?\"OW1?W%.
MJ_YL&OC'F?Q3JU_P*_=%_<4ZK_FP:^,>;%(GW-@\>[6&P*\$ONB*@E*M3P\?
MV>"W4MN:E@BUXFS?>C:M*2CX;#']N_3T5OW:U_1O(NOC'FRC^*A7/^!'[I/[
MBO4?_#RIKXQYG\5&N?\  C]TC]Q7J/\ X>#7QCS/XJ-<_P"!'[I'[BO4?_#P
M:^,>9_%1KG_ C]TC]Q7J/_AX-?&/-L9XM=Q3Y"E.I=#B\:\A^,#69-.J\</Y
M'<>L/&K.8E"1I4A,*  =B6N46KR&S;+/UB/1'U2'6O3U;WO9)BNS;["& P&
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M*O2:#44W#<O>E3=V70&!HU]<K6]I5/\ Q#Y/GVG?MV[[O3]'IA)Y\$C80P&
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M[4B%"0I:(J%K4I;K[K[[M8RRG*>/)OKADP& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
GP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g923025dsp008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923025dsp008.jpg
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M 0($!00#  ,!  ,   $1 A(A,4%1H5)A<8&1 _ B,C.QP1/1X4+Q8G*"_]H
M# ,!  (1 Q$ /P#_ '\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# _RMU[Y!.R*P(L^"U<[5G8#FNNCS@7$X27I)79DV'&8;Q/>L/\
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MEHFD40$Y:.GZP2@26$@MM*$B!Q<K2>U&IG3QYLLHG0&L/PI\W,"0I$0\:]'
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MK0MF&6P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P/$Y-K<\MR]H=T")U:75$J;71K<DI"YN<
MFY<08E6H%Z)46:F6(EB8T19I1@1 , +81:WK>]8'];V] TH$+4U(4;8UMB-,
MWMK:WIB42!O0(B0)D:%"C3 +3I$:1.6$LHHL(0%@#H(=:UK6L#V8# 8# 8#
M8# 8# 8# 8# 8# 8# \*-L;6\UQ/;VY"A/>%WU-V.1I$Z8UT<ODD;;]1<3"2
MP#6KOIS<G3_&-V(SX)!8/7V@#K0>[ P\@CL?EC.NCTI8F>2L#H6$ER8Y V(G
MEG<20&EG@*7-CB0I1*RP'E 'H)@!:T,.M_ZZU@9?6M:UK6M:UK6M:UK6O36M
M:^S6M:U]FM:U@?W 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# UJ232'0TI(?
M,)9&HH0O-,(0G21]:V(I:<2#1AI*0QT5)0*#2B]Z$((-[V$._7?V8&JEW;3!
MQI1)-N5@:<<862247/HH8::<:,)911187;8C###!:"$.M;V+>]:U]N#%;/)9
MO"X9I&*82^+Q0+B(\+>*2O[2Q:7"3:*$I"CVZ*TNE0DX3@;'H'N]FAA]?3UU
M@:VFNFG%BE.C26S6:I6K/)2I$J:=Q8]2J5*# DITR<@IU$:<>><,(  #K8A"
MWK6M;WO"XK89+/(/#!HRYA,HI%!N 3QH 261-#$-<%-LK2D2,+HL2[4A3[/!
MH>P>[V>\/KZ>NL(P2*Y*@<EB1N;K5K=>X+U)"-"A13F,*EBU8I,"2F2I$I#H
M8>H4J#AZ    [$,6]:UK>]X,5FI)8$#AIZ5++YM$8JI7%&'HD\DDC,QGK""1
MA+-.2E.:U*8H**,'H(A UO0=[UK?VX&';[AJ1W7HVIIM*N7-S<5!2-O;F^;Q
ME:O7*SQ: 2E1HTSF:H4J#A[] @ $0A;^S6L&*RLCL2OX<J3H9=.8=%ERI/\
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M%:%:2EQ+9XS8D%D;N:4<>4UL4M8'=Q,(3AT(\XM"WN"A2,H@.];&+0?0.O\
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ME+_8(Z'_ #54M^%\''3W3['ZJ7E+_8(Z'_-52WX7P<=/=/L?JI>4O]@CH?\
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M86@Q?"DD/<#?A)%>SU&UF]'F'F#U@NUOE&::?&#RRRR**RA"@GVG6'=N6'Y
MV41LX7FIP]#V>PN<<E*Q20(CVJ(:8VNYVD[1O>B2![T+0M^F#E?3#7IQXGN4
M9PS6*E'NUXG*Y[UL[]PM=IP>RG6-VA5?2#Y'FF)N4TJ:4D)S=19"JC;.!$:U
MFD+&U00:8$XDSU#[2\[Z8?J%>*#E*%1Z ->MVM+)-">NHYW*[VG.+*=9':5J
M=)15I<F!FFEKRL].3]Z$*1B<MHRVLHA&VD)RBP$DE:T+W#G?3#6 >'7D0NV
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M?T9T7$.LG^8QJQ'F/3>O>@H#'V",PRR:@D;<$M3 WB/-<<)"2$O1Y(OBG!,
M,LT0,$WVGV3+27'$:I6=1^RS+MZ;MZ;L-0NM,&.]VW0\3=%((\ZV.KLP4AD,
M63(F.'+)Z@=%?TY(\%-Y"I.R%%H0[^$'[1=L^2WV&3 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8' #Q\_P";CSE_RO"7]FI!D==OZ]?J[_Y7(P&
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M^JJA(<B7F/+QKFTG9P+%A;J3\=F?@;"M0B&,(=[+%L&$FUDQX9R]O*' 5/\
M)4UM6UV&979<]V74CB;/8MW]%68MM*S7F+P0E:3#H<F=C4#.U,L5C^W)082D
M1(DX1FG;&;LP6@;"-MKMT\(O'ADP& P& P& P& P& P& P& P& P& P& P&
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MBWP:<O,2>G(N%JB5C,UNKXF&I6.S.-2F*&I3*?C 5"* (SW"#K>5B;76YG=
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MOATU_AM\H[_X<S 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8' #Q\_YN/.7_*\)?V:D&1UV_KU^KO_ )7(P& P. 'E2_RE^ C_
M )#]5?V6B^'37^&WRCO_ (<S 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8' #Q\_YN/.7_ "O"7]FI!D==OZ]?J[_Y7(P& P.
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MWG&^YC#>"[M88#8KU<+_ # IF?;DL);/)G#&9Z(=42X25:HTI,7G+CT@O8(
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MF^*-?&]UQN"\_4]]^:?BS_/%MS1.73B/KU4+DK^G,<CB&I*Y'&-Y2\(P;-,
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M?J[_ .5R,!@,#@!Y4O\ *7X"/^0_57]EHOATU_AM\H[_ .',P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M2A#M:F_W"OBA#\0O^(/KK[< V.K6]HBG)F<D#NW'C4%DKVQ8G7HCC$BDU&J
M4J2&&D&#3*TYA1FM"WL!@!!WZ"UO6@^BM>A0:3B7+4B(*M6G0)1*U!*;2E<K
M'\-*B3[.&#1RM29_"66'U&,7V:UO>!_=+T(EQC8%8E$Y$I25YK?I03M<4A4G
M'ITZPQ)H?QP)3STIH &;#H AEBUK>]AWK0?)*Z-BY4Y(43B@6+6920C>$:56
MG4*FE6I1)G-,E<DY1@SD*E0VK25  &Z (9!P#-:V$0=[#WX'D<'! TH%KJZK
M4C8UMB12X.3DX*24:!O0(R1J5BU:L4C+3I$B1.6(PPPP00%@#L0MZUK>\#T%
MF%G%EG$F -*-  PHTL83"S"S Z$ PL8=[", P[UO6];WK>MX'[P& P/.H5I4
MFBA*E*=,$]02D(VH.+)T<J4CT6G3%;,$'1B@\S>@@!KU$(7V:UO>!Z,#R?/H
M?GMM?SJ3ZGI)I?MN^9)^>TAV=M/I;M)[_F/E-J-;!\3V^SWZ]OKZ_9@?U(N1
M.!9AR!8E6E$JEB$TU(H*4EE+6]4:B7HS!DC&$"I"M(&2<7O>AE&@$ 6M"UO6
M!C#91&B% 4ATB8B58W4AB E-=D!:@;XJ)/4)68)(U&C!.JE.F,,+3ZU\88"Q
M"T'>@[WH,[@,!@,!@>$;HV%N!328XH0.IZ<2LAL&K3A<#DH!" -24B$9I28G
M",&];'H.PZWK>O7[,#W8# 8# \!+JUJ7!<T)W) >ZM9"%2YMA*Q.:X-R9S^:
MTVJ%R(!@E*0AP^1/^ ,P(0F_!'[-[]@O0/PWO#0[_,_2G5M<_DC]IEGT]<E6
M_**0^ON3J?EC3?@'A]-^H!^@M?\ =@9+ 8'@0NK6YC7EMKD@<1M2\QJ= (5B
M=6-M="24ZDYM7A3F&;1KRDZLHP1)GM," T MZ]!:WL/?@>)P<FYI3"6NJ]$V
M(P"  :MP5$(TP!FBT L CU)A901&#WK0=;WZ[WOTU@>17(6!O,3DKWQG1&JU
M#6D2E*W-$F,4JGPX],RIDX#CP".4/"A*:6E '6Q*!EB"7H6P[UH/2)U; .93
M()R0!>5"!0ZD- EB<+F<V)%"5(K<BD&S-*S$"56M)*,.T#98##@!WO6QAUL/
M?@,!@,!@?#:I*%4!%M21I:80:J+2;.+TJ,2D&$E'*0)]B^*,@DU06$0]:]H1
M##K>_7>O4/@D<VUP.<4Z!P0K5#.NTV.Y"160I.:W(2%$YA;W$HDP8T*X3:Y)
MU&BC=!,V0H+,]/8,.]A[L!@81;)HXW/;+&G"0,B"1R0MS.CK M=4"5[?R64D
MI2\&LK4>>!<ZEM*<\!BD1!9FB #"(?MUO6\#V.#JUM($ICJY(&P"Y>B:D0W!
M8G1 6.CB<%,WMJ42DPO2A>O4"T622#U,-'O00ZWO[,#WX# 8# 8# 8'PTJ2[
M5#0Z4D;6ED%JC$FCB]J@)3C#22E(T^A?%"0::0,(1[U[1" +6M^NMX'WP& P
M/"X.;:TDE*'1P0MJ<]<WMA![@K(1DG.3NN3MC4WE&J#"P&+G-R5E)TY6M[,.
M/- 6#0ABUK8>[ 8&)5O[$@:=/ZYZ:4;%LM*=IZ5N*-.T[)7&DDHC=.)QP$>R
MUAR@L!0O?Z&"&'0?78M>H9; Q_U9K^J:8_J3?]:VW[=M,_SB?ZIMKTHTCVY:
M;_B?-[;]*Q:*^-[/A_$W[?7W?9@9# 8# 8# 8# X >/G_-QYR_Y7A+^S4@R.
MNW]>OU=_\KD8# 8' #RI?Y2_ 1_R'ZJ_LM%\.FO\-OE'?_#F8'#&\*8@C&H\
MERV!5S!(7*2G/E5#$Y2QUM'0+F11(&R G.BQO"C;$9BY,:Y[TI6I@FZ*5C!O
M1WKZBWATEMPWNZ;ZZ&K*7O=3);2=2H8SWX\Q19?$U=J=KEX9FM5S/6EN0N'/
MDVD56+ZE0)WB>2MYTG4J&(D]8D:2VP)_S)GQ#B23&?UW69Z#LBWX1RA6%@/-
MFUY7T^3HH(\6\KCTSA\8;YR8&".;G-(;2$XLR*2F))) ]2,D"MCVXM8P.:)(
M-%\1$-4%<F)).6/!4%3;\LCMS6T^I;RM>OHK;\XY+=I0IL9KAI3S0U$SRE'!
MR5SYNB#S#-H(*)SLYI;X6YNKD2O:&)>ZGF* :4)OB C6.GR2!">C)]()?!8M
M970KC7%(JWN^"*YZ)TSUO&5'1YD#L:(,U?,JV32F&N%>MFC8XZN7PQ-+>WF3
M<"#Z@UB+2%'EFU+)Y=59H9)[%D?+D[K"0OZVN'YJM^M#*7@Y,6;7EI=($=Y!
MHWLSH!,[.#?\>7R9/(504KBQ;,(21<!"8"M,H"X$+U4\&O\ ZS/UT6J>[FLR
M*V(Y5)971TFK.H8K;]LQ1=T@\QVKVV4+53+2G.]HUI6S[*'B!&U4QF/2NUI4
M>4N$R$J'-/%"$ ![4FGB45G$QF3J@:L+IM(V6HY;94\7T.AN*34.GO.WB8Y'
M(L>VHV[FB;O,#$-/8T?D4;K0%MR!G;#CPN*0P;>8ITS@$4L5$B#%LZ=.K3:+
MO3HAGA?-5?UY.(M&VYZK\J=PMXL-?$:@C5Z3V5]36TSSN.N[--H)(Y$X;(AB
M!H/*8(TJ9WA"?*2SM[-T!/HFED\5F87)[=EG]&)Q8]N'G+9(@[FDT"?9W%XX
MTU]6EJP%P.A]*$+6./-$>-<F^-4X1*W18)R6*E*\U*L4%FD T665$Q.T^#.\
M_P!IO=DSSF5R!(Y!,K 8YAT36=K2\;U")C$9I73%74?DSW)H!.ZZAT#B\VK%
M+:[E"T[8N^EI%:%>I6MQX *"5(,I9C+[.JRRX-T/TM8\4GKZU,X^Q.,:_75T
MGC$851F6,MG0+FJMIHZ2!U<&)=*S5:-DE036\UN7MY+>J;="."H+,/+V/"2^
M5076G1G8-BP5<\J[3C<3?)7*N=(A,6-$NK&965S[8EC]2P&MYI%T57)ZY:ET
M/CC=7+P]-^BYB:]+BW1L3K '' ,4B&6R9_7D\=OVWTA)#.Q*L=Y@TF,L)KWI
MF .%9RV2U]J<2VI6+EV0*X-9\5J]AKIILB43.<SQ4W.*IT2.H(R:@7+D)"(E
M2E* 6))TOR;,U]83BJ8Z[6BT72^=!\[TG#^=IO;#P5#8>6YDK;+:+7@U@52S
M!B$293$"Z#O0H1*1-!H#7QA(&H2KU!A2HHHL<<],8M7.M&SY]2?)U?NEL2&0
MZMJ4!K:%RZ:QA;7L-;(I8,U.2F/CJ^2R71B05] J^9'#:A"-S5M:S8"-DEDE
MF+3B1;,S%VZ=G-]-V;>;I&'55(.AUL FT?Y?F$]J6'(X5"'8=^7)$>E>BZLA
M+*H7O-:M2N9[L*.UY'DQC1'D$?6//U$3@W%(@!]"S7&9[=,I=1]3WL9.9L&%
M6<IM.W&+I+I2N"^3=QJ')6YNJV U=8,GA[J-2UQI%/3A-L[969("3"==M3@)
MQ^D?"$N&68 <9],1^V+H*P'F3TZS1F[!]&Q&1N?+$ALJ2OM>U_\ _P"J[0EU
MQ,3 \01"0RPQJ3Q%;)HTM<U6F1P =)X>-B :8K+$K!O8LGC,--E\WZ/EO*;N
MHD]Y6:[NUZ<'=86PX[CL7@L4<X),:E=:T!$45?'L$& [-Y3W&)ZL;W4I:8X*
MUNTX5*(:([W;R>!B9^5;_8]KO<!;KOM./7DC&6P6-3FC)(*8UJUS^Z^9&_F1
M%*(8V4E*95#9#63G-)9:Z^4/"=*G:B$TA5HW%N3GH=F /*I)G$_65S:(<AO-
MJ=3F-?UQKKMS.J&0:TO1FL+HR6;**F0N-C(_E-%$F,SP1%1Q9<N)"$.R'58H
M&+6CA&^IF]IYN8,6;X^D<*@YYIF4U7)F6%W[S6[H>MZ'B49-DDF:5+3<C,*+
MW6JVBD<2>>B6MI;E2Q0]#4+RU8G8;FJ:VXX8"%<:^-^R3;T["M^M:>4-#?-9
M>.WH*LZ^<HY+'0RLXHQVFV<\W/):WA,:?V=75,J7V58TA;FY$:HCT.0L1JY,
M-0LVI0!,2B+I-9GX=$]1&;7V\SV+*7FY9DH8+;Z<[)H(41;XC7[4W0&#5HDO
MQ?6LCB3L&&J7_P"^S*?5J,L+@YJG!O7DK1!-1C& DS(G3';PBIU;]2S.&57Q
M3 8):<\ETK8H/QVFL4Z;2JLU),[U;=M1^KK)B::/ JQVL:PY94Z)&\(WX2)<
MP!B B$IKHK/5:4:&G9;)F_5)#A>O4T;JTF?$6G*Y=(["J+MF3)V VOH/MOA+
MK0MCMY59JX8ULL+3O2IP(A1RE*X$N)[H%Z,T%04248$)8AC7_"]_/=[$W3;W
M2Z:,35LG-70=VJ5M@+NP%H%<;$8_5TGD$H^ARAO3Z3RI,)T5@T:>6I5E)U 3
M$^A &486"LV8D\W/^J[ B%:N]#$NL-I:3]?RCI%P@_2B.R6@T73R"23:8.S4
MML2MEPT*E]'6<?BB@:EJ4EZ^@:A^DI*4XDD(@Z-69S[</E$^WK.?95-)&US!
M_25'M-SO:*T4T45W)I)4\1?>M8M +:CT[30:MX\V568W4XX+3GIB=W%\?(VG
M2;6*52,T!QA@XSZ_^D[51>EHWMT@VL48N%R3TNALOJ-Q)41B)Q$])/8M3H>1
M4L*C2.4O,8<-BABMYLN0C-<6_>E3LE,W\LMT6$HX!+))\?\ ]9#MGIR:U39$
M-B%;O$@9Y.R$U1+W%I7.L$;HC8D>L&Y45?.,<8XR[0"86-:$A9F9L<#G4A@6
ML1$=1+$BU6M!LXG8!K,SJB$R]^JHG7H)\W3Z067++!I_NE_:(6Z5]$Q,D5DE
M%3PA'42N)M$4B[/)G1>ABZDTE>B6KE^Y&<6$1("#-A#N&)V^2:N+I"T27I#K
MAPCMV+NA(^3"N5T3=9JYNBA8UIOT:W')>S:D$#CT6ADG$VJ7/9PC$2,L2':O
MY([>S4XO2FW:>#E3S=)9/ ZT3S2FW^G&>Q&#D)6Q!DM'5\ UU@\HD?1U.,HT
M?6"5P.>V6<VP8C/5'QH@_:,],6EDPS4H0J2C0QN];U[9_P!+ZSB\.GXC?%DU
MLT68WA35(F1I&-ELB356S2>WJO+YY+F\DMEG@Z"K$$GG,]*L<]>4G4,*UOCJ
M7[NF(U" &]J1FF<:XSYBN[>B8-$$2"0W5)'=/+J<XBLZ>6N\0FO&];3:.X[5
M?83?DKBR%JA2.,MT8:(NV$*DY;XD> 1L0C5RHU0E+, $8EOW5O7].2>J:NZ-
M.JRUY/)):ZWMUG9D M8PVL8=%;))IJN:;0L\><1.]63$FU)0^N+NE(;6B'-:
M ^6)$"Q:0H3$:"/=,9LS\%UX_;M\FV:DE[A8[ZJB[AVJV4"75(XA$$T/15E(
M:#9I<>J,<RHSJ<GR5IGJDQ6F<A.^DX4__DC2#->XS9,3'T97I85>I.D%RWH(
M%9@AHN>V9+S<Y="H2UW/#;;VYE/!W""1C=-@C:*?+XMN'Z0;4#*<CVDI<6VB
MV'3B'9)G'3S5%F]RO]BUW2\S>DS-1,?/;O%K/#5$-@[<<WU4GE-Z]$L,D4M*
MYXB^E((BS1V/(1-XGE.<U1I.=M<),64-3\:-8_V\;K=,D,L]IFLGZ>>8(U,%
M,=NQFG>@BH;7ZP^[&."W!0BRL/CGKH4N@,@4+W#Z@WE)&9N0JIR4T?,MFPA&
M9LP8F.WDG5JZ6OQ;)VPZ73E9![T_JUS/#FCC<J+1D3?,:QL>)U Y6[--B7QY
M99"K4;,E,N<12!$[DL\>%%M(%A0QDKM*JF)]/-KS#<'3J*JJS=WOI)N+>[FY
M%BU\/TJM-NK&JHE!98UV91;:_1J(RLFNU[3!3)_"+(<&A*HD*"1EH'DI(NT0
M+6E!!A<3PGBZ3<WW%&KBJN#OK4[OISZK@D3D;XPSHZ-%66U(I$!R3LKO,FJ+
MD(&@@$G-85AJ!<D2D-SJ02)0CT(G>O0Q997->QNH[P8"9X[L%O+CKD;YUUK&
MI)S..&Q!0AJ2I:N@5U/%56R!-J+ZG8/C@B42>POCFY*V*1CDFV],GT(Y$!,:
MQ/IT6XN.;W-3/%),U9Y@]6!9P"*M.E%AOK7#V98QLL^L"(H+*G!+6TQ 408F
MFMH;(G)>CVJ:5Z5M2-Y9K@%: E0(Y4DEVQX*!7%.KUF=(39%(+13*/=S-T_,
MXW:]+OU<S66K(;!;KH<B,_5;9BE=(&'3LB8G%V1OR=D1I$*HI$6I&#2HK9A4
M:DDZ_&)SCC_8<&L>U[,@%L/<JA\E[CH>O@Q,#-!G**67%["YCYCCCI.'65(H
MW]86O;F<K3+D+BTK6]J3B2Z!M.82:=K=3O,>./\ :**LZ(ZYLFO(XZJK@9(^
MOL.:<I169 8W&JIQ9U)3ZRK(4L]RPH-?IZP;"*X9DD5$8@;4LM*>GAJ=6T9I
MYJO7QO>6S65?GIRP)%7SU0$3<;:=*:JJ6.,Q;[.OL2:%@=&YVC4."N@L772*
M7QEXKV%#L)T^;4G.*IL"4::U:;TWP3EY6&9,_&JU\K*K&LSIVO;>LF4S%4]+
M./GU,F1J(VQ1:,2AA3] 26.1.P-1Q5%02.+.%GPIG:I,>A*<""RCEH2]$A(+
M 2&>*W''$\T:W4RR15T9=T7*N&>$O;OUCX_9'$XX[;BKTG@\06O$:3.LPKZ-
M*XN#92$IT0K6P"Y7MQ;R5P-B4%G'EB".D[?2O#/^E.IV1V15FRV2TLIK \]3
M1F(6S9LAJVL&NQ;$K&T(]':EB%C.K_6;Q&WA*"*O?Q7-MCB1C>I GT8I1'%#
M2GZPN)W3 V2_I*:6JP-9]_S>)QV?=;]$4@M88W!:O$1$*WK2M)Q,XT;$WI_@
M#NX:E(I5#"R1/#GM>E4M:TQ/I&%1HA65$Q,=O!<WE*W%UKTA4SM,WYF76NZU
M1")C.FE)I$VNY?W@"Z-B23KHN0,)[&W2AUC3AM/_ +1:89R5061ZZ($$-9LQ
M>G9SIG/6=OO]TV'%JSM9'6\94L5]LZH^YI15[>CK*34?9M81%,Y.*-OJA<MH
MQKL- N?"(ZXS!?)#'-.X(W?30:01\$1OC,=5A[#Z.D97C]8KYALQFL">%C[3
M3(LGLZC<1F<J9VEXZ*@]7SN3FMD=82(3,6Y5'5KBH:W) WA0.;::G<$Y?L-!
MO"2?NPC: V[=TXN**0&%WW(9Y4*"S[R.CUEM\;K$]SO.&UM5?/DO;HF9,D<'
M!"]M#7;<YD$<5/C*WI3%J%O,3!-"L),6Z&)C-G5$R+JN]A0V*/,0NYQLNU)3
M1YLYL:K3X-"TI%0=0IY_4[57'-8FYLBS6_PYMMN52%\@RQLD*Q6_)6] :^DK
MD^T"U6:7$^F7XDW3]]-L=:Y.@?"12%\KKGM#<,N4QJ$0)SIEVEW2-ZQ*ZV<V
M5R&&2%!'6BIGE@(B"8][)=&QI+U]64Z.,,/6'#C.R981T!;L=L3FHJW;CBLQ
M8[(1.; BBE,SFJY2^+/F)K;GW6MRRD26NTA\ZKM?6K*RE/;Y$5,?;(T_MB\\
M252WJO>A)9.N%G^N;FE,+YQ2V?2[FWNB*12FGTQU@,[O'Q-,>JJ?3B,-LGLU
MLD;LSRR))6ULAKN:K)>%B%P:4!0]+U)1J4@S6R:S-Q7/BUNQ+V@%50\H$^2.
M=GMS3-+-C$FBT[J:25Y;U=IK>41&#Q54L;J@<E=U6FDC:+94B;(,FCJ5$$>U
MIJQ)\=*,J-366_!O-F3F46NRRYC>[^<8]<C3VO4,0;Z%)88 #530.(]RU:S5
MY92*(NL7'.Y2I?*^3-DB*?EK@K8%1CYKVI_ERBR"Z=)X=,?Z7 J]WNF751T]
M T5@N2^S*XL.TZMJBSY(QQ<E[-/(A,<DD">Y.WML?:H>\*&-XE@4III3:00L
M3(P[-+V:(T8C-QF>2IL$ZVO*TY?7ZQE<W-CB'6\CA[%1[.;#VPI75H.?W9J4
M=;C>%R]F,4*3I<TII G:A.FQA)-:RA)=:V9OW%XR3XS]15Z;.$SE5:*'1XLV
M1-$DL_QS<9R"+5QMHB+?7A$N+N-6"822'UDVQ=F^*IA!RQL6K$:10!.D+<2R
ME!84HT99,:G^ZZ^T@YSMQD'3=52J>RN3DUO8S-&H9/G=OB+?-"&.:4K6\\.T
M8='XFQQ)R51R32U=I"?MJWH) 2B5 3Q$B&96+CI7(VH5%E-E?1:>0V][#.FM
M0^-^VI$\R%P0P:82IRL^OK.&[%5O.E3S#%9!3?&'EF4(71H E2/AP3= ,6E&
M%>\<_P##=],KE4Y?O0UB=9O,9=I'#XY%V>P9 RNU0OLSA#<[J*:)J-'(8=/X
M+ !0C5JO;Z^S9S0K#'DQ^-C^VI0L1_+@5I >RLV21ANB>B[+B'0=W0Z+W@KC
MLB@$5Y7?:-H9/$X8O)N>5V3,YZRS:*JE3I&E\ODY$@;F5(E&2S+T*F-@]70X
M>B-ZV&$DQ,M+>>@.D7DXY+6UP+W?H%TG?2C5-.9S(9"E:"G(94*:S9%63SK1
M,2#,&5-*%L*B\?V[/3@L02HN;"5-H"O1$)(7$\>S^H>P>C)<Y"<:ZTZ2ILO]
MJD73',<>W R$2A/0E-QB8IWR N"@;:!6:MM:41V"'Z,6"VZIP6:<4E&7I"5\
M*G&/)4ES]16>RU"A#T$T!8+4N>K(RZ3.&.=.V/9T; YT+?=B6U#G1K:JL9XC
M6B<;Y#8X)G2N[6N?F@T]:0J&8$"<&"R3P=IM:]-:UO>Q;UK6O=OT]=^FO]=^
MFM:]=_\ X:UAS?W X >/G_-QYR_Y7A+^S4@R.NW]>OU=_P#*Y& P&!P \J7^
M4OP$?\A^JO[+1?#IK_#;Y1W_ ,.9@0)%NH^=YC')E,&.YJY'%:_G3S6LPD:Z
M7L36R,,S8G QK6LJ]S<5Z9&0<:L*%I,(0] 5AU[R=C!O6]EQ>V$QJ7Q@(8C9
M(L>&<F,E-GULY_4N"(MB+9@I]+MNYKJ:=IO V!2:^-\QLSX6B_X_=[?MPC15
MEW4HBCK/+7"W:M21.0:4&L$F63Z)D1U[TWN"9M5&,[R>[!;7+2%V5$IS-D&#
M^$H, #?H,0=;+BLTHLFMB96C@:J?0<J<.6S2$$,42EA+E;AL#:0\G$HXZ8NT
M[JM@:%!:H00$B]$Q@3=_P"T+9,7OX,(]7!7+>7-T3?*HG*))7;=MTE<)9YG"
M"Y,R%%B*V3IZ2/DC9T,;^(,8/8:YGHB-;WKU,UZZPN*_3I=E-LQTJ3N5IUTF
M<((PO4GF#:.91S;M%X]'SS$KZ\/;8%QVO:VYJ6$"(4&G%@ 4>'X8MZ'_  X,
M5ZH5;-:V-5T?N>*3&/NU6R6+)9LUS3;BD(8?NX:DTX"<ERY2:6G;0MQ0!?-!
M/$6-&:4,!N@#+%K1,8N/%D4%D5P\LYC\USV$NK 7'MRTYY02EB7,Y<4"<O3[
MDQCBG7&H@Q[2AI5 ^=V/Y;WIC0^_U+'K0Q4=6[T95E0)%6GN2QQSE#8YU^0L
M@J&3QHJ9(&JP9_%*\2RQ4QKW-.N1QQH53 E4K5C $H*4 ]Z%L6PZV62U(S8X
M5Y:;.QR5B<XE8# B>=/$<D+$Y-4E:4[ZS&JV\2]G>&Q0L2 <$!@U"8P1)GO!
MH1I0OL$,.R=FKM=AT0Z/+])6:?54Y/L78&MLDKPVR^*+5\:C3@N,5-"1Y5)G
M(TQC:')Q,V,G1VRBE)N@^GNV /H7%9='<-2.#BQLZ"TJY7.TG8-RR--:.;QE
M2XR&+!3JE0I*QHB7,:EV8 I41QFUB<)B;19(Q>_T +>ABLTWSF"N;@W-;7,(
MFX.KXU(I TMS?(&=6X/#&X)#5;<]MR1.K,4N#4M0I1FDJ2PC),*+$((MA#O>
MB(_1=!5(>*<+G*6,T8CT$D$8BZJ=2QU9(_!Y$ME\/CDW9#8?+5[F!JD+>I;I
M,21\0HS7JN*.)#H6R_79<5][K9JG>8>V*KBE+;&:]8I9&)4M/>9D1#(B\N30
MYEKXZURQ<H7-R!Y85#_I.HVWJ#=IER@DH)H#0>XL8F<].[;WBP8<VLCH\;D#
M$XD-YJMNVE2/+4<<N?$[*-^#&DP=JO8:_+&G6CRTGK\81(]&>WV;]V$P@FL+
M5YVG[<;U2W32(,KB]5#5C;/U+O84>V574<4Z>YU$XY.B"GLYBBK^B7V(N 88
M=LHT\1GLT(8  ]#5S_'XO'7MP\T164676M5S2-R26H9C&[+L5@:YQ'EJEL4]
M'3#:@B5?/2"0HD F10O<=K!)$9YAH"322DJ<T]2E(.&+WJ5JJOVEKJC^I15E
MCP^8,IKM.6D*IF>VT\1JVN9!]V9F8$@"CXXTK,YC(V8H]NRA)UB4_0MDJ2!F
M$LLZ5Y$72-#N,UF5?)+:@!DIKZOXM:<P0[E3* ECK^8_6!,4J6KAK0H@,YR9
ME&H-.]_L3I5*0XW8"EB81HQ>Z06($)D8T5A1D<<?=/K W(F^8,)Z!S3/4:3*
ME+FTE)'EO,/3.32F6+CSTVP&#++&>8(O>OB#]2,6DD%71*3DUZDD$'C\UEBA
MYER>%!>F1OE<D4."A8XODB3QX:HMY=_C'$GF'J0%&:UHH7J+00>FB]>[Y--N
M5*])).N8[.KIV00M(6Z3-8TS2-+TD30*DI[B4XR=0C<C26%(H1$&'A.5;* ,
MH AZWL.M[P8K#U3<L/N8ZQC(6H2N[/7,]308,E;71H?&"3GJZX@%BEOD:=&9
M8N2JFKZ=8A*38MC"/YE,=KT]OMWL68[L#2O2%7W? 44Y8)(PMANHRFE<HBKA
M)XV?)($U*PK#"3IJB;W-5] *$0A-,T8HV67L !;]?X1>@LLN&\)K7JA4ABCN
MCLJO%+9.E>T$'<TTQC9R&8KC7-,U"111:4XB3R%6:\JB4VRT8CAB4F +]/>(
M.MC%1Y.>G:BA*:+N7WOB\A9'RVB*??GYCE\64,M?R,4=DTC7&3=R&[!2,9;2
MEC)A:DDT85)1AQ?J#6M[WH8J4T-B5XO:!OK;.88M82&1ID9CRADS&I:"8X^F
M+26)^&X)UHT1;(\G-R@"15L>B% B#-%B%L O0F*^TNG,%@"1&ZSR8Q*%(5ZT
MIH0.4ND#/&TBUQ5>X9#6C6/*M&2H6J-%;V @ MF#]N]Z#OTP8M[/0?,(<C J
M,52B-)2DSP;'UHSWMK( GD!3?]5/9%0C%(0E/!;7KYD:8?H?I/KXFP^S[<"L
M4&[GYNL.11MLB=CQ)7%99$'"21RPE,ICC5$W5S;)^*N3H4B-<7)*J.E1CR7[
MRDP2]B-($ 0?7W@]QJZV+)JI[ D<P;X MFD02SYS0&NC5"E4C9B)@X-A8% S
MG%OC9JP+TK0%EHC=B.+)$7K10][W_#OT,_X:4=?]0DFJ%(K%@&XJW-CBN>YU
M_42O@1./K&]RBC:%D>51LH+<$CDM',40RQ?+"2@T<6 TXLU0E+/+BLXUW%4+
MQJ)?1;3K=U#/E#NF@OTN;QA=J:JV)6<C?D\2^4<S=2-0S+B#"E@$?QA)S0""
M9H(M;U@Q6L1Z^ZZ?DNU*=[86<;Y-IG!ZY1R"21UB6VN^0=R''GTR$)%C@!2[
M)A2I(I0DB  0S@D!4!#L@XD8QAZD%[5J=2IG0+R]$16O6R+.TFDKG)!%-Q\1
M)CXE*>5LS^$1@@I'J-/+6H;UB<(A[TN3"*#[Q>WU&+G'BTF!=;TE8LSW$&.9
MQL!3K$:LE\"?5TGCB5OLY';!$O4,[?!DQKD%Q>W1L*AYNE9!90A@&<$.M;$$
M>@BRQ,([+K,M=)VL=@04MR@84)DR;ARN/A70P#F$(&PR3I-K]'QT+@ W6B-J
M@DZ-T+6@>OKA,5Y6"WJFE;BT-$7M"NY([2!"XNC"V,$UC3PXO;:SJST#NXM"
M)N<U*ER0M:]*80I.)",L@XL0!["(.]:+BSN\+U<]4LEK1&BWN;QI#:L\BTEF
M<5@RQS1EOCS'8BN9$+PN3(#3=&CV!0^E;(+]/B*2TZHPH(P)%(BABXSX-EB,
M_@E@)5ZV!S6)39$U+S6ET5Q&1LTD2MKH2$(SFU>>S+%I2->4 8=B),V$P.MZ
MWO7VX1@W6X*?8@R$+Y:-;,P8:-N!*PNLVB[<&*C<G!2UM )#I8YDZ8QKW5 <
MG3:4_"V:H)&6#U& 6M%Q7N4V=6222M415V%!$TP>Q )8XPIED?)DKL)2A+=2
MRFIE-< NB\1[;[5(0DE#V(CT,UZA]-X1C%=STTF0N*Y=:]8IVUL?$,5=E:N=
M14I"WR5U)$>VQMQ4'.H2$CXY)P[&0C,V%0<#6]A!O6%Q7D1.])1:;V8<CD%=
M,MAK&QJFEM ^\3"FE)+%'F-&T,\DF:0U?IQ:V!I822BR5*D!20HH7NUO6QB$
M(=7K6733+:T,4D<+9K% Q2LDLR,ORR=Q5*T24@2PM 28Q.ASJ!&\$B<%020[
M3F&!V<9H&OXA:UL8KSQ"\*HGMAV55$0G4>?K"J%0RI;$BK>XIE#M&CG]N*=&
MX*U* S9GM$F."$P0=;"2=OX0]A,UL.AB]V>/LJMD#\[1%5/H.BD\<8C)(^Q@
M^5,*9^88RF)).-?W9E,7@<&MB(3GEC$J.*+3A ,.]BUK>L&*\)%O5(=%7J;I
M;0KDV$1A<:TR&7D36,F16/.28U,F.;7I_+<]M#2N3GK"2Q$GG%F &: .]:V(
M.MC%^K58/?E?S"M9E;IC@CC4#ADKM=@>9*\.;2%F&@J292*%N\M [I59S<*/
MNGW8&L2';-]=I#"_=H(O4.A9<X>J,="49-(G6$R9;5@!T=NIM0.=6GKI2QMQ
MTZ)<0)=DI(Z@<%J=8ZNA!RPLA0D*+&I3J=_!, $S6PX,5*RAW:DC@W-*MS;T
MKJ\!6B:&Q0M3$N#H%M*+.<1-R,PT*E<% 2: 9VR@B^$$6MB]-;UA&F_U:JC;
MNUL7]3*]V_/; ;*&5G^^<;^KN\7)3JEA\B:V_P"I?.+V I*@.-&K* -.$LD8
MMC] "WH8K2H)TUSY9L'BUC1*W:]<H9-9*MB,2>E,I9$"9_EK:Y*6PZ.-(7!8
MG&L?_FT@ME)"]"4&%[ 8 &P##O9;++A.^$0HW3#GMH>+4L1MFU4HWA *.LUR
MRXJ8QG1K'N-_46Z,-$]<Q.FRX]]*,<%9:5.L$G]AIYWM#[QCWLO7LDA9*HBA
MBY\U<))'$<+TT!?U,M6/#8GB^F$U*!2!Z/?CU &G308B$$S2D1OP=E;T+W>W
MTWA/@K8=<7/][PB::F4EC[)7<,O:(Q!!*7>>,+'');-J_<:\N"$N<6DZ)[*1
MN*)6^Z0B(3A.^(KVD.+$6(L6];+BR_%-;S;$"9UKRPHY)&7N51I5%4K_  IK
MET,32=@32U]9V%J7/#6]2!H^E(Q#>BC2PGB+.5@]"DA:A0820:,5^P6_4(WJ
M0QXNT*W%(8H%<HE;&";1@3U&P-A9 7(^0M@7/:YG"WE*"M'B4@+T4$8?=O6M
MZ]1BOD.Z*:!$U,[,MBL@P9,ZFL"R9#G<5U$R'PD?P3V53(1.NF<IU*'_  #3
M".T<'?V;#@Q6I.=Q\]S*36?1+O/8&YOT5JYOE=GQ%8_MA/TJKI^ED"'3D[F;
M6$A3,JIL93QK!>\.DB0]*<=LLM4F&8,6=7V?[II"JZG:Y@CF=>)8$GBRW^G*
M9GEL31-$M1Q5C4J4<9KU0-S(:7E3\@U;(3$)#!Z#H&M>F@AWZ#%MQXMT8;$B
M[G6,<M5U5H8?$W>&,4W.62A>W-*..-#TS)'4'UAR4*"VQ#\BF6Z+-,V;HH.]
M;]!>F#'7#Q.%S4TTL+-,'6UJR;(Q)$YAL>E+A.HJB87]*0K3HC3&9[4NA;>Z
M)R5ZTHH6R#3 A.. '?\ $/6MC%?BW;GK"AX(LLNVIDR0B$(%S(V*) ]+"4J+
MY^1.B1G:$I0QBU\8U6M6@^P/K[2]",%Z  ,6A);V:M6_1=:67+9O!6R0,C?+
M8?-'B))(ZNDD>&^R]"S1N+R8^81=E2N1SFX14Q%*B0A4Z*]NMEBWOT#L.]BR
MSJE&-32%S73J;#Y9%Y:&/NRM@>S(T_-3]ID?4?M^>974;6J5:;79+[@_%3'>
MPX'KKW!UA.L8%RN&HV8F2J'>TZY:D\+5($4Q/<IO&4),36NBY<UMB22FJG,H
M#$J<7-L4IB"U6RAG'IS2P:V,L6M%Q6QERV(BT(14FC@@_6T<<&(MZ;-Z^\CD
MD1KV]B%L*GT^MN"%P3GDI=_[YI1Y8PAV$8=[(U75S4V)H.DP;6K(3 F?%$44
M2'4ZBVV@B2)=:,51HYVTZ?)%/B8.]",1B,TH!K?KL&L+BM1;9!SW'));MOI;
M&@"5P&.(1&W)&IL1C$R1=="1O;;'&>0[4/&VF(.Z<V3*21EG?+GGC,"$>A;"
M'6AU[)?72.-M;"HESD_,;=&$S7IX5R=<Z($;"0RA(VK"ZJ'I0>6WE-84QGQ=
M'B-T5H O=[O3?KA&AZNVLRTCT^KYI#FJ#L[/$GP-BN$Z@I<*<D$S4.B1G.2.
MI4E.-2D'*FSX91ZPI*F6F&A"D,4" =HHN*P-<]"UC/8W&I!N0Q^)CG$YLR#0
MIFD4ECB-TFKM6MB2:O7,^*$EN0@R0MV5QO:U.%'LXW:143L>@B%O6"RQ.V$,
M#@!X^?\ -QYR_P"5X2_LU(,CKM_7K]7?_*Y& P&!P \J7^4OP$?\A^JO[+1?
M#IK_  V^4=_\.9@<P@<R7-%K )G;7!ZPG:" ]$]"6A&X:\S$]F;YS'NA6T9B
M>2 --@[JEB%DU:K/-:B@J25R=:TKW$12H@9Q96S>9Z)@C]%W36_%X:8KQ^A+
M?;J5,[JD DQ0-P./I)39BZ:OM>0DR31B1I$+)&(:]*HU%UCBQJTJ,*9$H4-H
MB2QI,)F7;-[*-1WG*\ZVNF!DN565A<\AEC'W?-RH]9<Y7.C9'6&V'+C%C3)W
MBP 53]$4250M9%WU9(0R$%K&Y0K^5,.$ >CYXM9EGEV_V]=-<JV@VR^P:=)B
ME=O+5 ;BX#4OW0[NK=&F>@,Y;H;EE]=]QMC51=T,D)<M'#SVQN4%/"8M!]6<
M=*M&;+$6KI=IC/S]6QR7A6\)#6[74Y+/4;1NL8ST2VL]MI)&ZBE=ZK;L2OZ%
M"1-FS4/*/C"9Q4OQ<@EHSESM\Y)FE&8E"87ZG$PY3.4_MG'K\B71)>4V5^W.
M1/4'95MR]Z2%>YS<X9T(QW\U18H]0%G)4O#IH4]CNW)&<8$@ &[^$PWY4CW$
MY?XB2H_2D@6\/QJ@+)KM@?9$R4]&:V>H2Q6(N9&5[7PM VLR-T9+#11Q&XL9
MK@:RE.J0_;<$U*H$ LS7J$0\J9_=F*K3'F+L%WKR>MH]53.YW=?*T]YOD3Q*
MIF>P[@2<Z>6X_P!;/+VJBM7H&RR'0F"682WOJA V,):I^;1*B2 IE@]IRRZY
M^K>Y/RM9[S'+JJ!; :IE$2M'H=FO7=K.LC-#(I!'U%^UW:3O7E@1)5#UARY=
M&HDP*XZVGE.2A H96QM)$ CU,))$VG?X+ATS6+E6\DZ$7*$[(C9+,NX-B1)"
MQ_[8$K(=3E/PM?\ 448$:-.A=%DMA;FI, 5\4)H3@G"'LPTP(3-N<?)R%I[C
MRU;HY=J!I5UM4T":&3G:5UX0#3JYEKK:2VI<=16&XAG<=40A&IC*5I9*W6'N
M"92I<QKWYSWLO99 !FGQNV3;ZK>2_E:T-S6P6V,PZKG.*S?I6G>DVFUUD@,9
MK$@[?4*>JC@52S1X$*7E!4KM5><QM;B2ZIT"-AD*G1Z80B#"'&LYF/HK-*>8
M;AY\J$YEC#M7J:\9K?\ ")E1+M' /1AC#,+N87VH;DIED;AMABY)3?/532IU
M6PM1\0LA$R-R<*I.E^G#./-9EOP7UZ#YY>5E'5?7M!QM&GF-+#9D])2%5-B(
M@75SBQ0![@#%)%I"^%3QDFS$6QNIC<[LJUL/*<&Q8H]FOCA*WHS+US6R=*U5
M/+*IJ)M+*T-\BN&(O4?E,8DS-,@UBFAEBM\9>V,R>L8G>*60U.#42)[5)3F1
MT;7%*J:5YY9@#AA"$8EDOP5E#S#TN)]:&%U(J1S8U?1T<Z1FECMLB?654I=#
MN>2JQEL:C5=CBZWZ>I*L5.)<B/.=AD:830%[U\T'8 ES/1'$0XBMM'7T!:I=
M5E8,[M3/-5,43'6FF+871-3-)Y6<MATS;+E12MTJ\)$9*KA\B>U,<;'1N=_F
M#7=S*6ZV09Z*R\IGIYI71<O]#*WU,XSD=72-_DB/@*2V#.&):;'TILZY>N9N
MF%H(6V*%1-,#;9(H_HQ4TJ"QI2AJB?@#2(RQ V F9_GU?EEYUZ'K\,<7Q&&5
M4^NL1<.VX,B1N,_<XZV.T-ZDMF+VU#[$-4HH$YJ$*F*'QPMK=V+X(S1@$(Y*
ML,T6668+9?1'TDXBO4Z#Q:),IT,+6-//?!L:=7=JE8&$UPG_ !M8+[*Y'"M_
M6*\F"3<7L1NDNOICLH1K@(5K65\VWF%"#O0Y3.?C?5<7FN.2"H2VRFSZ\FZ-
M([-5BW3,)R_3%KF+ SSR?6BL<S(,@>FN)0EK<G9\,=G)X.3MS8C1M)982]A,
M^9*-$2]>J(;HY\Z.LWI*'2TI^CG])(1;U(V1%RRY*D8!-,:@A(?OTPO<:1UJ
MX268S=Z>%B\UO6&R9,T$-:H*?28DXM0)<662?'")!<$3IKJ_GV+1UAJ,ASJ;
MFVM(/,H^8<>WQ>Q9_65\\YW7N)OBI)%5)RZ$S/56R!"H<5*4\U.:\B.$C/">
MH+$.4Z_-<7E2K)U7.^A'^>Q"OX$NN?H!PMMHB%=O"E^;69F75)4$&V%]<SH_
M&DZF6KWN!K5;@),E^6&8?H0!F;$(>R;7./DI>^>/JPUE"5;6,9.K^(26+<]6
MA )@X,ZO:%))9E)KUYZN1"TK7+</=1+HM,@5B^H7=8K;UFT^W@1NT"T)IQ0B
M\IG/Q237G%CXGE,:FKZBW'7M1%NKU#XZ/\R9K%ET,M"]"^>F"/3*#K6"OJ[C
M+6:5'ZC6J5.D*-&,E:H$/XAYJQ2;H79!T,X-N:*0RK5"B+0J6V%4<XYD$YM,
MYM%"Z5_84'YP8K31H%$/11FCHCJ&2 +M8YRQH,>$KHJ"=\(M4I"6E 8,O*?1
MZ$G-4L:KIHBO%'W3;U5I36VK@Z;KR+[<'M@B%,LU]N73%*1EL=C&5F;%J)FN
MI5MA4#/2H@NI<B>S$I'P2Q!",],K@=KT]?%U1IKAU3NK*FBKU$+6C$W:U<A;
M8>ZJ'V71UN98(]&R5?6UDJ]P9C 8[ ?&QM*;G-P^<2[+4B)(/3*#.MDN:A.)
M\L] QN0UU%SV^M'*"L'2-9]$2B>&S%[W(%)+!SVTU7)8BW1 R(B I? 39H^<
M*<#W,*=0SFZ]P JMB &+F?7#5(YPO96XI/X_)XU58G OE/I;G2 N?U4QV*6N
M=JV8]S..20TL^)I3(RU/+>M1:<B0Z4GI5"+0=;4!" S8NT\/-OJ_E*WE4JD3
M*-EK5>SSOH>@^AUM[KI&N'9T$!4#93Y3I F9@,AYQ[JXJS*N5-34X@>4B0IC
MD"D*@C8R3"7"F9Z-?:^4;[I^KZ004DP52DGE<\@*J"=RBG4MH;D$[F$YHARF
M$[CPUL1<&Q[<6AD@[TYH#'),$M>] 1A5E_!-.$ <I>_FP*/AJ8F6! W0N)*X
MK59\/H:+NL!CURL"9XKAVH6XIO:!,H5R-93T@>[#/G;W(DK^N4-[JP.*E\+4
M?.#/VI^;(+R^[:X]SS<44W0YD*C*5@F5!R%XKF26BX2,(FN74 WVHVS)<SF5
M?N*24$]6V!6Y))S<K1KV=S9)GL6MJM)R5 %),RK+U[3\G6<N3NOY$0EC\PN4
MF_I8Y-+@+:Y##7GH*7SV=$QQ;\$)@5&H<*<%HU0B=" :>E,&7ZZ%K#.>N58$
MG'%G/,-GZU\BE9,=AR:F^+J_C^BGXQ\TPN_-DZDTDD&B9.&)-RE,V&B<"5S6
M:0F+,VJ,W[RR1EZ'N-<IGX=4=*/'Q9;HR6_%I(-)+%3J?;B*&2>06&T*8?+(
ME=O2,3NJ5M,J@#?4+3("'8;+&R"%1CF^/R?2Y+OY?U*5"V15Y3HLJ#DEZ;K.
M<YVPLM?M E_<D<Z(VO;@!;W<==-O,+)3;@B&:D90#"_GR-,L_P#*:,^7-1*!
MF".]YQA>S/+I]/\ ;<.H: G5PRIL4P\UD;$$AYQZBYZ?Y6>YG-\D@"J\4%;*
M(O/F)&2UGCD9#"X5\<G4HP+FU0'3@ THW>@F!P2XGUAS]3-A1ZVG^V)G!*QI
MQ)NE*ZI1!752OZB0L3Z;!7V3O6Y@O5#B$*3H&EG3OH6V.(=I35:9"-5L\P'Q
M2R"A;TQW5VG/$UG;-W,X8)A)E"7L*Z[]=V-@D+'%U\^B=EP^3P6-GKI3*JSL
M)E*F,0:WPG99"UJ/3_)Z4$%*B1B+,V6;3T1#"^59O_42X:3AM?1-OB+(=X_F
M@5MRZ5N3C8< ;N?8Y#9D:GC[F*"D%V.M0$LVT3(L3&LP$CFH.-4DE$ZT4*1;
M>F;\6_2C@ZQBX!2K>P-\</5PY9U>DLJ%1261^%DRHKI><?>#4N32>5U)8[8O
M?&EF3G-ZTL]K3*AI'M9HA9K1>TZQ$Y3+[V+Q%<KC]_(/4BE!!ZK=&.JW=[0R
MJS=3%TN*Q*BDU"ND<<@.+O5;TOK11)H54JQ@E"I3I^:W49R%8)F.-"J$.DVG
MCW;5&^'WK>ESJ\1ID/5R.B>OHNZ-EA2UHL5R:[/Z/E]7NXCT3FTUW$8VCC3X
MA@AQ[D!"V)@D*E(]: J$<<<(<IZQ/_-%*V-4$\GRR5H8RX,\WKBA"QRIK?U"
MMY#-:WK5IKN4L;FUK&)*>K1JE+/]13.?S@]GA/\ AF$%#!L0R6R]E3^B>/NI
M;WG%E*'=\@ZZ+JF_I%E@NU$I(9F$V&6_S%8E-0N+JX4T5=IZ^\+7)Y2E-?W=
MTD+F$](3[DA.@:)2)"S;61+%D<E33^JCA9==Q.L'&/QV8\U3V/U4XK-Q=@FR
MVHH3>4!D+<[B11ET:F)S:$-DLSFP*QI5@!+XZC*-^6+)*.*)RZ837S=2$MKW
MGR8UI-6>!1=]F5A]*R_4?@2E6\0B-M=TV_8T_8&E <N98\<K^E,\P3EK-:1)
MBA*P&_" $O8-8+<W,4R%QM?1M6.<%5P*F'IVL[CJJ^4'IUD$U6JBZ+=:K(L!
MB'8<*V77IJB6L$B+ER:2ID!&V-P3/K:26:=O0P*T1>4SGXKI=2TQ95AUO#AT
MR_,S?==:R!(NA,MF"A0E3EI)-&'NJ;#6KW!N;W%8%<&OYLYN20H!.RU#TA1:
M,V6'7Q2R2R=^RN17&4TB[\OKR&Q*LMU>X= <[W1'K=<WQ4&RZYA]!M5-M:6K
MVR,ZB"D3DXFM=2&LS:O*>4J,ID?U6E!&QE&$N!>7CXX0V[\$W0[L\)8'I*VJ
MXJRP?H.A93%(5:+/$/JL&MNTF^<(+)9W:14M-]M2IV821(79M2E('1$>D2&)
MEZG1?\,7E/!U@K>3/4E12DETA4CAB6*3:00>.G2I0 ]RFK%%=I6PF>DDZ"%0
MF:)"Y%J?DMG;$8K2D@5ZW[% -:K%<M&[CCI5Z=9E-KD):)_*5U;02-I2XK;Z
M"$JC;7@ER#LMHM"NAM=)M<>KN,1U6?M:SM#HD?U)AFS4SD8JT8<<KC7*=HN#
M8=+W+/\ F2IX=+G& S2YZ^?Z$L*:MP G1BL;0DU23"+3"11D8B&!9ID9Y(>Q
MF?)'_2=IDZX*<X2(L@.R 5,R7,[*4N_"]ZO)[A,%D<@C+J07'U%*WJG:YL-K
M8V[41Z.BU2,9#M][)G2LT854S:@U^XIWDHIE2:4ER)<:E6[UK:=67E$J X]M
MAD=I-$:]1,\:IH]ZI"2*6:964=8#K-IY65V4#,E%B-BY17J%_A:USK^M'DI]
M1J')P1O;ZH0*"$Z$0%BA2.7GW5%.Y^D=J/)?-$08J;ERRM.=.X*ID]KM#H\N
M"N0.=SSZM#6LFW!&P9"7"'Z;JVQP4O38:L=U;FZ)%2L@(D9.E!T7,G7Y+SV9
MS;>Q%B6.^5!N(-%?6/8U;O4FBS*^LT(D;O&HQ2J^OE.VU]=:QL%HB2Q/*"VT
M:TQ*WB<'!D2? *5$^WY8^I+,=>Z(U/#MZ%5*W5D2I@ZARWROPU7;Q*D$L.;M
MK[$XZLYTFTDAQ^WFNY)M1";=9GKY AW4H5NT6D^_FVI07L)0ARF<_&^K\O?$
MUKHHN_KXM!(/.'VTJ=Z9K25P>\;/(?&Z$S"_9 SR Z>M[_%ZC;F-?'7\]B!J
M1-#:SMQPA_ &0<H,T>,0Y1;*R*!G,@YYH&#-0(J_RZCGRB)@Z0V2.*Q)!K)4
MU*D0$ND4<W<#2ZG(R3E9.W%I5G(%)1+P@0FG$_#"/822S-OFAV#\;RLZR%5F
M6!$:H3)9,FZZ>=UR@,W)&*MGB_F[FJ/,K,PJ'&-($+H:_-].O3K)UI*5&6)X
M?U0"BU)1PSS"W;PGP2Q,.?[ >^%8A0).HP[6?$JJI)F,+=7967&'J7U0*#NC
MD@W(3&9P6ID3\NBAR8E>- :(O2@)HR=ZT(&$S.6?!&2SD*=.ZB2/Y">'0V63
M/L,Z^UTC9UPU$D8(<Z\\%4^=I&]%LJ0]9*F$\8R""0C*3&HBM?[H-#V7HO*>
MC:^&^8Y?S^V+S;"(5!F*6M*EIT3FCL%FE45D<=J1-)PM+NQQYDJJL-QH@:R4
MJQE?4=.3IL@_1!I_M3@$83:Y13-N*[)+9(T^PCZ"EE<?Z]Z6OZ1L$=?V**J+
M!CMTNUO(8LN5RF4UG8+-N;1.,SU%_M+VDXG1 524E65OX1HHO+[8C\I^")>@
M7M,'B4D30FF"*#3EDF*)(NEMA1KIQDHY[YGB4M+7[86%$_,[#4DD+,^H!V@4
MB=8^@&6F*UZ")IR\?'+PT?PQ+(W**.EM@1QD&YUK.XBJEJ!VG;#.XRO9*RYT
MO&J8,_P%A9*>K)K9UK=)+8"%/\\E,<]-A)6S% 1(TY.0NW3#!./'70OTYN11
M0EKAM=59>+%9M4TPFM-G>7PI$.%W5$IHD;+/D=*/B!MCQ;I9+2]1EI>VM]4M
MREK6$Z<492I%INJ\I]<+>F\Z-C5QPU\])88XRE.RQ"-HF^(.-JJ6MU1O++(&
MV4MOTVU4$61?*KH6_)"U34H+9TZ30T"<GY8I/_ $SG]V57&CE/IE-)X;;T[3
M57:T[ACS3\E7Q%P?2F-MG X5#^K*_,2N;PBKHB.)9=#V2]F1R3N1#&C;W1Z:
ME9A2-K >1L@MVG:(OC'COMM**((YB@C1<6?F9YC$TA5/V8DA3+69(NN[HZ*:
M5\,<)+2\B?7AI-9[+:RS M9\87)W&-IM!V8 91R&+RCMOE<S X >/G_-QYR_
MY7A+^S4@R.NW]>OU=_\ *Y& P&!P \J7^4OP$?\ (?JK^RT7PZ:_PV^4=_\
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MCNJB3*J"D(/((81+1)VQ0<(]6G2A" 9INP^[&%Y5M47H^OZ9E<@L1EFTMB+
M_+2W22P]QER$BL5TN<FUEB8Y:I0.B'YE!(7LMM2!- G7$(E3@+:G:82PXPTP
MF;>CX61RW7-O3(V760Y364I01::11FA:J1_)0V,)[$@JZM9LZ,"-I0M[R0[2
M"&.JM(:(]<H3E"4C.)*+/]IH1-K.S43N*JM6J4AKM)[4>$JQ'7Z:Q&A=-=EL
MMT*:M$D^X[K:S:WMB%.^.C80W)4RHQ'IO \(4A"1R L2$EDA+RK[E<<T^%$K
MAJQSF;S7)DT;K&:::?9$C>:[C+LBERB8JDS PN#4>YE1)W?EIX3VE0K4M924
MX21,2G3Z"4$<KW\7H;>3Z841:<Q ATE[\S2NG7'FI\$NG2U^<FFLRG>;N*2(
M)7A2)4Y$.$5*L!6@2*%1IZ\I$2F+.,-&5\00Y7.7BDO(5)+7]U?']YF2..R*
M72*9@KL^<G(:U36O.V1TCCS/F:/' "(B8.I;XL5%$:4#;0/*HQR*1A<1?-8.
M58T?%=())7"%Q4@L)J)CDPKJS&>ODMA*T<1D%C4U%V"'1R>.T=T7I4]NZ:*,
M+<F<"M':;50DY2HY-M;H*G!RK-1/EFI(VT)8>U3"<.,(KV=0B;Q" .$X3N4=
MJ=QKZ0'2^-,,>+^2"]-T;2*C0@TB<5:OX;>22F*$4G* #1,WNQ3YR_6ELL]F
MQ4=C2%=4EE3=VELOKZ"R)M2L;LKES4TDV!%9 YIBW5<..2YS;?JXRT1C:X)E
M[BM,+5:"H"$LN;/FE-HH6-EUA:5;25<M?@7:KLI?9[XFV-H<'M39Z=8TNP4&
MP'K#&LADBQJ9H;-:,,&F0MZ?6Q#&#8A$SURCYRY$J&;V77-OR"03F9K:F7D+
M*N9%DO)/A$/,0!8BU*1N;&E B,=D9S_#FIR,)<E*X)#LTD'$?!V 81#E9,-/
M>^*><@N$D1R"1R].DEC-?:AOA[A8VT#+&V:\I4Q2R]'6*-.P)E/L>9DH1JSU
MJT:\;4:M"0F,3)SPD;+RJ>OZ$1E-;SC<K%(YS%GZ2:8QSJ.Q^0%)X58*V,M)
MS#'W65L*QO7#VZMC*,I)L] >A&K3I$Q:KXX$Q(0$STP3>B(S,[$CEJIY%.(1
M.F!E#%5;U!7\IH^]D, ]E2,N'RU"N;W5 Z,Z9Y 8<G-+*(<$GS2D*=24!2>$
MP9Z88YOYJJUN%"ME(7@XJ!2>ZI:QIE#RI,3B<[]<9:Z6&6X UH EB%2HFR[2
M0K>P_* $#0=_P:W@S44@XWI&$UTY1Q;,9ZT-@&NB&9).GN=HTTABQ7/$O52.
MD3FM]6MQ+62MBKRYE)BQJR%'U DHDI5I0+8]F%Y7+:D/*=8II,AG4*E=@Q&4
M(7^Q#WI^ATP(+-E26=VH\VM+X;+"E;:Z-ZYE26&\KSDH"RB'!JTJ4D)U!(#S
MP&$S7U:.1*P9+5C=JH'BQ0GPN=6'9<,@9DV<!UE%9Q;3+*F>R7YHB7P] V;+
M!S5T6F$J#STR-<M/-1EIOC'!,+RN,,]8W,E<6C)Y1*I(KF*=7,81#(4_(F&3
MJV-":.LYLX6+5LS;QHBP.C)/JUF+NJ6M#FB4IQ%F'_[P#M%DZ+)+8S]35?!J
MF63!J9I(\2J?3-Q0SRPI'-9&F?["DIQC>1$6!W>@D$MY*!C1-$6 VMQ"-$C;
MB@HC-%E_&VH&,6V_)%K1Q/2T7A#)#(4.;0@^*V=+K<ATVC<K4E3J)RV: >&U
MV):'IR3N:4Z,DP]Z%'4K0M2JVU.PIDJ4)/\ Y1.,LO*O@KX<HE:UHF,Y/,Q,
MVJZG%:25".:/!YD^:; EBJPGY_F;LK,4/RV= L=P5R),]I5:-P(>%9IVC-ZV
M$ 1RJ9VZH&?58R6IYC)IM:$=F+/(H])5\_>TZJ0.K!*&LUE=6<;G'&V- 2)1
M-AXRP"3E$G!V,1GOV;O8]DSUR@YLX<J=L9G) &4VRM?5[C3+FFG+A./F96Q*
M* 7+U=6%1[T:BXTTH6 AT4IC4X&W9"XD\S:D)IQ@S1%Y5<O#)@< /'S_ )N/
M.7_*\)?V:D&1UV_KU^KO_E<C 8# X >5+_*7X"/^0_57]EHOATU_AM\H[_X<
MS X;P**2M_O."PLF^[1W)F3MOMLI_>UVX&_3R 1IPK>6KXHSLA3K!E#+$VZ4
MM2U"XHC5[8M <A]=(] +- (MXNGAG'A&6KGJ;JFPK$I%D5RV'154Y0/F-[3-
M<NDD"KUENPB72)X07^\I8J\P-ZF4LDR-G9%"=K;8LZ-1;([EIS%A0TBP =PX
MR18WNYM?;N>8/R\Q5Q.[(CKBQR&VK9*@+Q"F!SC:5G2KX_1BL;A8$R@K&:K+
MN X,G;P$K#5(%D)"(16RMBWE37IU0"NZ-Z8G,!F,]33B3U+)Z.XA%:DVK-OA
MD#=TSCU'6D[N2%V?$Y.XNS#)5*V&[D%4GH-HV96E&K1*25B18#U*,,?%9K,X
M\ZD=99_21#Y()2V6?)WG;YU3TS0$4K($)@P8XU12'TA<LQKE:WGEQ34L<9@D
ML"O4/PERER,1*TBP20Q*,6RS]1,3MCP:2I[I6NC5\1NLIS>VA5SIR>F>I+##
MZ_BC= [UMN<6(T3)VFMB3>'R&&UXG:T<7(3/Y"]$J,8QFD$@0E+E:?0QQ^'B
MWOABPIO;%MJ9_81HW"3K>9FR.*WS:4!87M#!NM^J87'W82M-&H<WN*AXC3"C
M6&*DS4V)ENU'S)*1.2<64&FV)V[90G&Y+,:0NGKQW@J)V+<^M^HII24=6 ;5
MRUM8NBFJ U$AJV:K E%'%(F8ZL'%]5.RLP(4^T\(2$>_XAH-;+C,GPB+*4G5
MUTHS53SG2TDC5<PJ*.-L"JW=ERN'0EAMN2A[QZ&A4JA\@632#RB0352TP-A9
MAZ;XTM:7GYJ3 6"&?K:?90N+UO?_ -,[9-P]*V_5?6J=[LU5 DL7B'0Y\O@L
M5G]=$VW5AE<W&W-=5J8S!&VL-3J+Q1TK5M6F2%P?7)T"[%K$J]L-3D&:#D))
M+%F&>:VQ/>@#ZK@UVO44KU]LBT!GV+!8=5#G))M'XCREQY)(6];E;E!'B,NB
MMQD]@+EICIM$HVM2:TA*V!*40!/4Z8S>_P#[J!YIU_>(JW8YU(;T4TY.3J9X
M7EE;P)KA,'4-=WO-SOD=)O5X,:)5%9!(W,E*M7J67:=F6(M1 D@+BK]P%!0\
M+)/IU=!>IK+=X9.:7C+M<"SGBH9<W6HOFUR(D$0T:GF4401%17=<CD]A1Z50
MJ)%2]$[/KI\54B$>O''0HDY@1*! ,,R=+?%!_%)EB3V\9;<UI/LOU,99Q_RJ
M8ZQIR8F2.QL UM@=0)DCVV,)T73RZ*G2%ICZ9]&T'N9HF]2_J"3P"T6F F+M
MB3$\VD/J"'P_INT8=7DHKZT)M?KA;YCY(HFWLR_K[E:3$T^N=#5*R6F-4K*'
M2JD472LS0F<TK6H:'%Z0)$^W1,=HM*/#KV]$+17HBQ8G04&(;.DI$T.4)XCI
M6;T"D7L\$F[KU3?*U+,FV;UH_*54.4N\T=8M*X^S111'8Z8U2-O$YB5+#QJ1
MD'D%Q,_5NEO6S8L]I"\USI-0R/I"+7G"6]CXG<W2$0UCBZ&$=BU4EJM2J6_=
M(ZQE;=-&)(SN)TP-7J6,TJ0#,)) 24263"29GECO]'A?9A9<BDTBN6(W9-$L
M]KK@V\)C)5H*RA\=> 6U"+4&^[J&40N1QZ2ZC$:@;TUGM*AE 8:\KD6R3=O*
M@6]+53Q.F,>&4MO'1]KFVD[%E6<J9K"3W]0L%KOE,F,Q<]MLRBK 9ZJ6SZR_
MCK(X?8J\#<VR>4.^Y$@=D[,P"C.D*LD0REP553$]%.VNPG]10]&UA+;:<8$D
MCQ/BI:*GHPN*1P\FW(5))ESJ^3RPCS%\<53AQ/:)=IU;#%+8X(V^+@CP35Q(
MM*3-FQK$ES/BEJ/=*]@2R*6,^_U)BT,D9L@CD3D<,&YUK,Y_1<VD/7M:52SH
M&>I$T!:I$P1I+5[P_$+S9:M>!+U:="O1F:)..$*^"8USC]=ETZBLJ8L_6<WH
MR9VVY6ZGU"CW:%[CSA6Z]'!V>&M]<M;PAOF-1F",$JA%LR)]D!SBW. EPV&0
MHE2@"5$@&A 1HS9^W*NLLGLOJZ[>GFP-_P VB[-+>LJ+03M]?]PIY+H.B);S
ME%5X)]#FMTAXT$7C$EM-F)A6GYV*<F=M&H-4G:^=3*5 B]+)T\$J*9W-[,X"
M[+6O;NLL5"U0KK.'598PF!*0ON&NV2&R=)$IA]'C:!J:GH]6>8>V%K&I(F1/
MP6\*](4$I87K!C&T^BKKAU#<,:C!#75]X++;JE25RP@FM[+TM8P;^B3U835<
M0[(B )297"R!0TL"B'0],,F1M+DMB(Y/[%IVAGI!)BXGEUZK.7<NM.9^-A[6
MSF21!XLQ\:HE\.9P4]JG,8< &7(P$PN7IS6=N9(Y(UIT="@7N($*9,UFK]G@
M3@ E]GH2?SZ(BNF^NAJRE[W4R6TG4J&,]^/,467Q-7:G:Y>&9K5<SUI;D+AS
MY-I%5B^I4"=XGDK>=)U*AB)/6)&DML"?\R9\0X23&?UW85ALNS(K:+P"R[4:
M*.;;(L^ *KZN2")XRMB7]16+A'G=X8(5%)184:?HTUQ">RXQV.2+E"+2E>2R
ME-Y RCUGM$7$QT_76IFHFTC*H\6E(V N42D*T=4ULU >HX@CT+=6]VG\E:(J
MBEKD&Q6QUBU<1YL<)&!Q=U;TD4)(^V%GG'E&:3[ (EF=\(>HFS[&LB[.5)=9
M]QRMN1M\R[<I]L)02&'C@=KFQ"7PD-;%.SR16D.;)]('V*$+!HEK4D:@.B9I
M$J1%[!M4<HBV22R?!<WI^%,*Z^."I^<V*%<HCO2TBCK8Y;5NIR9G8Y#R]TBI
M>_@M856V5*H<E34D+,6[(TIV6 ).C=%C$ 59U[6?! S2_P#.UI]ZC65N\U#7
M4FY\.MAEL21LKC"X]<-WVW)H=IME$-$R@T3)Y97M/QXH;L]+W$E4D.DB9 4E
M]=,Z[>B]>/7Q0G99\*7V38!JU_1V%T*_3O@]RXTL%Y2M"^<36K"MU8I=YA6+
MFQ-;<W?=I;*BYPY34; 0D; -2LX2\HM <0 469Q\.K8N301W=S<Z)XDC0DWV
MULO5(>WST:'2>8?4ELN0C3:N-7HH#@H6NMH 3JHAIS&,1K(%2:U?^[_BBW2]
MKGMTPRMKU3N<]OW;+'@^IX%#ZY;N$)N]W9+T:L-GQ ,+L"T927%JO>]HTC:R
M([!/;RV1V4G.8 A0N:@H2-5\;0=PE_;/JT6-R68TA=/7CO!43L6Y];]132DH
MZL VKEK:Q=%-4!J)#5LU6!**.*1,QU8.+ZJ=E9@0I]IX0D(]_P 0T&MTQF3X
M1<KQV(H377.L4I)B<DZ5;#YMU 6PQI>K#J2G0B.=7V_&$,C5(CQ?/*$Z@P).
MC5>P[ :H.]?=O8M>IG;-N5?&.7PN!=R]GRF1%T K>H])XY*FMB4L:5WZ_D"!
MBXNJYP.24FA/5$K'MJ4A;%1)*1,69L]1I<7ZZV+?H7'[9W_UW08A[-N4UAG\
MI/N;8:T@#_5<^$G3SZBWJXK&BDUK^?O<AJ2IYJAI=JJ&86=&WJ.MZP410H%3
M@J,&>UE/A8QE$ZBXGU;1-K>M*I+-O%B8KAFB9IG'9+>7.7B<SBJH8HI:NWCD
M*&32O"V=YGE7R&,UY'+!L!O-9B%CRW+$BHQF&WIS2W0\]093$LGR_P!MW<K?
MZY!7U_2YVN- US2MZDY7:(^UP")PJ5UB&R+::H@IL*R6MT<HG]9G#:(];\5H
M2A4)FX@DX_XA1VC"1)QC7,GQJ]=#.4N727I2J9_*'>S&:MK+88S&Y!-6>+D/
MCO%)G2]:SMP9G\,6C<7C#VG;WZ6."<DT#>4+:+99!WQ1E",&9O:6*/US#(E4
MK=T2_5Q6E?Q%Y5^3.FH!\ZTUE$"3ON"_6?RRV.C4D#N/B"G;4Z9Q4GICBM!V
MWK-:5IQE*2@&@+>N/E_Y:$UVSUDIK)#.5G14X&Z.'$M[]1GMQ%:50F2)K'JB
M2,":"Q%$6.OSU)<'<F=^&2]H#1&NCH<F+.2K4'N/+-+C7.,>*:ZRZ)O:4]52
MQIE4Q@D+@<0GDM0R:M);.X$PJ2:*:*@(DT9L^)PM5"RK-<')TERU$XJ7X^0#
MC8&<]:E$26I1AV EDD^*U_45HR")T<VSNM9*0U,S_,JD0OUJLR)LE2> U)-9
MM'&Z9VLUIE:1W8EZ9AASF<K*7*DZML0%"^H*BCDB8T C,G7%4GC=I7U9EC.%
M<PSI*6G5(PM_3CM!KVCD(JIS?K?;ZUC7*:Z-"V]KH$M@3NVP.Q;1E#&<Y-#6
MG3R EK^$(6SB5"@9K$GAU;KT=-&:P^/>,K)NXB(IV.:6YQ).K2+E*- F@B(,
MD>8J^/VWQ)(MG-B!@3.:_>O:M%LLGT!H0O=K6\$F-K)\4!/-F/%5&6$]\O'E
M5]R79'1];1-!.V=9%Z]KN+*/Z+6*\VO+JHD$_ALMK>&U[,K-8(BP;=_I!K J
MD"MU^4$%<J^;PN,]_P"6$HLG0=\EGKT=H6Q'V>TXASI!IY2E95^K@9T([&L1
MUCTX<%IS-+GJ)&KIP0\/;4U-8V6(F-![>8>)5]I*] (HF)X=L_9J-17/T_9S
M-42$70#5]WK4N2L(NZ3&%.E.V+9\;^JT#?U@VO#W5M::M9HG627Z_#XV8SIG
M9K6O[0:<L3JAF! 0#"V2>");<LV_'CET:ZPK:DDM_J12UDSU[$HJZ+G(H+(*
M#Z]YXA<2DT7B\/C"!Y7*%$.EZQ>\MZL]>2Y+46CDA2,CW)LAB2_KR2-.^H+N
M:')5&(+=FY11A]X/T68^K'>0TM"RC (:'B\Y35^?9KM6+M2RI"FLIS<B N7T
M4L:OZ<)CTH^>*.&922=[W74Y7DE[3BP;:<+CL-(N#!6FE8D17\':H[JL2I=*
M>?*?L6Q98R2HZ/%S.4H5$VD"XMG&)<2D(0&CT,@PP9>R#.V,3".;!C3/$NT;
MRG;3%)D]O4E\?[TX2$F%N#P9-I4HBT[<DK'&80K4*SR61]TD^*6TID/RY1;B
ML&H]GQCS3!SQ6?QGS5R\:+M%*_E,T*=Y72;BB<Z6YE8R9Q2!!4.JQN<3GV71
M2'UK;)#@!$4_]=/K_)/8YN8ODUKZ48C(TS,XBBB%57?UZ_KY+5^1":4:U5W'
M*VLMBIA^L>Y_O?!::,O,$630:%K%C"6FF]I2!_E>@)6&.UVP+REBK20XIS=%
M DK:CWI0L+$ SK+G,SA2Z<,4*CTCF,5T_EV!T*D?N!6SBBP) :5(;"FE61Y!
M5"1?+ZVDX-*3U["LE2&;.,W5-9WRHFQ6>:Z;VC/*V.-=>_AU;[%TW,?2ED=7
M/U4S.E:=A!O.?0'/+BJA2F&M\WL=5*'D@5O=#V'"V=P:713#*KD+1M!&USL
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MS@D4-G8E<1J#UXP.<G*0,BI.A@ZRNJE;D*MP($H6F#DKP+:86_39PY9[]_\
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MP;:MX1G:6FT5?1=LK%G7I?'S".;5*)*><W,KG:T(<VIY1"6&I(V,8XMI22N
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M032)B42UH:FU\=HN0[(#I$ULCRH7I&AX<60M0)S1-3JK:E1290:4$D\Q,:$
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M   =[WO6M>N!]4RE.L3D+$9Y*I(J)*4I528T!Z=2G/ $T@\@\H0BCB3BA:$
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M>A:]1BO(DMNEUSC/OD;-K!6[5<C/_JC\I-(HH<:[;VT"I<I^_P!\%R&IB*-
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M09\,(?>><+[1CWZB%O\ UW@?E(B1MY $J!(F0I2]CV6F2$%)B ;,'L8]@))
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MDQ4UF,*3Z*$<$XDHX4PWSU[?#O\ 5,=E>-3IZ=G>1&$-E5T,P'=\19#)(5U
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MERQ-97@Y:S.5:F+B4(G9&[K4"5.Q(34*;1F]!)ASF9MY8Z(5M_Q=]9VLGO-
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M,DXA0F-?])UQYU/KCX=+95JD3['SJ?KZS'_M/R>W)-KJC)ZPFQ-5'V/5/1,
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M_P"5R,!@,#@!Y4O\I?@(_P"0_57]EHOATU_AM\H[_P"',P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P&!P \?/^;CSE_P KPE_9
MJ09'7;^O7ZN_^5R,!@,#@!Y4O\I?@(_Y#]5?V6B^'37^&WRCO_AS,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@< /'S_FX\Y?
M\KPE_9J09'7;^O7ZN_\ E<C 8# X >5+_*7X"/\ D/U5_9:+X=-?X;?*._\
MAS,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<
M /'S_FX\Y?\ *\)?V:D&1UV_KU^KO_E<C 8# X >5+_*7X"/^0_57]EHOATU
M_AM\H[_X<S 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8' #Q\_YN/.7_*\)?V:D&1UV_KU^KO_ )7(P& P. 'E2_RE^ C_ )#]
M5?V6B^'37^&WRCO_ (<S 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8' #Q\_YN/.7_ "O"7]FI!D==OZ]?J[_Y7(P& P. 'E2_
MRE^ C_D/U5_9:+X=-?X;?*._^',P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P&!P \?/^;CSE_RO"7]FI!D==OZ]?J[_P"5R,!@
M,#@!Y4O\I?@(_P"0_57]EHOATU_AM\H[_P"',P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P&!P \?/^;CSE_P KPE_9J09'7;^O
M7ZN_^5R,!@,#@!Y4O\I?@(_Y#]5?V6B^'37^&WRCO_AS,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@< /'S_FX\Y?\KPE_9J0
M9'7;^O7ZN_\ E<C 8# X >5+_*7X"/\ D/U5_9:+X=-?X;?*._\ AS,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@< /'S_FX\
MY?\ *\)?V:D&1UV_KU^KO_E<C 8# X >5+_*7X"/^0_57]EHOATU_AM\H[_X
M<S 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'
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ME<WN;F6O)[1+!%(5TAP51/2*.QVJ8N"YLB/1%]1*SYK!:*>R5[2C 7'9@U5
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M]D[TL#K0?_:>NQ;WE-MN77'5$5N^+Z1=!](N%_W1T>B>@1^N.G*PIQBA'/\
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M8=-/X;?)_H%PYF P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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2!@,!@,!@,!@,!@,!@,!@?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g923025g00n04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923025g00n04.jpg
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M  (# 0$!            " 8' P4)! (!_\0 51   0," @,*!@H0!@(" P
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MY,4IY'C>8[GWCS+?(VC,+SB5!: =+SZ.:FPSBFH+J1Y$='62.VQ'>$;S^;Q
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M,2YOR50:U]H!MXM^B>PM R=,Q]0X\I>]Q'T9+8*BL>9,UJ8[8)!$1<#0B(@
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MWE<*YZX95M0#O^$=WE<"T#$"J35$_):^^>M_@"EM5'JB.'V,7YO&*QA_Z?\
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M?2%SUXC/1S^2%@2#F"01QA9-8,?8JL+F^Q5^KXF-WHG2F2/Y#LV_0JBO&@7
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MOU)AG#M?>+@[<T]+&7D9Y%YWFM'.3D!TKL*VJIZ&DFJJR:."FA:7R2R.#6M
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M:K6YL\Y(V/?GY#.TC,\P/*K,6.:/L(T6"L,4UHH/*+/+FF(R,TA]LX]P'$
MLC45D]S-6BKIQQ^0IHUO_P 8X8ZJ?O8J74T:W_XQPQU4_>Q>T\CS4^VR>41%
M899DVC#A&PO^TJ?UC5>Z@C1APC87_:5/ZQJO=37^47Z/BPB(D%@1$0 1$0 1
M$0!)NMIPC6[]E1^NF6E%NO6TX1K=^RH_73+2BMKXHR;_ '&%L+5^X7L._KR^
MI>M>K86K]PO8=_7E]2]>RXLYKYK[+;1$4)L!:)UK,4^(8<HL.TTF4]P?X:<
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MD)DCA9"6_?,O)))/%O\ 2 M[(BYE)R[L9"N,%B(1$7)V$1$ $1$ $1$ $1$
M$1$ 3IB/5REKK[7U=KO5-244\SI(H'0.)C!.>YS!WAGD.9? W5GN&7E8DI1T
M4KC_ %*FD3.K(1Z:OX)F^YFKOA+3?-'?W)]S-7?"6F^:._N5,HCJR^0]-7\'
M1X&L]98,*6ZTW&M;73T<7@1.UA9NFCVNPD[S<AO\28XLC\282NMGBF; ^M@,
M0D<W,-SX\EWB+C/?([:L;28_N9[E\(Z/YL[ZT^YGN7PCH_FSOK5.(N^K(1Z:
MOX)C^YGN7PCH_FSOK6^M'F'I,*X-MEDFJ&5$E(QS#*QNY#LW%V]VK(D7DIN7
M9G<*80>8A=%CRSSX@P=>+31OC945E,^&-TI(:"1QY G)=ZBX3P,:RL$G?<X8
ML_Y&R_O9/_6GW.&+/^1LO[V3_P!:K%$WK2)_2UDG?<X8L_Y&R_O9/_6J)T88
M?JL+8%M5EN$D,E52,>U[H22PYO<[82 =XCB64(N96.2PQE=,:WF(1$7 T(B(
M _$T4<T3XIF-DB>"US'C,.!XB.-:FQCH$PK?7R3VP2V6J=M_!@'1$\\9WNAI
M"VXB]4G'P<RA&?:2)-O6KGBBD<XVNMMUPCXANS$\]A&7_98K5:&L>TSB'X>E
M>.6.>)^?H<K<1-5TB=Z2#\$,MT3XY<<AAJN[=R/YKL:+0CCZI(SL@@;^=-4Q
M-^C=9_0K51'7D>+20^62O9-6Z_U#FF\7:WT49WQ"'3/'9DT?2MIX1T$X1L+V
M35D,MXJF[=U6$&,'FC&SY6:VJBY=DG^1L=/7'\'YABCAB9%"QL<;!N6L8,@T
M<@"_2(EC@I]QKH K<08KNMW@OM-!'6U#IQ$Z!Q+=T<\L\U02+J,G'P<3KC-8
MD3']S/<OA'1_-G?6@U9[EG^4='\V=]:IQ%UU9"O35_!^(&>"@CC)S+6AN?0%
M^T1+*##M*V"W8[PL+.RN%$?#LF\*8O">U!V99CE6G?N99_A3'\Q/]ZI-%W&<
MHK"%3IA-YDB;/N99_A3'\Q/]Z?<RS_"F/YB?[U2:+WJS^3GTU?P?/;*;Q*W4
MM*7;LP1,BW666>Y &?T+Z$1+'A$1 !$1 !$1 !:0TI:$ZW&F,:J]4]YIZ6.:
M.-@B?"YQ&Y:!O@\RW>BZC)Q>4<3@IK$B8_N9[E\(Z/YL[ZT^YGN7PCH_FSOK
M5.(NNK(5Z:OX-+:)=#-9@;%@O%1>*>K8('P^#9"6G-V6W,GF6Z41<RDY/+&P
M@H+$0B(N3L(B( +Y;G;:*ZT;Z2YTD%73/]M%/&'M/85]2( TMBS5YPW="^:Q
MU%19YSM#!]^AS_5<=T.QW8M38AT XRMA<Z@BI+K"-H-/,&NRYVOR] )5A(F*
MV2$2TU<OQ@\_;MA+$-H+A<['<J4#?=)3/#?E99+I""#D=A7HZOAK;/;*[W;;
MJ.HZZ!K^\)BO^4)>C^&>>"*^I<"82E.<F%[&X\OB$6?\*XV:/<',.S"UD[:*
M,]X7O77P<>CE\D$KZJ&W5MPDW%!1U-2_\V&)SSZ %?5+A7#U(<Z6PVJ$\L='
M&WN"[>.-D30V)C6-&\&C(+QW_HZ6C^61%8]$&-[P6F&PU%-&=^2L(@ ['9.]
M 6SL,:M<A<R3$][:UO'!0,S)^.X?TJD47#NDQL=+!>>YBN#]'^&<(M!LEKAC
MJ,LC4R??)3\<[1T#(+*D1+;;\E"2BL((B+P]"(B "U9IIT75.D.IM4M+<X:(
M43)&D21%^ZW1:>(_HK::+V+<7E',HJ:PR8_N9[E\(Z/YL[ZT^YGN7PCH_FSO
MK5.(N^K(3Z:OX)XPGJ^5]CQ/:;K)?J65E%51U!C; X%P:X.R!SYE0Z(N92<O
M(V%<:^T0B(N3L(B( (B( (B( T[ICT05>/\ $U-=::[04;(:-M,8Y(B\DA[W
M9Y@_I_0L%^YGN7PCH_FSOK5.(F*R26$)EIX2>6B8_N9[E\(Z/YL[ZUDFCG05
J782QG;;Y->Z:ICI'/)B9 YI=NF.;OD_I+?"(=LGV/%IZT\I!$1+'G__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-25-293675-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-293675-xbrl.zip
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M'^3/_>U?2L\_G'1,^@0Y(Y;I$=@[EH,I6 K=8$F/"5%JY/92R/0IKC=BK$F
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M7FM5%I4UCJ:VE'LY9CH;\!S9>]RD0AGD_(\%OJ&_1TF=<-8/Y_\ 4$L#!!0
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M&2?.''"U"H/ ;?7.(S2% _K]+-;QN+J5<J489  2>^:J6#JB]45WZ.I#IJ^
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MD;D6"+SB&A@F]Z$%:L-&5:4#6K;0QD7&4-QZT1FKHMZTX.T=%"CH)YS(%+B
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MPI'AE/;_<%+PU&I_;R>!>YLX&_B ,"!_99PFA"-30<-I&(3$5/)WRXSV6*1
M>?Z(@*6 B($NM)].6;@D:)C'W%VI'F9I%JLGC%0P2/*4]QJ=ICAT5(^RG'((
M&6.@;Y:XOR_1V(LW>U0NDERSP31_MCJSQ3\(3':\=G==(51-DG%W:<TC&ML
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M0[N3#!LKF_1Y82=U/"S%:RC*79>M89\1U5S/Z]74UZ@A3]T((]Y=,6&Q<8H
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MY:8#=MW'2>I<G+[KFB"%2X6 [OS=!ML!*Q$VY,3"&AQ9#U&F4Y]JFB=PR<,
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MXX',2,/>^]XL[!_"/3(C(ICSMA=TH/C/P8$B6-.5#/XPT[8OK/S+N-3H^Z<
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MM=/740.U5L-Y=L7MQ>R*Q.1[4UMIU[6R,"3.P]DC%]R,2F?SZI1W6:NS8G5
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M"\-L__(=W!7C?\6T:5U 38J;C!>%M8QXS7YK]ELU^V']/!]WA Z**"MFI9:
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M[!+SU24@7E]&NRZYZTG%/46BEZOV3)HW\KW_%6<X>IL,QW>1X< W2?O^X^L
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M;Z?<VR=I[$+TL(\Q]/&.@7L8, @  /T$VC;_-8>6[6*]K5T$KP/,YJ:54VU
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MJ4]7UDS5]OME!5$IZ"!:932)=7N4=.C,8'_7BY@C1+8>:O=*>8LLA7+!K:5
MP$?_5,WNEV.<YNI 5%+@=I@3']+"10MU"(\NHF6N"[RW",A;GWRC)?!?9F*S
MZ M 8J5P10P&^*'Z:;1;!GOM%^SRG[&!7(88--@>)0^N.II&6[XF]M=Z\0RV
M8<W]*AJPE4#R:RU1?BH/EM5P5=&'91;+I_7H71S,.-%J59+\HE7$MR3!3%*9
M"A E$ $I,,]@;. >@STF(F#-H.;0T5.=V!KOK[[V8-F5F9_83*^P\LB=BHMC
M8IU1'W)*FN'8<');=K;R3&(/J[@+-$R+@$_?XE"6J"AX_X"ILNN_U1?.,_BY
MH4???GF1ST64?V[8$XR59)IHAO4:?KX%UJ?-7FLT#UK"[#0]SN3$QYG2N:_,
MN\TR/(T2?0#-=!(T?BAOHVT)X@DIWW%FO-:1=<#.(16"^/-XBQ <O3KC@/":
M)\47&*C%\89I(A)9/>@M[(/X%BF1BK71:LYF8=0>!$VS_(M@'9,U!"N1D)V/
M^7--/8>31G(<6%R.,2*F,X3\]>2VR[M=LD'@9)K]Y6U5BYN,^7L/7HQQ-,4H
M^4R, 1$2,Y:GC)E7 ^7)C''H"X%B?K1 '5L?FT3WEG2- !97G5?= :.AT,\N
MKT)!9=_=@8BQH[]N*^Q65"OJ7Z.PS)EHOK;BU4,S!G5"8N(6[1:PM&C7]B^U
M74MFEWQ4(.FU2K8=?A-C!!'$3.6LDGMDWA(Q/S"4TJSF^K%MN>%41EENNY\+
M02FFX[DH7*;(K/40^:;FS+)/=6;6;Q][#G_0-(-KI#E7GKVJKC2\@JO=QP.^
MY/UNL5N7EK[]=>]_*%RG+J%<*/I$PH5 XA3GLWMW'XW/).#^;2V#K1PDH^Q]
M&76WI&+??F%*JKQ739KJ%>.K[V_R)\^8/ZG/KZXFB[+Z*[-Z5PZ51_D5".LW
M2?U7>-L:M=9QLK\OZ.9=3(+=?.W6,IHNX_HLLM*9L=*?J-S(HD\6Z_:ET?9[
MFB+E2D$RS^TDFTQ!(3YS??)"W#TUK#@MM,USDJ$"UN61YF24:AZS/C+D1-9>
M8J0#C9B"K)@VC#,#K("%K##()NWQ LGL+!1=EO/,'3*-%/,(,F7BWJ@K*):0
M/%N<PWF.+IK:10K.9R8G/.!UDU"09(*W.#0 0YO$48H'9K1H MMLS#+!Y$_=
MS@Y]5&WR&-FU7II/\ROT%*3!191'@UL@HKP@<B^__&RQR2W_ANRK*4L$"SL9
M)E&>Q,5V@ZR-YN@1,XU8*Z)+%C?D<')E#O,B-(FIG@15AY?WJ_=VYU=[MZ1D
M8)IKJET9J9G?("9**987WESS*IF%" Y2WWKH]R*+K!>X-?-LS.D7%KW\S2!3
M8BLT;,^N $_5?:2F["@67/HSJ[!_';3?%08>[(90#R@D[/9!7;D GT_;O-L-
M@1%G+]1[9[<FJ+57/Z;SK&0VIEG;N@5I%T4J24*L3Q949)[$5.1@V'287NW?
ML<M>K)0>9>!$P5+KD,DN,REH"E_+9FDV [YB+#(WE#]YK.0E0O+:,0PVA9XH
MNIB58S-&LP+OUZ]E6F>XV:G#B(H5_BM*Y^J&YI7"A=H/X1PQ1;"=4O8]#L43
M/N HEFJO74GS^#[057+SIK??T5BQY'T<,XDE&7/%0Q=OF'%0W2R/)I16P]_K
M[H5O=W>T[X]^A5^.ZDB5L%LC5?O1VSL*E=]:1RFHC+P(2T"CKU$RCB3QYJ&W
M7L#CM%*2IO]XO?1,NSO+T3-U#U? K=0]6,5#ZD?R!!WSS\S09+,1\0-*G:^=
M'0ATN<VO"_M\=>2EF4!E*WIV.I@U3[C_/!-^:=,>/)H*9RVG[)WO"ERV;;G%
M.F-P>QS=_X+J_0VH\T<Q:C'?[(FZ?VZR_'X5^!/K%2!B6J)!N51+]/=91G_V
MB7'J3%W3\9!^!)UG]#>'E$K=U.>&2E$WNL&OT)&Y^OV)N>5>FFI::/K]*2WS
M0O3%RV/S?0477,")/[46F"8KJ_Q &) ?47762SXN\27:J7J!C\5:Q5^"Q?J1
M_/8S-ESQY]2U1+XC_J#B/S*#V>DW*'^#\^&\$JUSLN=/LO%\DM*GH^T-X=G3
MP*+5^KL,(8%!%1MN8MD3UM,G[/M *MH]W E[AX]"VUEV"7?7A57TTVHQGMYV
MND<;E")"*7K[6)2B985H;WMKORI'/SPL9*W^PV+\.AWXG>BR#1;M"UJ-'V=-
MJDK'.K/3;ZV"5']=P<K6?.F!7CAF/<!>+^&YV6'6ES6&59W:S3JN\KQO5G.#
M&[LX$9K-HO'W8H:LP*7:N$;?B\6Q M?HAS U=DFA#K,YI&W7I-67&,3+-39^
MC)7<K&=K@\,"?-X@/6^0GA<B/0<U2,]8!VD2@2ZD'*0"[Z(<6C:+CI,P]%;D
M%QHAPH8CP=ZB1<-0*P@0MO3:/D/CUKR$RZ2PU"Q*@S(X90UZ].ML;#K8-#;Q
MDY^AL>D'5&F]UZ#2S@2&!&I:>SO='4S2AOS/7NF?N_Q/K'64'VD(9FK+N9CG
M@UM \,!"D2WX&!=+GUY=7'!=]':]+OGQ!&7W-0@*-,,DQ0P+4;>2[:!WL!\>
M'O;JJERQG!7V43?<VBA#S=?B5J*>W]W9"_=W=MH]'Y CN"7#?[%MQ,V(V]YK
M$+?CQDI^QBB#_^OM]<+#_5HY=(NL"3&+*JQ+*BW-=/'W@J^PCH0./TM#@N"^
MW0_W]@X>-A10CIW@F"O;V0YC6X^JP7M'X='>V[JG4V<"+HD2+M, FV*5C]77
M#A9L_I6[:I:H02]W"]!F[ O2V-Y^>'14>UR?:'2P:'4#"['Y"J@:$$\*&H\&
M4#N/C]"X+V"?0"O(0+TPG5/?&&+&V2#_2:K["8)]:BC8*!2C4/9?@T(YMX^[
M ?Y&G+1F2:R1/2@3H"Y9+4,$R,T"5".7>RC9*)?N;TFI24=[GLUORI^ [^_N
M0C'"_L_2#V*&_7&NWO[F0S*>(R()3<+V*TT323*9Q$,@#%##A5[;&']?5K:!
M@%< <FLL/:$$8DX0&U09 =KK?8:$(TICVR2^3O&?^L<DF<WBF'H(\>B^\&W@
M?D+ED!4SL7NZ>NE7ON A63X'>^&.8_C  MO:-(2U51]-MNF;]B95UL^[774;
M\P+8H>!W>$3?$P-+$9 ?^\P-UY\S)GRUVNX87XON>F,O9$01,QA'A7>[K"<D
M6#T>"H2%!C5%04:6+C!;&;J5Y;<50<_93(@ U#,*1'/$3FG>>.JNG\:#9 0W
M'1L9B QP/^4IT&SQ( (?4I^!Q4QS'??I.N0^-.+Z/MV^Q<1$%@_>ZX,97+4+
MZ\*GT?T;Y2I(*Z 999L685C$$N8G4&#EL=W3V'00GE7L_P#;XE) !Y^=_4P)
MCV:)VQ4P"HIR KL,=LLJ(?Z:S33,A=#/(93$)/IGEG.+-/SR*[9>$J 4M*@J
M!:J,VWX!<2CMY_7S[ NHK"Q]0Y^7$"= J:EK(=><9O1K> I\,61+3NE0Z E%
MY8]G3)U)IL_C Z:$A]!4S:CH5\Y\F[:[M_<$V^T+1U[_XS1X?WY\^2$X_QA\
M.+L\/;D^O[P*?O]\_/GLM_/?KS[]3Z!^=O[;;Z>?/UP%Q\$?Y]>G#>->1="T
MS;"=,XR_'T*'*AZH7X@A2>F?O_S]X_FE'&.8Z<6GX\_!,<Q%_7<=7%R>7YQ?
M'7_JO&:@K,--//GYXLGK%/H@&:HY9H.CWJ[R,__W\"]_%_D-]GX)SB^NS\X_
MJ\-Z<7EV<O;Y5RW<#T%+>-RE<JZ\L*^)^L SWR>,9U[$\1<=X:/K@DNJ(P*[
M,!;$0E,@2^,W@' H2B37C*A;H-DYPERF2Y5HLXW<41][%/S4648FWFT,D#;W
M!CB"C3M-U!UR@$:C1_BXNE--#!E1XI!<.VKFETE /W^P9?%#89!A.]A2)QRQ
M:@'I@6"@))@^9M1NFC/?QC+AT!_D0NL.KTHWLU>X0#5F;  AY#;@>0:):U6V
MDI$+,6<DA>/YS;R8V?[7;K"%;HM09#5,S9H4PO/ >LVGQ P91#<W0*5)9DFW
MNP-!*/:*:OTGPI$LOX6B4S)Z!'V\BJ<S]-#4B'G4VC.?IS'/9T^BDKC5&@ $
M5T29/YHRPUUPH?+Y:7>G<[B/W_VIN]OK]/;5\&QB6,WB4!9N)B+E@T7@,:5)
M!1.U[(@ODZ3SF(TI@S%C406!DPW;RQYY;AO(2(!9*[8@:LCM@@^ZHRDR^CT[
MT!P=J/<[/PJ0$,2B!),#:C=FH3Z=?!K+4Q0SU(AV5+OJ]*%$,$&:Q-P&R+?,
MT8K08!K?^FRBEFM@81%5")PA#JG64^G)-,X[ZK4#)63@I4^R(;&GUGPS!&X(
M(792;ETAJH7P40PC:FF(EI(BA&NE  DQ*1+BQ7N;6+7,)""Y%?06D4V&WJ-/
M+H/F30A:1[F)ZI_*;!D0$ L9Y,^/='6>!N>#6:;#*]U]"0L;B93^GM "%0*@
M5[PS>1O\(ENAD[#O-0UEIQFZ*;9U3!'FW^)XAIOAVV7DU;#[CMH^C-8969]+
M.MP<5'3:Z\X&,"R /BFK$#EW5>W"FN?N-D,.D+9JA=4QJA7VT\H7(7%/"QZ7
MCR.[<JYNHX+N'PES8!1P24VT[8LD]J%:AH",-?%*',UH,EL2A*. ",Y5K[ O
M&,3GG^&C\@@V .V#R01C%YH/OKK).CEJWC@89P5"8>41P:>V& &O^>?_N3J5
MOQOA$;AZ+<\<,5PL@GRA#[6D\6U>$D+-A:GF@E\HB6'CV#T/KJAN;?.)KD,D
M?(:]- Q.->J2I_A.2X[#31'-'G_;A;Y[FG4H9$U@[Q'U4'D\2:K6MW:!',M7
M/NVN06))**YV^<4.CXLC>ZU,<@!0-#C!*<#^%H#XZ55 SH O8XX%X:^,B8<A
M\#I=H[&#KUBO7,9<V':;3!W3E-6$MGVW8:8"#!X+CS(HF1,,4'J^RQ!HB"B&
M*-^1.O>QYL&JF )B.GJ2I]ONTKIS+X?S:Q6MNI25%VHH+)/<YL2IZ-S<7AN\
MU7G&<""8/J=A6,&60V(4ZJ_Z!P=GZIZ-<FM49LU@?,!H&8SC&2C/Z3R'9 [1
M4J.B]PDH/QW$U(*?91FZR;(AST34BAKSC' 6PZ;GJ0.$!P[=NB8[,!DU/4;O
M2);7CVF[$WS.9K !VN_$<'JF')<,[VX> \%.PJ5R+*(07 '=XBG^HEF\G9VT
M1+>TJ2!J[ZT+I(257ZL1FT\>G291N(*E"@=+ ZBZ>:BZ;'SSD?/MQ'; QD*]
M3,"[K2>_,CG&"6Z=6'O6O$%#99L@38/AQ7K"U0_]1F/K\Z69<&;(_3!#.PY\
M*7._TK5HK"_WJJN;C#Y>&@#;@A#65ZKW3I3TUV 0C^,\XE>KFVZ<H&*/4H^Z
M?'X/YUK;&LJ=3=0B66GTJMNI"0G[RI]#'G.HE"O*?KY4=MKV'N*JJJW1V7K-
M<UX0Y"C!^B);LOJI\!+5..JB)=1#YCD&<QP;FFS4(635DXQYA^\0[5>-=SZ>
MT>T':A>-?#B:&B%4K&J\B0N^5D65FD\A+GO\#8E/(:59U+VE_!T;)J)30B8U
MEI^$6PJ*M^#6P.(32#QD=0G9/")7'L2)?J7YPF IP0<M_'L9$=E0@MDTDGAL
M$ "3'0XC&,XYX*K#APWQJ[5KKSC+\G:397G]61;U[%F&5TRI^A>H1&=9AE0"
MR*K*_'?$C*#.H58,>",Y2FH4#4#!@_K1@8A<Z^@( KQT6<>HX?ISY3F#)U?,
M0,??(-6S>F(N+$KR38?<H1I=L^@^FU2>%#WP<[]:#,O*OZ0S'Q&3)O(D%%"3
MJ(\L5G/D\!<[F>)J%"Z+!:R:^52S.J '30H):J@&<V!MYF4GAQ+X+M0-2[K_
M)L_N9K=K*("XC$B7DGUFE-TSIZZ.B^!6C6K,+56 !9]D\P(+RBH@[J:$()2K
MQ^P8EZH@7K7:HP3#27B%*,>9J<J=G!$L_Y=8B>%"SQLJ)O3WQ/W662FV!)$&
M$*PPERB!HFGS<01U&3?J^RD.0TN&6H7H1DL.W'K]><XDZTP'HB['./XW5E+T
MH4))K0""_--9:#5ZALFW*GOH55DZA]+; I81O)L>L#D.,'1"/,V9=:%5EMR!
M<4)R &VRE/)VM9DZSO39&3O&ZU=J(H/[-$F_()G!W"95G\8Y8LJG'/6^C<?3
M@DXF)ERR.[5RZ"JII<<R*G5,XW2@GD*KK99WHKE&63<2B<* .")1>_,GD]PR
MX-CBS0H=,2O9;BD8-?! ^'8\4N.<L<7#&F5>S"+V"Z3V.4FKBJ83_(KB@@6-
M<#<5O.*S1&MDL*K ]!AP2992V0+0KJZF9*@T((]8GPA<+G7<E(,RP:#@EV0\
MQA' 7-3WU/!R=2HJ^^[*M<G$.E=*R'(P!D+/R+$;\VP<RVLLWR":J?M@, NU
M,2M+B()!)-=)>4:W&=PN8NRIQZMS](4NDDFF[&WF#!G-Q\3VD/3G=./15@/;
MW*WZJIP[OI+4#:!OJ0S3#6"]/;^G<2))32L8FEI,'_4I=?#F*-PDMQZ+TEFJ
MTVKPK;O;F*SA##)H8W(Z_5DP8VA;'BW170^)H("8-;3#PQQ-5D]N*2!.VL9W
MN[LY82(=@3!]GG"-L?KK"%M10*11Q\CYRFSOET-R=3DZ/JM4&&U?S;!\SI%R
M!'@8#Z"X2@AM*+*MA&VD=@X"L^J!QP4Q%RJE0TU\-19*"OP2ZN]ZXW!"Y9RU
MD6(@N$ V<#*5!KA=G(/(D=?$M]!;V6B&]!6&HTU-D(,@&#:]@\65&(C2)X^G
ME5CX 7Z]DN$WV>B-FL\;->#X7@?O7#X*34M17EC[#,@BBEF89KATN/UR6R7_
MQD_F+"9X=.8ZG4\^=Z%.F\YX45N)U7RR(N:'OSF0 VO@?SCJ/8[_H7>T'/_#
M*N@?7OXS-@02-3A#+=&Q+T&+N>#8#LK[12X*750J 9,S#OD&3[R,)X[0X.-[
M=;P)U[UTU?Z(*_8Q2GB]?D,;A?[^!UA(PB1P0O<GMM:3W 'E(ZSJ!NJ^_4+_
MS"0!7T4^8>5Q.2L++_(KZ/5Z]0.U\OC#=:W^!L:^':VAS\C[[(N8L.MOX@)K
M 51<+9+@PI7 <E,:]1OZXZ?N[GZGMU\KF3\B"F'O*-S9>7Y$RI<F3=W.V_U7
MN A/(!"+Z0O#@X/>S\[!.@QWN]V?5WNN?GC _DK@]H=0VOL5I7VXIY8/<=F/
MWFU4M[68AT?A_L&J\&-?KTQM5/<2JOMHMZ2Z$8+A=:CNUV^]GYADVP^AS*L6
M^%ZOL[]1YCX[/-SK[;S"I=CH\I=CAO?"WM'A4^AR"R>:<)LW<-$;N&CK91!D
ME.PSE6I!ZVE44'.TW;[UP+:M"AE\:^RF)RD3^%UG<'4&E$NIU<P&<6(Z&M6Z
MZ%XR1%C"2M5D-AMCAT*:644]E")U:O&&<UTX#O3&$2+/2$/U[+;:;"TEX-R=
M;>?8J1E\)774=F.COXX:"]O3\3V5!YAB0ZMJC$I-[&*)^M+#/G2W07D+E4U
MSRA4$$(1733)!)1 HINU!4Y0W*[^!85J(+W4[V"JN;$,.^.2*:SZ@L<B  -@
M_BCA&%HUE%131 .'BB!_09)@7-%*TZ>I6E]]!RIBGK_(Y4(::*CU42HJ_ 4H
M_M8^F-I?,T'#HSYB+H2R>LB+& OSU&(KV4DC74?O;P=6TEG$[F<% ?Z7^C*
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M]1X&#KI2<2L07-#0'3-Z"N B),5@7A12 !!JV@+I0A6[V:@%M[C!9U WE35
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M'!$9BD6:%B@132;S":R'QH:UAZN\SP+\0\$+15 [J$/-D*YQ)%YZ 96D]\H
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MZNCR^L_0QV^ $.B?$J(1N%2V:+#;[75V=K?ZVUN)>A;_:["-3^%_#;?EXGN
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M:A*-PPC4\-=L/)]X8"5)L*5= <:A!=2G+<3R&8''CME]SJNIBVU(;N0]%\A
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MPZ5O X'<U!K! (E;H$>!";6(J>&8#H("HEZAK$R\#G",-_-D2-K,]P@!]"2
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M2HUAD?+[OL1O_KP%G(:/ZMZ/F,;RI(I_R(90@XE!J.X5*%2<(@EC/[9:W+
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MRY:UDY@UM'+] 7[T)=^I[_BJN71#_6M0F!!)S">DS0D"GH3)1K*L].N2@3"
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M49#-5 G&(%7<_8 PVKHR4/[Q(1X3Y#Z:S4 T0.5;^(/C.NU4Q#-,/!(U7)T
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MF3&-$87]0UV08OC9"L8^$7B>0GPLAB6=PN>F&-+,B:\ "1P9!H;"K';8Y)A
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MT=UO*M\Q?-_72$H,FP@;G!&Z@6YMH!TD$<..?KT;&.IFR7#CC_B083(:0>[
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M(7Q#K3"]Y!J]^MXU:MPZC<"!K-965$T@EO/BT#V*I2DUP #EDO/Y&\4<>I4
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M 1J.UPGN:(VCRMUDH\TYNTO"+,MLLW9JRYR*!LGB44G?]# KE9I031<23JJ
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M@M-K9 Z=,>*4P)2@NNGWB+]DF,-4_-B&%Z,B1:-(.CS3_58@N)D9:5U;5TI
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MVIM-)V"0.T: O2ZBP"1":!0\'?H?Q\V3AQ!OSX5ZRY.:SC2TVYOES3$YL)D
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MK_Z!SN&#?<_*$[:]TDG_'09AK$/X3@*?T[-2SP45OJ3W!MCB!(AWI(B"JQ=
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M9B:^HHGS<\[4F<U>DAQ5Y3##5+QK":=TZ<^8!UR)<9[<D?IU'CC>!V2R&.Y
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M5JL6$"%K9%X&@2I./]5B=V=763%&UPD #8 3FE6,YY=O0DD>_)7[@(@6.V<
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M;][PXM7+-SN_IB]>O-A\\0*T+P>1K+)6"'8 8N"QABA 7C9<UN6GWXW="N&
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MKD/-*]>0[B'O'=G=9[N"QWC+P974Q%.X$$^7_-O"*W5[BU?#OT=]OVS98Z)
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MB-(/G7S@[\7RI^\Y_?.# /:YIG]NI6S_XD)5KON;5@*%-A(=9>&ME-#MU0T
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MRLHN['W6=!5=W*2M9_N+ &7P_.W RO0*.2''=S,E@37_=4 ]2B'*';.2*/
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M'0O/6GH+G=XG4E[D=O)%U*UX5M04?-M$4W[:;WA&[AL'Y9QWOQ(32%<'EX5
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M$/M+-"!"I0MFK+B:^-G'6U*_3XLL+YGPRHU%O8AS<VYB,JY*:%MPWK6.(=<
M QSH1M@41,.C!^<^'1X\G[SU@M@<- N]8V@.O[I*9 X^Z.6K00*9^P8>H3L7
M4&<E]+^^4<HZDJ>VT+\0*[D\(/CGC/9]%P%V-I<#(LP.L62(]S!G]*?JV,7%
MD-F,,W(""&]Q$Z6RW3E1AF,\3QC',+R5QFU]'$(HIJ214I5]<:+.V>M)#(CP
MS<1^<^%:=:U4$T:8VOQ2=^,N6<Q&(N'U.#58@K[6D"(BNI:#PFH*9UV-_D1%
MQGU&]L.L3QC8T[&G9H$^,/W*GF)>6:SITX[E3AE J2Q>H#$:VY(L&DJF*SY'
M<[QSVMPO*KPZ;WM7P6&PK?4Z3SI17A'SG2R//6)86:C]7-]@P*":"X:+<0Y6
MA\^)BRK#D<K&ZVK+:-%!QW%!4F"\ >KYF$T958.DM'A'4M7.NG.A+?Q<UA;7
MIZ%XXBA7/3Y<>R;$AU!!NH-&=8B8O>,ZT2QM) MJ;CU(ZI'N9,+YQK'<0!'4
M2EUF0X[VY*738#J.2X&9[E8Q-JF#(D\&^$S1'-G2:]@@LG6N\>HHZL%\ O"C
M =<XT GQ!+&1-$8Q039.ZMKJ.O8I8SFJ(=&'KLJXI@1[M]%]*T@F.C;+NK9"
MS4@%.[:":"%=DZ,J4&SVEM.PN_@V$O-Z+JIT65ZQMR3Y%T8=(L7I]@"$,1Z;
MZ0(SU&\E&M\]W5^;B6K3]O%FT]/H[&%AH6W[G+M+^F8,5X ]G@D,))8RTV:Y
M(J8$>+$1.1#4+F,GH#OSZY3\".3V$LMP>=;]^\Y<O/Z1N?COE+DX<X%4JUZ^
MB]!_.^Y/]R,WAUYTTX21^5CXW<;\G3\>OF]Q#!H Y?9O]\D^^"F'AX=R?3K\
M=F"N>U%<W@[5"1T@N%?HI[(.=G^E&-(:,KN#),R@UD9HR#E@?FFDB[H1ZT3'
MDC #!$LBPV%I;M/C=G]61ZCB9>KZINTJK!C5N256CW!5N*%TC2/&I"FW-&!T
MLF:F:D0ECF16LACZ&824TY'==EW$ 7MXX=_KG?Z^\;9W:D3_NQ!Z<XV9A=MX
MB][.+:",K6]%0J7A9SP91$5*I3W4KD\[WYEN<(@[:Y5H$.K7K5#\,&"W5^3<
M'WB@M)PUKJG7*R4</9<"4M\$$3B?YR&<KQD3#)8S!,H&Q-DL^*+'H,67#+8'
M1$:2-'2RE3FZ2MC)7- 0]>QXJZ2OJ-.DD9ZRHHO,H0MI$;#(>S(?9SPT_%--
MW<*7=Y>Q[$FNNVUHLF?="V-C'S$6!(\;V&$C-1\3B]7#ZX/]@\\'^_W#_:3_
MGY\./O<^] _/GEG97[</M9(B6.""M35"YX<7%/PIM2"W$CF!*D83=)5%W4*Q
MER#B(IF1L%M7V'^M>Z NN<%Z3#1 ,>-.'LVZC>3P>R"0@V/@1K%^W&?QP@37
MI>L6R/T</*  W']5:0' RZ*+R+X!WX-KW77A(1SIHJS)@DUW"8!P32/Q$ON<
MW#ZG<2X^+Y.$( "JLW2=<)<'"%7 8IE:_N  *A@8*DI6JZ!#7"@_$(R4]W:2
MW6C(AP!^W??4^%7P4EZ#FM$A9Q?0<DG!B?=-L2!%V3,I% \*&[V/;X0MS!X#
M_QE8%HXD U4;CR,J>'/1QK93F$*8%9XFXM"J)N?BW,QTU[X$Z#F8JBL3)IG:
MHWQ<?"+D*$0E/EH:H21>Z*JH*9AK]=']NE9&"V-AK>A6K;#W:)O&P>S$_FXW
M4W5F7WTL^==I4:-C<9X+?((,A*PLY]B?SJG>)IOD8<%3\/[G$[?\LP43&HDF
M+%68/X('3,_H@XU@^.Q?/!-SZ2R*AM)B&D'9LU#MK)U;W+R09K1QC,4H!P1&
MJN/2O 91<F341W[P'160_ZO%.$GS\8NY>461V8H#VU\V]I"B'&33;& 6 (K5
M6\-; $Y>%9.,-27?<QQ\>^M'(/S/$ C_B\7H4BH3LN;G3.;H3AERU4&)6]X,
MA&1G"%=1<<Z-Q.O$YRD8&M^^,0J?.U=3QR9$^,8.%-U3:9S[&)XWFQF?GOQI
MXDV5&-DXO[)%X]3G5 B#L(TB)<:EK,8\\JJHN-DR66V*) YX N'+5U7QC(P&
M_];O#3SK(632"!5RMI[&P%V,%-$@$2HN(KMQF6D!;%'UD/6[T:_6+JVIUZU%
MM@I7-?4; RQ1F/=< _X'\HZELQ:I2FH#N$YN@.R?NC*^0>\OA/.[)Q83XT$5
MU#43MBR9Y*"[&0M6SYM98]FBSO,R'Q4.CAM^HR)*7B.^#)!O7(_1R!<2(BOA
MRTZ^E@9EI#-56 @N,9#6-MJ":]D\Y Z>5T:<\,:!,SU20:2VZ^OS;F%(,& -
M0I[$LN(+%"GF9?_/<^\JQ#O.5EY4G#%X/B?K'>W!1]P#>Z3>D2J;(O]E*_T-
M-DXJ.&5O$P6M3/H$.KA%K)_!90&F@W'-I_Q/^,20_TT,9O1G^3?^W?YA6LV!
M1@\BDX !XA^;XGR,S#EED4/Q<YE/+_/K%5J(+OW !&^%#;BBLNN4UT@.T_T?
M/\H>]/'&I'^P9P^SN;FA'W#PY_6BM5^E^^'R]0&&H*XW.&+:; A<>%>YN\I!
MH5%QU]3H*0(9U4%$T\K\)0@ILM&N*1LC XZ0K&6"0P$2*5NO*7.3\YL:]/_T
M%R@&ZOJ0['X3@B=2\(/"W%G(9VEL&1C9"%1I)BC6E8:'7;ZK,2=CRNS"XH6,
M Y%C Q"/X1##PS<K/[ZZ+K_YY)GW0";^C!@E]G/PN:SK_U9VJ7:>JD^]Z,A#
MPY@@0N-5]-T8(A-WE4'37(QI8SXETJ!TR",!Y.RY&P:%K>3'@N"%EI],L9O4
M#GD+QXB#:ZXG J?8F*2?+.R@[XLZ8\/<:%(5FAVJ=;(&+H 1"9SK8<[1MI">
MXYWH6(_Z@8@,8/!4GF^1B/%4V '48WJK9)?7+B.;"V;;<TQ[:%>?^3/T9[TE
M1@U@''[[92]6X!WG^L:M1VPAD:/Z$1+I9[W_G?QQ</;[[T<?]@\.WS^7\(\0
MUIN]X'[E+@*DSPNN8=H%MB:B6)< 5@WKG?A[1%^N))<2T%:@9BXC1 RME#5N
M^'KBKAB\E573"&=<4&=*M16634[LNY38S8-&.9A5^9+KU@>-JS:J:OL-_Y0X
MKTB'RF&.[W* =8S!L#/+0VYK!26I1.>NO%?']VMVP%S*;,$CGWL^;A4:AREE
MYI2 >5*&:V'PDS=QUJTPP2P(T+,$L![.!U0!3$!0G ;6,FMEIN?5*ASP,H1J
MJ/8D,J$]5TP(B4:.@69BL3ROJB]P77*'&X*_ZL+=]3"+6'@,4I[WPVAX(QR:
M;]\- O055B6C'*A"@E6P-X]Z1[JF$RN!NUCBM%RY*'SG<K!@VM7H"-U$Y%6>
M1:7OT4X4G$?V DKV2LRZ6H*4BXFL'7NU+6;0PS&B0;=:/ES7&7::X4WK\ZRH
MC#0O!GCSY^P)CC4H$8P.J(<Y*1BS\#67 U/A0=XT3CUFD)HQ;A[F04@?91"U
M2L:%9!8 .3+'GAR.$;SMW!)-JII7VET08J<0]F-24)A"2C,GN3"1,F3GRJ\K
M8>^"U7=4:4<A3AAO&#?5@XLMB)-J?7,-]Q!:* -"/2UI;],MOF;,-M(TOL%<
M@BL@ CYPQPG1 &"3* V$ =\O=H+T6RE"<2NA?01"\';MU%TS7?="#$HY*JP[
M!/*'%B9AS/*)M*AIC];>43E<)3-[/QHCHY"^6>8S 47L34?A&,FR([0?CUM!
M<'2WC!4KL(T ^L5W^PS/,3LYWW4":?M' NE/D4 *FQQ8]("Z%[#2UW8TD'9C
M5?DO"="[ D -<I:8*AP OEH@L,J$)NTSNV9;F>&/.!)^AB1"?)QER">J,$^N
MM-.K278L4EW #&IY!20#H$+@OUT%SQ$M@3V(S-J1,R'()5'< H)RLX-UEB !
M@BGL"C2YN<OHTJ,;A6 2LJ1K*ZXIV=#6@N9T#0*S!+ .8"7[5KLVDLZY]0NY
M2TQ9^>6B/C9V6A>5I=1SI  TM,2<X'%!E[/E?FR*K\G$"/(E5VZ6\+V;!3&5
MC@44UG%^;&<TAOH_8T+'][ X0#/.;EI&''34LA^1B>/+V?EPXNJBDN:T9.-9
MX2AC=.V^L82H?G4!>S9)WKMY#5<9T[UXA8T@@4KD%$V;ZR@\C#=W]=S)CEO1
M-1?]@K:QA]Z06F@FUU0I+%Z?QH7<(*6I*/%=P$ZZU.D;'V!$B\ZBIFAG@#4/
M#T_A+/O"[3V!"]O8LOF21Y![#%A&_IYUGWDBM!@MHDFH;1[?2 ^E0O>L"1QM
M<L/1EK0B82SK.:K56#.@1R>B/^N??#PXI.XP1^^2T_[)YX.]?G+2_X"_._W]
MX#A-SDYZAZ?O^B=I\J'?^]R'#_;>GO8/]_IITC_;6S3*QX5*^1"U& S-NMX'
M<9Q1[#N@%,2A[8U&QIO#D)J41+A?8:Q3VC;K#Z=>Z"OD6!(..PO"&^HD>'1$
MH\!KE'/U\ (3^JOR9IJB:UN,:K/Q@]0\WRS$$F;123Y\3^FLU<Y3H1H#_CR.
MI:G=MH:%G][W]UT^!)>;^RI^#/V41^E*FPG>PRR^L:6O*/)[WF#8#D1I A$*
MC,3S/D"0HQA\*<U%F#)GFDJ(26K"/C2"[G:KV2IX-;-?F@@%ZB6[%S8!VB!H
M$$_14# Q& *@.$W.>!=,\&4#!$F[1-&T&A>#FXY:Q-:R7&>N 9I+>/AVI?,T
M7;]D#?]X>)>^][%_N&_^_^PTZ1WN)UJ;/[)3#S?EVXJ-$:1ZPO. N-)L@I1/
MB+=D!J_<F0(":XGPY\2?,@ 7?$SR.)]9I!690JH]-LHH1(,H]@*?&5Q2N1C4
M<6;7;<DVOQS-Q_)E,AC%[,TT&PYT-JP+RWN:#:_RN@&K("-&\5I7),5'*CR5
M,UMRXD IT)L1[(\50+XO .-K)O%B;;">VH>2-:X9-03QA0$V#RW47GR;'O4Q
M:5029=M)M[M8Z4GZP"XH=N[LH )OY&7+X5F$6Z#.DK39#!"$I5Y%=>#!;10R
MPWM*%;:U7#BX OL"HMR@L$@1BJIG:#I[1#KM0\XKVX5-;FS  LU!^VR4>8SO
M<EM9KV)3XIC)N""V&-^H7U+[:*N00G;<(5%/E<U<>G.MV@Q2#J_YG@L9K-+?
MDKX&9WFB+ 3?\[?H1#-0R\[N9+E!F.4E-ZE&[SPLIF!F3VSQV5H.>\ZRN3DM
M-03G83DQPPBN/1UTYRAU^FGZ[#U&0\?>V:=3L+Z//_0>7<&'K>WI2K4$92[.
MQ(P5C:.2LIW['!)8/$6NZDK#K+-7>H]/THB&S&$)HFU%P&.ETTO!8IL.KZ1E
M^H5Q3VN@(,;:OZH.S;WYJDTM\J_@&0/7L\>R9\9?,GT:NPX*9R)*XZ"#'BYZ
M&XJP_A?3?L'$I'J<H+ N9:_3Y&:K)GGN=<Z.9'0;G=*U>X%)=[M786Z;P^46
M#Q!#Q^9?L>?=P+4&7CC8H@G[Y+%;P:T($V21-H_[OBF+MG=^1-K_#)'V]_W#
M_DGO0W)\<O3YX!3B)<\E%')8)?NJ&F1%Q $B\!A 2C1KSI+SDZ>N&-WQSS.
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MYA4'YLQ:#*$E>,\B5R-@'^NN1IU-<BZGMN\$I88UG:S/8=]-'QM?_S#)//+
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MNMNM8O&CZE!_O8$<V$QV4A:C&^_SV45F;IB9T-X!C@HFJ$L<Y"/>:TK+<B6
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MX[NGAO.6SFHX!4$^9T(.F-6"VEB@;BCTG_WP*T'6)82OB;Y&:@.>MY?YKJ9
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M_]EMO?P)0&0[K4";$8O>7TXO+D[?O]EIOGJI[%JW^'O-0&=W]N[M+NQK;3V
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M+K3#V'5O;;1'GE;QJ=M%(8,;2SO7\R[Q5CS]P8<,\&K:I#[PZ"B6: 2(:,G
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M43]VJ,\+L]2F@ZQ+O.4YAR9_W(0FUS0T>;_4H?[B::07*5[\IY"Y'D>'$B?
MW^N20?G:Y>1.'=[(4.A]3DLK-J-.G\1],$PSH==AHCRTHP,3]!<Y8EZ.?)7M
M Z_AI+R26L?35.(U%%]Q$^9)/19VZ53WSK 7!'F OG33M%<^*?BPJ[ZG+(P%
M(X8C-27$]V)BA7CQ(XO!793R0T.' C+/T\DC70>1UK&TE[!D7G_2!2OT.K+R
ME36'>SV;R)?5#:B>ZVWB1@\>-WJU5I&:KS-N]/*!1K6WB1MMXD:;N-$F;O24
MB64MG5@&4QMMZO8]=NBIO1_])=J*5K16W$1C$[]:F]2V6E=I:V=R58L5U#KO
MG>P%3^-_;K&R_\HI4X*#@Q2:>L[8P,H^TI9QG4&\1/Z6Y,P(25=?BC^5FBNP
M9UMU/0W"K;/X5I%$V%HTJE/.-.3[QI97HXNV6CL,49UCUG=2-9[1/:SZE6^Y
MV64&JS,UL[C@S(/K#57M5:[4!4?^$B;8%"5$9XXP5KH;#0\"]S!1<SF&%OHV
MPZ6_3\,^J14%(A^#W;LRL_K3<+7'N1-SATE9:A(<KQ5]$WY^DTV4DM']]F=F
MVNK%T55^ S3'[*^*C9.P<J<@KEHM_2B/U#=&$W0ZR0Z;CJMH]$KE+4A; ]_@
M>.)Y)J4[XF8,WC@FJMJ,+J[216*S\[O4;PA>'$IY=:>#9$)1&-XKM8<-^GT%
M<DSICP$764A_5,L+U$^@/8Y_;CS-%?N (>#007##PN02_][UA?]7!HL7FXD5
M\&1>+A[@:)OS!9OE+,V+RV24_2^-X/ ZK=89U(2\N&N(6CG%/!!:-RIY-TDF
MTTE>W'($081CK)ZU7P&_=Y,QBBSY"V@+X#)(I!+Q,"TNU<QFH^M\<"W[T.P#
M=42ACB>R H](GU-37V)D0^@>H;NT:I64]VJ0=4M*:,X*L6)\W1PA?+VCZ*$J
M:*5IH=JI4UQT.NJ6YL^,$AFI&CX)B4+N\#%+*&S<FP*= /N[>E?9R[H"V%)2
M)5??I%5O&"&C7O16[0$()D!E@'U.?I%X^2 ;9CKSB^D656M6P+TV[&P"5&9M
MG,RFV\";&W?(NPEMU%!N#6S%:>=W?G\;1+72TH^.CJ*MX^R/J6RR#QJ\UHBM
MRTB7!0B]CC$.OFRELU&DPT3M/GNS@9PW4A>C\KAIC!83$^8 31/"(8#LFK^%
M>(];< OL="4',P!%$"TO-$#,QK=1"M9N#P HS&@L"&)(/7O.F(#6S@84L*:@
M@.7RE1<C./'*/?,5$CPLH#M<AC54ZSP\P)O0XHKUR>TBW$J]0DF# EJV=6;/
MD^$X+QR_1@6L.+)/LEV1VBJ\*SI;1>%6"DA)R<KJ-:$J'4+BBZJOADZI?TGK
MXE<M<./$-BI<FS56'TT_9O5VR]R-UG?]GDLD/QMASYEA0L^V97NZ&T FUQIA
MQ]X5R, ^4@<87  .%_NX2+H3>0C1(@-:#+Y,C5 MY?[U[@;KG5R,Q)#)LP)^
M[;(CUTUU,_H44A!\)23OJ'-."GOU_@_<_JY6OY7K8CR@U><%SQU8$G9=Y!O5
MA'IZ5WN8G!+-+DD152L9=34()GR;LWT:W:C;%MQ72@',#!1^(>VGS_;NF.C#
MW3?C:26C.C$I#($;7] [L4,I$EA9M=N#*@@ /Z4/CJEGE ZK7E+@/#2CMTDV
MF)*ER-N&^L^30OL95.2$G2)72&-46**BKND+:[E-.WB#B!*OCL%ED:;:+$F
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M:9+=?FS^^)V>[@<H61#4S6RT\AV$;$4V7:4#C>6V8H;O.">E)KAFRG3;X4
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M966)=I8^1!3"1/8FZ.,HE=687%77*->W!Q,,4>3.A BIIZ4 #24J2IE#J2\
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M(Y8Q1<0C'H("<E$N45<8\YB9EKMK)?)(P16NL82_LTEHOB7M6!4.T:JC>JR
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M*Y<< )T:M?EAPU\JRVC$=K/>FZB.!\<X'?&0<)QS9Q[/5:SD,!S+JQ1R8>!
M#I,,,RO1M,7F<$C4BY@E[?S6J42(-7J_WG O':>X4TG"&DT<#]?<]J>4O%/F
MD@FLFJ1WKOSD_+#PR7F78AY&^9/2^)56IL8QL9,:FM$%.)[X(9UYFA1@!KA$
M*I(L75 R" K;429>,"O[><17*2T'9E[1_J)]9?="C@._5U=&D;<UHT]D[<[9
MT_CVDA,6*<6J2W8Q)5(+PK:7=Z?RET3MCRY5;NZ0!48Y7CJ1%74%S?E&B8&
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M(Z::@>](*$AIL\4HO8W9HP6EHA-39!)^U>GN_0PX]G#_C>GEEQ@RF")]ZF2
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MGLN^6GB>>;">=U1Q;/U$(,H9\"9W1 G:<4D()5Q]+7(H%8_#YKT/JK,1Z4;
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MFF3'R.@7I$X/Y7!\O^5:7!'&>K6T]5$$(7GQ=NC'R1Z\ <2ANGDI+)M[7R)
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M%8GI89]"R8EKX6/&80_1,>;%R.Z_I+WD5!L&U@UW1$49?WMUK6,KC*4J+KQ
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MJ=FA;&OY*%!F>^4]O/"G2%X%W%K-_!WN4\F/G\!D*#'^IKX5^W1";V*?A>0
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MW28PY9LF?#X$W]3)D*8^I=P]A=(W-J71G"F/;9OF&&=9[1O6+O]\9]M2AP[
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M970-ND7+2&59I_)-!M&YW5I.))EEI UZ92JEZ?'63O1(ZE76>\W%:L<,K2*
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M6I>FCV1JN.Y6O79WV1_3B.,VS^A3-(,K,SA#UGE,X5ZJBSG91H"B.(0:X_;
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M^-(&O_^+4%<P_^(,2>FZMAX4,Z3A-V]"%M(N).7S^A*2MC5P]CU*N37!&Y]
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M99JLF<=JO)HYFI^=]<V_!(#$;EZH^TJ03E14VDK+E.')/2#(/]^4^&ND0]F
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ME<:U[QKRU",1I(#_X2'EVS] _C=./%&2NG_F4.F1>\_$5%'M)-</U^E1U\L
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M/^@X MMS(7VR29"6PO@<5UM/S<X5UF<.2%:MXDXAU6T$:SCX4%DD.H8E<TT
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MXW 3-JH%Q,MVOF*.VB ,?>!\(!'.]P8Y[="_,"HRKE>=@'*\"@L&-UZZ $;
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M*UB$H;&U."6/+,DJ%S):.M!E;(,TP9Y2MZ$MT3\TR[9#?^+E41]#04'(6C8
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M3SB0]K+0--4MVOBT2TCM[MD-/?U24PK$3"69OT]I2M.P^3;A$C1NLM0Z0=V
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M)X" PM!9AS*GSF1<M%((.\SH8<>6,[EAOY,S>:Z)FNOXL &P/-I@Q61%4.:
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MR%E$8[/.9T-= U5C-5Q+\Z?1X]KIE,9Q-HCIT6OS53X[P69SAKM2+;_:&JR
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M1L\;44^X'O/V;K8)EG?.PLMG =Q'M26L]V6YV%\FR6B.^FT?G#5>0BQ9WA.
M]OH;BAKF7JH*T^05U JTS?__S8YT,M&1^C;O.#CW-A."F%PAG$>+'D[%4&>.
M1]#>;0JA"TB@2X+6>\GCT>W1D9<PYXEC'2A^+#-K-IBC )PV>H-3AU0$_$N-
MF].OK?="76]PZ1B-X#>X!%)Q_^NLDIL"Q!>7"^'_CU>=0\_9;BTO4KJ5T/(]
MWN!(C=W_&%!YQ H!9O(Q:SW."NSQ8IM),S^S[9&@N'?3^8Q+DQ[%!Y^2WB9!
MZ 5>R K7H=DZ%FK#.4M[Q)_0X?PZ P:VSU->1S92[KB,!X]3KJ!GYZ]:E/^F
MN(&X*O>L^MI-=H6QJW7'K-5;+%QL)/V/$=T2$?,A9\G]?H/>I2TG;D[V)3?!
M3\D:9R2K^1N .F1%N#6H^ :_$OY<4=#LV/7>SQ;U-'$%Z5LG_]_2TI]+F_F6
MXPF9KM$8M)TS@M*A(DHE"<$VG[4Y$P]P(U(^-6E4?V8T\6FV8K<MZ>F;.-@?
M<!9R^H)[8.<QS?4DWA-Y).]:CN(Z\INH3XJ%Z99G:7P=GIT8=Y=J0Y92].":
M8 /^BK[^X>)"$'M:KV:P2M6&A[0,9!FJ_'.0C]ZI!;O!WJYNRM"Q7%M<VBFL
MP]U;V7]VX,#9N@]W)_.IC*$2J"[W_KSC>>RWEEBP&>PN_B)Y8/D]WYQ.^+%3
MTN!&J@Z-^FJ$_VF,>0+F/#U[R"OZ'Y.@_T?;40OG3#S)Y6RF@A]*8%)/F_"A
M2A&W3\*Y +Y48K@GWS>X*.@ZZTM*-^N9;7?</.M^S.KZ\_\O19:3>JVJE4\B
M;_.#\GCJ85V5:V*+Z^-1M#\G [Q]D26AWTVE=E9TFA!\;14$F=Z/30ML-7[^
M8L?43QU)J=?>#!(8KO1M:D-HQ#Q.>>"10I)+7(V7%?]4-+_$0]TW4/6!O<F_
M5JD(,I)>&K0%- 0+@)W=ZOITOQ9Z'8MWU!)K$V)(\3G/&I?M;Z"CTVGH^B31
MZ2K<?&71W&[<Q%DHU_;[RCLP$^]P.%=8BW40KG;(4G<!/'LWCCB/IEWU^6GP
M>JY/.6)Q RE*]]N+QFN6;)!=P=P>7X4Z:&%,V[R5 D?IM[TYTEE3DKPWH^R#
M(Y!>'YIT+<+5O3\X!T:3]GNM3.":Z2\_F=4DPZ+),^!-"TT"B2!/ N/=U_[^
M;>VSG! ;6I$DNW;9IJD+VWEP\@%F7E7<MMZ( )/;R)R.$;_K5@\C'1PY4-1J
M2?4A4)7FW0:J@=RQ\'Z?D4-73 G->1H8%9ZSH_"UV[S%GWY>FO,1\MF6J(NN
M<YA\V=E4=TL*)134<[,ZZ3,BYFTXIG2BOS@/=%4+D#@'#=G3)_+/V#": QFO
M8[B!'R)EB8$IURI.N)+5KB+UW&)IBKX0]9:(F\0A@[[ O^92/_HMZ\7TYPGU
MD^13;J0M.= !R[__SE(YO<'1' KFCAK?/-[,==4UXH/=TIIYX7Y"6S0(^.ZQ
M(V>WH+583(J,2BV]\8)FW"U(*20X."1WRQ;BJ:EV[IC_)_<+S!6R>2!:;.D2
M@R%FPG)_RBE=$H&7#KG#V%MW7K.M!2U+1IE>WJM@XGI"K*(EE1K_(LL?@A,"
ME(U/H1FA]'U%280#%*:@][-"Y_I;]]YAFD47:P7&M3?M 5Q8PY*2M<XYKXOT
MJPKC,_W^Y^;Q$;VC5VEB6MW1_(H=0*=*+#.;JGQ&<+&\]>Y4ZPCXB_%_PB%T
M-V<5H_"^=J<H)7[!]GD6\)2AVWIG?<0=7WLBG_QA0R,7GC)GT=M5*;QO!F-\
M-H8:A&U<+E?ZS&.\2<\0548*-IDFIC!]?(,[^MKHM]@17^!2(4#[0((UGH,3
M[?Z4-E5'4ZM:?AD=/":T[JLVZN1ZGWBIN=WD7X',P?_$I*BY]R&C:;NSEZE"
M_D5UZQ!G_PVN(57>;XD)MSH3TR\B6!=1K?1Z#4HTQ-"#XC+DH>@!S%OO8,7&
MNR;>L?_1-IL>TV:5I%(D@__!.:*5_KHABUR%>'J6<[,G8%SX58@?8XVB(1Y7
ML_3:K!&&?.RVCYY4+PE>MM3SQ%SN4MWWPRR5'6-?98!./(HR \:N4=%,8_!\
M4X_N:/BS[,TP^TQ6&UX1O+*LK]!'=AIZDM@2VW)XZYVD.^Y1)8^:,C[^UV,(
M=I7M-D_2L%@ZUVXAGT? ;F]$:1U^S/![N*$W3#?NLL6*R:U$HF;H_V)<"A#.
MN4T1[F4SNE+:BKGK047/P3^]#1#Q=/DG[VX?WN"(8CJ-GEA_&JW,!E%6&TV0
MM7<]Z$<B_"<-W5AA<D\? T:%DXQ6&HW04U_3_,C7G_E2\8I%@F($+;0_T?^,
M%F"^0V;G)W)9\0VB+%#R<L$<-J=?K.T3!^V"#*LI&.FUJC,DX_'U/UE"Y8J7
MYZA'0(KUUHX?S_O?\9F]IUOJ2;B_G=^B4%=DRHK.@CG8/*3=\IVNEX"+X<&^
M7>GVLI;G69,>;-3PF?*0F1_VL@J_0FHWY:G_R<]7@\]8[_K9\*3 8R1)(+0R
M^O5BU)2?7EH,8K&<T0X3\0>_5?-0IVQNQGB_.2%)XW)3H5F[)Z%\WIR<)IA;
MOFTZ1IJVG9O* DJT&B)/'DJFA1'W"U7J\EZ%U_\QSO*5OS71T2(_!-;TV:I+
MJ7S9VI5V&AN13*"T9Y:]>ZSP6?R\\[ NS-7V.JI2UM^LEKSS6#TT)SJQ:NLR
MSGDU#7Q*0EX-23ZNS)-UYAEHI$=>NSNN,F[UK@Z6<#M0)2Z:68GE76XR.:]N
M(7$0J1.:MA,V_G64=^JDT-$K([I;8.,GH]C8^ C4QC-P.I-,G32A37;)$OM5
M.AR,HQX^7B"N3H$STJNNR<FQ%5T:+#N<.#=9Y>M,U;;EA[<U6[=21WY]]/MG
M!8"A0N^+4W=5B./@A1DYKJ.8*BY]GAPE(:,:'E>9['*8&? ^?N^VBG;^>I.
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M-J+!@?997_ N$6G'2FFDX]M^0A?=T.[_-\O<.LMWDQ(*%5">$[TW'X=/"JR
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M+)GD@:GCYZ-I(=GRY=1RI-)9.1)V_J"A4:C!M0]S.VGHYQY=P8%3$=X.H G
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M[T6G?'041N/N\*!]^-EBD7IGN$O;+<V.GOSC.32S&0]E'"Q[@_4=:Q-?<V5
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M@9<CG-??I#LP@"C'!TYIO_3\//5PWZUC:IPU5CF/<B"D<:TDXO?U!]R!+8X
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MVA(]Q[?WFX(!\7<P<"( D0N^5/V:4SPQ,X73'WGRA7O$E6-*TK?0TYK+/GK
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M^KMH.=&I2OE&##CL7UL8GIUW8P-M)9JPWB-D;LIQ[JXG2W@ ^Y; FL[T9GY
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MWBH:B_ZY+2T&-NA14(&6-'C2+\L YH QQ:SUO"A@>=+,P_(6#Q[_TFU+ZN]
MZD+-UWC51H\JCCA+YZ97C@,,-YS9"^@Y]/)1/T+QA$9I478S%<1E43/0TH/$
M/)Z.C44T+6GP9J;*,+)RPEF]N]:I:]FWIX?4(W['JG.T$LOQSG['5:'K;Z)]
MCS ])<C&FSYP<,=5^)XJXMBH3I/1N-$I(C.NM6JUD8BY9X6P_KL=[UA_,0V\
MD"/HDAG5=G).@%Z6=FRH$7^_/QFY.\'&<OP 917S=.YW:34OHP'@#?B.K+F>
M1&?"^SLJ2'B5^#G[+?^#D2',XTQIB/L_SP*KZQ[)?RF-2=O29YO>R ;16:*+
M-B_C752MTAA^D51<&.I*Y;\06N6'(=_\HDZNO82@],2; GP4GC>K;WJ7N2A#
MP\\P&6.2E-1Y#1YS#=D4C(1,K2)FY0HK7RP7;)J-(AO*,;SA)E)[_!BWXW(N
M[&9@;B7LE+7&K"<0CN6_UH@WO-8GA+/]B1?MZ\VZ!3?.ZLG!0>]"4O>NLA8=
M4Z%Z##P?IFJ01A6UNI-/?#19#'1B_J_9E6[$^(P^5KS_HVK/$;I\2W\VA&?7
MW")J)"[C>'\YV\3<VGB D*:=S0LC/HY!L87N[S@.XE[7WD-J\?IV]^Y^HHQR
MSK.>+FF=;MRB>R+57J-^[Y ,G M=7$BC"R>] Z+\@NMZ>9FW0,,6J>7D4V(Q
M43LC<XP<V*^"/3$F\^0J@]&QWU82Q%:3KZ,H&>5RZ,&#+/X&?RE$R45$-><=
MG^"/J08/0X3;:0^G"7"_@]$_UIU/)XE$:7T2#U)2]-=V$G@%*Q)GM$E"M)T5
MVS.HW6M^E=[%C]K3?A,H@]5D8J\I0+\2T#5;X[PZ8 "I@8W\S\(&6NJC=*XB
M9A#CRE]9&)^(-VFW&8?9C\5Z]/HVRK*R%T>C>/B'K:%X%"+,>%,:_C]$VB21
MQA%"Y<Q: KZJL)8G\Y3[A*T,BR!(0\:JAZO4]N\1*U^U)RW44+@$3R<C<?(N
M/30+J&5[_,*TA(&WL_0I]''9&HWXR^ ]+^7BII25J"U\*Y3<^_5Z%X JWQ3_
M/QCV@B[B>H^.V$@5&+APZDP.)F=,%G:O*U>9D4US3LJ93'*Q,%G'I89VXM6V
M'KD)[U_;TF#[XAR^]1@MQM8/[E4FJ^=R/0.[HW=[Z9;M:Z_=W4L:,1AD80!
ML@0M;L[ZEPQ92=LB6H""3:>LC(G1+<++V@W[B"\JB >?8"%O2R+9ORTR5K#+
M'J+7(3".(6M3B>,^ZI%U6CO@^4!@H0Y$MV7NI&+KSD7KPN\XCB4H*&68W7HO
M" Z4Y3O#M7C^.N/]!S4EFI-V28L/P0/3!>DG)NODXE>4ESQ<U\][\<ET1\1[
M:6<+A4$8\\*]K>@Q;FQ,X_IA:JGA]PL5!I_]R];CT4DX=RQ..$/2-"$LDW)U
M5>0U+DR8,.)O/NK[,<Y^BHH[K8TNC["_=RP_"W82RGK953-6&C1H23"CI#<A
M1F"FZL)\D\=(\UJB; /J3\)8FP%N++D0_;(<)7OHDN]^KPL!XTKWZ[VZV-(@
M2N<-KVK1RBIB4%,Q@IZD=X=?&;34V$BLTY0U3$31:XM=(KG*KJMAPV?4380&
M2<96ZO(X*)K_8 @[/<:XJ ;/$1'??U92XUL*U>LEG8QAV]^'_XP<R6V053S?
M.P "YI2O]R,L%/7UTGB8/BP0YI=><8;KCM1J;"&L3S*:?I=>];HUW(C7TN29
M<3IH<Q#1<X?0K2+ZO33_,.,N8^YEW(U&/9>!AS"!6A9[ K(TY'\PX5OZ]09.
M,'';/KAG6P1YBQ7*6O';.LAUAPJU>I5Z$]+8UAND''M>MZ;D&B;1IUN2?M8?
MY,OS]PZ.&/KU,=TR:[,5SL93 @I=4$%5G?9E4[D.(V=.1EC6HO$5<7B'A\G$
M2IR<GW J>1K.,P"RT"ZPWKK&&S=;/+I2PM?(K<_R' @:FW4+2"A1.L8KC,]+
MM(,I#MQQZMR5\N;66R5(62'W3-JECNFKKOE6Z?L@S0TDF?#AWJ&9",;3[\WN
MVXVTOV:EVHG:)]V0_!=]4Z$X/T"?Z/MN;VH<?_)*_3[++K+BX\F5^2&JG1\2
M?E#HYV&H@^>Y/]AJ4$>Z>E7+A2F:/GO.@XU-8^ '8L&ATXC86<>4$5C5'ODF
MYQ%L<'0PE0ZX3'!72UK?]L1H2XF1V^:YC<L?V^AL7_3[B*C';TX@HQ4P/Z1I
M1VH9<AF\DH\R#$)QT"ZK3:KI\^0XE+=64D_4N;3RT^>5S\A3+ASXWWT$RW\_
M]C]D6Y..X"_QB0!;Q\LZ1Q$_[L_5<)I1VAA&]F8(0ZA2F3MQ8$<-OWC<@9?!
M?_QMEW=<^76S['E4+_\,,-%:X'D78+:B)!R:.V M9Q;*%0XMOV&BZ!?);'X#
MP%,BK@5OA#$*1V('=B2$-NRS<BX3KUMI\ T&J;ROEXM\K\4,<4QP@X'U:B,'
MX^]WY!)5(P[6%MR,18=/7T1N#TU96-.P5QY@[KL1VV;^!W1AL]QIU*/H-BN(
M]6YJS[I8A9HUR=>GK%)B>T5TB>(XC8@)3?-LV,I?@";^ECO:V=X;\%P&UI:!
M .76$\5LL#[7B$H029Q>VPD3*OBS 3/L%3$71_2M[]TD:K(^+?#^MD1L;K+A
M+AZD.\];WG+T2THSW%BG<?J/O+O7T@LY\*5#^]267*,TNFE3D-K(N"WA;C<F
MR#2D&Z%#JQK7&A97G8,R#XG\$/"V&3@8>0XX@!"U3D:55%O7,]Z Y&^?1Q*Z
M$0:%2EX_+Z6-H#3>>VQ5C>XMK:(1_[X@\T36 @T:B!V/Q)"#2F\[9A8V?2+1
M8/.AI2.>2Q+')6PB5/F##C]>T0 ]HUA:;,2P,^4&QSS*?N=6^NCCL*-]L?""
M0)N*MQW)=/.XC,$\LEHBL\?"51:&[DL]N;:W^NF7G\-)X,]+;T9E%>:]:I4C
M $3$8$Q:)[+E?(+<^_UE,;MZX,'X^X9F@F]I6[BAP^R2X%VV:J<MB2+YE]WT
M>,?<\D:4VB8O6<[W5N;5107\MNNJ3@99\W8')D,J_H0U>OP .PF[@*4Z7-Z4
M,NP_SF/+:*5 SWQ2AJ>@Z@4AQ^,RR>J5\]9ULLSKR?U@NWE=^XRX)NP,\W[S
M-/Y@RV524J-38H*2.I+ZIJG:8J?F6N9$84;,2!-,'_><OL/*NH> 0X-"O+J3
M[H(YN29$VD6FXAA=]?U,31\OOQ"4G0(A[&4B$@MI8]>C?"F1YH^,=;W8C4%G
MHDKN8NL:WH54,2F+( . ;QV&%93GI7&7#%?Z>\[O:!%S1'X7;_(H]M!7>R=<
M0C\GS5C>L+=TV\S?P_]@7AQN>5M-^-"NTK"2 &^_)TJ+IJ8M?1MW!2UXWL8)
M<?^0A!6M]2+6\4IE#*+WYXI\(LQE0%)8!64KP!^DOD<5^KQ"_;+D-CJZLSJ=
MC@!,H35:"@X"-'F9F.(OS@'W +%ZHCRYGSGWI:1UF#$83G(QACTB@*.LC03+
M@D175/SRO978Q(/5#JRXGA6I>(MVC3+Z\9=6"0G1)JW>< \?M;!J\QWR!T4#
MW+,WE'8<^1]M]]JM?&0M0-2T0ZJE+KCC?DL52K]]JX[,/"MK(\X 1]?72Q'V
M>(&T[R>&'@[Q@SD0F6,63H/3O[3 D]!NV[(U P=>Y=+L^0")6HWV48,CMC5#
M.OWS%%UNT,^]I>K@L#@['DY'5JLX_O#BJ="/T$T&QW8VA84O#*Y$&ZXDQ@<L
MMQ"2H)4NOH*0,PM!OPD%FL.@(^-+X_KQ+P9.GT$R&3TLPP09?8NS#9/UV+UC
M:D0@O/+^_E]3_!M0$\8<$I?2D,G=G:.>P3FA3\]+*VB9[=JLN#HP6N?7RBB"
MG1K[@(1./:*;'O"JD)7 U[$Q2.X;_ULR)+G[Z^4&M1-N7.X?#XV<?'W2F-"3
M);-'4)%#N&E8/<:9[+1\YM0FH5K@,J%7B39Y&$J6C-DXE@BY%].,]--I;/D^
MB4A<8/OITY?2J>2Y2904Y=WD6)FJQ7-/XM<U4_(OKP'RQ)>>U+]E2OILD&D$
M6;_,==+79'*N,,U?-A9=,Q15[VD95TX*RE*363,05P>P$%;<SD5@.'BJNB0Q
MC!0-AZO>9O(2AI5'*@ZO,=!J?'ZXGV8 ;_@.522G3C?'T>T_6D3VVN1AVX<J
M&&9A-$/Q*2G#TVD,SP$BE YB-T4%+C)6^A1.B!\,KB,#CAD7?@#R*IKI\BG
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M7-.NI:/[Q^=$[#J+OH$3@-<-2E*17(.*EW#&'H),G1"K=B%#)GJIK3>("*H
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M*#Z)KD&]'D=E=8;UUH)HG&$3MEY:<O3DZ\\<AZFG"4>)=+I*7SQ=P,*:%TG
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MHBQI538GO^X;RK\3960E/)+BW-!W6@*(A(P>[J,\,++4G"(#; :)!/10H?O
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MPN;_H)8E:>,LMI#K631/=!!+36M'_9'5-5^W_>(37!\ @TA!.X)']>BV:MU
M M!IBHW"ZW\&DRY:&)9,J6O%LM[&/W"NC?H9IF]P:QZS"0%Z1B[Y_ _N7J2C
M=G2:'D36SS]G(EG$;S1T!P,]1RPDUX/L-!@D4)IY&DWJ4S"/S)2--;Z"%MV\
M,P>X 6O_\[_C?UK;N_RX?O$WFQ59@^K"=R)R%Q0JFW<'=TMCFFK._ZJDQ6FM
MG_TM15,A9>"O7%).5CL'W9;4V-/2R92:?:,\^)3+<3R_!>NLJH'LTC]'J9,O
M1PH(,D9%X0VMH3 SOA>Y&IEEP[Y3K"HAC[__O*[_7C].- =)L?V#<X,@OZG
M";MZ5"-K'S+SAYC#7"[/YC?=*=<!N@4&\5<:[1F1686I35VNO$6!&FLG/E*B
MWX^ %)T\-/[?&;:4I6S81U0U^H4HJ;+#I5L(4E"]"FTB W[M$=1@"A&-*0!@
MG_5"A'-YTQMDY&\[GPA(G9.(+OM2,*#?IKZ"Q>(QD2, K+9;XI@GTFB+BIVT
MQ&627;ARL;)OM/?>*52O4;8:K_S_;M3]?_#67/E'^=N9NR.A-K9!\R \C]U*
M\K=_6;HU\,AGJ)*F8-6/J2  F<NPBP2GK$XNX3EX5.)KZJN-.JNM102TFW[
MX73AYT[8(>ZY7>J>/DC6>(.T@%6:0YY@CI>;>A WV9*D3'(MH/4VE&>W>7&C
M,G'@0DEO4ZVJJ+ZK!N/EAY#T!*UCL53AZ0"@XLLB1@M:O:-$+!RZ"GS#/BUQ
MW8E6N22<!HU<"$8[WT<PA-$[??Z)L"8[#1%I;#\.E*1\V&0S8L0)K\F=E@/-
MYE&<F\VAIOMM;#QX5<DI*A)W8TO8A1'%&P=EIITIC50;,14C?%2[(I:SQ! :
M%*UK^9Q"OV5WH]!&$YU9&\#7W?@ B4"_?6BKF'+X:*F?Y3S/U@!AX^DNQK90
MG5R]K]WC)42I_<>,J4W(R#RE#3OT75<2(!4*M$M'0^QZU??$:Z1(K:J580$=
M&\M!W#]H@22Y*CBA8Y'1;Y2LW(Q+L5Y"%>#8-*OSR2M1&O=GQTUC%Y4GJAJ#
M6G06&DD[/+8X2SXP-L/TU,<H'0KQ\U)F\[/!M#;T!"?S+89Q3&3E?D4U1MB(
MV!II#_>5P?97WNKI M/M)'=/C"R^><HW/.8:^6/?CV+:&_'VJ%V ?:#S92H5
M?.)^;^F;HOJ+7!&1N3U*OU$D_M,SXQ^W[EY@@.3T;5+"CU2!QPV6,CXOL%I.
MJQZUJ-W;'@9)<UKP9'/1D%OZ[)9<I7VI]_8C>TP9^ :_J&"LIK)M/==G[%Z9
M]Z&Y.E81YSO7.4),-NIGX&O0/AR3ESFR=<F0=<RPG2G8=M]>465HQ.(^[O,%
MEK 1Z?Z6RC9R-F%I*%3M^XX,81-NMF6+?AEB]'LDSQBQQ'CYX#JHI'DA-G%]
MO^_1?M$79!#+QC8W]#K UF-;O=K/MUF*:[D[E .02/5&5_FB(&L7)AA4>\$B
MA__-XO=KF5:5B<D _/8& OMUG@+*E8*9?4Q1_9>3;F$WL/WMD6V1&^U=&UPQ
MAP9A>B0CY;N8,#E;F>IG'3O&@:Q4%@PDSC$,GA:\8*R&=TE0RK#1.)5IZ@ 9
M[P/CWK.KS1.069E0I</-5FU</DNA3VI<NM,(W+(XK%P;'4%3KF733QA/!B9>
M$ .33*X0)0Z$F^BP84(ZZ2[JPC_2S"2DRD53T3+\6P+6T#=$I^.8!> #(C5R
MLI=YI;&).<) M[1OV5SA*?%\V$73"4MY5[U!40.=X\ TM _-(:Q#C9@64FIU
M $GZ< $03555$I#D'+%;GA!&'6^>G"MLX=8_+E1#J=XA$9-=H2RV/FA/&VL4
M/>_&VX2"!2^F8Y9+7;PU5\NQ<#:^?737'M=R_UK'X[SXC%'/$E&=Z#GJ,!J$
MFM/86A=?)3I/Z*FX';KUS([W#T<+RD0EW=KT;M?K:,O_NFN';;Z2ML=S":;D
M]8*SQCF@^$5=#_=<-UQK$H[I+HH]$<JG]#OEKGDC$A\O'_'GBH1U/$.=NT,H
M6(TE?I+ >CMC ?)6>Z&T%]VE+0%S5#&W339EFF1-,-^$)*@5!=AQZAI3JOZA
M8E  .39D??#>4BE52UD]%"-CIT6>9CDL2>N622VDOI?!J\3A_VB7@+"><VI2
M2B%@G_T2MCM@!J(2>&!VV61CU?2]ON'[U(CH%-?,HZF:<^?%4BS+YTV@AO@+
M;BP5Y=A3XCQ^L?]KNY&7EV)JQ@G0G-I1<&.Z5,I2J(;X+>33S"L)[J,WOGRG
M4;A+SH=DE1.3RO!H?N5U1+"0C3%;*%Z9M6;8-L[=7D2U]$V"WDY=F]!CF3X8
MPWM E=*O:2OFEK/WBR*O1:K)[,R6*:G^*SZU;4:SH$S0UQQNXP"#U3ED?%'I
M5"1I>:UM<-QXPJWLOWOGT?DE)C 27D:_K69DJ)?7,D$GCR6@/G1_)6KC/%0"
MAEGXO/S.DJX<3 ECALXF52T8G@5JJ3&P161D_N_:U/\(_&R]MI^J','K[L=5
M_\*%'F7F!?^#G2:]G?>I7;__QUXBX+GK#+S<TF5KLU/H]B_4>@?4*/NG^2U>
M^3_Q_L? X+^K7_]'W.O_M[G$)R4?X'Z72\SD24([\C6R1">89EV78JA"HK0
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M<OT"\ ]F\V)8<TP;1UID8Q[>[<G8O [AMHHLRAF$:TJP*%]+2R1@(J6KO?9
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MB;Z(7C-O6D(**^L">%1Y]?MZ']E_!$Q"85(Z8M!O5#+>:$1-M.=44QS$]+L
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MU;B+Z7R/(]#I(7!3+, -]$^BP8?8^VJ<';L5-$@#!W=-M5#/MO4Y*_(%UQX
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M[VR)V'[QA8 A48-R^5I3 B+"*'Z_>0%*,M0=G#<Q(9V!$CAXG.P0B*%^S,N
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MZ65W\JV&C>\1RX7L7<=U[569S2JEQ;$*] '04CI/=H&WL[C16AKFGMXI4/L
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MUP/YY][LO9W][:% ;P\WAG^<J)3S?[+HY_=HSM[6WD$08B?"*V!O)\HK(NP
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M7N(KG)KI%Y@[^"C2M50^PQG"Y?9\WKB:%^58UZ/\5NXM&*>WD:NREN>GBOV
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M^'[=VZMC]:/3;^(T.V4F)VOHCJOCU<A+[:2I<@Q'>D5_68_8NF);Z??_#7\
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M7E,B6"T#!^5N?&4:;I5@QUG\?"O94P7@)Y-">-].R'6$8A$5#<]S]Z>YFS]
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MG9)_:5M_\>QZ _0)+WCW7FU,%LM.Y=#JZC(^P17;R*:7!HUBE7^)[[<+/Z-
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M7=MC0C5%T4B4I0H3#]+MGU\?@&VPH:I[6K[U07,.(Z]F$C["47\0[QZ?/AR
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M8F&//_IXO:"]N'K9>Z@=KKH%"JTYX09%'4_6EMK70&')JN2;40!44Y'',9;
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M6E+_E_&S]Q4ZF4Z2^EG(ZM<-><0Z/)FJL:#K3\TQ,M#D4ST6<!TF!QY+O.^
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M3M% 0$N??Z@N#S192&\L+G!)SU&HA\G(TXF)G,0]!GQ/M3VW'QBR=.'=FHK
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M\L,TZ]7Q<5CI8@G37TSS'A%.;__L8>/B^'$RQLM:,".S&^3E+LA<HWD8F:A
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MQQ-5QD1(U[0UV;/S16_3J\4I\UYAAR'!R$PZ%RPS.X%E 6G?SM9L9L70:M!
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ME[NMMMJ64V*QJ!-:N-3'//?7+%/=T<!=1(=NY?/^&/ZQ:6PU'6<52?<23/G
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MMXT3:7J-1!D6OSM>F[0I?XJ*2Q0$NX0SX,UNK<+S,F2D)'=:Q$E:ACRYM+I
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MHPYQE7@U;;!3B>MBX^)LTNGLEX&S0=A2J$+ T/^X_Q\]SU&AP20:!+OC^TO
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M^WR\O--A\'T/ ["."9XYLE2>KCP7P5''=7M_@W^H),$.2*)W3ABLGBPLL9K
MB<)L1U9F))A'Z,M;+(U@)"AG7.\_*#^!>^.G-_F-&SLHC\<<T%QHO*#7&7%7
M*M_LX4'2=;39ZW$BU&M-8^R+":RGFOH5VOF?J@2E$9^H#"IR;>9C/M TB)2+
MC5NKMV4:W)W/T;T*'[U_3#,= T6((M8#B,QH"G[TF_(3SS6ZD$<G+-MK S2_
M_LCK/^VK??U[CK(*(B\SE4[/10Z]S?NB2T>TH<PH_& -T:RA*_SJV[E70BSU
M?*/=U8K*94G5C_K9 0KQRJE7$A]=Q894?5_*^@YTVZ,V@"63WHH4UJ-JXT?/
M)WD!/!;BX8C(K.8QK%_9'];I2UTLOKR#*LSS&Y8=AHK<5+\E\<&MWY=0HDRY
MTC].P#,5RYDXK-14W&@OT8$+?%W9R7E%_9O 08K4%?.&_A^(XMU@T:GYW=KD
MV@I$G<$4D^?D!8%?W6^;ZB:63*4$[W-'6"WE^-8F(.^U*J9+@K,>K3JMA\U[
M7^6.MDLXNU"E<70L@TF1BX25Z>GZ5F!E_DH&>QS0D#MWC*X$6=.=V1G2Q,C$
M?E<&&^,M__D@B:7X)5@]&U8>2^ AW/[F7!?IY,$KK>/$H7EJ%L/W=?22.^U<
M<\I?^D-[E .T1>)8+)9E;?_IP.4IU"OS#!BDS+ZC9$SO[*:A56H>;P"XM2:^
M%%0*1B?<U<MDX-**.JDLNBREY3E,?,C[,-/!*1@F)2VM=+*@7K(!7]P;$,^>
M9E53RL#/S[6@YR!Q#!5WSBPU0@^B-9_Y@8!*J1*M:&#C24]#AJ_:"9[*M[7&
M*VQ<&S,+ZZQ>@M'R"$.9CW^>EW?U(/U?+!ZY/[Z6DNXJ1-1DY0<F2H90=X 2
MW*^6K*5?Y1Y=4ONJ/M QAZ9N-(I ?8<LZD!:(,?'R83P!I+K2P!F.6.F1 ,7
MFR& 42PMJZ+L,@[CX[+F\ ?Q@\"#9]X1)-X)NT-D]USJG-:OLAEC23E4CZ$?
MPR(ITFPRKJ, S'TZ6]=4*49(L! 1LT=A]9GM_I(\R$2W]6BJI#^_0,(U3:>\
M@XV7<0[*\BYK5ITMV)JMM=@O'W0?<JXT"4YCH1H#JMFP@95\JY9PTOYTL_"_
MVP5(GBXM__24[WA%%\,6FBW1QAJ_F@@AG)0+L^4W:95CB^MNZ;&V5X\D:4@M
MG/@RE@9L72:A929GYV0OS.3@:,&R,A94>GIHCI4R=3TH"9"&R]4:XWBZO$JT
MOJG8\72&&T(*WUS^AS''*^[-D9VG%J*271S\PGRAO8^S_4=;T%1YW\Y<F@Z@
MNZ?*P%)A=:3:,0WDBL7EA&CC"NI4*]?AIB@>,&?.,YG5,L\G$.,NAJ2O*'@V
M$+BY>-SA4,V.X:7YK3JG>0P2HLM3-C3K:'^_K>H0%A>N'],C"U0J",O>OI!;
MF%A&IJ"ET;:Z/K:$&N3J6:W^%G]DY.9?Q^C)CS*P-G!H)CHB1(M(M'X<@K6@
MK3(6HOI;V'(F"8]Y[0KO=_QCUJV?0+&?G!J'UP 9(16OZTUG=G!^U9VYOBX0
ME=->9\X8YXBG+R.[-RJII5*A>A9I5,E7,D7%MEM3"/XZX@&??FE#&).Y>!,W
M)QM7OHCAN4XST?SZ#BTGJ&:;X.BD8^DG9B!,E;_KG>[DH:@^J&\<$3'LK-$L
M4C*$4[U<P4N B C#U"JYJ6KX=J"*,S9GJL\79.JLH5!U-.]1W?Z3+T*GT,#,
M^S0/L,'98-!S!<LUI@3XXL9^+&<'2G>4S6C<K53CWXD*M7KTAXBF_E,K,C\@
MBZ[@$SX2.R><UF.%-Q?=9G9LLIL7N)I$1SLAX2H!Z[F&I5DJ^<F>L'!;HB5^
M<7W)RZV("2&<7NL2]59IM[/:"&@"4Z^=*#1-(Z$ON#)]@-\]7<RXA8Y#]ODM
M:\LF>Z^'Z_+(WA!/L<FG1U2&>ZY%J8N\X6Z$=8M5&V\7?"">*\+Q!1QGF/GC
MJ\W(+\<NV .EK'5NA$D3H]&4))<&]K'0Y'#\@+,B7G)UUTM!V";GD%0J4ER!
MPQT;></)D<3I:;CFUE"/RN+J[-HBE#?J\32=+)VK4@%73-;!3#I=B;Q('W]&
MFFF)X0&:,X6GRB=42+0E%\"5#\0[N\V=(MF^N[O5[T>$^[>4SKG[*YWM[54,
M#\*L[S(TRRFQHM.P%)V;+HKQ!]$6IJ]7#>AN>KT-EW\CPV )#79DLE,$;/3C
M-@JKUY07X:M8QBJ48I.'S0&+<6!#H^R/YQC\-XKZ_5NTLV/D0U84Q3-R]9/E
M<X.Z2W**U-+B8KHKZ&$)*KB'AB!XU2(1L7QI'Q_8]L^D6Q.7&U+ -G(N!AY:
MI<:ZP[JI93)?K3/VJ"A39SQT,>=J?7)/]A'=+F+<+IV_[<Q (A#D202\6@Q;
MS'!=5\;H_&6T<[D6R:(Y_T=;1<YNI9]?A"L/O"N[4'#1 #SU^ A/94KEMK)1
M)Q%C0)9?\GF)=DU$ZH<)UD@ME8+F-T-R,-]B?#Q$[\M>6BOC=M73YW\Y&1/\
M:M"V#K;/?]HZ-?GEQBPBXT=]NR?;,[FD7="DL>_@.%$7'2OA8@3K9'&&81V5
MB,BF Q*AG,[2/0?DKH^G=E(6E-00"M97K4A3<X95OYI4MB>XT ">K[F=?DXJ
M)PJ9)%W"MZ]IBXZ]GP*@.=FE4 D*6\XJ6W.S*E? 6I-J#=>VPI5 <#/3N]P1
M9TOQ3;=.I=PV3?F#GJW9^LM8PP$9";*=#)%2\K.^E_@0LK0)(@H***L@\'?&
MN-@O [[H.I^<OG4N'88ZQUS$@TK2<6]B+UL63W:-]N>A;RLA.0;< 4>5D0\9
MA"OM:/0>AS;8]YG@#6/C>YKBSO2S*'+$C&*,9LBM6$.!]W'EH$ !Z!T243<5
MD-=5%LL9".'459%2!3=1%6D4&U0V\I+S)D@-JYF.D!WY9,5K31BAUA]-QQ]S
M4%(7\99L.1&]\D@D_:IXHZR#;_+K^9S2<0PV-IMS\_U15?)R;'?LJ5+&>#4:
M\M U4N.D5U1+!)Q>4:,:_%PE]NF$YS-.C:@-\.*( [6X.(U-C#IW\N(N3;F>
MQUE)(F@RGW!QR]V(XP@H+;%V"O1"UJWH9;IH;"N9A1@->1W@-SKIQ_4I8>Q)
MZ1XQ5>^XGF$N_5HF#OR$(EKV=6<K52)A\S9IW.M$@>TB(<@P$H!D+^73]'UY
MR[SCJ+J]AJE1IM'NEKE@8U$+UTJ=Q]31K ['!CD4.]=NUY146L#'_;EK6L7>
M-0)^Q:<-,HDH8N7O;CU&;_&8;?I%E9MKFH+>X6XU3%D[#7!M;#$RKVR>K8GU
MXN)]#AZFGW!(H,\I;H4)#58H??EH3C9&$JLR;U%Z(J!2Y?A@Z>,YP0'(R=W*
M"2("'JNB;O0BE6<4J=E6RCS<$(JQXPY."L.Y^8F<D^!OJ1=+;T9"F<)LR8X<
MAO5"]@N11)%IC!'J@KHHL]FW59XQ76;;BM,,CGWEVI#IQ36>Y28NPXN@'!ZU
MNOM:M3YWM7H"@D3M_!]I+3?5WY_)Z70\I7;J(-(ST&?-"N&YTN8G3,T]$\*-
M:<T9X4>H.>'8_?!VK3W/E&;K G.DRW*9-JPQ&6<D$F=>&Q#,)BK:S)Y9$T2Y
M3RYC R<V-E^A^E.1TI_Z62Z#7> 52*F[?Q6[5,8IE1;IH\43@_-1K(QW!8W+
M'3E8F&V?]U13[T')!V<-E*JB+#S/;*[0ORD;V??Y9 %OR*3SP%@+XXPUJLH3
M6%+J;/I3A$/RXOU@_;=959:#8#6 I;0Z]8Q3/4F8:PD=2K?PQ'E9PV[49Z3?
M*#E-NO[>U1OD4!_?UXW.;JYE55\AX$%E(!0[Y+*M3$'5+WG7>,LFG/2K+3^0
MHUG?-[\,?A>CC<^_"8'N5MVZ:NVU#&5T]$@VP#5M^QJE>8AX8O#J@1 E/YRP
MV\^VHM8FR2IU=""SW9KP_5&"']VK,?!A%D>=_!=052?J9?[JPLEWSG&A<MB.
MTR_$?6&VP)=R(N+3>N)TB 'A0:&^!J%YLYU)"YA(D$J-1H-=@<48.7&4 IMM
M>JV]DO-WZ=:H!).9[;'8)AD1O5IH0D]Y/:DSNI+<\=6_'Z2+#J<M6O8*AL8_
M7'(<!JMS-7X"/VKOZ,_S\S*NJ>7\&T+EVP>14[\(*$K5"N*A7113#=O:41+3
MV(XG9!>#OF=PP1-V_\0!6QRY:[,BFR2.(G7'E^=STJJ?\-V2Y(,8G7.#<C'W
MVC<R8RHYKA"ZB>DO@RG]^)16:K8-FRK :([_,(X B2TWC1$#C"4F[27VTJ]G
MM+<:*JG*,O"/4U[DR".:../KN$^>\EI:*15 !5CC7J9LV@\9,$DL9JI<_\0O
M'60XR.J"GB*G57O.ZF,11'LQ4W;K1.F2\>UCVWD9:1U%="O4$CIVPNB>A,EF
M(,$L\IGCB,++7YCN>K-WXT'[?HK4;6^JH#EG$@,N,;6^>B4VG8N8CCPXAKN!
M>7"G5U>CU/OI$Y+$BFU8%\'VAN&=#@(<MQ)E7/DVL^1!QM/#7/]_'SA(&3Z7
MH#I_SQ$1<?UN"^!RN!S8YOU[Z?_-<WD"!S'4F=D8+]I"^1U/?QK@@6X'*>W'
MKEXF*")?6;(O$(EA@?;/]O(#U6#=YQ[5375@U32+#B8JHR/L8\FV6>09!V$_
MO!<_2Z.0S/J:UZY12+(:W:*=5)"FY-^QT5IJX)9\5"ELJZS1A+DC-4DMV9MG
M[7&2K2 H; KH99/9'V?MJ$<5"9)5O)#:,O&M/;BS:^XR _#PT=5,=Y$2%_3A
MU(EK4"LIL5*U=(".=(+]%/EZ)"NXA>@2[\7V]2"3IU>L5-42==M[J9*^<W+J
M,-TK#<N/@/2N7J%)H_KHJS=&A1^<-S/*Z=O FF9I-G)@H?%1QU:IVVHF^,<E
M%7D-3E!F:,&)9X'ALA@.I 6'BYCVP CR2L.BE?[(->AH5)S?.YNCB6]%@0"9
MQ4[.I]&D20P6=FN]!P Z7M.#"\]@IZL_&>HJ)3NB+,XFSPK+FH:__RKU);WO
M.*%F5YG<<K73V;NA=0\LJ&>TB)P_%%2I&A/.?<.B!#E"W F/[^U_^64WE+=-
MO97S-])YA^-[4$Z+5/TM0M',:F&PYVN-K?>C+9\.?8QD5U5@DE"IF5W9K$Y<
MYJ7Z#"I-FIM:']'![;&IY-W-/Y;:$_SS"V'<1J=\YSEO.2>3&=[JM+E9#V\-
MM@%KK6,MEH$Z95SV^>#HO6%+*Q;E;SU\#?5/^_0D;ETS'_$3>#57U\&BQJ]/
MM#39C6> / =NA/6[67PQ2F;NW3S_C[6W#(K#C=U%ER+%W2GN[A1WV\7=W;W(
MXK2XN[LOOOABA19WE\4I[E(<2N7\_N?,G;D?[J<S]U/R*9/))$^>S#MO$C16
M5J9=$QQFNXC#DJJFV]Z_9A13];((SRG)ST"PC/[<46*'D0!__@=8$K/=DF#W
M6 EQ+KJ>T7NG0A+K(W+WPJ'_Q8S ;27:X".%MYE^%3^26X.@:,(();O^2I6R
M*;5IT;M+X^'Z32QUF7QL62"'470 M$7B%/&\2W#CD;#)PC5!VF&MV1"L><)0
MH+0O#AE+5S:!'[EK*L5.E7>2281V.R47R%>X:+LH@];P,Z4)EL\2=_X!WFJH
MG%:?8^M]19:C'W34U=6K_,V-3/KS]WC 6'Y!,[.OE$R/_KSE>D2IREL3(%A@
MMEFUO6&"UCMEC/COGP@)Q3DRSE;FS:M:M_<R\LWYKCYQG,1'FVX[<Q>8QJ;*
M"S@'9&HA*2CXF29K6"E!-&O2M!_4YQI+B+1IJ7H]Y\O5+>5+I7FFBSAO97YK
MV\5)]-IU"E:^<2^/&HW]KK-I<)J(2Q>C ,#7**7SZ#=MT!9\[DYK%XES?SDL
MM%,=.Q8L?Z]A^(FA4/7.^BJ.5WQ#[APU6*KJBA0<P-($18/]VO/(?:6+ZVSC
MOKC6SR#0:/01!$TX)6FWQH!J"<W8^64=!*#.Y!_,4QDT.N7''-LKAIH\Y#F)
M3A.(F65D8EW/6 GD,IECSXSZWJ4%B>.[7ZQ\G%QN8UKO<_P-T151Z5V <[*G
MM"D0*ME4"2IO#A\SJN"0IZ4&( _/K?28P&<2)"JY!6<S-,=_R7(&#)JLO13-
M+.)AV2241?IRZF;7:]=Z;-,WV+DM*3(D7C.K8IE#$A<K$7G2I8'RV:H,><6&
M-P_^%O;$IO%J=-W6'VT7.)YZ=C<';1B-T2>I*?V18:@PE+>>:"V,M+'*GD3%
M4@\UA_8:.X3HWD:%5K7-R3 /%3UQ]=RQ:.W-,:6-XPWUD2P'-OOFC!_+',1?
MC_AL>+TW72?9^AWJLN<:OB>W"H?$]V+-M ;(?3M4ILQHXT'GKV2;P)TT)=+C
ME2"\:AS\HB6W (OLV/ ,8T@AV(>45U=@Q"OA,&U% 9E,SU_%FU-X@SUU]X:?
MXGR+3#"UUW:3OG&A_E0S56ZOG"D@'\[AW\^NV&9?PQ^')+[] 2;(,=B/TZ>)
M?.!Q!S?,?E&8J90(,M;C."4[EY\GKB5 <N(T__E;]MZNWARIS]B'?2&O7%U8
M]AM:DG?*JMU234-M@I31S.E$4<>1>_4RR[.C^<$L4<_#)U]_EQ O^,_HUR1%
MRT3\&H4VNI#4#_M;NXQ#5JGENJ5H6C3DN'@50I^WZAM:@[CK&W>*7;'^ 802
MVE0")Q-DQ$*^;+$>]F#'9M]GZODSSQ]W*OO/*QS@FZCEYNJ7%,5[.;B11^@6
M-16I0J03%B>6!MA8BV8N9]]=PIK<+SAT.34;VV+TLGER\5._[36NT[;ZI+'&
M+!PXDN<7I^@'Q'00M]32V6H,>* _1"%!HBY0>-M_L5W$:&[QU@Q@@4-V6S?K
M=+.F4)DZ6Q]@B12_&!ZM!$WE6ND F7FF'&%R*N]B?21X)M+:NSECDS4NC7VC
M V68N)ASS.M%_+C:CS\+4<%G;=/>)_#>UC'^//ZDLU'-&P,@\^(AP,BI%BSJ
M3A>A-_;Q82'I"D.WG;%O6M]5!S ^!>)_D8R-/_O60]Z:T[<\X<:L79;X?#"M
M97<KZ%OMDA-M#S.=,S9)[?(^W%#0YZ[59/8O!NWX%(&BZ30,TRH[^DONF8+E
M(O_GO(B5H>M7/G;'WG=3,'*6XTVZN5"V;XW*=/Z3:SF/1 F1 =M[X42$F89:
MU:=+IK)!7+QKAPF9=(M9AZV9.]*3$@[M"L-C&JO&>34%RI,5(Q!Z2RXM5O2%
M%<$V3:J*6/KY3OUGI]]9Y6SQQH<41"UP3E.E@@\,EIY^^@]ILLIO5@Z% 8I.
MDOUT1D4_8VH*)$=;N69U<XR>/T"[*8*G.EF?!C65K0["-HZ'&7^FPD?$Q-.,
MY0J8%]^OE6&@Q+EH*Y:*,CGA5RI<4NAZQ78 .4J09\Y>=- O#L*K3X18#%B2
M']KC1=>.8.[53 XVJ7?/RK5!+YQ6>AVZ=1^R!!DX1K[2@WP-WZDG+=C@(ANM
MPDJ0,!?_ 6;A)8%)=N[WFJO:[L&B:W8M#*Z-/%V/0WZ;7HZ^!7:X"WP1\A-'
M65=25"SN<RI;0-W4,SI;9,;')=&KTS[_QUM97Z.?D">U4.?5!U\2V>_J+Q)3
M21PDF5",$P+C9NA*O-DQ44(!@8FWWS:DM?P$6T>K&3>M&0LTBW^7(.T)(#0J
M#!;MX%)#\O/[*,H<1R^K]@2?6J&]NE\H6PR(6<Z>2DT2:A0,9,%&)^[9 *C7
MT5;S)BJV(@.A%F_?]Q-\^AJ#?(;875;$"I_^;'+X2U:'R5UD7^,6]&VG/S@/
M.0PC8C1SD@$]G?MN'!>%6NF;-3PXT]:!LY:HFMTU+,HKP6[O/^4\S=4K)$W8
M"T0MK2;_U%4?Z7[\KJ7&RG+>+]1HO#&RH*9)'H=E(FB('R]<J3JFC\U=5Y25
MBUN]X2\K*_$/@#OOXC-J^Z(P>;L63V#FW:"=;NVEGN4JZ;:,W#R:4X]=62U+
M7V3A,8H[OD(G;B%>)AKQ7_P-FB]1:L16M_L2S*M\9[H-1D6"N9"W^DI8TTBD
MV0-3@ ?I51V,'$YFO_Y*AR4DU)T@IFL[:NB"QCH@M*ZZ0%8"8OLY+<C(KPOK
M'V6>;PY?'K=1:"\W,^%DORO?"JR@-#B/IB_ I;F:SOKXT7@UE]>WK>C*VN,:
M)]^Z:"L'Q9T*Z 4RGFR83G@%2I"11E2B'4%-5XG^@E GE"U]IM<PMY&LW#YO
MS+8S1\2_<):MQCK>^*O_(8OM8B]GT7& P;B-X*'70#/%C#VMS937<'RB/46@
MMXJ/^".*#O[$W3^ V_;DCXM4@]6'[HT#Z54!Z+FZ@6,*K)_N4ZV9-07=AG,L
M:W-#=J<22PG< :M<PF/$$42$5A#+</"75LEQ4+[0QG3BMGY53D0E!QBH75LR
M27DYZKPQ994X>DB@[]^-DWP++.(VGMTB*QDB3AHYP'':_ %)1IL0P#K"<.PP
M>A^LE4F/8O^4S?+'&S-.%[J-_\=4/^NWPI%%AJ@SPCU4,%,ZX]ON=Z/?K6NG
MRZEB*;&LFSI5GMJ!-O'SOCMMQOJ%=JPL**&=C9(6KXYJOG-&K VIL_H^NKON
MR1]4@A[)KH;ULV1MXQH"RY7[\S'PY TO[I=SWGLY?";C=L3":TR.8>(XK-<,
M2N%8/# ]H&)M;#TMV-!9T1[-TQU%PP@;9DY?YG->-!$+XZEEBG>L0<U0='TI
MY-3EJ!<<F%@TA1'$YQP<(B:%%3[6R@.=M6(L&=,UXE<?B2IHXA9FVGK@(#D=
M_M^3E;)_G-OH7+.80Y<SC-H]>QQ<!*OTT[;C NU)O?,F)TUK13N&D3'.T>-%
MZ&RDZ?G (]K^VY 0HVS^*&_,,U:G%7J,+^IB,DV.AW1UWI\[-R\,5UD;DS \
M7$I5+-6OFL6(%S)Y"P_GX47BH=G?(VE=]W59R!J >RL]#SX+^4,'.WRM[OMT
MK&O'V2?XZE"Z(Y9YIG ZS+1CMI<_G</IG(5K86'\^7\N-MI-.$JD'66?74P&
MF(1:@S4)9G)O]<BL).YNCPRV<FQ]0MP(9,0<C$B:7+I:4TYA\?<N4W5Q2'\I
M.*%[L,O)&<O89K<?9RC-;*GLX%<99*^F@L&#_VHM&S^!6>8'8W$?99FKTOJ5
M<(RH3'4FQ,ZB/JP(]=(%#RXA_,G86Z#[G,'Y;  'QTU-S<8N-G<^*" FSF #
M]/".);>8LNW)69!H;NG)6U ^T@RP\ARXW,V.^K5RE/!,?:TCV..\'>N/Y<;/
M9WUX/BR?V8CQUV])(1M1!WM8TQ5*88MH62XN+B9GNC^=B=?,=RH1'Y<&=F<@
MY]]*;;CJXR6([;1[O+05':<I8)\$/T-A_^?+X/NL24(YR 5);V>]1 "7BI;C
M810]_58!;1SWQ02]^J_P:T<O/=+P[8),K9@=G 5[R0:_U,7YUL1WY%3<(FH6
M)?9?];F66RM9_QM Z-X=/6B/-IT-VBRF%+/LY0&9@[;!(N; ('4."J?!@^9%
M+DRBJJPX/(N!C8J>!E .*."NI,75R(:AYO366P1$1.#T;G]]E'&XDA:A8GZ<
M9R"G%?,J496^ $5@#O^*8M)WB3!/H@\8_*5/6!D8U25.)I3%DJ"^E=XR:H6^
MS"Z>K;3-\ )IKY*[.R+>;W:6*"&]5_UP:_3;8<:TU_&K ONKZGQU@!G3?MQL
M]K$^GP-A&+)<W>@)08G=@G*(BVOJ+I*"U./2Q>^,M>-C[@SC7UJQXTO\PO$L
M47I^CQ>_7CDMTM @Y"MF8^PNG/&YGUNNO_3]-':<FL:SG7<T'DEDK"K8T'[_
M:AZ:%2UFULS-:@UE$*[^J/ .M)$2J-G< IAM/>$7UCX;(F23H,\=\?EK%C9?
M2]U%U!;/@88 479EA1A1R>@R6'!#*W<7,U:;&[)H"X1G5@2+[LI=]0,:"S;X
M)]<.S()>P!XM/EMCB]E*!E)Z_*+Z19$4LR$(<UQL92 KZ'T0I6[989C)-H[5
MX/H6N1GA$%LWAN*\XJH8 ,8^9_[4II@=Y46_HD,,Y YN<" V3-5G>*(,7OM>
M-!.F6)7UP-77?7J: -8Q,]-^_<!^8C!4D!=!E]$.;(BU4@.\&]J@W%+6+ (J
MG"*Q@!K"$Z\>IQS/+D"[C5#C#0+4 %V5+\I"Y;6EBM6)Y7Y87UP%U,@M;#,0
MZ@1[[V86VMD+BPX9A%&'144)C:Q0HBL#!8 <,S^U\1Z/<@>C,ZP2>[IYI_#5
M:4"VGF5$AD-[;6MF3>M>^5F!RBL^R8W@PCES&]QHNWBJK#:N%!JK]5I38E:!
MI634"E.'B\.V[8VG>Z*LCU,VITML?LFWU;9<[DL1[]#8W>'1(>-TC'S'#C[8
M:MAVK&BR_P!3-33S%*4>GV?>/H\XF'_WX;;W.5$9RS#!ZX@![^K-ZE2!=G9R
M:IT3E& =*F.E-LXN4S35S_X1AUH%OUPF/R=L%:+L0(HP(E[TNY@%_L/PN@DI
MBR;!KTV-K-,:R<=^@@W7:O&-5#-NP'R+LYB:I-Q_ .8P)<I#1=EEB*]-\IC+
MV!N" )@629@\JS?:2KB:9X 8WY<G,C?'54$-$G@\#.2PY5N D?NIM?OHMG;[
MM!0=IJ+Y."V$G626/36PMDSNQ*WJM=/.6[9]*%PHUX<GAF/I*AMWU%J'/U9@
M@(LI_P&>H,0?%8R$ODL!]"'3MX2>7QJ[=I1,X:,RUJ=)W\:L3=VBC7"N,1/H
M:'-KS,>]^/(3U:>##*VE@=4D=)'&18&CE2-GMX8YUV'-9(4<*+6":PXB"F18
METZ<WDS63:5BR+7.LK^2EV);^E<8 F-$*S(Y$H?R\K*2DMK;[P+RYD99T=M4
M:1:.5 -4G_X!,(#^/_3_ )4T0]X]4QDO-@^WM)-$@<(*N4PP.^"-6:UR]$?D
M=$3?.O.G%M0]CT-R@67SVL)4_$^<B"9H>8P=;'(GRH^9ZAB2B3TJA)*J(F63
M#9";>E+>KDI.BK9'F$]SC9Y/Q2?O6 EY&S2KPGGC]]Z$;MUR%$9W>VRFF8LF
MD0#%%NX5'/$M^+*]@Z6A%W:L8XJQ] %4;/'] (+9!L<V^3/>J60"EHBYJ,KB
MZ@3=4I[7\=',%;>J)Q*4"YN=)+>6+-(1ZEJ^;YY[EM7WY>S9L")&#>@F9FZ'
M7Z#O]5&YDCN/MJPV_P-:: ],SH0N!QWLBZ2PL*.\QK@H1UUH1V\HW!""QX:N
MGVKL:HSH(AYDA3G8TW&(+_JZX^)V-<JPM' _Z;/VFUS#4&SSZ=XD,KK8K?&8
M9T6E%FXO-DF$*N1XF/:;U[[K5T7!#.MP%+MB;*"N2<.#2:-T^O6W8PS@#E"\
MQ>TDOV/U@I'O(1F%;YJCHX)._T_Z?CY57%Y<5NA2<<[H8J7QUDX .<\_0"W!
M3XE:+%5#S*L?ER?7305L.^X;W5@'PDGPK&?@K?P$9>B82.T/Q7!!UUYEY2R%
MDZ</DF4)<*6VL0\FN,&+A(?UG+6! \RZ^Z5]V3*\#<#[D?_Y*)D7UH]#+75\
M,&MQU\OX)S_5%KSYZ_'7UW^ K/'_?=/Q2.4WY 7U'R#UC]Z?[(2])8N]SDFQ
M?X 8?D1#H$!4(V]-.]_XX% E)CN$PU+Y]W+I6->05E)EM_)&.*@L;B*J?373
M2L)*\N$PSD@4][%-YAJ'W_0OX*^IF0H#G.I!=[I:$+=BXS"Q46%RPH%#+D"2
MRUFA&OFAJA765XNO5E".>-%R*3H0_[NLQ>4_;I>PZ?!I%8G;XRV>GU..V58_
M:T>3L,[ 76"M,FH4O^\W2UJAWT162\V" N;G.4>%/DQ]W5IYV_O4:CKY8:\8
M Z5H_45T/P^>$^::Z]5WTHN1I2QK<%%>-*AZ-JYYI+-9U4=%)"G,SV'E_P F
M+@R_ G3OA:+'C"BH<<?F)Z@<-*W)&-A7!=I%3CNRD("$'X##^==(Y>KM[?&C
MGR2.,ODP&0Y4XN_T.K<YP6/?[O2).20MQVT:;@L.VON$:M83V&MQ*W3<SG@T
M7H:4Y\^=Q 3^ 3P&\3 (J,M<(0R8 W9%[$*MVU"".DZ(P!WI$8,1@=9'^_C.
MR8-SAG34;L[C'N)?X[/OL1J]'+03BQ)A=L0,@^]O@_Y\=\?493M8@\F!V68\
MT+SXM\SJV2;7)!N8@"1_*]J&&^[+*X6$>UKB-N5 4<U>@Y)6AGWX_P" OFB,
M94G(@7?D+'A,@PC_;VD-C%U[-TJ$?.5YZVS8%(]N!TUXV4'HSQ%%55[HH78H
M9AG![3<6I;+W@8_PQ\B1RV?V=G:4H\8:@[54 6S5A0.(A^/*E,V$/DP!+WT+
M(I^U(C(+D, ,H/-KC\:RVGAGW=^0YAJX4+H6%Y\DLY0%X&@7[%Y"+:<SKS\5
M?Z+FU>&.3R,H()+(G-I/U'H)7/CZWN-&D2TFUU(Z1S%T<9FH_(G6(W#!,Z@Y
M>SHP)4\CM7/V4M#=R_^K6/": %N0+1R^SJKI0%"EBL]<5\:_J#4.6/X9BAYN
M-8Q&=J"LGAFY/P&090JF1A3=J5]^EY-#!4.E;CSL_7OVH7XN36' JL+A^U%S
M5P'!?LU9<H\^M$Y@CX]CY)P :?\!*2:8,U$&WB&\M7Z8'^6B-\"E_ZDA%Q48
MUI4^)RR@0WJ=$/V5Y:,MLTM6BKODVD7<B8LE H80L)RX3X#R!H4=&WRB!"&'
MUG3590XIC]3R7159#J.1.XY+1\Z/Z[FZ[ZUSR'!N\[0W?(Y[(%+P^'%J*:'(
M;B4ZU)C!&=/)4BB;T3473[Z&CE@Y;<>93] .@?*:2K# (U_)3.0;F&*'9<0L
M4+<Q@IX23-9YM1ZC%G^_Z2O:$SCU=5H(\/93Y]$1@#<R6NLE.1E2>]+GYZB^
MJ"9936X4Z7%K/3&),^;B]UN%8X<:#N/OPVTO1AN<0(<'' 6#EC-Q)9G\-. L
M#1JUJSON'#E*@VHAB#PP"Q&8C)1%9L5J,,6)/<LB2\-86&B?J#_\Y@#7"D 4
M,%>S&J!?K+Y#%96B#,D>V[#%<<INY(3Q-LQ@8Z-MF<;J'UW1O*-IB1SZ@]"D
M]<L%+?X95/U)^>,B9L%TN>9-DW#V^*"(;ERQU&..G=C[04='@I[A$BU/36X/
MF(CDO=)W#>F;RX$$PUUC/=]M.]61M6;*OD$=9-?M&OS3ZVUKY<=+5+W)U*BA
MXS4=E_WWQKR&()Q;EZLW<-1(0.[5>;SRX>PJ13M[S', C]E3_]:8X'\,11F1
M0N#A9M-!.6SZ4;W,4CP"T+8;.9=%BD0@\17^&$'T'A0DF1\75B37&N!90WVS
MJ@Y6/$T+XXO^!V@:*P(FJ51-X5#DR:KHRC$Y2\:>WUGZ(#7FOP2Q2.-BX?G_
MD,^N>HNHL CI("WZ!SBX3Z W>?@'L'37:,VD]8THL&3$=#0Q@W87$]/YXD7.
M,,_K!B*:['Q/0$O^01QC^[BMI[\ZOXDOO\FK/R!5QZ&2E$0A1A_8R3OB$@\Q
M&Z,#=;-59P)UOK''5Y$YQ;T,LAP-+M@(-'O8.V4D]5'[2I;0R6]^9"Q.^YJU
M)C@,2Z;EK0[]813N/^N:SI%O/?RGDYX3H ^JP.9@Z^=A8Y*7B+S1/0#H(BDX
MVES.+S_#.'Q O$)V*<9\I_4P>[,)(4_K:'RITQEKDF>6R0F[AIV?/Q?WMW1T
M?H-W(Q8$\7^>E+8(%R,-J6?:[_GO3' >5%7@?15L;,_I;QAOT0Y1E7E7(M:F
M1-C/\9X%24OU3GJ5PG""W3^MTMA4K<7Y(0+LZJK:5?5(S>44 9"ELZDR8<3S
M^6)>>B6$#NH9:]Q?S+TT-\#5LOFB 2@WHLCE#[MMF>C#).\O8O% I5@F:)OP
M0B<"X U@)Q _.#0;148Q%\E8V;=4YTU;:_$?)MOQC\9FC!NM)7WQY[$C5C$A
M4Z_'3UJ8'B@&1$;^XMF^M()'/%V@K9PHV*ZJ:[?M)BV=:K\.:A.SZ6$IL%KK
ML:MF=4MK"[-*BLO>4T[0OFLYK8BF\\%/W GGO/ABCVG^%_6)Y#,\F[.)'FK9
MV)"!S!M+@;D]:D4<DJ)<T;]Y6&>!Q\?'V' !+Y0/J[657JACF7DOS7'W>'']
M[*(P,FHR[B;:I7*$%=92*N8=?B9LG[27,^;[[0-1M9.H&0C_;.B8?D._5!3A
MBQ#^9YK'J]7&O].D3?*!$XV,<:B>\1IE?+H8^'V-JM\DV*P#E&L)K8R%7ND&
MB82:M(%G-E.%.JE=_0F6RDY'H=NA<M@=O!:U6"EFPP<UC(O=AUR"^+X; -C$
M(5^TD.-%:I'R1E5S::"7:5Z+_9;.>WOF!?N$ T3SW<"+JX'X!3?LT$;GD;0J
M)8,G);+@.C/]4?+2<0;/NV/F<AA'S;;M)@>=>,MXC$):58P1J2Z;>'I,4VCA
M#X<NJZ?==#BX\:!QA3G"Z=B ,.Z[X?#;WJW2:R6]%QE"CY@\%CV:Z^)'6WR=
M*6$9[+^Y99820_"^G:\/ ]&SY19HZH8?B";I*@D@<U"%1LV'>:U KP3<\RK5
M#62F6M3/@:)Y:9X)$_/?Z*09Q!5/R5EF(G.=C\QTRR/6%O'<]*IKTWM"N 1R
M:P]5EW[L=!SO+SP<\TF?TU.:"=TM0[D'-"JP7BO'2,YN,4A]3 UN-RXK\W2E
M*H([V4:S/--]1$ &3I= ]-A?7^J24F2_T-JT*,(('K][2>F1<T@)GAO\77KY
M9-UAIW/*1O(46[[> /Q0)0VOO8T6J%.<+?ISE86F6 S;*RL\"O7T<E&4H2>K
M0^.P(P9@6!/#H'N\^XE5$@ISN,I(._.IIK!QR\=^7'?77ZO<UD%THMY-;6<L
MIM*+W5:U6T5_:3[K"4=49+I\AD0:#TZX#:H%E,C0IVFJ5_(;9F R+$,O0+F]
MX^L;^U7TOB]2('TT]*-( 2SVDNF<NV/'&ZL?N)(S-]M-VC8#+TQ#H2S@E.;J
MPJ&YX.P.XD<B>R;529>&O-Q#T%:\;THG@F.VA!#Y5N@C@@0/)HL\KN4#MR/R
M?YRIFR5U24?0PR>S3LOBF[AJ;LD!=U;\*S_IH<8T1M[';GK@;6H7PI4L/?VU
M^2,-FL5@YA6F>1AQ9^OC]0,]S&FY!B)?VNHB?[7BCR'WD95AE$N;[6?[)B^9
M\I$TXS##<*AT.F9I=MO1 V56\X7QTXTQ*52OOBK@=L>&L2F_D7Q/-9L"(W+N
MQWP:E^6K_4M(^.[Q"F[ XA7W*Z*V2+WK//CG*'<TD>.PE*,^9+V"",;:S;IH
M%>?*Z MQU//?;W.+K49WP+.4(Q%V?$3KV,D&N53E+C<L9D;G_ SUC[E%)PV1
MD.MSM'ZR)3):27="U!5TBT*BTZ-]L6M5T%.A/U*FEK3"608AZI#5#^Z?W&XJ
MW Z5@ZB[DMX>SW$Z4=A?0DH,TWM4MZJ&PC*/D D<JUAPLL?Z>SY\3 -$)TVD
MY^Y5' R"R4/#/LX@%96T"98&]6T\DC9%NJ_7'C5BS>!A</5FB/:ULZ2WPT:/
MM3ISWOLB7:BZZ__=BFN9 &5=(0EGTF'J:BHJJV/WTSH:[S1;?Z.&!P9=_SIS
M>#2'O36L_>P0/V)\>R1Y^[;S=R/SJ)'#I?AS[<-A"BH>,\]!!JFE.DLIJC5V
M!/1&CBA";9XP(2J+L*K@,M8F*TJX:=58BW3(^\#Z$9^4/K!C>2BU_8HM0MDT
M3KJPW\LMI\4-Y)4LW.0I3\Z#:>HP\$$C2"@F?'K'I8W)-87?/W*P/'[NH,:"
M+*,AC+%K9]8N9<*V_)-Q;F8#-%RC+>=&=CT.1&;^\\*!J Q;Z%&M>I/(VO#!
MU[1JJFEIA/$B74C^\&2Z J($P589_H3;.6:>Z(7ALG%4H6X?S\I;E6O?S_G>
MY.%'Z8ASAI.%I%B8H<,]6\U='?"#UZ=+-,(>/AG!WWD8K>UX0,)0F+MM=G]7
MS)TZ)UZ]@,5??^CI]^>$U7;P3W?U;$[GK0,BF\ BF=2OZCZ&>YC7Z;Y(C?R4
M%.6^FOO0\U4$U1A%)YG/VY4(.]]^_OJROUK+JP4EF/]9'&;F&M)/H1,96-M2
M=+X]3F&GY? / /VF^$"X*!>Z2NGE94#IKGBM%;=X]GE"Q%,A>,#N-(V8EGB:
M>3=5^7V;+%"&Q_@!+XR#G!3V%%) !2OSL+#'"PV,&3E4V7=/272;3=AMJIK8
M.]?')5"@2BVA#H[/O5O[;[[OD(L^:-4[$W"H&L;7RX,&!O5]$E+%.>DT[R&I
MZMN #Y4%NJP:$P^UN)C\ Y@YFF#W?;EY@+]_1@C[C2J+>TH+#\>]D$&5@SK2
M8L/.H"[&;X)0%\37R_?M-$_OUZ@]VB6W@^0N=SIP'$,D!"_7P'U?ML_"_CS%
M!,&?H1[_<?C.LR8S1_/B*Y<O3X&_0KJP(ND>GI'HGA)D<1IAWV5<_B W63P0
M?[_I_[O+(R4*$"Q]+XW=;E$]!(^ .E*%K0E>PF&GU-(>@6]2EV\\% !?3APK
M[&%*5%KB1VB"#$G5,*7'TO\XWV3V9?,L] GQ12I4ZNH?X/*_H='B/XD]\)O:
MX>=_\H_DW!N/5 \<UG=C#._@_)40"(>U>"S)//[X\_848_P/< =_?[]&[3YT
MA=-N?O,I1/"*Y'O0VA_PV=EWW^?O%F]_/DD9_M^OWO9/_RDXZYFA4^X!OA?-
MKIVZT@-R+A6<H9=O>8(Y\[JVI\<2LSW_\#G.MVYI,]G?2;(QBC4=% @")>\E
M$;[I/![/3G=E7[@&M?Q@A8'; ]1<F"2>X]"-#X]WLK^Q78O?_PIA"!-%W4]?
MPV\@V/A1CA]S'&J)SH#RFS+P37[#_X_YA!_J['IE2N2RQ2=0J($G*F/W;&*Z
MPBP:H9 OHR=YQ&HBMI=7*A^;>C1V:T^M26K])QH0<:X(>W]'KLG#^E!VT/,_
M %!(:?;9YHO8$,U*N:.*V[:2Z#"'\>C Y\RNW GN#ML:!K0FOUHVW18=4T/-
M\0@K8"B.QQS:I]7(@<@2M1BTO,*=:4+$&*(!+K:SPTR>Y_C!II:%\0-DL5S&
ME"-!OMM@Q,(-*E4/P5)'&.N'<M&N):6*SCY&K=L'^QG2A 7W]9(F(<&<HD"J
M[TB>P8ID>I)?Y0V>MLC(/[*^%8);-BB6LZ?--V+6HNL4WGEK1JGJONRY)5]:
M(-DGOL.;T"?[V6\4OAZ"]_:>$LSK$7R\P) VI"OG&.[$^S&$2E=%A]S>4(F[
MML:>]Z;GK.X*Q+#XC,&[/>/EIW='TXDB5)-Y!&&X2^9X,:NV2$#_&NVAQR/'
MEIU=@R'/IR6G,U_01[&U>Z;JO-7B<IK$B,OX)UJ\ZMU[?[184O8L3G4FA'&W
M)JA3FB/\JH[?66OE?Y8-?FYYW7FC,["'UFG$?Y1QK;\3$TU3)*?.IVUE-@11
MN4?I52#:)NVW-1N78RL8>C;E>[XJ[G%]LGO?#+'#5&023Y\&WT22?+B]=6Z^
M_QU/W<D"U/^^W!6RW'G\_DOFUM[7K+IS?"FZ*)')0UQ6THU\\R-P12V47G_Z
M.+,-6Q4"TM J-,28=-A;:6'>K65-?=M%;E922=_HK;6&+[1H,-8PXZ35.T^T
M7Q>(2G\ZA!(]F$&JN&!_/RWOE0D*X1+6HQ,G, 2I&XWV$N08'65?,!U>V"W:
M<-HJ3QE34F8\\FMHX076?S;' ):Q:POQ2U4I*,&(!6S /%4R\O%>&/V:[[";
M!X<5YU 6BT540_ B/>*Y48<4 M )V5+24]6:!IY^YR_X98B2L$?\ RS^UBBQ
M6G(4!];PV"SW)O;KS*(?7 CM1@E-IG*PRC"D;,-DK\1^[Z!/C65>9=,LX9<P
M>V3U#.V(P+F\'\(#9VBBC&!]5LL\['#+\PZ43:UA>*?R]M)0DC%^\>KWHFHE
MQCB?!MOBP)5W5[]^<8BJBVA]Y<5<F.0V;E!5 DOYI$<D*X-R"&C&O*:NN*G>
METU_CDB'3<S)M"ZY?@%$ L,=L5^B +W,7"4:3TT+GQ';-RH?;[VB+/0B_JS5
MTMTDS9MPUGU@^[EA4MIP$2_05]CI'*[X\# >&!"A55GI"$XA+W+1S$C9D8%0
MY:YL^(OC_@-09]=CR8G%BT5AQD];-UJ#+YF4'^T%BU#:\.2OCET^'25K=1B[
M2UY@^F9T*WVF@8NQ9M2YF=ZUTP@";41 Y5YY+\P=V#)9PJ:+8EQ^Y(TD[9+O
MZU9I[$T_V3J3&5AH4>E8V@-+.5,04/^BZ2'^^H@8=G:>N>^#FXN,$MIEUF/]
M^6MM^VQ^EOYFI!8V)YBQQ,&P58K\>BJ1=_UQ<2XL;Q;GH4)@7"N;5I:8] W9
M2<-(? )7$FL!RF]TC1T-1;#!8X36YP6^@'WLM4Q-CA\^./]2,U[UUAU=G1-8
MRA25$1/D+PJ$9R]^2A4TTHR!\/@1KVPVEP^"1-C5)^0K(S9-@*R@YFJ>:?XE
M4IT #V0S_$DH)9<WEG@29P#V&>HO,66^]_R'?0#V]1[Y>9/@UU+-_9GDSCYT
M>9+UZ&5.W\4S>F,9"$*4AP.^N<[W"9&UPA1A.J#'FJ"X?HV:0/#9!NBV*7K7
M\6"7M[B^LE23P-C"=..@+AL6O!P6-=P46J 8.KH2'1@K)C[X4ZV7.\/"Z.#.
MAL61*/@&+"GKLO8/() W>R47VR93V:03U6'X]]Y'HH)I)0(M]5J*M6@FK8.%
MQNTD<K=PBY&>?\?QG>81\QQ'7P#HX>[C9E3Z<L)@)><?9H.5U NVA43#'UP=
M_(S)VF-Z]]5/IW*%/!%4RCZ![.[*"8N+7S8,RJ>?8HLN;3O\_05$_@%8?5:F
M-%OUVIA$\^G "I-^4%J"0*OFPY2S*Q64V4H9$.\XEK(/7IR9!ZHRW&OD/('G
MQ("&35,&.6A*71"=[E@E[WC'0N2B_&P\:<K4FTY1KMQWI8DDBX@;#/M1<!UK
M2Z>"C:@P&E8,%DB>,_@V,R^F@$^$[^.OVWEZ:O&$>V';0B=?GI=#_*(H:C'M
MI[0MPF%<WLBV1FA\<QC;R0@J:WQBGTP_%:K1WK3JD>!.$J:):<(J3\03"QMS
MH"7-)RS<C^.*KI31A,AZYAW\8&4B,S1'[Q&YMG%:66#N(E248JQG(3HT[C==
M16^8LY,W/L/H%53%C#J_?(M:*.)S@)3P.7%,0Y@54^16E]6\F.QYR?\P&J^9
M7M"G@W)/F9R?"*R[YE=TO8MJ:Y<B9QGQM'\P9-"76#1-Z8_0M719$_)T'D9]
MR(*1='LI[UL6NJ^PT&0>=9CG!;VU1I[.ACF:(=>;'P!I^.+#)Z.%R\WHE+ ^
MN;780NB8^%E2>Y,[FJE+2I5Q\1W5'1TE\H#UDJ0S KN_>2N8.M1A#1/^V?I_
M%QCDMX)EZ>ERP5*@36SO42UR,OY@MK/2Z_BHI 71P0+\!A,V)RUA>[P)I #;
M,SYJZ9J="6Z3A*G?BO=3#Q(E"%T6E\ ^-W5]S+?C?*YH-\>Z0Q>+)'^_&MNG
M@O"3$2M1(FS536+>5OO4#OG-A0N"=(+P"JL?S0BUKFW41*Z%GA[JFQYP_JC2
M$XMQZ7\ Y"X7*'&=:B8O*[O 37F-"1^3G"Y:<9W=LEY:8T<#"8WO4GW!?4)$
M]R_<9)Z6W,HAT\I1ZL^E)W% @L[,5'!:UT-%10]G*SNAAQ7MY^W..7T-4;A
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MSMF MIM-_5$7L]G+N&-M3[MGRN[3T5V5'$G5!AJB,!'^T[YL>U2H/9J5^])
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M\"]9)JP_G@\KWQGBM+GC"]%"*X?"2[?QRI/X7>MY(WE(,5$0$4+[+?]?R@?
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M#2/V\O@'B,7='0E:^V'$< G5%EX:THT6_[V5M)WTFC1 W\8^I1(&T V;J5U
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M[H(7!_]UI>3_IA]*/[GU=LR__MO!"E:9U%$J=;U(8R47B.FRIES7#4EP7\[
MB0_+"C:$\9+]8ZB@[B*5 2Y\%,'!UZ;BEY%T3QO\=0?UZZ27W0N3Y(WSV?ZR
MQK<0P3FF1OUNU0,-G\%S<[,I/.>CG;5B19KFCLX7#K5R>-.-$,L%FT^K8?OV
MS/:G&9#UPR@@[)<[_W^-QW8P<2PXYA$_N2<HO .L3;:<]S%K<RH#N-^O^SBA
MCMJ-(D6>(<[VU8_-+9&Y!9,2U-)<$?Z;<=/VQ=8-YNG0\-%FVR7QH-!G[$O"
M(]+ESKC:3+% E1GK9E"YU78307/#17V#@?;#,K@N'1RGA_<1O:2$7($KNLL
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MN3."E_$H*T-/0GA<J,L?KZ :-OY;4T=-2P97!ZW0'PGMC52SV?BG[1\1RU8
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MMR:Z?NUB5"Z@.GW/'LK,HLF4"*G<\*7;T/W )P.;&4O@+L<USSV1[K+8P?
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M* E$70H7M/?[1R(;S!P/.1! P]!MLM4_*[2&'290%A"KLJ*'"X^"D=!?JQ^
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M E,160KM$YDRF5MC4SEKP[_BB^E'U?BSJ"3H7R(#0DLBZ_'42^=&&VT#I2'
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M>Y!"70%9QD2W>:"7$& I+YOX"U[CP=@FX%BZBK\XLH#+WSV<@4HN#2^F*(_
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MC5T ,@NHU)R[1VY19?*]+>YT%>@$HKO-D7\5YMX=5R*1:)U@M [B;H#&X7
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M(Z?XZ*I P)O41R)"5<(752B$ JU*RHJI%4H5X&$A%)LTX<5X:-B',&0<"6(
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M==["I7O"!WKDME9]?=_G/<]KU(_SUK99VA^K/V7HQ@')4YJ*1QM^$R@</?%
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MV5"@_)$^QKL4/FZG?BVJZ;E;=5&O(W:X,%A4>R=$#U-:NOPIN8*R*]=5I_)
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M_PM#IUM(/.J[)(HE25:'TLK[#5NWCDCGQ!XEPB 41" 3_\'G]OL8"N>8T!N
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MW;LGOA^/NLI/^ ?2A'69G_8$ZG TU'NZ_2T;(OG83SO"IO--_S%)%5[&6'T
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M_34M_6)3394PQY3M@D/_OK-FRMC#M*Q-: J1)##UD2E4MV*_MCN_4IO2HO;
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M2$3D+"/1N"Y/#X&4XXS*@SF<T.%>UUP,_S%-<9$UBX0M;(95".GF]IF=_<G
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MG7K]:P^]8(:ZDQJ%5&8BSH7VX'F/%<13TS#@1HUFZ:W@+:Z#<$C_B;B^S_B
M#"%1[[N;V?\%4$L! A0#%     @ N(!X6VL<VF+U @  C@L  !$
M     ( !     &%L=7(M,C R-#$R,S$N>'-D4$L! A0#%     @ N(!X6W6I
MYB!T,0( 6AH/ !(              ( !) ,  &0Y,C,P,C5D9&5F,31A+FAT
M;5!+ 0(4 Q0    ( +B >%LIP_"'Y3(" &EA @ 1              "  <@T
M @!G.3(S,#(U9'-P,# W+FIP9U!+ 0(4 Q0    ( +B >%MC+ Z1T($! 'NS
M 0 1              "  =QG! !G.3(S,#(U9'-P,# X+FIP9U!+ 0(4 Q0
M   ( +B >%L&!*M JV,  -']   1              "  =OI!0!G.3(S,#(U
@9S P;C T+FIP9U!+!08     !0 % #P!  "U308    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>d923025ddef14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="alur-20241231.xsd" xlink:type="simple"/>
    <context id="P01_01_2024To12_31_2024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001964979</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <dei:DocumentType contextRef="P01_01_2024To12_31_2024" id="hidden150173850">DEF 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="P01_01_2024To12_31_2024" id="ixv-7425">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="P01_01_2024To12_31_2024" id="ixv-7426">0001964979</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="P01_01_2024To12_31_2024" id="ixv-7436">Allurion Technologies, Inc.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="P01_01_2024To12_31_2024" id="ixv-7440">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-4465">&lt;div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"&gt;Equity Grant Timing &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;Our Compensation Committee makes equity award grants periodically, including stock option grants to our Named Executive Officers. In addition, new hires may receive stock option grants at the time of their hiring. During 2024, our Compensation Committee did not take into account any material nonpublic information when &lt;div style="display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="display:inline;"&gt;determining&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; the timing and terms of equity incentive awards in order to take advantage of a depressed stock price or an anticipated increase in stock price, and we did &lt;div style="display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="display:inline;"&gt;not time&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. During 2024, we did not grant stock options to our Named Executive Officers during any period beginning four business days before and ending one business day after the filing or furnishing of a Form &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;10-Q,&lt;/div&gt; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;10-K&lt;/div&gt; or &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;8-K&lt;/div&gt; that discloses material nonpublic &lt;div style="display:inline;"&gt;information&lt;/div&gt;. &lt;/div&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMethodTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-7441">Our Compensation Committee makes equity award grants periodically, including stock option grants to our Named Executive Officers. In addition, new hires may receive stock option grants at the time of their hiring.</ecd:AwardTmgMethodTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="P01_01_2024To12_31_2024" id="ixv-4468">false</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="P01_01_2024To12_31_2024" id="ixv-4469">During 2024, our Compensation Committee did not take into account any material nonpublic information when &lt;div style="display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="display:inline;"&gt;determining&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; the timing and terms of equity incentive awards in order to take advantage of a depressed stock price or an anticipated increase in stock price, and we did &lt;div style="display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="display:inline;"&gt;not time&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgPredtrmndFlag contextRef="P01_01_2024To12_31_2024" id="ixv-7442">true</ecd:AwardTmgPredtrmndFlag>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="P01_01_2024To12_31_2024" id="ixv-7443">false</ecd:MnpiDiscTimedForCompValFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Allurion Technologies, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001964979<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text"><div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Equity Grant Timing </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation Committee makes equity award grants periodically, including stock option grants to our Named Executive Officers. In addition, new hires may receive stock option grants at the time of their hiring. During 2024, our Compensation Committee did not take into account any material nonpublic information when <div style="display:inline;"><div style="display:inline;"><div style="display:inline;">determining</div></div></div> the timing and terms of equity incentive awards in order to take advantage of a depressed stock price or an anticipated increase in stock price, and we did <div style="display:inline;"><div style="display:inline;"><div style="display:inline;">not time</div></div></div> the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. During 2024, we did not grant stock options to our Named Executive Officers during any period beginning four business days before and ending one business day after the filing or furnishing of a Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">10-Q,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">10-K</div> or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">8-K</div> that discloses material nonpublic <div style="display:inline;">information</div>. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AwardTmgMethodTextBlock', window );">Award Timing Method</a></td>
<td class="text">Our Compensation Committee makes equity award grants periodically, including stock option grants to our Named Executive Officers. In addition, new hires may receive stock option grants at the time of their hiring.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered</a></td>
<td class="text">During 2024, our Compensation Committee did not take into account any material nonpublic information when <div style="display:inline;"><div style="display:inline;"><div style="display:inline;">determining</div></div></div> the timing and terms of equity incentive awards in order to take advantage of a depressed stock price or an anticipated increase in stock price, and we did <div style="display:inline;"><div style="display:inline;"><div style="display:inline;">not time</div></div></div> the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>11</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d923025ddef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d923025ddef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d923025ddef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>alur-20241231.xsd</File>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="d923025ddef14a.htm">d923025ddef14a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g923025dsp007.jpg</File>
    <File>g923025dsp008.jpg</File>
    <File>g923025g00n04.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="7">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>25
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d923025ddef14a.htm": {
   "nsprefix": "alur",
   "nsuri": "http://www.allurion.com/20241231",
   "dts": {
    "schema": {
     "local": [
      "alur-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_def.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_pre.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "inline": {
     "local": [
      "d923025ddef14a.htm"
     ]
    }
   },
   "keyStandard": 11,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 266,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2025": 7,
    "http://xbrl.sec.gov/dei/2025": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d923025ddef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d923025ddef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d923025ddef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d923025ddef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d923025ddef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2024To12_31_2024",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d923025ddef14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r20",
      "r31",
      "r47",
      "r82"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r23",
      "r34",
      "r50",
      "r85"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r24",
      "r35",
      "r51",
      "r77",
      "r86",
      "r90",
      "r98"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r15",
      "r27"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r15",
      "r27"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r15",
      "r27"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r15",
      "r27"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r54"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r54"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r15",
      "r27"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r15",
      "r27",
      "r78"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r15",
      "r27",
      "r78"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r20",
      "r31",
      "r47",
      "r82"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r17",
      "r28",
      "r44",
      "r79"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r24",
      "r35",
      "r51",
      "r86"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r24",
      "r35",
      "r51",
      "r86"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r24",
      "r35",
      "r51",
      "r86"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r24",
      "r35",
      "r51",
      "r86"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r24",
      "r35",
      "r51",
      "r86"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r38"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r15",
      "r27"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r24",
      "r35",
      "r51",
      "r77",
      "r86",
      "r90",
      "r98"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r102"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r102"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r102"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r40",
      "r41",
      "r42",
      "r43"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r40",
      "r41",
      "r42",
      "r43"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r24",
      "r35",
      "r51",
      "r77",
      "r86"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r22",
      "r33",
      "r49",
      "r84"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r36",
      "r52",
      "r87"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r36",
      "r52",
      "r87"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r17",
      "r28",
      "r44",
      "r79"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r18",
      "r29",
      "r45",
      "r80"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r19",
      "r30",
      "r46",
      "r81"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r26",
      "r37",
      "r53",
      "r88"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r21",
      "r32",
      "r48",
      "r83"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
